The truth about blood tests for cancer
Drs. Ruth Etzioni and Scott Ramsey discussed multi-cancer early detection blood tests. Etzioni noted, “The future of screening is going to look different from the past” although “we’re not quite there.”
COVID vaccine update: CDC now recommends second dose for older adults, immunocompromised
Dr. Larry Corey talked about the evolution of COVID noting, “The effects that the early vaccination had have long worn off, and the virus has escaped from them. The hope is double boosting will transfer your immunity.”
Should First-Line Dual Checkpoint Blockade Be Used for NSCLC With Specific Mutations?
Dr. Lei Deng shared his thoughts on non-small cell lung cancer treatment data: “It is still not strong enough or definitive enough to make it standard of care to use dual checkpoint blockade for [patients with STK11 and/or KEAP1 mutations].”
‘Stark’ finding: Cancer research in U.S. dominated by industry sponsors
Dr. Joe Unger pointed out that: “Federally sponsored, cancer clinical research has a unique role in identifying treatments that are best for patients. It’s not a role that can be supplanted by industry.”
What We Really Want From Life (But Might Not Know It) -- Medium, Oct. 23, 2024
Dr. Megan Shen summarized from her research of people facing serious illnesses that what people really want in life is “peace and love.” She added: “These are the only things that seemingly encompass all the other desires we have as humans.”
myeloMATCH to use genomics to enroll patients into target-based leukemia trials
Dr. Jerry Radich explained his lab’s involvement in a new NCI-led effort to use genomics testing to screen patients. He said, “What we learn from myeloMATCH may have a major impact on the future of clinical trials in leukemia and beyond.”
Advancing diversity, equity and inclusion through a challenging policy landscape
Dr. Chris Li and peers discussed DEI in the cancer workforce at a recent policy summit. In recruiting a diverse pool of job applicants, Li urged others to “treat search as a verb.”
The long shots: When patients defy all odds
Dr. Danielle Kirkey explained the balance of hope and reality when caring for patients. She said, "Anything we can do to give the best quality of life for as long as possible is always at the forefront of our mind.”
Meet the 2024 STAT Wunderkinds
STAT included Miguel Paredes in the Bedford Lab and Yapeng Su in the Greenberg Lab in its Wunkerkinds awards to 27 of the “most impressive doctors and researchers on the cusp of launching their careers.”
Mammogram centers must now inform women about their breast density. Here’s how it could affect you
Dr. Brian Dontchos talked about dense breast classification: “Classification can vary depending on the doctor reading the mammogram because it’s somewhat subjective.” The story was syndicated in several news outlets.
What does it mean to be immunocompromised?
Fred Hutch patient Kaley Karaffa and Dr. Josh Hill explained how being immunocompromised impacts daily life. Karaffa said, “I had to become cautious about who I saw, the activities I was involved in and even the kind of food I ate.”
A viral gene drive could offer a new approach to fighting herpes
Drs. Keith Jerome and Marius Walter discussed their Nature Communications study on gene editing for herpes. Jerome explained his hope for a herpes cure: “You don’t ever have to worry about this virus again.”
The biology of ‘precancer’: stopping cancer before it starts
Dr. Ming Yu explained how aging cells that accumulate in the body can create a “tumor-promoting microenvironment,” but a certain drug may be able to eliminate these “zombie cells” and prevent them from developing into cancer.
Can AI cure cancer? New alliance unites tech giants and big research orgs in quest for breakthroughs
Dr. Thomas Lynch discussed the newly formed Cancer AI Alliance: “What was interesting about this whole process was how we were able to bring together these four incredible cancer centers, and these four major tech companies.”
Was Missouri’s bird flu case a one-off or something more? Quest for answers faces testing delay
Dr. Jesse Bloom explained how virus mutations could change the accuracy of serology tests for infections: "This type of mutation could make you want to then redo the assays with a virus that contained that mutation.”
Drug industry taking bigger role in cancer clinical trials
Dr. Joe Unger explained the scale of the cancer clinical trial funding gap: “We recognized that industry was playing an increasing role in cancer clinical research compared to decades ago. But we didn't realize the difference was this dramatic.”
Why Some Men Keep Their Prostate Cancer a Secret
Dr. Jesse Fann explained the negative impact of keeping a cancer diagnosis private: “In the long term, holding emotions back without an outlet can lead to an increase in stress, anxiety, depression, [and] social isolation.”
These four common infections can cause cancer
Drs. Denise Galloway and Nina Salama discussed how HPV and H. Pylori can cause cancer. Galloway said, “If you vaccinate someone who’s young, the risk goes down to zero.”
A simple intervention could help address overlooked pain among older adults with cancer in rural America
Dr. Megan Shen wrote about how to improve communication about pain between patients and their health care providers: “Addressing this vulnerable group’s pain needs is a critical public health concern.”
Fred Hutch Cancer Center makes big real estate pivot in South Lake Union
Fred Hutch’s announcement of the acquisition of three buildings in South Lake Union, including the Steam Plant, was featured. It noted the change from building a new facility on campus to instead acquiring the space.
Speeding up with CAR T-cell therapy in multiple myeloma
Dr. Rahul Banerjee explained symptoms of multiple myeloma and treating the disease with CAR-T. He said, “Cancers of the immune system often know all the tricks of the immune system and are able to bypass them. With CAR-T, you level the playing field.”
FDA authorizes updated COVID vaccines. Who should get the shot and when, according to experts
Dr. Larry Corey recommended everyone eligible for the COVID vaccine update get one. He said, “When we look at people who are currently hospitalized, they haven’t been boosted for a long time.”
Cancer treatment costs: are you left in the dark?
Dr. Veena Shankaran highlighted how financial strain impacts patients: “Cancer affects work, income, depletes savings, changes the way you spend your money, contributes to debt, and may affect how you plan financially for your family members.”
Fred Hutch expects to eclipse fundraising record after big Obliteride turnout
Kelly O’Brien was quoted in this story which highlighted the record-breaking Obliteride turnout. She said, “Obliteride brings together a powerful, one-of-a-kind community.”
Sickle cell disease in India: The quest for a cure
Dr. Jennifer Adair explained the need for gene therapy clinical trials to include people from different populations around the world. Otherwise, she said: “we’re killing time thinking that we’ve got something that’s going to be a one shot fits all.”
You can now get a blood test to screen for colorectal cancer
Dr. Bill Grady commented on new tests to detect circulating tumor DNA in blood: “There is a lot of work going on in the field of blood-based cancer screening tests to improve on their current accuracy.
There’s more data for trans people with HIV than any other disease — but it’s still flawed
Brian Minalga discussed the lack of health data about trans people: “Even though trans people are participating in clinical research and giving our biospecimens, our blood, our tissues, our time... [those data] don’t make it back to us.”
Myeloma-related questions to ask after diagnosis
Dr. Rahul Banerjee recommended that patients ask their oncologists for trusted sources of information. He said, “I think patient support groups for my patients have been tremendously important because they learn from each other.”
FDA approves new blood test to screen for colon cancer
Dr. Bill Grady emphasized: “What breaks my heart is that it’s preventable. One of my biggest joys is when I’m doing colonoscopy and I can take out polyps.” Grady was also quoted in stories in Axios, CNN, MedPage Today and VeryWell Health.
Despite Gilead’s Promising HIV Prevention Drug, A Vaccine Is Still The ‘Holy Grail’
Dr. Jim Kublin characterized an effective HIV vaccine as the “holy grail of HIV prevention.”
Active Surveillance Viable Option for Some With Prostate Cancer
Dr. Lisa Newcomb commented on her recent study of active surveillance for prostate cancer. She said, “These results demonstrate active surveillance as an effective management strategy for patients diagnosed with favorable-risk prostate cancer.”
Addressing fertility concerns for female patients with sarcoma
Dr. Elizabeth Loggers spoke about cancer treatment and fertility: “After you start treatment, you may already have some lasting effects on your fertility. It is important to have that conversation upfront and to act if it is important to you.”
What to know about skin cancer risks: HealthLink
Dr. Lindsay Gunnell explained why skin cancer rates are increasing in Washington: “There's a false sense of security here with our cloud cover that we're getting protection.”
Transvaginal ultrasonography unreliable in identifying endometrial cancer for Black women
Dr. Kemi Doll discussed the results of her JAMA Oncology study saying, “These findings suggest that the transvaginal ultrasonography triage strategy is not reliable among Black adults at risk for endometrial cancer.” Medscape also covered the study.
Fred Hutch establishes scientific training program for high school and middle school teachers
The Cancer Letter highlighted Science Education’s new program, Partners in Science 2.0, along with other summer programs at Fred Hutch that aim to educate students and teachers.
AIDS crisis from 1980s to today: How Seattle responded with hope, healing
Ro Yoon and Dr. Larry Corey shared perspectives on HIV research, activism and public fatigue. Yoon emphasized the importance of keeping HIV “relevant to an audience that might not be aware of the long, hard history of activism.”
Why deaths from prostate and testicular cancer are down
Dr. Yaw Nyame encouraged men in their 40s to discuss cancer screening with their doctors. “That routine of going in annually having to check up, discussing preventative health,” he said, “unfortunately, that’s not the norm for a lot of men.”
What do we know about quality of life and patient reported outcomes after transplant and CAR-T therapy?
Dr. Stephanie Lee advocated for having “quality of life” be an endpoint in cancer treatments, along with survival. She said: “It's not just survival. If you look at FDA parlance, it's length of life and it's quality of life.”
Combo of approved agents active in high-risk large B-cell lymphoma
Dr. Mazyar Shadman discussed CAR-T vs. standard of care for large B-cell lymphoma patients: “CAR-T remains to be standard of care for patients who are eligible and if they have access to it.”
Herpes cure on the horizon
Dr. Keith Jerome discussed his team’s progress in developing a gene therapy for herpes simplex virus. He said, “There’s not a cure yet that everybody can go out and get, but we’re getting closer to a cure.”
ASCO 2024: How to best use new breast cancer data
Dr. Sara Hurvitz discussed three breast cancer studies presented at ASCO, “this was an exciting conference, with a large amount of data out.” The three abstracts discussed were DB-06, postMONARCH and INAVO120 study.
2024 Cancer Health 25: People who power clinical trials
A feature on leaders in cancer clinical trials included Drs. Garnet Anderson, Ruth Etzioni, Ziding Feng, Katherine Guthrie, Charles Kooperberg and Scott Ramsey for their work on the new Cancer Screening Research Network, based at Fred Hutch.
Fred Hutch’s Christopher Li: Cancer centers should commit more resources to meet NCI’s Plan to Enhance Diversity requirements
Dr. Chris Li explained: “I felt a responsibility to try and enhance the diversity of our faculty more broadly and provide some of that mentorship and sponsorship that I think could help promote further diversity in science.”
Palliative care for cancer patients is found to be as effective given virtually as in person
Dr. Elizabeth Loggers discussed the benefits of offering patients palliative care virtually: “They can be at home, in their pajamas, and their caregivers or anyone else across the country can sit in on that appointment to act as support.”
Seattle virologists find promising new results for potential herpes cure
Dr. Keith Jerome described how his team’s herpes cure research could help people who want to be cured of their infection: “What we want to do is offer a tool that says if this really matters to you, we can help make your life better.”
Study confirms effectiveness of 'Watch-and-Wait' approach to prostate cancer
Dr. Lisa Newcomb discussed active surveillance for prostate cancer in her new study: “We hope that this study encourages the national acceptance of active surveillance instead of immediate treatment for prostate cancer.”
There’s bird flu RNA in grocery store milk. How sequncing it might help fight avian influenza
Dr. Pavitra Roychoudhury described how researchers sequenced a bird flu genome from store-bought milk, noting that “this is, to our knowledge, the first time it’s been done in commercially available milk, to obtain the full genome.”
Cancer is capsizing Americans’ finances. ‘I was losing everything.’
Dr. Scott Ramsey emphasized that cancer patients who file for bankruptcy have an 80% higher risk of dying from cancer than patients who don’t file. He said, “There actually was a pretty big detriment for survival.”
Move over, wastewater. Store-bought milk could be another way to track the bird flu outbreak in cows
Dr. Trevor Bedford noted that “separate from the sequencing for evolution [of the virus], which I think is very important, just even understanding prevalence through space and time... would be really helpful and important.”
The new horizon of HIV vaccines
Louis Shackleford emphasized that “the prospect of having a vaccine that can last for years and give us sustained protection from HIV would be an amazing boon for communities such as the Black community who disproportionately are suffering from HIV.”
How early and often should women get mammograms?
Dr. Janie Lee discussed how early screening saves lives: “And increasingly now, there's information that screening in the 40s also reduces breast cancer as well."
More patients participate in cancer clinical trials than previously estimated
Dr. Joe Unger and collaborators pointed out that in their study of cancer clinical trial participation, “these results suggest that contributions to clinical research for adults with cancer is more common than is typically realized.”
Lower prevalence of employment seen for survivors of childhood cancer
Dr. Neel Bhatt and co-authors found lower employment rates in adult survivors of childhood cancer, suggesting “a multidisciplinary approach involving survivors, clinicians, and employers” is needed to address their long-term employment needs.
Q&A with Jennifer Adair, researcher on a mission to increase global access to gene therapies
Dr. Jennifer Adair discussed her work with collaborators across the globe and the challenges of gene therapy access. She also said, “I would love to see patients engaged as co-creators in these medicines in much more meaningful ways.”
New mutations identified in bird flu virus
Dr. Jesse Bloom shared context amidst ongoing concerns about the H5N1 virus: “H5N1 has been circulating in various species and causing sporadic human infections for over two decades, and so far we haven’t had a pandemic.”
With younger women getting breast cancer, national panel lowers mammogram screening age to 40
Dr. Janie Lee commented on new breast cancer screening guidelines. She said they would help create “less confusion among women about breast cancer screening” and that “the scientific evidence is clear mammography saves lives.”
Exa-cel a ‘first step’ in gene therapy for sickle cell disease, beta-thalassemia
In an editorial, Dr. Hans-Peter Kiem praised success in gene therapies and called for more research in in vivo gene therapy to enable expanding “the availability away from specialized centers.”
The mouth microbe implicated in colorectal cancer
Dr. Chris Johnston described next steps for work published in Nature with Dr. Susan Bullman: “Because this bacterium is so intimately associated with cancers, it raises the question, ‘can we harness this?’ That’s something we’re very interested in.”
A blood test to detect cancer? Some patients are using them already
Dr. William Grady explained the limitations of new blood tests for cancer noting they are “not effective for brain cancer because brain cancer spreads rapidly, even when early and very small, so it is not often curable even at an early stage.”
Anti-aging medicines could cure cancer
Dr. Ming Yu discussed research of therapies that “cause ‘zombie cells’ to die without harming normal cells” as having potential “not only to help people live longer, but also live healthier and hopefully cancer-free.”
One in five people with cancer participate in medical research studies, Fred Hutchinson study shows
Dr. Joe Unger underscored that “as we work to increase participation in cancer research studies and make them more accessible to patients, we need an inclusive, accurate assessment of current participation to inform these policies.”
As FDA weighs another myeloma endpoint for accelerated approvals, experts say timely access is at stake
Dr. Rahul Banerjee encouraged use of minimal residual disease to guide multiple myeloma treatments. He said, “I would be very excited about trials that use MRD as an endpoint to get more drugs to our patients sooner.” He also spoke with Endpoints.
How to support your adult child with cancer
Dr. Megan Shen shared tips on how parents can support their adult children who are coping with cancer. She emphasized communication, since an “an adult cancer patient’s needs ‘can be wildly different from one child to the next.’”
Colorectal cancer now becoming a problem for younger people
Natalie Phelps, a patient with colorectal cancer, advocated for lowering the screening age: “lowering the age from 50 to 45 for the start of (having a) colonoscopy is a good step in the right direction. I’d like to see it lowered even more.”
Why are so many young people getting cancer? It’s complicated
Matthew Triplette discussed trends in people younger than age 50 getting cancer, and how he doubts there’s “some new, very dangerous cancer risk factor out there that’s causing tons of excessive cases in younger folks.”
Geeks Give Back at the GeekWire Awards: Meet three groups wielding tech for good causes
Fred Hutch’s Hanako Osuga received the GeekWire award for her work with the Coding for Cancer program, which helps students from underrepresented groups in STEM get experience with computing skills in biomedicine.
What’s next for the coronavirus?
Dr. Jesse Bloom explained how researchers are studying how coronavirus works as populations have immunity to it. He said, “The virus is still evolving, it’s still infecting large numbers of people. We need to keep tracking this.”
A new type of bacteria was found in 50% of colon cancers. Many were aggressive cases.
Dr. Susan Bullman explained a new Nature study she co-authored with Dr. Chris Johnston and how a specific subtype of bacterium helps tumor cells hide from therapies: “It acts like a cloak.” Many medical and health news outlets also covered the study.
Fred Hutch unveils results of new blood test that detects colon cancer
Dr. Rachel Issaka noted: “If people have more options that are convenient for them, they are more likely to participate in colon cancer screening, and we can pick up earlier cases where treatments are most effective.”
The resilience of monoclonal antibodies and their makers
Dr. David Maloney explained the work he did in the 1990s to develop antibodies targeting cancer. He said, “With this approach, it was one antibody that was only good for one patient. You had to make an antibody for essentially every patient.”
A blood test for colon cancer performed well in a study, expanding options for screening
Dr. Bill Grady commented on results from a study he led of a new blood test for colorectal cancer, emphasizing that “more screening should result in fewer cancer deaths.” This story ran in local outlets across the U.S.
A new way to screen for colon cancer may be on the horizon, study suggests
Dr. Bill Grady explained that colonoscopies and “stool-based tests have that kind of ‘ick’ factor related to them. We need to find tests that people are going to use.”
11 women making moves in health care
Denene Prophet-Williams, MBA, MLA, BSN, is featured as Fred Hutch’s newly-named vice president and chief nursing officer. The Cancer Letter and GeekWire also covered the news.
Fred Hutchinson Cancer Center and the National Coalition of 100 Black Women Inc. Host colorectal cancer awareness event at Seattle’s FAME Church
Dr. Rachel Issaka stressed the importance of prevention and screening: “March is colorectal cancer awareness month, and colon cancer is one of the most common cancers. But we can all do things to reduce our risk.”
After decades of failures, researchers have renewed hopes for an effective HIV vaccine
Dr. Julie McElrath declared in a plenary talk at CROI that “An HIV vaccine could end HIV. So I say, ‘Let’s just get on with it.’”
What’s next for the world’s first HIV vaccine?
Dr. Yunda Huang discussed HIV vaccines at CROI: “I've been working in this field for 20 years now and there is a misconception that with pre-exposure prophylaxis, our job is done, but HIV is so far away from being solved.”
Promising combination therapy targets triple-negative breast cancer
Dr. Janice Kim commented on a new study to treat triple-negative breast cancer.
The future of precision cancer therapy might be to try everything
Dr. Christopher Kemp discussed using lab tests of existing drugs on patients’ tumor cells to see which treatment works best.
AI chatbot helps smokers quit tobacco
Dr. Jonathan Bricker shared his motivation to create QuitBot.
Cancer deaths are falling, but there may be an asterisk
Dr. Ruth Etzioni gave context to breast cancer incidence rates.
Differentiating muscle-invasive, non-muscle-invasive bladder cancer
Dr. Petros Grivas discussed the different bladder cancer types.
Early-onset cancers are on the rise: Why it’s happening and what we can do
Dr. Bill Grady explained why earlier screening is not covered by insurance.
Why some people keep serious illnesses private
Dr. Jesse Fann shared insight as to why some people choose to keep their cancer diagnosis private.
Dr. Jim Boonyaratanakornkit discusses respiratory illnesses
Dr. Jim Boonyaratanakornkit encouraged people to get vaccinated for COVID, flu and RSV.
FDA approves gene editing technology to treat sickle cell disease: HealthLink
Dr. Kleber Fertrin discusses the significance of new treatments.
New coronavirus variant JN.1 is spreading fast. Here’s what to know.
Dr. Jesse Bloom said it is too early to say whether the latest COVID variant called JN.1 will cause surges of infections.
Making space for grief during the holidays
Dr. Megan Shen listed reasons why the holiday season can trigger grief.
Tucatinib regimen extends PFS in advanced HER2-positive breast cancer
Dr. Sara Hurvitz received substantial media attention for HER2CLIMB-02 trial results she presented at the San Antonio Breast Cancer Symposium.
Why it’s so tough to grieve in America
Dr. Megan Shen discussed how open conversations can improve how people cope with grief, pain and other challenges.
Inside long COVID’s war on the body: Researchers are trying to find out whether the virus has the ability to cause cancer
Dr. Julie Overbaugh commented that “many people probably have very low levels of potential tumor cells in the body that are kept at bay by the immune system.
Evolutionary virologist Daniel Blanco-Melo seeks out ancient pathogens
Dr. Daniel Blanco-Melo was named a Science News “Scientist to Watch.”
More adults should be screened for lung cancer under updated guideline, American Cancer Society says
Dr. Matty Triplette discussed new expanded guidelines for lung cancer screening.
COVID-19 vaccine in patients with hematologic cancer receiving HSCT or CAR-T therapy
Dr. Josh Hill pointed out the need for preventive COVID-19 therapies.
How a common stomach bug causes cancer
Dr. Nina Salama explained the biology of the bacteria H. pylori.
CAR-T may move more patients with CLL ‘toward a potential cure’
Dr. David Maloney discussed CAR T-cell therapy for treating CLL.
Affordable Care Act increased cancer trial participation among Medicaid-insured patients
Dr. Joe Unger found that the Medicaid expansion of the Affordable Care Act enabled many low-income individuals to become eligible for Medicaid.
Lawrence Fong named scientific director of Immunotherapy Integrated Research Center at Fred Hutch
A news brief covered the Fred Hutch announcement of Dr. Lawrence Fong joining Fred Hutch.
State of the Art Monitoring and Diagnostics in Chronic Myeloid Leukemia: the Philadelphia Chromosome and Future of CML
Dr. Jerry Radich described the substantial progress in diagnosing and treating CML.
Lung-MAP Study May Improve Access to Clinical Trials for Underrepresented Patients
Dr. Riha Vaidya and collaborators commented on clinical trial access.
Seattle medical and ballroom communities mourn loss of Stephaun E. Wallace
Dr. Larry Corey said we can honor Dr. Stephaun Wallace “not only in developing safe and effective vaccines against HIV and COVID, but in seeing the equitable distribution and accessibility of these vaccines globally. He would expect no less of us.”
Jill Biden touts Seattle’s cancer research during Fred Hutch visit
Coverage of First Lady Jill Biden's visit to Fred Hutch appeared on the front page.
Study Identifies Gene Variants Associated With Aggressive Prostate Cancer
A new study led by Dr. Burcu Darst could change gene panel testing.
Coding saves lives, and Fred Hutch Cancer Center wants the next generation to take note
Hanako Osuga, Coding for Cancer program lead, commented on the importance of the program.
Cancer treatment has come far, fast: Better prevention, early detection, new treatment
Dr. Phil Greenberg, president of AACR, expressed optimism for some cancers.
Fred Hutchinson granted $38.7M to serve as national coordinating center for Asian American, Native Hawaiian & Pacific Islander health studies
In a brief, The Cancer Letter covered the announcement of Fred Hutch’s leadership of a new Asian American, Native Hawaiian and Pacific Islander cohort study.
The microbiome: a benign infection to help keep disease at bay
Dr. Motoko Koyama described her study on the microbiome.
Medicaid Expansion and Participation in Cancer Clinical Trials Among Patients Insured by Medicaid
Dr. Joe Unger emphasized that findings from a study.
How 10,000 years of plagues left their mark on our DNA
Dr. Harmit Malik commented on a new study identifying how certain genes that help us survive also can harm us.
Celebrities are getting full-body health scans – Should you?
Dr. Marianne Dubard-Gault emphasized the importance of health providers providing context to people who get health screenings.
Proteomics pathway diagnostic helps identify platinum-refractory ovarian cancers
Dr. Amanda Paulovich described her new study to better improve treatment for ovarian tumors.
Biden aims to diversify research ranks with cancer moonshot awards
The Biden administration named Dr. Matthew Triplette a cancer moonshot scholar.
Spokane teachers learn from cancer researchers
The Science Education Program was featured.
Health care heroes: Dr. Rachel Issaka, Fred Hutch
Dr. Rachel Issaka shared her experience as a clinician.
Fever: The hunt for covid’s origin
In a podcast, Dr. Jesse Bloom commented on how he got interested in hte covid pandemic origins.
Fred Appelbaum shares contributions to 'Living Medicine' with Dr. Don Thomas
Dr. Fred Appelbaum explained how bone marrow transplantation has led to other treatments.
Prostate cancer awareness among Black patients: HealthLink
Dr. Yaw Nyame and his patient, Floyd Gossett, spoke about the importance of Black men getting screened for prostate cancer.
How financial toxicity impacts cancer care
Dr. Veena Shankaran discussed financial toxicity.
Aaron Ring on immunotherapy for cancer and more
Dr. Aaron Ring commented on his move to Fred Hutch.
Fred Appelbaum’s “Living Medicine” tells the story of bone marrow transplantation and Don Thomas’s discoveries
In a podcast and Q&A, Dr. Fred Appelbaum spoke of his newly published book on Dr. Don Thomas’s life and research.
What 40-somethings should know about breast cancer risk
Dr. Rachel Yung commented on new mammogram guidelines.
New AI tool may help predict best treatments for colorectal cancer
Dr. Stacey Cohen commented on a study of an experimental AI tool.
Fibroids linked to ovarian cancer risk in Black women, study finds
Dr. Holly Harris commented on her new study looking at ovarian cancer risk.
Continuing the quest after Mosaico
Dr. Larry Corey discussed the current approach in HIV vaccine research.
Depression is often overlooked in cancer patients
Dr. Jesse Fann discussed the importance of screening for depression among cancer patients.
HIV vaccine research ‘at a crossroads’ after recent failures
Dr. Larry Corey discussed HIV vaccine research.
To make immunotherapy safe for brain tumors, researchers will have to tackle new risks
Dr. Eric Holland discussed a new study to understand side effects of immunotherapies.
The new rules of colon health
Dr. Bill Grady emphasized the importance of colon cancer screening.
At-home test or a colonoscopy? Which screening is best for you
Dr. Rachel Issaka pointed out health disparities in colorectal cancer survival.
Fred Hutchinson Cancer Center opens $320M campus addition
A story on the opening of the new clinical space at Fred Hutch.
F.D.A. Will Require Dense Breast Disclosure at Mammogram Clinics
Dr. Christoph Lee commented on the new dense breast disclosure requirements.
The Women Working To Solve The Home Health Caregiver Crisis
Dr. Megan Shen discussed her work with families making health care decisions.
Fred Hutch Cancer Center’s MET-X Program wants to study metastasis, stop tumors from spreading –
Dr. Cyrus Ghajar discussed the vision for MET-X.
NCI-funded clinical trials add 14.2 M life-years for patients with cancer over 4 decades
Dr. Joe Unger explained additional benefits of publicly-funded cancer clinical trials.
Radioligand therapy, a ‘game-changer’ for cancer treatment, forces manufacturers to race against a ticking clock
Dr. Delphine Chen shared her thoughts on the use of radioligand therapy.
Saiyare Refaei: Part Iranian, part Chinese, all community
Saiyare Refaei shared details about their partnership with Fred Hutch’s PACD program.
Are we on the cusp of a breast cancer vaccine?
Dr. Shaveta Vinayak commented on progress by Dr. Nora Disis’ team on therapeutic breast cancer vaccines.
Is mesothelin a key to tackling solid tumors? Some biotech companies are betting that it is
Dr. Kristin Anderson explained why mesothelin is a high-priority target for solid tumor cell therapies.
New variant XBB.1.5 is ‘most transmissible’ yet, could fuel covid wave
Dr. Jesse Bloom put XBB.1.5 into context with virus evolution.
Omicron offshoot XBB.1.5 could drive new COVID-19 surge in U.S.
Dr. Jesse Bloom commented on mutations that make XBB.1.5 different from the omicron variant.
Seattle Philanthropists Have a Message: Just Give
Kathy Surace-Smith was featured among six Seattle philanthropists.
Get ready to play ‘guess the viral variant’
A feature story on COVID-19 variants and implications for vaccines cited a 2021 study led by Dr. Jesse Bloom.
Stem cell transplantation underutilized for acute myeloid leukemia
Dr. Molly Tokaz shared additional insights about her research presented at ASH 2022.
Washington Research Foundation awards additional $1M to Fred Hutchinson Cancer Cente
Hilary Hehman commented on the program.
Multiomic Study Points to New Colorectal Cancer Risk Contributors
Dr. Ulrike Peters commented on her Nature Genetics paper.
Brush up on oral hygiene after cancer
Dr. David Dean commented on issues in oral health, including cavities and dry mouth, following cancer treatment.
U.S. COVID clinical trials under-enrolled women, Black and Asian people, Fred Hutch study says
Dr. Hong Xiao pointed out that his analysis found health disparities and “trials’ failure to report certain demographics, despite federal requirements.
Scientists may be closer to effective HIV vaccine
Dr. Julie McElrath explained the germline targeting vaccine approach.
Miracles start in the lab: the quest to find a vaccine to cure AIDS
Dr. Larry Corey underscored that implementation of vaccines is important.
After a year, omicron still driving surges and worries
Dr. Trevor Bedford explained that vaccines and infections from earlier SARS-CoV-2 variants created the initial niche for omicron to spread.
How immunocompromised experts are approaching the holidays
Dr. Steve Pergam gave practical guidance for managing risk of infection as an immunocompromised person.
WA advocates highlight health disparities during Trans Awareness Week
Dr. Stephaun Wallace explained how lack of data on transgender people living in WA leads to health inequities.
CAR-T therapy may treat conditions other than blood cancers, research shows
Dr. Mazyar Shadman commented on a clinical trial for a CAR T-cell therapy that was developed at Fred Hutch to target CD20 protein on cancer cells.
New Covid variants are circulating. Here’s what to know
Dr. Alpana Waghmare discussed how existing treatment options are less effective against new COVID variants.
What we know about ultraprocessed foods and cancer risk
Dr. Anne McTiernan recommended a reasonable approach to limiting ultraprocessed foods.
Why our third COVID winter could be ‘a variant soup’ – but also less severe
Dr. Larry Corey urged the development of new COVID drugs and vaccines.
A ‘tripledemic’? Flu, RSV and COVID may collide this winter, experts say
Dr. Alpana Waghmare commented on rising cases of respiratory illness this fall and winter.
Combating burnout: Fred Hutch psychologist on how employers can support workers
Dr. Megan Shen shared tips on avoiding burnout.
XBB, BQ.1.1, BA.2.75.2 — a variant swarm could fuel a winter surge
Dr. Jesse Bloom commented on how COVID variants could change in the fall and winter.
Bezos family donates $710M to Fred Hutchinson Cancer Center
Dr. Thomas Lynch commented on the Bezos family gift.
Bezos Family to Donate $711 Million to Cancer Center in Seattle
Coverage of the Bezos family gift to Fred Hutchinson Cancer Center.
New guidelines recommend best uses of acupuncture, massage, and other non-drug treatments for cancer pain
Dr. Heather Greenlee discussed new guidelines issued by SIO/ASCO on non-drug cancer pain treatments.
How Breast Cancer Radiation Treatments Affect the Body
Dr. Janice Kim spoke about radiation therapy for breast cancer and what patients need to know about therapies and effects on the body.
The ‘end’ of COVID is still far worse than we imagined
Dr. Trevor Bedford projected that COVID-19 will infect roughly 50% of people in the U.S. each year.
The fatal error of an ancient, HIV-like virus
Drs. Michael Emerman and Daniel Blanco-Melo discussed how viruses work their way into genomes and over time no longer infect others.
How do I reduce the risk of infection during chemotherapy?
Dr. Jim Boonyaratanakornkit shared advice for how caregivers can help prevent infection when a loved one is receiving treatment.
Seattle’s Fred Hutchinson Cancer Center receives largest donation in 47-year-history
Kelly O'Brien commented on what the $78 million gift for precision oncology will mean for Fred Hutch.
Top Doctors 2022
More than more than 80 physicians, physician assistants and nurse practitioners were included in the Seattle Met Magazine’s 2022 Top Doctors list.
Cultural neglect makes AAPI dementia harder
Dr. Aakanksha Singhvi discussed the biological changes in the brain during aging, including interactions between types of brain cells.
Targeted Therapies for Metastatic Breast Cancer— Here's What You Should Know
Dr. Hannah Linden discussed endocrine therapy.
Fred Hutch doctor outlines lessons learned during the pandemic
Dr. Larry Corey joined Jake Whittenberg for a bike ride and then sat down to discuss lessons learned during COVID.
What to Know About Enhertu, the First Targeted Treatment for HER2-Low Breast Cancer
Dr. Will Gwin provided commentary about the recently FDA-approved treatment for HER2-Low breast cancer.
12 of Washington’s most vital medical interventions
Seattle Met recognized bone marrow transplantation advanced by Fred Hutch as one of the top medical innovations developed in the region.
Psoriasis, psoriatic arthritis and endometriosis: new evidence of a link
Dr. Holly Harris commented on her study on the link between psoriasis, psoriatic arthritis and endometriosis.
I eat at restaurants for a living. That’s not why my stomach always hurt
Dr. Nina Salama discussed H. pylori.
COVID-19 variants keep getting more contagious. Here’s why
Dr. Trevor Bedford commented that a virus’s ability to mutate around our immune defenses can continue indefinitely.
In Seattle, Fauci talks COVID politics, monkeypox and life in the public eye
Highlights from Dr. Anthony Fauci and Dr. Larry Corey’s fireside chat was covered as well as the presentation of the honorary Hutch Award.
Fauci receives honorary Hutch Award before Mariners game
The presentation of the honorary Hutch Award to Dr. Anthony Fauci at the Mariners game was covered.
Legislation and cancer care
Arlyce Coumar, an advanced practice nurse at Fred Hutch, commented on the importance of advocacy for oncology nurses.
How long can the coronavirus keep infecting us?
Kathryn Kistler of the Bedford lab and Dr. Jesse Bloom discussed how SARS-CoV-2 will keep evolving.
HIV infections remain persistently high, UN reports
Dr. Stephaun Wallace provided context around rising HIV infections globally.
'None of us has a crystal ball’: Scientists try to keep up with faster coronavirus evolution
Dr. Jesse Bloom agreed with F.D.A. recommendations for the COVID vaccine to be updated based on Omicron, despite ongoing evolution of the virus.
How we talk about monkeypox could protect lives
Dr. Stephaun Wallace commented on monkeypox risk.
‘Watershed moment’: Doctors finding new hope in treatments for deadly pancreatic cancer
Dr. Gabriela Chiorean described new findings in chemotherapy and radiation regimens for people with advanced pancreatic cancer.
Updated covid shots are coming. Will they be too late?
Drs. Jesse Bloom, Trevor Bedford and other experts encourage updating covid vaccines to protect against Omicron subvariants.
They’re Here To Save Your Life
Seattle Magazine featured Fred Hutch scientists Drs. Phil Greenberg, Denise Galloway, E. Gabriela Chiorean and Petros Grivas in an article about doctors who continue to make Seattle a hotbed of cancer research and treatment.
Meet the 2022 class of Pew scholars in biomedical sciences
Dr. Melody Campbell is listed as one of the 22 Pew scholars.
Can these drugs stop a COVID infection in its tracks? Seattle researchers are on the forefront of new treatments
Dr. Liz Duke explained a study of antivirals to prevent COVID.
Women at greater risk for more severe adverse events from cancer treatments
Dr. Joe Unger commented on a study he led on treatment-associated adverse events by sex.
There’s still no HIV vaccine. The science behind coronavirus vaccines may help
Dr. Larry Corey compared the challenge of developing effective HIV vaccines with raising children.
Novel genetic experiment shrinks tough-to-treat cancer
Dr. Josh Veatch discussed a New England Journal of Medicine study about a T cell receptor therapy for pancreatic cancer.
6 steps you can take to quit smoking and live a healthier life
Dr. Jonathan Bricker discussed smoking cessation.
New area eligibility for high-demand COVID-19 prevention drug
Dr. Catherine Liu and Rebecca Relyea, a patient, discussed a monoclonal antibody drug that prevents COVID in people who are immunocompromised.
American Association for Cancer Research announces president-elect
Dr. Phil Greenberg commented on his recent AACR election.
COVID cases are up. Most mandates ended months ago. So where does WA stand?
Drs. Josh Schiffer and Trevor Bedford shared COVID-19 insights.
What’s next? How the COVID-19 pandemic is likely to look over the next few months
Dr. Rachel Bender Ignacio advocated for expanded access to COVID antivirals.
Women suffer more after cancer treatments than men
Dr. Joe Unger shared his hopes for the treatment of cancer patients.
COVID hasn’t given up all its secrets. Here are 6 mysteries experts hope to unravel
A STAT special report noted Dr. Trevor Bedford’s COVID predictions.
Women with breast cancer at higher risk for cardiovascular disease events, mortality
Dr. Heather Greenlee discussed her new study on breast cancer and cardiovascular risk.
‘The future of cancer care’: Seattle institutions connect research, clinics under Fred Hutch name
Drs. Tom Lynch and Paul Ramsey describe unified adult cancer care.
In an unprecedented move, Huntsman and Fred Hutch add dramatically to their catchment areas in western U.S.
Dr. Tom Lynch spoke about Fred Hutch’s growing catchment area and how to serve populations across WA state.
Seattle health care systems restructure to form new Fred Hutchinson Cancer Center
Drs. Paul Ramsey and Tom Lynch discuss the cancer care restructure.
A human genome has finally, fully been decoded
Dr. Steven Henikoff discussed new Science papers detailing gaps in the human genome, including on centromeres.
We study virus evolution. Here’s where we think the coronavirus is going.
Dr. Bloom and Dr. Starr study virus evolution.
Cancer leads to financial hardship, even among the privately insured
Dr. Veena Shankaran and coauthors urged more support for people with cancer.
As COVID rates rise in Europe and Asia, how worried should Americans be about another wave?
Dr. Josh Schiffer reflected on the evolving nature of the pandemic.
As virus data mounts, the J&J vaccine holds its own
Dr. Larry Corey commented on longer-term immune data on the J&J COVID vaccine.
Women see more adverse events with chemo and newer cancer treatments, study finds
Dr. Joe Unger discussed future research building on a study he led.
What health experts say about the ‘natural experiment’ of ditching mask mandates in WA
Dr. Josh Schiffer recommended a flexible approach to SARS-CoV-2 measures going forward.
As COVID-19 cases fall, experts are optimistic, but for how long?
Dr. Elizabeth Halloran shared her thoughts on COVID-19 outlook in the U.S.
A ‘living’ cancer drug helped two patients stay disease-free for a decade
Dr. David Maloney commented on a report of long term remissions with CAR T-cell therapy.
A Twist on Stem Cell Transplants Could Help Blood Cancer Patients
Dr. Marie Bleakley discussed her work on naive T cells and graft-vs-host disease.
Project underway at Fred Hutch to bring more diversity to clinical trials
Drs. Michele Andrasik and Stephaun Wallace discussed diversity in vaccine trials.
COVID predictions? These experts are done with them
Drs. Josh Schiffer, Pavitra Roychoudhury and Trevor Bedford shared omicron insights.
COVID antiviral pills work against omicron– when people can get them
Dr. Elizabeth Duke explained how COVID antivirals work.
Even if uninsured, people with advanced cancer often face financial problems
Dr. Veena Shankaran shared findings from a recent study.
After omicron, some scientists foresee a period of quiet
Dr. Trevor Bedford shared predictions about omicron.
Could Genomic Surveillance Prevent The Next Pandemic?
Dr. Trevor Bedford discussed the Seattle Flu Study and tracking viruses in a Bloomberg mini-documentary on genomic surveillance.
Halting progress and happy progress: How mRNA vaccines were made
Drs. Elizabeth Halloran and Larry Corey described decades of scientific effort that led to COVID vaccines.
Covid has exposed problems in how scientists share data
Dr. Jesse Bloom and other experts call for new standards for data transparency.
Young Hispanic/Latinx patients face access barriers to CAR-T clinical trials
Travel, language and barriers are all barriers to CAR T treatment, Dr. Anurekha Hall explained from findings she presented at ASH.
Biotech in 2022: Industry leaders and investors on trends and challenges to watch
Hilary Hehman described the Pacific Northwest’s growing biotech role.
Hockey fan spots cancerous mole on staff member’s neck at game
Dr. Sylvia Lee emphasized early detection in the treatment of melanoma.
Omicron is spreading at lightning speed. Scientists are trying to figure out why
Dr. Josh Schiffer compared omicron to previous variants.
Healthy, boosted people unlikely to develop severe omicron infections, but jury’s out on older, at-risk populations
Dr. Larry Corey highlighted the strain on hospital systems.
How contagious is omicron? What does that mean for you?
Dr. Josh Schiffer characterized recent COVID variants.
A computational biologist weighs in on omicron, the future of vaccines and the CDC’s variant forecast
Dr. Trevor Bedford shared insights in a Q&A, including updating COVID vaccines to circulating variants.
Gauteng’s Omicron Wave Is Already Peaking. Why?
In a Q&A, Dr. Trevor Bedford discussed the rapid rise of omicron and challenges in detecting cases.
Omicron surge predicted to peak higher than delta wave in King County: ‘It’s here and it’s moving fast'
Dr. Trevor Bedford joined a press briefing on omicron.
How the little-known B and T cells can protect against COVID variants
Dr. Jennifer Lund explained the immune response to COVID.
A Guide to Mixed-Vaccination-Status Holidays
Dr. Larry Corey talked about the complexity of COVID, quarantines and young children.
Preparing for the Omicron Wave (with Trevor Bedford)
Dr. Trevor Bedford and Andy Slavitt discussed omicron.
Testing indicates that the Omicron variant is surging in Washington State
Dr. Trevor Bedford predicted a coming wave of omicron infections.
What to know about bladder cancer
Dr. Andrew Hsieh gave an overview of bladder cancer and what treatments are on the horizon.
A scientist’s guide to understanding omicron
Dr. Jesse Bloom and a coauthor answered questions about omicron.
Special report: Meet 20 extraordinary women who are supercharging biopharma R&D
In a profile, Dr. Shivani Srivastava talked about how she first got interested in immunology.
Scientists in Washington researching COVID-19 Omicron variant to help protect public
Dr. Josh Schiffer described his concerns about omicron infections.
How did omicron mutate, and how could it evade antibodies? Fred Hutch scientist Trevor Bedford answers our questions
In an omicron-focused Q&A, Dr. Trevor Bedford mentioned how to prevent future variants.
Why Didn’t the U.S. Detect Omicron Cases Sooner?
Dr. Trevor Bedford commented on genomic surveillance of SARS-CoV-2.
Dr. Larry Corey on the Omicron variant of COVID
Dr. Larry Corey answered viewer questions about omicron, including vaccine efficacy.
Omicron’s Best- and Worst-Case Scenarios
Dr. Elizabeth Halloran talked about implications of the latest COVID-19 variant.
The mystery of where omicron came from — and why it matters
Dr. Trevor Bedford discussed omicron’s evolutionary path.
Mysteries of omicron variant could take weeks to untangle
Dr. Trevor Bedford discussed early reports of spread of the omicron variant.
COVID-19 experts answer questions about Omicron -- and where the variant may have come from
Drs. Larry Corey and Pavitra Roycoudhury discussed the Omicron variant.
The Omicron variant might have originated in someone with a suppressed immune system
Dr. Trevor Bedford explained how omicron differs from other gradually evolving strains of SARS-CoV-2.
U.S. tracking of virus variants has improved after a slow start
Dr. Trevor Bedford spoke on sequencing of variants.
How bad will omicron be? Scientists won’t really know for months
Dr. Josh Schiffer noted that larger data sets are needed to understand omicron.
A different type of COVID vaccine is about to roll around the world
Dr. Julie McElrath provided context about subunit protein vaccines, like those made by Novavax and Sanofi.
Nonprofits accept cryptocurrency as Bitcoin and Ether values spike – is it a fad or the next frontier?
Kelly O’Brien discussed crypto donations to Fred Hutch, which is limited at this point but an important new way to reach donors.
Treatments will change the pandemic, but they can’t end it alone
Dr. Larry Corey reflected on how COVID will change our response to respiratory illnesses.
The pandemic’s next turn hinges on three unknowns
Dr. Elizabeth Halloran commented on COVID-19 immunity in the U.S.
COVID-19 Virus to Keep Mutating, but at Slower Rate, Expert Predicts
Dr. Trevor Bedford’s recent Twitter thread on how SARS-CoV-2 might continue to evolve was featured.
COVID Vaccine Trials Offer Lessons For Improving Clinical Trial Diversity
Dr. Michele Andrasik noted that HVTN and CoVPN’s experience in engaging diverse communities in vaccine studies can support other areas of research.
The COVID Cancer Effect
Kathy Briant and Dr. Rachel Issaka discussed how the pandemic has reduced cancer screenings.
Meet the 2021 STAT Wunderkinds
Dr. Tyler Starr received a STAT Wunderkind award for his research on SARS-CoV-2 evolution.
New-onset diabetes provides ‘window of opportunity’ for early pancreatic cancer detection
Dr. Ziding Feng discussed the link between diabetes and pancreatic cancer, specifically the need for more testing.
COVID vaccines were rolled out 10 months ago in Washington state. Where do we stand now?
Dr. Larry Corey commented on measures enacted to fight COVID-19.
FDA clears first coronavirus vaccine for 5- to 11-year-olds
Dr. Larry Corey reflected on the FDA’s approval of Pfizer’s COVID vaccine in children.
Local doctors say children 5-11 years old could get vaccine by Thanksgiving
Dr. Larry Corey discussed when 5-11 year olds may receive the vaccine.
Can New Variants of the Coronavirus Keep Emerging?
Dr. Josh Schiffer discussed implications for immunity against COVID-19 as SARS-CoV-2 continues to mutate.
Scientists are starting to understand the likely endgame for COVID-19
Rachel Eguia, a research technician in the Bloom Lab, and Katie Kistler, a graduate student in the Bedford Lab, described SARS-CoV-2’s mutations.
What to know about your risk of a serious or fatal breakthrough COVID infection
Dr. Rachel Bender Ignacio provided perspective on breakthrough COVID infections.
Why COVID boosters weren’t tweaked to better match variants
Dr. Trevor Bedford advocated for updating COVID vaccines against the Delta variant.
Rachel Issaka is proud to inspire the next generation of doctors
Dr. Rachel Issaka was featured as one of PSBJ's 40 under 40.
What the future may hold for the coronavirus and us
Dr. Jesse Bloom explained how SARS-CoV-2 has changed.
Yes, We’re Still Talking about Covid Vaccine Myths
Dr. Larry Corey underscored the safety of COVID vaccines.
Is There Another Reason Biden Likes Boosters?
Dr. Larry Corey commented on COVID vaccine boosters.
Merck COVID drug studied at Fred Hutch
Dr. Rachel Bender Ingacio characterized clinical trial results for molnupiravir.
TCR T cells ‘poised to play a central role’ in cancer immunotherapy
Dr. Marie Bleakley discussed progress in T-cell receptor therapy.
Merck Says It Has the First Antiviral Pill Found to Be Effective Against Covid
Dr. Elizabeth Duke explained the potential of molnupiravir.
Fred Hutch’s Trevor Bedford receives ‘genius grant’ for work on COVID-19 and other viruses
Dr. Trevor Bedford commented on being named a 2021 MacArthur Fellow.
Trevor Bedford: Two astounding awards for virologist who raised early COVID alarms
Dr. Trevor Bedford reflected on receiving recognition for his research on viral evolution.
A daily pill to treat COVID could be just months away, scientists say
Dr. Elizabeth Duke spoke about the promise of an oral antiviral to treat and even prevent COVID.
These three Seattle scientists study the coronavirus. Now they’re getting millions to chase their ‘wildest scientific ideas’
Drs. Erick Matsen and Trevor Bedford were named Howard Hughes Medical Institute investigators.
Machine Learning Method Allows Highly Multiplexed Cell Surface Protein Analysis via Flow Cytometry
Dr. Mark Headley discussed his research on how to make single-cell experiments more efficient.
Remdesivir Averts Hospitalization in Study of High-Risk Patients
Dr. Josh Hill commented on a study of Remdesivir in high-risk patients:
Seattle brothers expand billion-dollar biotech company's focus to include COVID
Hilary Hehman described the entrepreneurial culture at Fred Hutch that has allowed its commercial endeavors to thrive.
Winter is coming, again: What to expect from Covid-19 as the season looms
Dr. Trevor Bedford predicted near-term and future spread of SARS-CoV-2.
COVID vaccine immunity is waning — how much does that matter?
Dr. Julie McElrath noted that COVID vaccines continue to prevent hospitalization and death.
Long-haul COVID-19 can last months. But here’s why experts are optimistic about recovery.
Dr. Julie McElrath and collaborators from the Allen Institute discussed research in immune response and understanding long COVID.
Analysis: U.S. hopes COVID vaccine boosters will decrease not just deaths, but virus spread
Dr. Larry Corey noted that vaccine boosters may prevent transmission.
Pioneering Gene Therapy Freed Her of Sickle Cell. Is a Cure at Hand?
Dr. Scott Ramsey commented on how the standard treatment for sickle cell disease is more costly than a new curative approach.
Covid-19 Could Become Like the Flu if More People Get Vaccinated
Dr. Jesse Bloom talked about the evolution of coronaviruses, including SARS-CoV-2.
Covid-19 Virus Variants Mu and Lambda Unlikely to Supplant Delta
Dr. Trevor Bedford characterized the landscape of COVID variants.
United States boosts tracking of coronavirus strains as Mu variant draws scrutiny
Dr. Trevor Bedford commented on the volume of COVID genomes now available in the U.S.
Researchers Investigate Molecular Clues in Puzzling Alaska Native Cancer Disparity
Dr. Riki Peters and collaborators spoke about new research to understand colorectal cancer disparities in Alaska Native people.
Johnson & Johnson’s HIV vaccine fails first efficacy trial
Dr. Larry Corey characterized results from an HIV vaccine study he helped lead.
Improving CAR-T cell therapy with more sensitive tumor identification
A new study from Dr. Stan Riddell’s lab shows how to improve CAR T-cell targeting.
Many patients with cancer lack adequate immunity to measles, mumps
Dr. Steve Pergam and Elizabeth Krantz discussed their study on cancer patients and immunity to measles and mumps.
New Evidence Points To Antibodies As A Reliable Indicator Of Vaccine Protection
Dr. Holly Janes spoke with NPR.
Q&A: Seattle COVID-19 vaccine expert answers questions about booster shots
Dr. Larry Corey discussed COVID vaccine boosters.
As Delta Surges, Covid-19 Breakthrough Cases Remain Uncommon
Dr. Larry Corey discussed breakthrough cases of COVID.
Why a fast-spreading coronavirus and a half-vaccinated public can be a recipe for disaster
Dr. Josh Schiffer discussed the rise of variants.
Patients With Cancer May Have an Increased Risk for Measles and Mumps
Dr. Steve Pergam and Elizabeth Krantz discussed their study on measles and mumps immunity in cancer patients.
Many People With Cancer Lack Protection Against Measles and Mumps
Dr. Steven Pergam and biostatistician Elizabeth Krantz discussed their research on cancer patients and immunity to mumps and measles.
How will the coronavirus evolve?
Dr. Tyler Starr discussed his research on SARS-CoV-2 evolution.
Study showing antibody levels protecting against COVID-19 could speed creation of new vaccines, boosters
Dr. Peter Gilbert explained a study identifying correlates of protection for the Moderna virus.
Antibody levels predictive of Moderna's vaccine efficacy -study
Dr. Peter Gilbert explained a study identifying correlates of protection for the Moderna virus.
Scientists may have found a marker of how effective COVID-19 vaccines are
Dr. Peter Gilbert explained a new study identifying correlates of protection for the Moderna vaccine.
Will COVID vaccine booster shots be needed? It's likely, experts say, but the immunocompromised should be prioritized.
Dr. Larry Corey commented on COVID vaccines in immunocompromised people.
‘Goldilocks virus’: Delta vanquishes all variant rivals as scientists race to understand its tricks
Dr. Trevor Bedford commented on the delta variant with The Washington Post.
People who already had COVID-19 should still get vaccinated, scientists urge
Allison Greaney, a graduate student in Dr. Jesse Bloom’s lab, discussed her recent study on SARS-CoV-2 immunity.
How to quit smoking: 5 actions you can take now 5 actions you can take now to end the addiction
Dr. Jonathan Bricker shared strategies for quitting smoking.
There Are Few Good COVID Antivirals, but That Could Be Changing
Dr. Rachel Bender Ignacio explained how small molecule antivirals still work when viruses develop resistance.
Videos reduce HPV vaccine hesitancy among parents
Dr. Parth Shah discussed his study on how to encourage HPV vaccination.
Fred Hutch, Seattle Children’s, UW Medicine announce plans for new cancer partnership
Dr. Tom Lynch joined Seattle Cancer Care Alliance, UW Medicine and Seattle Children’s leaders in describing how the new structure will expedite new therapies.
Cancer care and research in Pacific Northwest to be streamlined under proposed reorganization
Dr. Tom Lynch described how the restructure of Fred Hutch, UW Medicine, Seattle Children's, and Seattle Cancer Care Alliance could improve startups.
New study on delta variant reveals importance of receiving both vaccine shots, highlights challenges posed by mutations -
Dr. Jesse Bloom discussed how SARS-CoV-2 will continue to evolve.
Can we stretch existing Covid vaccines to inoculate more people? Experts are divided
Dr. Larry Corey expressed concern about using partial doses of COVID vaccines to increase global access to the vaccines without clinical data.
Covid’s Lambda variant: worth watching, but no cause for alarm
Dr. Trevor Bedford described the newly emerged Lambda variant.
12 lessons COVID-19 taught us about developing vaccines during a pandemic
Dr. Larry Corey shared his reflections on the COVID vaccine program.
The COVID pandemic’s lingering impact on clinical trials
Dr. Joe Unger discussed efforts to measure whether changes to clinical trials during the pandemic affected data quality.
'We need to continue to innovate': How charities are using NFTs as a way to fundraise
Kelly O’Brien shared that Fred Hutch received its first cryptocurrency philanthropic gift.
Fred Hutch study: Mangling RNA may extend use of immunotherapy drugs
Dr. Roberty Bradley discussed a new study that is using experimental compounds that alter RNA to boost the effectiveness of immunotherapy drugs against cancer cells.
Vaccine Hesitancy or Systemic Racism?
Dr. Stephaun Wallace and co-authors wrote an op-ed on the misperceptions around vaccine hesitancy.
Scientist Finds Early Virus Sequences That Had Been Mysteriously Deleted
Dr. Jesse Bloom’s preprint on recovered sequences of early SARS-CoV-2 cases was featured.
Study testing Moderna vaccine in transmission prevention to include young adults
Dr. Larry Corey commented on a study that is testing whether the Moderna COVID-19 vaccine works to prevent infection and transmission of the virus.
Two reasons why doctors say anyone who's had COVID still needs to get poked
Dr. Stephaun Wallace explained why people who previously had COVID-19 still need to get vaccinated.
One year or five? Doctors and drug companies increasingly disagree about when we'll need COVID-19 booster shots
Dr. Larry Corey gave context around COVID vaccine efficacy and durability. He said, “If the duration of protection is such that you can still get a mild cold, but you don't end up in the hospital, the vaccine will still be a success.”
The Human Genome Is—Finally!—Complete
Dr. Steve Henikoff commented on a “landmark” study that adds greater detail of the genome. He said it will enable other research questions, including “What happens in cancer?” and “What happens if you compare offspring to parents?”
Stephaun Wallace on Seattle Gay News' inaugural podcast
In Seattle Gay News’ inaugural podcast, Dr. Stephaun Wallace discussed COVID and HIV vaccine research and engaging communities in science. He said, “One of the things I really appreciate about science is that you’re always learning something.”
A pandemic upside: The flu virus became less diverse, simplifying the task of making flu shots
Dr. Trevor Bedford reacted to speculation that a clade of the influenza virus may have gone extinct during the pandemic. He said, “I think it has a decent chance that it’s gone. But the world’s a big place.”
Who really needs coronavirus herd immunity? People with weakened immune systems
Drs. Josh Hill and Steve Pergam discussed COVID immunity among immunocompromised people. Dr. Hill pointed out that for those with weakened immune systems, “Antibody tests are just the tip of the iceberg of what the immune system is doing.”
Have half the world’s COVID-19 deaths gone uncounted? Here’s why some experts think so
Dr. Ruth Etzioni characterized how she thinks about the true COVID death toll.
As Covid dissipates in the U.S., cold and flu viruses may return with a vengeance
Dr. Trevor Bedford commented on the rise in circulating respiratory viruses as COVID restrictions decrease.
Finding how much protection is enough when it comes to COVID-19 vaccines
Dr. Peter Gilbert told KIRO 7 about how he is working to find the “correlate of protection."
Researchers in biotech, academia and Big Pharma are offering puzzle pieces to crack CAR-T for solid tumors. Will they ever snap together?
Drs. Stan Riddell and Shivani Srivastava described research in cell therapies for solid tumors. She said, “All the reasons that make it technically complex are also the reasons why the insights you get are...more likely to be clinically relevant.”
A Clue to Why the 1918 Pandemic Came Back Stronger Than Before
Dr. Jesse Bloom commented on how the 1918 flu virus evolved to become more deadly.
New Guidelines Say Colonoscopies Should Start At Age 45
Dr. Rachel Issaka gave insights on the new guidelines for colonoscopies.
A Kent church is closing the vaccine equity gap, sometimes to a round of applause
Dr. Michele Andrasik commented on building vaccine confidence.
Masks and social distancing may still be needed for people with compromised immunity
Dr. Josh Hill emphasized how broad COVID vaccination can “protect our vulnerable patient populations within the community who either can’t get vaccinated for some reason, or who may not have as good of a vaccine response.”
Local 'Drink Pink' campaign raises money to fight breast cancer
Kelly O’Brien shares how a local milk company is raising money for cancer research.
Lab accident or jump from animals? Hutch virus expert calls for a new probe of COVID-19 origins
Dr. Jesse Bloom commented on a Science letter he wrote with 17 other scientists.
The race to avoid a possible "monster" COVID variant
Dr. Josh Schiffer stressed rapid vaccination.
Bisphosphonates may lower risk for invasive breast cancer among women with DCIS
Dr. Chris Li shared results from his study of bisphosphonates and breast cancer.
A vaccine without needles? It’s on the way
Dr. Jim Kublin spoke with CNN about next-gen vaccine delivery technologies.
College Students Are Helping Answer Key Vaccine Questions, but Finding Enough of Them Is Tough
Dr. Holly Janes explained the PreventCOVIDU study of COVID vaccines and transmission.
Meet the Seattle doctor who Dr. Fauci trusted to help develop COVID-19 vaccines
Drs. Tony Fauci and Larry Corey reflected on their collaboration on HIV and COVID vaccines.
Overcoming Challenges to Broaden Adoptive T-Cell Therapy in Lung Cancer
In a profile, Dr. Leah Schmidt talked about her research in Dr. Phil Greenberg’s lab to develop T-cell therapy for lung cancer.
A doctor trained nurse practitioners to do colonoscopies. Critics say his research exploited Black patients
Dr. Rachel Issaka critiqued a study’s consent process.
New Blood Tests Should Show How Long A COVID-19 Vaccine Will Protect You
Dr. Peter Gilbert discussed studies of what immune responses protect against COVID-19.
New high-tech lab at Fred Hutch creates 3D maps of proteins to aid therapeutics and vaccine research
Drs. Melody Campbell and Barry Stoddard described the newly-opened cryoEM facility.
Scientists Are Working On Booster Shots In Case COVID-19 Vaccines Lose Their Effect
Dr. Peter Gilbert discussed how to test vaccine protection against SARS-CoV-2 variants.
What the Recent HIV Vaccine Research Findings Really Mean
Dr. Larry Corey commented on the challenge of creating an effective HIV vaccine.
Behind the mask: Public health innovator Dr. Stephaun Wallace
Dr. Stephaun Wallace reflected on his career in public health.
A vaccine study in college students will help determine when it’s safe to take masks off
Dr. Larry Corey explained one of the questions the Prevent COVID U study is designed to answer:
You got vaccinated. Now what? 7 things to know for your post-COVID vaccine behavior
Dr. Josh Schiffer spoke with Geekwire and gave his input on SARS-CoV-2 variants.
Meet an epidemiologist fighting to make vaccines work for communities of color
Bill Gates featured Dr. Stephaun Wallace’s work in his personal blog.
Covid Mutants Multiply as Scientists Race to Decode Variations
Dr. Jesse Bloom discussed COVID mutations with Bloomberg.
Researchers pursuing novel treatments for herpes infections and diabetes win STAT Madness
Drs. Keith Jerome and Martine Aubert won the annual STAT Madness contest for biomedical research.
The race between COVID vaccines and emerging variants
Allison Greaney of Dr. Jesse Bloom’s lab discussed SARS-CoV-2 virus mutations.
NCCN Guidelines Urge Patients With Cancer to Get a COVID-19 Vaccine, Whichever is Available
In a Q&A, Dr. Steve Pergam discussed national guidelines on COVID vaccines in cancer patients.
Luck is essential for any successful coronavirus variant, study shows
Dr. Josh Schiffer explained his team’s latest analysis of how super-spreader events allow variants to become predominant and create new variants.
Unlocking the COVID code
Dr. Trevor Bedford commented on advances in the viral genomics field.
Do COVID-19 vaccines stop transmission? Top scientists are now recruiting thousands of college students to find out
Dr. Larry Corey discussed a new study to find out if COVID vaccines prevent transmission.
Fred Hutch scientist answers latest COVID-19 questions on vaccines, variants, and more
GeekWire covered Fred Hutch’s Science Says virtual event where Hutch scientists discussed their latest work.
Patients with cancer living in poorer areas have worse survival outcomes
Dr. Joe Unger explained his study showing that in cancer patients, “access to guideline-based care...alone is not sufficient to eliminate disparate outcomes related to socioeconomic deprivation.”
Disappointment and Hope From Two HIV Prevention Trials
Dr. Larry Corey characterized results from the Antibody Mediated Prevention studies, coordinated through the HIV Vaccine Trials Network, as “important proof of concept” in using antibody infusions to prevent HIV.
‘On your toes’ approach to managing infection risk needed as CAR T-cell therapy evolves
In a Q&A, Dr. Josh Hill discussed treating infections in people receiving CAR T-cell therapy.
COVID-19 precautions shut down flu this season, but what will next winter bring?
Dr. Steve Pergam reflected on how public health measures helped reduce spread of other respiratory viruses.
Is it really time to roll back gathering restrictions? Some experts are optimistic about WA moving to Phase 3
Dr. Josh Schiffer discussed his computational modeling of COVID-19 and a potential fourth wave of infections.
Did Washington Get Its Vaccine Line Right?
Dr. Laura Matrajt discussed her mathematical models of COVID-19 vaccine distribution.
‘Then the world caved in’: 11 experts describe the day they realized Covid-19 was here to stay
STAT opinion included reflections on the pandemic from a variety of experts when they realized COVID-19 was here to stay.
We may never reach herd immunity on coronavirus — but it probably doesn’t matter
Drs. Larry Corey, Josh Schiffer and Trevor Bedford spoke with The Seattle Times about herd immunity.
This scientist is searching for secrets of life in close brushes with death
Dr. Mark Roth discussed his research on suspended animation and how it’s inspired by people who survive near-death experiences.
Worried About Coronavirus Variants? Here's What You Need To Know
Dr. Trevor Bedford commented on which variants we should watch and how concerned people should be..
The Coronavirus Is Plotting a Comeback. Here’s Our Chance to Stop It for Good.
Dr. Josh Schiffer provided context on how the new coronavirus variants makes modeling difficult.
Washington high schools return to play knowing the COVID-19 risks, but hopeful about safety protocols
Dr. Josh Hill cautioned that high school sports may be disrupted by COVID-19.
People Who Have Had Covid Should Get Single Vaccine Dose, Studies Suggest
Dr. Andy McGuire discussed findings from the Seattle COVID Cohort Study showing a “massive, massive boost” from the vaccine administered to people who had had COVID.
People of color are underrepresented in US vaccine trials, study finds
Drs. Steve Pergam and Michele Andrasik stressed the need for more diversity and inclusion in vaccine clinical trials.
To get ahead of variants, Covid-19 drug makers use evolutionary biology as a guide
Dr. Tyler Starr discussed how viruses like SARS-CoV-2 evolve and spread through populations of people.
C.D.C. Announces $200 Million ‘Down Payment’ to Track Virus Variants
Dr. Trevor Bedford commented on new funding to support genomic surveillance and data collection related to COVID.
Keep it Flowing: Combating COVID-19 Blood Shortages in Cancer Treatment
Dr. Stephanie Lee discussed how cancer treatment can be adjusted due to the pandemic.
Drugmakers Look for New Ways to Test Covid-19 Vaccines
Dr. Peter Gilbert described measuring immune responses to vaccines as a way of testing their efficacy.
The coronavirus is going to stick around forever. Get ready for the new normal.
Dr. Larry Corey gave his thoughts to Business Insider about SARS-CoV-2 becoming endemic.
Ruxolitinib improves response rate, failure-free survival in chronic GVHD
Dr. Stephanie Lee discussed new clinical trial results.
Fred Hutch, Univ. of Washington biotech spinout Ensoma launches with $70M in funding
A new company called Ensoma launched based on research from Dr. Hans-Peter Kiem’s lab. The company is developing gene editing treatments, gene therapies and gene regulators.
Covid masks save lives. The CDC says double-masking may save more.
In an op-ed, Dr. Josh Schiffer advocated for increased masking to limit the COVID-19 pandemic.
Mapping Which Coronavirus Variants Will Resist Antibody Treatments
Drs. Jesse Bloom and Tyler Starr are highlighted in The National Institutes of Health's Director's Blog about which coronavirus variants will resist antibody treatment.
Approval of new CAR-T may have ‘immediate impact’ on treatment of large B-cell lymphoma
Dr. David Maloney commented on the FDA approval of a CAR T-cell therapy developed in part at Fred Hutch.
Fred Hutch initiative Cook for Your Life brings cancer nutrition research to the kitchen
Dr. Heather Greenlee described her goal for the Cook for Your Life website.
As Covid-19 Vaccines Raise Hope, Cold Reality Dawns That Illness Is Likely Here to Stay
Dr. Rachel Bender Ignacio stressed the need for treatments as COVID-19 likely becomes endemic.
South Africa suspends Oxford-AstraZeneca vaccine rollout after researchers report ‘minimal’ protection against coronavirus variant
Dr. Larry Corey gave his insight on the pause in rolling out the AstraZeneca vaccine in South Africa.
With COVID-19 vaccine in short supply, scramble is on for second shots
Dr. Steve Pergam explained why people should get their COVID-19 vaccines from the same provider.
Mutated virus may reinfect people already stricken once with covid-19, sparking debate and concerns
Dr. Larry Corey was quoted in The Washington Post on the potential for reinfection from some variants.
New COVID-19 prediction models forecast a potential fourth wave — and how to minimize it
Dr. Josh Schiffer shared his prediction of what the next wave of the coronavirus pandemic could look like.
If I have cancer, dementia or MS, should I get the Covid vaccine?
Dr. Catherine Liu commented on emerging recommendations for cancer patients receiving COVID-19 vaccines.
MapLab: The topology of a virus
Dr. Tyler Starr discussed his research on predicting possible mutations to SARS-CoV-2, including one that is now part of the variant called B.1.1.7.
For the first time, researchers say infusions of antibodies can prevent HIV infection
Dr. Larry Corey reflected on results from the Antibody Mediated Prevention study.
Why vaccines alone will not end the pandemic
Dr. Trevor Bedford weighed in on modeling that predicted lifting public health guidelines in February could cause 29 million additional coronavirus cases by July.
We could know soon whether vaccines work against a scary new coronavirus variant
Dr. Larry Corey discussed the global significance of the upcoming Janssen vaccine trial results.
New strains of COVID swiftly moving through the US need careful watch, scientists say
Dr. Larry Corey stressed that to slow the spread of variants of concern, as we expand access to COVID-19 vaccines, “We have to do everything we can to decrease the risk of transmission and acquisition.”
Mobile labs take vaccine studies to diverse neighborhoods
Dr. Stephaun Wallace explained how mobile sites can increase vaccination rates among communities of color.
A new COVID-19 challenge: Mutations rise along with cases
The story quoted tweets from Dr. Trevor Bedford, in which he noted that “The fact that we’ve observed three variants of concern emerge since September suggests that there are likely more to come.”
Are new coronavirus variants already in Washington state? With limited surveillance it’s hard to know
Drs. Pavitra Roychoudhury, Jesse Bloom and Trevor Bedford commented on efforts to track SARS-CoV-2 variants.
C.D.C. Warns the New Virus Variant Could Fuel Huge Spikes in Covid-19 Cases
Dr. Trevor Bedford estimated that with a more transmissible variant, “It makes the same situations that generate spread now — people living in the same household, these sorts of non-ventilated indoor contacts — to be more likely to spread.”
Cancer Death Rate in U.S. Falls by Largest Yearly Amount on Record
Dr. Thomas Lynch described the gratification of improving lung cancer death rates in the US.
COVID-19 measures also suppress flu—for now
Dr. Trevor Bedford explained that the lack of flu virus genomes will make it difficult to select strains for next season’s flu vaccine.
New stem cell study provides clues for treatments that could eliminate HIV in infected patients
Dr. Fabian Cardozo-Ojeda described the collaboration that went into utilizing models to potentially cure HIV through stem cell transplants.
Why You Should Still Wear A Mask And Avoid Crowds After Getting The COVID-19 Vaccine
Dr. Larry Corey discussed why COVID vaccine Phase 3 trials focused on finding out if the vaccines reduced severe disease and didn’t measure transmission.
Can You Still Spread Covid-19 After You Get Vaccinated?
Dr. Larry Corey commented on the limited data about whether COVID vaccines prevent transmission.
A Colonoscopy Alternative Comes Home
Dr. Rachel Issaka described how patients should approach at-home colon cancer tests with their doctors.
Math Can Help In Deciding How To Distribute The Vaccine
Dr. Laura Matrajt discussed her computer model that showed the benefit of administering one-dose vaccines to end the pandemic.
Scientists are monitoring a coronavirus mutation that could affect the strength of vaccines
Dr. Jesse Bloom discussed his latest paper about coronavirus mutations and their implications for vaccine efficacy.
What Happens If U.K. Variant Of The Coronavirus Spreads In The U.S.?
Dr. Trevor Bedford predicted the SARS-CoV-2 variant of concern “to go from initial arrivals in the U.S. in December to starting to kind of dominate the virus population in, say, March.”
CIOs’ Top Priorities For 2021 Include Digital Defense, Data Mining And Distributed Work
Kathy Alexion shared some of her top priorities for 2021 as Fred Hutch’s Chief Information Officer
New variants of SARS-Cov2
Allison Greaney of Dr. Jesse Bloom’s lab described their study of 4,000 SARS-CoV-2 mutations.
Fred Hutch seeks volunteers with COVID-19 to join tests of therapies
Research nurse Corrie Moreau described her motivation for being involved with COVID-19 therapy studies.
How it started: A Q&A with Helen Branswell, one year after Covid-19 became a full-time job
Infectious disease reporter Helen Branswell recalled an interview with Dr. Trevor Bedoford about SARS-CoV-2 in early 2020.
As spotlight shines on COVID-19 vaccines, treatment trials continue
Dr. Rachel Bender Ignacio emphasized the importance of COVID-19 treatment studies.
Where Year Two of the Pandemic Will Take Us
Dr. Jesse Bloom cautioned not to overly concerned about a new coronavirus strain and how dangerous it could be.
Cancer clinics confident in COVID-19 precautions to protect patients, survivors
Dr. Steve Pergam shared the importance of COVID-19 prevention measures for cancer patients.
Can vaccinated people still transmit COVID-19? The answer is key for herd immunity, research finds
Dr. Josh Schffer emphasized why it’s important to understand if COVID-19 vaccines prevent asymptomatic infections and transmissions.
Scientists urge calm about coronavirus mutations, which are not unexpected
Evolutionary biologist Dr. Jesse Bloom discussed how viruses mutate.
The Coronavirus Is Mutating. What Does That Mean for Us?
Drs. Jesse Bloom and Trevor Bedford discussed implications of SARS-CoV-2 mutating.
COVID-19 Vaccines: Safe for Immunocompromised Patients?
Dr. Jim Boonyaratanakornit shared guidance for cancer patients and COVID-19 vaccines.
FDA review clears path for second coronavirus vaccine, this one developed by Moderna
Dr. Larry Corey commented on the diverse populations that were enrolled in the Moderna vaccine study.
'It's history making:' Moderna's COVID-19 vaccine could be released this week
Dr. Jim Kublin reflected on progress in developing COVID-19 vaccines:
Black volunteers give COVID-19 vaccine trials a shot in the arm
Drs. Michele Andrasik and Adrienne Shapiro emphasized the disproportionate impact of COVID-19 on communities of color.
Q&A with Dr. Larry Corey: With a coronavirus vaccine on the way, clinical trials leader reflects on what’s next
Dr. Larry Corey underscored the benefit of COVID vaccines.
These Drugs Might Prevent Severe COVID
Dr. Rachel Bender Ignacio discussed a machine learning approach that could help identify drugs to treat COVID-19.
Questions remain about whether cancer patients should get vaccine
Dr. Josh Hill shared guidance for cancer patients and the COVID-19 vaccine.
Amid Pandemic, Scientists Reassess Routine Medical Care
Dr. Scott Ramsey discussed how some of the changes to health care during the pandemic may result in improved quality of care and greater efficiency.
11 Vitamin D Myths and Facts
Dr. Anne McTiernan provided expert commentary on the myths and benefits of Vitamin D.
Impressive Redmond holiday lights show raised $40,000 for cancer research
Fred Hutch fundraiser Bruce Haldors summarized his efforts to support a cancer patient through a holiday light display.
Countdown to a Coronavirus Vaccine
The New Yorker gave updates on vaccine trials and the first vaccines to get emergency approval.
Fred Hutch’s holiday gala going virtual with singer Sheryl Crow and a celebration of ‘fearless science’
Kelly O’Brien described how this year’s holiday gala is changing due to the COVID-19 pandemic.
CDC release revised guidance for quarantine length
Dr. Josh Hill shared insight into the CDC’s new guidelines around quarantining after exposure to COVID-19.
Many Trial Volunteers Got Placebo Vaccines. Do They Now Deserve the Real Ones?
Dr. Holly Janes discussed biostatistical implications of having placebo-treated volunteers offered the vaccine.
The Covid-19 vaccines are a marvel of science. Here’s how we can make the best use of them
Dr. Larry Corey spoke about the challenge of continuing to test some COVID vaccines, even as effective ones emerge.
Fred Hutch virologist on Moderna ask for emergency vaccine use
Dr. Larry Corey characterized the latest data on Moderna’s COVID-19 vaccine candidate.
We don't know if the coronavirus vaccines can stop the virus from spreading, but top scientists are pitching a new trial that could figure that out
Dr. Larry Corey outlined a new plan to test if COVID-19 vaccines prevent infection.
Finding a Fix for Faulty Genes
Dr. David Maloney discussed advances in cell therapies and what it means for blood cancer patients.
Covid-19 vaccine efficacy results are not enough
Dr. Holly Janes discussed the importance of large clinical trials for assessing safety of vaccine candidates.
Evidence Builds That an Early Mutation Made the Pandemic Harder to Stop
Dr. Trevor Bedford confirmed his assessment that scientific evidence shows the 614G variant of SARS-CoV-2 is more easily transmitted.
ASH president says planning, flexibility helped her lead society through challenging year
In a Q&A about her position as ASH president, Dr. Stephanie Lee encouraged others to pursue leadership roles.
Make the necessary sacrifices to avoid an unimaginable catastrophe
Dr. Josh Schiffer authored an opinion piece urging Americans to take proper COVID-19 measures.
How Many Americans Are About to Die?
Dr. Trevor Bedford predicted that U.S. COVID-19 deaths could reach 2,000 a day within weeks, and that “Importantly, this doesn’t assume any further increases in circulation and is essentially ‘baked into’ currently reported cases.”
What Is the Best Strategy to Deploy a Covid-19 Vaccine?
Dr. Laura Matrajt discussed how her computer modeling studies on vaccine distribution strategies have adapted with the pandemic.
The Race for a Coronavirus Vaccine Runs Through Fred Hutch
Dr. Larry Corey summarized the role Fred Hutch and the COVID-19 Prevention Network is playing during the pandemic.
MLS Cup playoffs begin as COVID-19 cases spike: Will postseason be finished safely outside a bubble?
Dr. Josh Schiffer detailed why the MLS may face more COVID-19 related cancellations.
Using data science and analytics to fight childhood cancer
Dr. Soheil Meshinchi discussed how computational tools are revealing how to best match cancer therapies for patients.
Covid complicates Thanksgiving as families struggle to modify 2020 holiday plans
Dr. Steve Pergam stressed the need for families to rethink holiday gatherings during the COVID-19 pandemic.
Why It’s a Big Deal If the First Covid Vaccine Is ‘Genetic’
Dr. Larry Corey reflected on the speed of COVID-19 vaccine development.
How to sign up for Seattle-area COVID vaccine trials
Dr. Julie McElrath explained that her team is working to enroll people who “are over 65 years old, those who may have some kind of underlying medical conditions such as heart disease, high blood pressure, diabetes” into the Fred Hutch vaccine trial.
Roll up your sleeve to fight COVID-19: 3 new vaccine trials will start soon in the Seattle area
Dr. Julie McElrath discussed several COVID vaccines being tested in phase 3 trials in the Seattle area.
Research alliance co-founded by Fred Hutch and Microsoft announces initial cancer studies
GeekWire detailed the cancer research projects within the Fred Hutch-led Cascadia Data Alliance.
Who should get a COVID-19 vaccine first?
The New York Times magazine’s “Studies Show” featured Dr. Laura Matrajt’s vaccine modeling preprint paper.
Dismantling structural racism in medicine is good for us all
Dr. Rachel Issaka spoke with KING 5 about how structural racism affects both doctors of color and patients.
Science, art and humor on display in Fred Hutch’s Halloween pumpkin carving contest
Dr. Andrew Hsieh thanked a former postdoc for inspiring his lab’s “most scientific” pumpkin in Fred Hutch’s annual contest.
Therapies in the works
Dr. Rachel Bender Ignacio emphasized the importance of studies at the COVID-19 Clinical Research Center.
Health workers worried about Halloween COVID-19 increases
Dr. Steve Pergam underscored the importance of taking COVID-19 precautions during the holidays.
Cancer health disparities continue
Kathy Briant summarized the importance of equity in cancer care and discussed Fred Hutch’s community outreach work
Health experts weigh in on what we’ll have to do to get through a winter of COVID-19
Dr. Trevor Bedford reflected on how the pandemic “will leave us with generally strengthened surveillance systems and public health, and an ability to deal with something like this in the future to a better degree.”
Most influential people fight against COVID-19: Kathleen Neuzil and Larry Corey
Dr. Larry Corey touted the expertise Fred Hutch brings to coordinate COVID-19 vaccine trials.
Moderna’s coronavirus vaccine trial is fully enrolled, 37 percent of participants are minorities
Dr. Larry Corey reflected on full enrollment in the first Phase 3 vaccine trial.
A perfect match
Dr. Stephanie Lee discussed disparities in blood cancer treatment and survival rates.
How an ill-fated fishing voyage helped us understand Covid-19
Dr. Jesse Bloom’s recent study of cases aboard a fishing boat provided evidence that antibodies protect against COVID-19.
5 questions ahead of this week's FDA meeting on coronavirus vaccines
Dr. Larry Corey discussed how the COVID-19 Prevention Trials Network has supported enrolling diverse populations into COVID-19 vaccine trials.
Full steam ahead as Fred Hutch moves into historic building and expands Seattle campus
Dr. Thomas Lynch described why he’s excited about the opening of the Lake Union Steam Plant.
Cancer researchers cross over to COVID-19 clinical trials
Dr. Josh Hill discussed treating immune responses in COVID-19 patients.
Trying to prevent cancer cells from metastasizing
Dr. Kevin Cheung noted epigen’s role in the spread of breast cancer.
Fred Hutch opens COVID-19 Clinical Research Center
Fred Hutchinson Cancer Research Center Research announced Monday that it has opened its COVID-19 Clinical Research Center.
Against Covid-19, imperfect measures do the most good
In an op-ed piece, Dr. Josh Schiffer suggested COVID-19 strategies can be flawed but still effective in reducing transmission.
Monoclonal antibodies could fill the COVID-19 treatment gap until vaccines arrive — but at a cost
Drs. Shelly Karuna and Larry Corey commented on the potential of monoclonal antibodies to treat and prevent COVID-19.
Ending systemic racism in oncology is everyone's responsibility
In a Q&A, Dr. Rachel Issaka discussed how health care professionals can dismantle systemic racism in medicine, including examining “the policies and structures within medicine that make it more difficult for minority patients to thrive.”
Fred Hutch seeks increased diversity among volunteers for COVID-19 study
Dr. Alpana Waghmare described why Fred Hutch's CovidWatch study is now available for Spanish-speaking volunteers.
Junior Geek of the Month: Future doctor Nicole Magaki wants to make health care more accessible
Dr. Katherine Lalish described the qualities that make Fred Hutch intern Nicole Magaki a fitting “Junior Geek of the Month.”
Three scientists race to track deadly pathogen in their city
Dr. Trevor Bedford reflected on discovering the first case of community transmission in the region in this comic feature.
Coronavirus pandemic could impact cancer rates and care in the future
Dr. Chris Li described how obesity is driving an increase in cancer rates.
Quitting smoking apps that help you acknowledge your triggers work better, study shows
Dr. Jonathan Bricker explained how acknowledging and accepting cravings is the key to quitting smoking.
Colds Nearly Vanished Under Lockdown. Now They’re Coming Back
Dr. Steve Pergam described how the COVID-19 pandemic could impact other infections.
A look back at the first death from COVID-19 in the U.S
Dr. Trevor Bedford spoke about the early cases of COVID in the U.S.
VIDEO: Quickest way to reduce COVID-19 numbers
Dr. Daniel Reeves described how increased masking is the key to lowering COVID-19 transmissions.
As COVID-19 trials move at warp speed, recruiting black volunteers takes time
Rev. Edwin Sanders, a faith ambassador with the CoVPN Faith Initiative, characterized his approach with his community and congregation.
New ads encourage minorities to participate in vaccine trials
Dr. Larry Corey discussed the importance of conducting vaccine trials to the highest scientific standards.
Hair dye not linked to increased risk of most cancers
Dr. Anne McTiernan explained the limitations of studying hair dye and cancer risk.
New ads encourage minorities to roll up their sleeves and participate in coronavirus vaccine trials
Dr. Larry Corey discussed the purpose of CoVPN’s national ad campaign.
Cancer clinical trials: Screeching halt, now some recovery
Dr. Fred Appelbaum discussed policies to keep clinical trials for cancer moving forward during COVID-19.
How can you tell if a COVID-19 vaccine is working?
In an FAQ about vaccine trial statistics, Holly Janes explained how the COVID-19 trials are based on how many cases of the disease.
How volunteers and scientists help determine if a vaccine works
Holly Janes explained statistics of COVID-19 vaccine trials.
Why volunteer for a vaccine study? Duty, love and a willingness to experiment, participants say
Dr. Jim Kublin discussed the need for volunteers in the COVID-19 clinical trial registry.
Fortune 40 under 40 - Trevor Bedford
Dr. Trevor Bedford was selected for Fortune’s 40 under 40 in the healthcare category.
Scientists use gene therapy to tackle oral herpes in mice
Dr. Keith Jerome discussed the importance of his new paper showing a 90% reduction of latent herpes virus.
How do viruses leap from animals to people and spark pandemics?
Dr. Tyler Starr discussed how viruses mutate and what that means for SARS-CoV-2.
How the COVID-19 pandemic has changed cancer care, in 4 charts
Dr. Rachel Issaka commented on the importance of home screening tests for colorectal cancer.
When school buildings reopen, start with elementaries, Bellevue-based institute says
Dr. Dobromir Dimitrov provided outside commentary on a new model focused on safely reopening schools.
One Meeting in Boston Seeded Tens of Thousands of Infections, Study Finds
Dr. Josh Schiffer provided outside commentary on a new study looking at a COVID-19 superspreading event in Boston.
Editing out herpes
Dr. Keith Jerome discussed his new study showing how gene editing removed 90% of herpes in mice.
‘Warp Speed’ COVID-19 Vaccine Efforts Aim for Diverse Volunteers and Long-Lasting Protection
Peter Gilbert discussed vaccine clinical trial design in a story about national efforts to rapidly find a safe and effective vaccine.
Researchers Report Covid-19 Reinfection in Hong Kong
Dr. Josh Schiffer described the role T-cells play in COVID-19 immune responses.
'Sign me up': Why people of color are vital to getting a successful COVID vaccine
USA Today covered the need for diversity in COVID-19 vaccine trials, mentioning Fred Hutch and the CoVPN.
Researchers create synthetic proteins that use logic to choose which cells to kill
In a study in Science, Fred Hutch researchers with collaborators at UW’s Institute for Protein Design found a way to kill only “the cells with the desired combinations of surface markers.”
Will Covid-19 vaccines be safe for children and pregnant women? The data, so far, are lacking
Dr. Larry Corey commented on how discussions are underway to include pregnant women and children in COVID-19 vaccine trials.
This trawler’s haul: Evidence that antibodies block the coronavirus
The New York Times reported on a study addressing whether previous COVID-19 infection protects from reinfection, quoting a Tweet from co-author Jesse Bloom, “Knowing the answer to this question is critical for vaccine design and epidemiology.”
Fred Hutch study: Here’s what it would take to reopen schools safely during the pandemic
Fred Hutch scientists described their new analysis on safely reopening schools.
How to participate In a vaccine trial
Dr. Elizabeth Halloran discussed the design of vaccine clinical trials and shared information on how people can register as a volunteer..
How to decide if you should get tested for Covid-19 before seeing friends and family
Dr. Steve Pergam raised concerns about how unnecessary COVID-19 testing could lead to negative behaviors.
Immunology institute founded by Paul Allen shifts focus to tackle coronavirus
Dr. Julie McElrath discussed the benefits of working with the Allen Institute for COVID-19 research.
Global virology star Dr. Larry Corey leads the hunt for a COVID-19 vaccine
A profile of Dr. Larry Corey and his role leading operations for the CoVPN.
Fred Hutch and Allen Institute launch study of milder COVID-19 cases, aiming for unique insights
Dr. Julie McElrath’s work with the Allen Institute to understand the characteristics of an effective COVID-19 immune response was covered by GeekWire.
How ‘super spreader’ events can fuel coronavirus transmission -
Dr. Josh Schiffer described how to prevent COVID-19 superspreader events
Why Herd Immunity Won't Save Us
Dr. Josh Schiffer shot down the idea of achieving natural herd immunity for COVID-19.
MLS will resume the regular season: What we know and what we don't
Dr. Steve Pergam raised concerns over MLS matches resuming.
Why the Coronavirus is More Likely to ‘Superspread’ Than the Flu
Dr. Josh Schiffer emphasized the importance of “superspreader” events and COVID-19.
America’s obesity epidemic threatens effectiveness of any COVID vaccine
Kaiser Health News explored issues of vaccine efficacy in obese individuals, quoting Dr. Larry Corey.
Seattle skyline glows orange to support national cancer research at Fred Hutch
Jim Birrell shared the community’s excitement for this year’s Obliteride.
Do you want to be a vaccine volunteer?
Dr. Larry Corey explained aspects of participating in a COVID-19 vaccine trial.
Can Taking a Vitamin D Supplement Help You Lose Weight?
Dr. Anne McTiernan outlined how Vitamin D impacts weight.
2020 flu shot strategy: Get yours early in the season
Dr. Steve Pergam described the importance of getting flu shots, especially for protecting babies, older people and others with compromised immune systems.
Covid-19 testing delays create a public health nightmare as schools and workplaces try to reopen
Dr. Steve Pergam expressed concerns over COVID-19 testing and the impact on underrepresented populations.
Large U.S. COVID-19 vaccine trials will exclude pregnant women for now
Dr. Larry Corey emphasized the need for COVID vaccine data in pregnant women to find what is the safest vaccine for them.
'Obliteride' seeing record turnout despite going virtual amid pandemic
Kelly O’Brien shared how the COVID-19 pandemic isn’t hurting Obliteride participation.
Q&A: Millions of volunteers needed for COVID-19 vaccine trials
Dr. Jim Kublin answered questions about the CoVPN program, the challenges of the program and more.
New pandemic vaccine could emerge from Seattle, here's how you can help
South Seattle Emerald covered the region’s important role in testing potential COVID vaccines.
Fred Hutchinson doctor overseeing all COVID-19 vaccine trials in phase 3
Dr. Larry Corey explained CoVPN’s focus on including people at most risk for COVID-19 in the vaccine trials, specifically minorities and people with comorbidities.
COVID-19 vaccine trials: What older volunteers need to know
Michele Andrasik spoke about the priorities of CoVPN and the COVID-19 vaccine trials.
Adaptive Biotech pushes ahead with new Seattle HQ, showing strength of life sciences industry
GeekWire mentioned Fred Hutch’s planned expansion into the Steam Plant.
The color of COVID: Will vaccine trials reflect America’s diversity?
Stephaun Wallace spoke about the barriers to clinical trial enrollment in Black, Latino and other minority populations, and the strategies to encourage those populations to participate in clinical trials.
Virus vaccine put to final test in thousands of volunteers
Dr. Larry Corey discussed CoVPN trial enrollment goals in terms of reaching a diverse, multigenerational population.
A trial for coronavirus vaccine researchers: Making sure black and Hispanic communities are included in studies
Michele Andrasik discussed how outreach methods may need to differ depending on the communities that researchers are trying to reach with COVID-19 trials.
6 months since we had the nation’s first diagnosis, here’s how Washington’s COVID-19 fight is going
Ruth Etzioni weighed in on how family interactions can be a large source of COVID-19 spread to at risk populations.
Without a vaccine, researchers say, herd immunity may never be achieved
Dr. Joshua Schiffer predicted what may happen if the U.S. tries to achieve herd immunity without a COVID-19 vaccine.
On eve of first big coronavirus vaccine study, trial leaders brace for 'unprecedented' task
Dr. Jim Kublin discussed the CoVPN program, trial recruitment and vaccine development.
GeekWire Awards 2020 revealed: Big winners, celebrities and surprises power virtual event
Dr. Matthias Stephan talked about his methodology to deliver immune cells to tumors with thin metal mesh, which won Health Innovation of the Year in the 2020 GeekWire awards.
The U.S. now has 4 million cases of coronavirus. As numbers continue to rise, what can be done now?
Dr. Steve Pergam weighed in on what we can do now to slow COVID-19, emphasizing physical distancing measures, PPE, test and tracing plans and masking.
How a group of Seattle scientists revealed COVID-19′s stateside spread
Trevor Bedford’s work and comments on COVID-19 from the beginning of the pandemic are referenced.
Obliteride shifts gears for 2020
KING 5 described how Fred Hutch’s Obliteride is changing formats in response to the COVID-19 pandemic.
Want to sign up for a COVID-19 vaccine trial? Here’s what to know
Stephaun Wallace discussed the details of the CoVPN clinical trials and the focuses of the program.
Inside the global quest to trace the origins of COVID-19—and predict where it will go next
Trevor Bedford discussed his work with Nextstrain and the start of tracking COVID-19 in Seattle.
Nine ways to help prevent breast cancer
Anne McTiernan provided information on ways to reduce breast cancer risk, including reducing alcohol intake.
Coronavirus antibody study will gauge prevalence of COVID-19 in Washington state
Keith Jerome’s antibody work and antibody study results from the Fred Hutch campus are discussed.
UK coronavirus vaccine prompts immune response in early test
Dr. Larry Corey’s comments saying a vaccine that is safe and works in at least 50% of people would be viable are discussed.
Over 100,000 people volunteered for COVID-19 vaccine trial in less than two weeks
Forbes covered the CoVPN program, its goals and how the network will be run.
Exploring alternatives to CAR T-cell therapy
Dr. Ryan Cassaday spoke about alternative to CAR T-cell therapies and the benefits of other treatments.
Researchers recruit volunteers for COVID-19 vaccine trials
Stephaun Wallace provided information about the CoVPN network, specifically the call for diverse applicants across ethnic, racial, occupational groups and ages.
Help wanted: Volunteers for COVID vaccine trials
Dr. Jim Kublin explained the CoVPN network, and the goals of the program.
Listen: Coronavirus vaccine data, saving the U.S.’s pandemic response, and systemic racism in medicine
Dr. Rachel Issaka discussed her recent essay on structural racism in academic medicine, and what should be done to change it.
'You can beat the pandemic.' Former front-line workers share tips for coping with the COVID-19 surge
Dr. Steve Pergam shares tips to reduce the infection risk of COVID-19.
Moderna’s COVID-19 vaccine moves to bigger study
Dr. Larry Corey is mentioned for comments on the CoVPN registry, and the call for diverse trial participants.
Why this coronavirus mutation is not cause for alarm
Tyler Starr commented on the possibility of a SARS-CoV-2 mutation causing the virus to be more infectious.
Joel McHale and Ken Jeong look for light in the darkest timeline
Comedian Joel McHale spoke about his conversations on COVID-19 with Dr. Joshua Schiffer.
Decades of research on an HIV vaccine boosts the bid for one against coronavirus
Dr. Larry Corey discussed how building the HIV trial network laid the foundation for CoVPN.
Rate of new COVID-19 cases in Washington now exceeds March peak
Research from Fred Hutch indicating the COVID-19 infection rate in Washington is increasing above peak levels from March is referenced.
Microbial signatures in blood are associated with various cancers
Susan Bullman commented on an outside study suggesting certain microbial signatures in blood are associated with cancer.
More young people are getting — and spreading — the coronavirus
Dr. Joshua Schiffer commented on the trend of younger people getting COVID-19 and their risks.
Fred Hutch to lead COVID-19 vaccine trials
The CoVPN announcement is covered by KING 5.
Everett Firefighters partner with Fred Hutch to research COVID-19's impact on frontline workers
Julie Czartoski explained the goals of the COVID cohort study and the value of enrolling first responders like firefighters.
Everett firefighters joining Fred Hutch COVID-19 study
Julie Czartoski discussed testing the Everett’ Fire Station as part of the COVID cohort study.
First Seattle volunteer in human COVID-19 vaccine trials says she feels 'fantastic'
Dr. Jim Kublin commented on the timeline and goals of the CoVPN network.
Meet the doctor democratizing COVID-19 data on Twitter
Trevor Bedford discussed his work on SARS-CoV-2 genomic epidemiology using twitter for science outreach and communications.
Drugmakers will need to test their coronavirus vaccines in tens of thousands of people to see how well they work
Dr. Larry Corey discussed the CoVPN network, how the vaccine trials will be run and his role in the program.
Fred Hutch to coordinate large-scale vaccine trials for COVID-19 Prevention Network
Dr. Larry Corey discussed how the CoVPN trial network will work and the goals of the program.
COVID-19 vaccine trials now open to volunteers in U.S.
Forbes covered the CoVPN announcement and Fred Hutch’s role in the network of clinical trials.
Volunteers can now sign up for large coronavirus vaccine studies
Dr. Larry Corey commented on the role Fred Hutch will take in developing coronavirus vaccines, building off of work with HIV vaccines.
Here's how to volunteer for a COVID-19 vaccine trial
CNN covered the announcement of the CoVPN network, of which Fred Hutch will serve as the coordination center and Dr. Larry Corey as the lead.
The sports restart has a plan for everything—except a coronavirus outbreak
Dr. Steve Pergam commented on the restarting of professional sports in July, reinforcing that it may be necessary to stop if COVID-19 cases rise.
In early February, the coronavirus was moving through New York
Trevor Bedford weighed in on new findings suggesting COVID-19 was spreading in New York City in early February.
a16z Podcast: Preventing pandemics with genomic epidemiology
Trevor Bedford explained how Nextstrain and genomic epidemiology can inform public health and discussed the COVID-19 pandemic.
Public health officials do a reality check on Elon Musk’s tweets about COVID-19 tests
Dr. Keith Jerome and Trevor Bedford explained the rise in positive COVID-19 tests, indicating a rise in infections rather than false positives.
Fred Hutch studies immune response to COVID-19, needs participants
Dr. Julie McElrath discussed the COVID Cohort study to gather information on first responders and those who are likely to be exposed to the virus.
FDA pilot program to communicate patient reported outcomes from cancer clinical trials
Joseph Unger commented on his new study on the impact of insurance status on health outcomes.
Treating cancer patients with COVID-19: A New York City experience
Dr. Catherine Liu commented on COVID-19 and cancer patients, and the risk for more severe infection.
Fred Hutchinson Cancer Research Center names new board chair and adds trustees
The announcement of new board chair Kathy Surace-Smith and vice chair Leigh Morgan, along with two new board members, Dr. Connie Kravas and Pete Shimer, is covered by GeekWire.
Nanostring executive appointed chairwoman on Fred Hutch board
The announcement of a new board chair and vice chair, along with two new board members is covered.
CDC acknowledges true coronavirus count is likely 10 times higher than official count
Elizabeth Halloran commented on the lack of clarity in COVID-19 infection case counts, suggesting the total number is much higher than current estimates.
Will Trump’s ‘Operation Warp Speed’ rush the science of a coronavirus vaccine?
Dr. Larry Corey explained ‘Operation Warp Speed’ for developing COVID-19 vaccines, and the safety and efficacy standards of the program.
How the virus won
The New York Times recapped the COVID-19 pandemic, referencing Trevor Bedford’s work tracking the virus through Nextstrain and the Seattle Flu Study.
Black patients are underrepresented in cancer clinical trials but more likely to be enrolled in public-sponsored vs pharmaceutical-sponsored studies
Joseph Unger’s and the SWOG network's latest research illustrating that Black patients are better represented in publicly funded cancer clinical trials is discussed.
The cost of racial disparities in clinical trials
Joe Unger commented on how a lack of Black patients in clinical trials can lead to a lack of data on how drugs impact vulnerable populations.
Early data show no uptick in COVID-19 transmission from protests
Dr. Steve Pergam weighed in on the potential impact of reopening restaurants, loosening other restrictions, and protests on COVID-19 infection rates.
Seattle researcher advocates early COVID-19 testing and treatment
Dr. Joshua Schiffer’s new review paper, with co-authors from Fred Hutch and UW, suggesting that an early test and treat strategy is the best way to control COVID-19, is covered.
COVID-19 must be treated earlier to save lives, scientists advise
A review article by Dr. Joshua Schiffer on ways to keep COVID-19 from getting out of control again is covered, highlighting the need for widespread testing and treatment early in diagnosis.
Researchers want to pick up the pace on early testing and treatment for COVID-19
Dr. Joshua Schiffer’s new article emphasizing the need for widespread testing and early treatment for COVID-19 is discussed.
COVID-19 transmission in Seattle region rises back above key threshold, new estimates show
Data on COVID-19 infection rates from Fred Hutch, suggesting the infection rate in Washington State has risen, is referenced.
The enormous risks and stakes driving the NBA's safety discussions
Dr. Steve Pergam weighed in on the risks of starting up the NBA season during COVID-19.
Insurance status linked to survival benefit in cancer treatment trials
Dr. Joe Unger’s research with the SWOG network suggesting health insurance plays a role in clinical trial success for patients is discussed.
As pressure for vaccine builds, regulators may face difficult decision
Dr. Larry Corey discussed COVID-19 vaccine trials and the challenges involved.
Brooks releases special-edition launch 7 in honor of Gabriele Grunewald
Brooks announced the Brave Like Gabe shoe, in honor of Gabriele Grunewald, where proceeds will go to a researcher at Fred Hutch.
Searching for coronavirus clues in single cells
Yuan Tian explained how inflammation factors into COVID-19, and the need for further studies on immune cells.
Brooks introduces a special edition launch 7 in honor of Gabe Grunewald
The Brave Like Gabe shoe launch, with proceeds going to a Fred Hutch researcher, is profiled.
A coronavirus vaccine in 2020? Maybe. Here’s what has to go right
Dr. Larry Corey explained the complexities of COVID-19 vaccine trial setup and development.
Amid COVID-19 pandemic, experts lay out 10-point plan for a genomic revolution in public health
Trevor Bedford and Allison Black discussed a paper they co-authored on how to build a scientific ecosystem that is better equipped to tackle COVID-19.
A second wave of coronavirus infections could begin in September, UW model suggests
Ruth Etzioni explained the predicted COVID-19 infection trends for the fall, suggesting infections will increase.
‘Flying blind’: Doctors race to understand what Covid-19 means for people with HIV
Fred Hutch is mentioned for involvement in an HIV and COVID-19 study team, to determine if patients with HIV are at higher risk of more severe infection.
Coronavirus vaccine candidates’ pivotal U.S. testing to start this summer
Dr. Larry Corey discussed COVID-19 vaccine trials, the timelines, and how they will be structured.
'Protest is a profound public health intervention': Why so many doctors are supporting protests in the middle of the COVID-19 pandemic
Trevor Bedford’s tweets on COVID-19 and protesting are referenced.
Is antiperspirant bad for you? No, it doesn't pose health risks
A Fred Hutch study on the relationship between breast cancer and deodorant use is cited.
Researchers gauge the effect of protests and reopenings on reviving the pandemic
Trevor Bedford’s estimates of COVID-19 infections resulting from protests are referenced.
A delicate balance: Weighing protest against the risks of the coronavirus
Trevor Bedford’s tweets on estimates of COVID-19 infection rates after protests in the U.S. are referenced.
Everything will have to go 'perfectly' to have coronavirus vaccine by January, experts say
Dr. Larry Corey and Dr. John Mascola’s webinar on COVID-19 vaccine development is quoted, specifically that vaccine development will require coordination from all industries.
Vaccine veterans preview milestones on the long road to the end of the pandemic
A Fred Hutch webinar featuring Dr. Larry Corey and Dr. John Mascola of NIAID on COVID-19 vaccine development is recapped by GeekWire.
How and why social distancing works
Laura Matarajt explained how and why physical distancing works to help prevent the spread of COVID-19.
Some cities are shutting down coronavirus testing during the protests
Ruth Etzioni weighed in on the potential impact of the protests on COVID-19 cases and policies.
Amazon is really interested in the blood of COVID-19 patients
Medium referenced the CovidWatch program as part of Amazon’s role in COVID-19 response.
Some people may have an immunological 'head start' against new coronavirus, even if they've never been exposed, new research finds
Yuan Tian discussed the value that further research on T-cell responses in people with severe and mild COVID-19 infection could provide, in light of an outside study showing immune response in those without exposure.
In conversation with Tom Lynch, president and director of Fred Hutchinson Cancer Research Center
Fred Hutch President and Director Dr. Tom Lynch spoke with Fierce Biotech about his new role, the Hutch’s scientific priorities and COVID-19.
Airlines say it’s safe to travel. But is it?
Dr. Joshua Schiffer weighed in on the safety of travel during the COVID-19 pandemic, and possible ways to keep infection risk low.
A conversation with Trevor Bedford, the Fred Hutch scientist who became a leading voice of the coronavirus pandemic
Trevor Bedford discussed his COVID-19 research, the test, trace, isolate strategy and next steps to reopen.
Large-scale survey of Seattle-area kids shows 1% had antibodies to the coronavirus
Jesse Bloom and colleagues explained results of a recent study showing 1% of children tested had COVID-19 antibodies, about at the same rate as adults.
Virus ignited in U.S. no earlier than mid-January, study says
Trevor Bedford commented on the possibility of COVID-19 infection in early January, suggesting it was likely flu.
UW expert: CDC ‘hopelessly compromised’ by White House in virus response
Dr. Steve Pergam commented on the need for public health to be driven by science and the value of the CDC.
CCC19 data point to extensive use of hydroxychloroquine, azithromycin, or both, by patients with cancer and COVID-19
Dr. Gary Lyman’s work with the COVID-19 and Cancer Consortium is referenced, revealing that patients with active cancer have a higher risk of death after contracting SARS-CoV-2.
'Major financial hardship' hits most patients battling advanced colon cancer
New research from the Hutch's health economics group HICOR and Dr. Veena Shankaran, suggesting nearly 75% of patients with advanced colon cancer experience financial hardship as a result of treatment is discussed.
Researchers revise their timeline for the coronavirus’ rise in Washington state
Trevor Bedford is quoted on an updated analysis suggesting the WA1 COVID-19 patient was not the initial start to the outbreak in Washington.
Coronavirus contact tracing apps are coming to your phone. Here's how they work.
Allison Black explained COVID-19 contact tracing apps, and how they can be leveraged to slow COVID-19 spread.
New research suggests nation's first COVID-19 case was not the source of Washington's outbreak
Louise Moncla discussed new research suggesting a second introduction of COVID-19 led to the outbreak in Washington.
Drayer: Hutch Award winner Dee Gordon makes most of virtual ceremony
The first virtual Hutch Award ceremony and winner Dee Gordon are profiled.
Hutch award winner draws inspiration from history
The Hutch Award and 2020 winner Dee Gordon are profiled, specifically his philanthropic work and how he got into baseball.
Coronavirus epidemics began later than believed, study concludes
Trevor Bedford discussed his updated analysis suggesting the COVID-19 outbreak began in Seattle in February.
Genetic analysis raises more questions about the history of Washington state’s coronavirus outbreak
Trevor Bedford’s analysis of COVID-19 genomes suggesting Washington’s outbreak came from an alternative source than the original patient is referenced.
New research rewrites history of when COVID-19 arrived in U.S. — and points to missed chances to stop it
Trevor Bedford’s tweets on the start of the COVID-19 outbreak in Washington and patient WA1 are discussed.
Merck, one of Big Pharma’s biggest players, reveals its COVID-19 vaccine and therapy plans
Dr. Larry Corey is quoted on COVID-19 vaccine development progress.
Is the coronavirus mutating? Yes. But here’s why you don’t need to panic
Louise Moncla commented on mutations in SARS-CoV-2 and the lack of knowledge around the impact they have on the virus.
Fred Hutch president on response to coronavirus pandemic
President Dr. Thomas Lynch discussed Fred Hutch’s work related to COVID-19 virology, epidemiology and vaccine programs.
Explainer: what do we now know about COVID-19 – and can you get it twice?
Dr. Joshua Schiffer weighed in on the possibility of reinfection with COVID-19.
Seattle researchers part of accelerated coronavirus vaccine testing program
Dr. Larry Corey suggested potential timeframes for the development of a COVID-19 vaccine.
Exclusive: U.S. plans massive coronavirus vaccine testing effort to meet year-end deadline
Dr. Larry Corey discussed the current status of COVID-19 vaccine trials.
COVID-19 contact tracing apps are coming to a phone near you. How will we know whether they work?
Allison Black weighed in on COVID-19 contact tracing apps and the features they need to be effective.
Pandemic science speeds up — but there are limits
Dr. Joshua Schiffer weighed in on the possibility of reinfection with COVID-19, saying more research is needed.
Fred Hutch’s president says a new strain of virus research center is needed to fight future outbreaks
President Dr. Thomas Lynch explained the work Fred Hutch is doing on COVID-19 research and vaccines.
HIV vaccine trials group steps up to the COVID-19 plate
Dr. Larry Corey is quoted for the announcement of COVID-19 vaccine trials.
What computer-based models can tell us about coronavirus — and what they can’t
Dr. Elizabeth Halloran explained how we can use COVID-19 models to our advantage, and her recent modeling work and some of the caveats of model predictions.
No, we’re not all in this together — look at what’s happening with coronavirus in Yakima
Trevor Bedford is quoted on the lack of full COVID-19 suppression in the U.S. and the implications on further physical distancing policies.
Webby Awards: Tom Hanks, 'Game of Thrones,' Cardi B, LeBron James among winners
Trevor Bedford is listed for receiving a Webby Special Achievement award for Nextstrain.
Join GeekWire this week for a live virtual event with Fred Hutch President Dr. Thomas Lynch
Dr. Thomas Lynch and his live virtual chat with GeekWire are highlighted.
Amazon wants to innovate its way out of the pandemic
Bloomberg cited the CovidWatch study as one of the ways Amazon is working to stop COVID-19.
Coronavirus investigated: Scaling vaccines
Dr. Larry Corey explained COVID-19 vaccine strategy and the current status of research around COVID-19 in this video interview with Science.
Bowman: Federal bureaucrats continue to ravage Washington’s coronavirus response
Dr. Steve Pergam commented on the shutdown of SCAN by the FDA.
The coronavirus is most infectious before people even know they have it, UW virologist says
Dr. Keith Jerome discussed COVID-19 virology, the possibility of reinfection, and transmission.
California locked down early and took the coronavirus seriously. Why are its cases still rising?
Trevor Bedford’s comments on the COVID-19 status and lack of viral suppression in the U.S. are referenced.
Fred Hutch study targets front-line workers most at risk from the coronavirus
The Covidwatch study is profiled, with Dr. Michael Boeckh explaining the study goals.
Nancy Davidson describes plans for reopening the Seattle Cancer Care Alliance as COVID-19 wave recedes
Dr. Nancy Davidson described plans to reopen SCCA safely as COVID-19 cases decline in Washington.
When did the coronavirus arrive in the U.S.? Here’s a review of the evidence
Dr. Trevor Bedford weighed in on when COVID-19 arrived in the U.S., the origins of the virus, and more.
A conversation about COVID-19 with biostatisticians and epidemiologists
Dr. Elizabeth Halloran discussed COVID-19 testing, strategy, and modeling with other biostatisticians and epidemiologists studying the virus.
Is there a safe way to throw socially distanced shows?
Dr. Joshua Schiffer commented on the feasibility of staying safe from COVID-19 in large group gatherings such as concerts.
Amid the COVID-19 pandemic some scientists bring the bench home
Steven Heinkoff explained his at home CUT&Tag protocol and how he was able to bring his lab work home.
The genetic evolutionary tree of the U.S COVID outbreak
Trevor Bedford’s genomic analysis exploring the spread of COVID-19 across the U.S. is highlighted, along with Nextstrain.
Fred Hutch recruits essential workers for COVID-19 study
KIRO 7 covered the CovidWatch program, led by Dr. Michael Boeckh, which aims to better understand COVID-19.
Data forecast modeling for COVID-19 poses challenges
Ruth Etzioni explained the complications of COVID-19 modeling and the issues with the predictions they can make.
Arming immune foot soldiers against cancer
Dr. Monica Thakar commented on her work using natural killer cells to target solid tumors.
Coronavirus-tracking project backed by Bill Gates is put on hold due to FDA concerns
The SCAN program is explored, specifically it’s challenges and goals to track COVID-19 spread.
Coronavirus vaccine strategy: Larry Corey on the Long Run
Dr. Larry Corey discussed COVID-19 vaccine development and clinical trials.
Bill Gates is funding an at-home coronavirus test program — and it's already testing 300 people per day
The SCAN Initiative and the role of Gates Ventures in the program are discussed.
To take on the coronavirus, U.S. vaccine makers consider an unprecedented strategy: working together
Dr. Larry Corey commented on COVID-19 vaccine trials and strategy.
NIH Director Francis Collins shares his best-case scenario for a coronavirus vaccine: We could have a shot by fall but mass-producing it will be 'a heck of a stretch' by the end of the year.
Business Insider referenced an editorial piece co-written by Drs. Larry Corey, Anthony Fauci and other experts on COVID-19 vaccine development.
Scanning for answers to a pandemic
The SCAN initiative is profiled by Gates Notes, mentioning Fred Hutch as a partner.
Bill Gates is funding a new at-home COVID-19 testing program and it's already testing 300 people a day
The SCAN initiative and Gates Notes article on the program are discussed.
Let’s say there’s a COVID-19 vaccine—Who gets it first?
Dr. Larry Corey’s co-authored editorial in Science, explaining a roadmap to a COVID-19 vaccine and calling for a variety of approaches and collaboration, is discussed.
14 percent of American adults would refuse coronavirus vaccine, poll finds
The Science piece co-authored by Drs. Larry Corey, Anthony Fauci, Francis Collins and John Mascola is cited.
Fauci and other experts outline COVID-19 vaccine strategy
Dr. Larry Corey is quoted on the need for collaboration and multiple COVID-19 vaccines, in relation to the release of a co-authored piece on COVID-19 vaccine development in Science.
Bank of America gives $500,000 to Fred Hutch and Seattle Cancer Care Alliance for COVID-19 relief
GeekWire highlighted a Bank of America grant that will fund Fred Hutch COVID-19 response and the purchase of medical supplies for SCCA.
Disease experts declare it’s time to join forces for multiple COVID-19 vaccines
GeekWire featured Dr. Larry Corey’s Science perspective, co-authored with Drs Anthony Fauci, John Mascola and Francis Collins, on proposed COVID-19 vaccine plans.
Essential workers asked to volunteer for coronavirus study
KOMO profiled the COVIDWatch study led by Dr. Michael Boeckh to track COVID-19 in the population.
Bill Gates has regrets
Trevor Bedford’s discovery of COVID-19 community spread through the Seattle Flu Study is referenced.
Anthony Fauci, NIH director Collins say we’ll likely need more than one coronavirus vaccine to end pandemic
Dr. Larry Corey is discussed along with the co-authors Drs. Anthony Fauci, John Mascola and Francis Collins, on a Science perspective piece on the development of a COVID-19 vaccine.
What happens if a contact tracer contacts you?
Allison Black is mentioned for a segment where she discussed COVID-19 tracking and her work in the Bedford lab.
Big decline in Wash. State coronavirus cases after 'stay home' orders
Dr. Keith Jerome is quoted on the impact that early physical distancing measures had in lowering COVID-19 rates in Washington.
The virus is constantly mutating. What that means for treating COVID-19 is up for debate
Bloomberg quoted Trevor Bedford on statements suggesting that further research is needed to determine if one COVID-19 strain is more transmissible than others.
Cancer patients without insurance or Medicaid don’t experience the same benefits of clinical trials
A SWOG study led by Joseph Unger is featured, specifically findings that insurance plays a large role in whether a patient benefits from clinical trials.
The life-saving medicines inspired by animals
Dr. Jim Olson’s work with tumor paint to identify cancerous tissue and the motivation behind his research are discussed.
The porn industry tests and traces. Could it offer a model for reopening amid COVID-19?
Dr. Elizabeth Halloran explained how easily accessible and repeated testing, contract tracing and isolation when sick could keep COVID-19 under control without a vaccine.
You’ll probably never know if you had the coronavirus in January
Trevor Bedford weighed in on serology testing, the true COVID-19 incidence in the U.S., and how we could use blood samples to retroactively test for COVID-19.
The US is reopening too soon. One chart shows cases are still on the rise outside the tristate area.
Dr. Elizabeth Halloran discussed the need for increased COVID-19 testing and contact tracing to justify loosening physical distancing measures
Mutations in the coronavirus spike protein
Trevor Bedford’s statements on the implications of a mutation in SARS-Cov-2’s spike proteins are referenced.
Amazon lends its expertise — and its cash — to COVID-19 research
STAT covered the new COVIDWatch study and partnership with Amazon, aimed at learning more about COVID-19’s infection rate and if infection confers immunity.
'One big statistics lesson'
Dr. Ruth Etzioni explained the intricacies of modeling and how that relates to COVID-19 predictions.
Live updates: ‘Dangerous’ COVID-19 ‘parties’ begin to surface in Washington
Dr. Steve Pergam criticized those neglecting to follow physical distancing restrictions.
Why fully recovering from coronavirus might take longer than expected
Dr. Josh Schiffer explained the complexity of COVID-19 immune response and variability across patients.
Giving models and modelers a bad name
Dr. Ruth Etzioni commented on the IHME model and conclusions being drawn from that model.
A mutated coronavirus strain seems responsible for most of the world's COVID-19 infections. That doesn't mean it's more dangerous than the original
Business Insider discussed Nextstrain work and Trevor Bedford’s comments on COVID-19 lineages and the unknown impact on transmissibility.
Studies of coronavirus evolution stir up a controversy for scientists on social media
Trevor Bedford’s commentary on a COVID-19 spike mutation is referenced, suggesting we don’t know the impact of the mutation on transmissibility.
So many people are convinced that they had COVID-19 already
Trevor Bedford stated that it’s not possible SARS-CoV-2 was circulating in the U.S. in or before November 2019.
Researchers find new coronavirus strain 'more contagious', potentially impacting COVID-19 vaccine search
Trevor Bedford’s statements on the impacts of a SARS-Cov-2 mutation are cited, saying we need further research to determine if it impacts transmissibility.
Coronavirus in the U.S.: an unrelenting crush of cases and deaths
Trevor Bedford’s statements predicting continued COVID-19 infections across the U.S. are cited.
The spirit of giving is more powerful than ever
Kelly O’Brien discussed COVID-19 and the value of giving to scientific progress.
What COVID-19 antibody tests can and cannot tell us
Trevor Bedford’s commentary on the lack of accuracy of some COVID-19 antibody tests is included.
As pandemic claims non-COVID patients, some face difficult decisions
Dr. Gary Lyman discussed the risk cancer patients face with COVID-19 and his work with the COVID-19 and Cancer Consortium.
Mathematical models help predict the trajectory of the coronavirus outbreak. But can they be believed?
Dr. Elizabeth Halloran Ruth Etzioni explained how COVID-19 models help scientists and policy makers understand the impact of different restrictions on viral spread.
The search is on for America’s earliest coronavirus deaths
Louise Moncla provided insight to why there are likely unknown early February COVID-19 deaths.
How early COVID-19 detection sounded ‘tornado siren’ for WA response
Dr. Steve Pergam discussed the importance of early detection of COVID-19 in Washington’s virus response.
The fight against COVID-19 threatens to cause collateral health damage
Rachel Issaka weighed in on the need to continue cancer and other chronic disease management and prevention work despite COVID-19.
Was the new coronavirus accidentally released from a Wuhan lab? It’s doubtful.
Trevor Bedford reinforced the scientific reasons why COVID-19 did not originate from a lab, but rather a natural setting.
Led by ex-Husky Tanner Swanson, Northwest-based MLB coaches band together for ‘Coaches vs. COVID’ program
The Seattle Times profiled Tanner Swanson and his fundraising efforts for Coaches vs. COVID.
How coronavirus mutates and spreads
Trevor Bedford is listed as a source of COVID-19 spread and tracking data.
Labs across U.S. join federal initiative to study coronavirus genome
Pavitra Roychoudhury discussed her work with COVID-19 genomics and tracking, specifically a sequence sharing project.
Helping cancer survivors cope with cancer-related anxiety and distress
Karen Syrjala provided insight on helping cancer survivors manage stress and anxiety, and the limitations of current information.
One in 8 Americans say they know someone who died of COVID-19, according to a new Insider poll
Dr. Elizabeth Halloran commented on the potential outcomes of easing physical distancing restrictions too early.
Can antibody tests tell if you're immune to COVID-19?
Jesse Bloom explained how COVID-19 serology tests work.
Gilead, without details, says COVID-19 drug clears crucial clinical test
Dr. Elizabeth Duke explained issues trying to find a drug to properly control and treat COVID-19.
South Africa's HIV failures cost more than 300,000 lives. Now this painful past is helping in COVID-19 fight.
Dr. Larry Corey weighed in on the use of HIV ARV’s as potential treatments for COVID-19.
Keeping an academic lab afloat in a pandemic
Dr. Jim Olson discussed the challenges of running a lab during COVID-19.
COVID-19 was here earlier than most Americans thought. Now what?
Trevor Bedford’s analysis that COVID-19 was introduced to the US sometime in January is referenced.
Mariners' Dee Gordon honored with prestigious 'Hutch Award'
KING 5 profiled the 2020 Hutch Award winner Dee Gordon.
Top Seattle-area health official worries COVID-19 could spread across country as states reopen
GeekWire highlighted Trevor Bedford’s research tracking COVID-19, and referenced a webinar featuring Dr. Elizabeth Halloran.
ASCO panel outlines cancer care challenges during COVID-19 pandemic
Dr. Gary Lyman’s comments from a panel on COVID-19 and cancer care are highlighted.
The AIDS crisis forged a generation of activists; now they’re supporting the LGBTQ+ community in the coronavirus pandemic
Russell Campbell commented on how the COVID-19 pandemic echoes the AIDs epidemic in its impact on minorities and under-served populations.
Scott Gottlieb discusses coronavirus on "Face the Nation,"
Trevor Bedford’s timeline of the COVID-19 pandemic in the U.S. beginning in early January is referenced.
White House medic Deborah Birx said coronavirus deaths will 'dramatically' decrease by the end of May, but social distancing will go on for much longer
Dr. Elizabeth Halloran suggested what may happen as a result of relaxing physical distancing measures too early.
New York's low coronavirus transmission rate suggests the state's outbreak is contained for now
Dr. Elizabeth Halloran gave insight to what may happen is physical distancing measures are loosened.
Giants bench coach Kai Correa on teaching defense, #CoachesvsCOVID, and his path to MLB
Kai Correa, Giants bench coach, discussed his work fundraising for Fred Hutch as part of the Coaches vs. COVID program.
Who to follow on Twitter for legit, trustworthy coronavirus info
Trevor Bedford is included as a credible source of COVID-19 information.
The real problem with the manufactured coronavirus liberty protests
Trevor Bedford is quoted on his test, trace, isolate strategies to stop the COVID-19 pandemic.
Why experts are questioning two hyped antibody studies in coronavirus hotspots
Trevor Bedford’s comments on new antibody study results suggesting high antibody prevalence in the community are included.
The coronavirus isn’t just the flu, bro
Trevor Bedford’s analysis of the death rate from COVID-19 in New York City is referenced.
Yes, the coronavirus mutates. But those tiny changes haven't affected how dangerous it is — instead, they help scientists track its spread.
Trevor Bedford’s and Nextstrain collaborator Emma Hodcraft’s comments on the mutation rate of COVID-19 and the implications of that for vaccine efficacy are discussed.
How to build and deploy testing systems at unprecedented scale
Trevor Bedford’s test, trace and isolate plan to stop COVID-19 spread is explored.
Dee Gordon wins 2019 Hutch Award
Hutch award winner Dee Gordon is featured, specifically his baseball and philanthropic achievements.
How Hutch Award winner Dee Gordon is helping during coronavirus pandemic
ESPN profiled 2020 Hutch Award winner Dee Gordon of the Mariners, highlighting his philanthropic work throughout his career.
Intense radiotherapy slows prostate cancer growth
Dr. Andrew Hsieh commented on new research on a treatment for prostate cancer growth.
Italy's lockdowns prevented 200,000 hospitalizations and reduced coronavirus transmission by nearly half, a new study finds
Dr. Elizabeth Halloran discussed how COVID-19 differs from other infectious diseases like measles, specifically in its higher transmissibility.
Mariners’ Dee Gordon receives 2020 Hutch Award
The Tacoma News Tribune profiled Dee Gordon, who was chosen as the 2020 Hutch Award winner.
Mariners second baseman Dee Gordan receives 2020 Hutch Award
Dee Gordon’s work with charities to provide food during COVID-19 and support those affected by domestic violence is discussed in light of him receiving the 2020 Hutch Award.
A woman who recovered from the coronavirus tried to donate her plasma, but she barely had any antibodies. It highlights lingering questions about immunity.
Dr. Elizabeth Halloran suggested that while we hope being infected with COVID-19 produces immunity for at least a year, further research is needed to confirm.
The race to make vaccines faster
Andy McGuire commented on the vaccine development process in reference to COVID-19 vaccine research.
Hidden outbreaks spread through U.S. cities far earlier than Americans knew, estimates say
Trevor Bedford’s statements suggesting undetected COVID-19 spread across Washington in late February are cited.
'Expert Twitter' only goes so far. Bring back blogs
Wired discussed Trevor Bedford’s rise to Twitter fame through his research communications in a larger piece on Twitter as a news source.
Mariners' Gordon wins prestigious Hutch Award
Reuters highlighted the new Hutch Award recipient, Dee Gordon, for his charitable work.
Charitable works earn Mariners infielder Dee Gordon the 55th Hutch Award
Dee Gordon’s statements on receiving the 2020 Hutch Award are quoted, in a profile of his charity work.
A coronavirus death in early February was ‘probably the tip of an iceberg’
The New York Times referenced Trevor Bedford’s genetic analysis work placing the start of the COVID-19 outbreak in Washington in early February, in light of new data on an early February COVID-19 death.
Some Americans are convinced they had the coronavirus in December or January. Experts say it's highly unlikely.
Trevor Bedford’s tweets reinforcing that COVID-19 was not circulating in the U.S. in December are cited.
News feature: Venom back in vogue as a wellspring for drug candidates
Dr. Jim Olson’s research on using scorpion venom peptides to locate tumors is explored.
Coronavirus model used by white house increases death toll 10%
Dr. Ruth Etzioni’s statements on the use of the IHME model to make policy decisions are quoted.
New York's subway may have boosted the coronavirus' spread, but researchers think one-third of coronavirus transmission happens in the home
Dr. Elizabeth Halloran commented on physical distancing measures in Washington, and the impact it had on slowing COVID-19 transmission.
Solving the mysteries of coronavirus with genetic fingerprints
The New York Times recalled the story of the Washington COVID-19 outbreak and how genomic analysis helped track the virus, quoting Pavitra Roychoudhury and Trevor Bedford.
CDC: First US coronavirus deaths happened weeks before first death in Kirkland
Louise Moncla explained why we need to expand COVID-19 tracing and testing abilities to interpret the spread that led to early deaths in California.
STAT Health Tech newsletter
STAT News highlighted a Fred Hutch and AWS collaboration on a COVID-19 study called COVIDWatch
How to navigate the blizzard of COVID-19 antibody studies
Dr. Ruth Etzioni gave context to all of the new antibody studies coming out, reinforcing the wide range in accuracy across tests.
Mutations map holds the key to bringing coronavirus under control
Trevor Bedford’s statements on when COVID-19 began circulating in the U.S. and Nextstrain findings are referenced.
UPDATED: Datavant boots up a big COVID-19 registry — looking to shine a light on virus spread, impact and most effective therapies
Dr. Joshua Schiffer commented on a new COVID-19 patient registry to improve research efforts.
Stepping up exercise could help beat the cold virus
A Fred Hutch study on the health benefits of adding walking into the lives of otherwise sedentary people is referenced.
COVID-19 Q&A with experts
Dr. Joshua Schiffer is quoted on the use of hydroxychloroquine for COVID-19 treatment and the lack of understanding of its impact.
To know the real number of coronavirus cases in the US, China, or Italy, researchers say multiply by 10
Dr. Elizabeth Halloran emphasized the difficulty in determining to number of COVID-19 cases due to lack of testing.
Washington state may be able to ease social distancing in a month, according to models
Ruth Etzioni commented on the use of COVID-19 models to inform policy decisions, noting some models are not being interpreted properly.
What viral evolution can teach us about the coronavirus pandemic
Trevor Bedford’s work is referenced as part of an analysis of how we study pandemics and disease.
UW coronavirus model says Washington state could potentially start safely reopening the week of May 18
In light of new modeling results, Ruth Etzioni reinforced that policy makers should draw on multiple models to make policy decisions.
Saving a city: How Seattle’s corporate giants banded together to flatten the curve
Drs. Tom Lynch and Larry Corey recalled the start of the COVID-19 epidemic and discussed Fred Hutch’s efforts to track and control the virus along with other notable Seattle companies.
A New York City hospital developed one of the few FDA-approved antibody tests for the coronavirus. It could test up to 2,000 people per day
Dr. Elizabeth Halloran explained that COVID-19 serological tests have not yet been perfected, and some may give false results.
Risky business: Scientists seek volunteers for ‘CovidWatch’ virus-tracking study
GeekWire covered a new Fred Hutch study, Covidwatch, focused on those most at risk to get COVID-19, to help us better understand characteristics of the virus.
Seattle researchers report early results from first US ‘swab and send’ COVID-19 surveillance program
Early results from the SCAN program, of which Fred Hutch is a partner, are discussed.
Chris Cuomo says his one coronavirus 'silver lining' just came crashing down
Trevor Bedford’s statements reinforcing COVID-19 was not in the U.S. last fall are referenced.
Getting it right: Walking the diagnostic and serologic testing tightrope
Ruth Etzioni explained serologic and diagnostic COVID-19 tests, and the uncertainties associated with each.
Have you recovered from COVID-19? The UW Medicine Virology Lab wants to test your blood
Drs. Larry Corey and Jesse Bloom discussed new COVID-19 antibody tests and research on neutralizing antibodies
Greater Seattle coronavirus assessment network (SCAN) releases data from first 18 days of testing
Dr. Tom Lynch commented on the hard work and early data from the SCAN COVID-19 testing program.
Another month? Computer modelers estimate how much longer coronavirus shutdowns should last
Ruth Etzioni explained despite its predictions, the IHME model should not be the only model used to make policy decisions around COVID-19.
How coronavirus testing and contact tracing work together to quell COVID-19
Trevor Bedford’s tweets explaining his test, trace, and isolate strategies for COVID-19 using digital and non-digital tools are discussed.
Leading experts launch COVID-19 & cancer consortium
Gary Lyman’s comments on the new COVID-19 cancer registry are discussed.
How Fred Hutch unlocks siloed data with AWS and open-source software
Fred Hutch’s use of a new software to de-silo and streamline data with AWS is discussed.
The US is 'a long way' from beating the coronavirus with herd immunity, experts say, since that would require 50% of the population being immune
Dr. Elizabeth Halloran commented on the possibility of herd immunity to COVID-19, suggesting we have not reached that level of infection.
The coronavirus is mutating. What does that mean for a vaccine?
Trevor Bedford commented on how mutation rates may or may not impact a COVID-19 vaccine.
One key figure helps countries decide when their coronavirus outbreaks are over — but scientists say it's a moving target
Dr. Elizabeth Halloran advised on the conditions necessary to lift COVID-19 lockdowns and keep the virus under control.
U.S. grapples with how to drastically ramp up COVID-19 contact tracing
Trevor Bedford’s digital tracing endeavor, Nexttrace, is cited as one way to slow COVID-19.
Another sign the curve is bending: Positive coronavirus tests at UW peaked March 28
Larry Corey provided context to a new study from Fred Hutch and UW suggesting Washington state has successfully lowered COVID-19 infections through physical distancing measures.
Avoid Twitter’s swamp of misinformation by following these epidemiology experts
Trevor Bedford is listed as a COVID-19 expert, to help reduce misinformation about the virus.
Tips on using science Twitter during COVID-19
PLoS Blogs delved into science communications, referencing Trevor Bedford’s use of twitter to explain COVID-19 research.
Genetic tracking helped us fight Ebola. Why can’t it halt COVID-19?
Trevor Bedford’s genomic analysis work to track COVID-19 from the initial outbreak in the U.S. is mentioned.
Why COVID-19 can’t be directly compared with the flu
Ruth Etzioni explained from a statistical point of view why despite some similarities, COVID-19 is not comparable to the flu.
NY death toll passes 10,000; new hot spots slow to emerge
Trevor Bedford suggested even with lifted physical distancing measures, COVID-19 may not rebound as strongly as the public exercises more caution.
Coaches team up in battle against COVID-19
Fred Hutch Coaches vs. COVID fundraiser Tanner Swanson discussed why he was motivated to fundraise for Fred Hutch research.
Seattle researcher debunks theory COVID-19 spread in Calif. in November
KOMO covered Trevor Bedford’s latest tweets debunking beliefs that COVID-19 was circulating prior to January in Washington and California.
More on that alleged intel report, and when did COVID-19 really begin?
Trevor Bedford’s statements reinforcing the timeline of the U.S. COVID-19 outbreak are included, along with data from Nextstrain.
When will this end, and what comes next? Health officials and epidemiologists are working to figure out Washington’s coronavirus end game
Dr. Elizabeth Halloran and Trevor Bedford’s recommendations to keep COVID-19 at bay and loosen physical distancing measures are discussed.
Taken out of the ball game, coaches go online to teach skills and aid Fred Hutch’s COVID-19 fight
The Coaches vs. COVID fundraising campaign for Fred Hutch is profiled, with fundraiser Tanner Swanson sharing what motivated him to fundraise for COVID-19 research.
Episode 8: The virus-eye view
Jesse Bloom and Harmit Malik explained the process of a viral infection, referencing SARS-CoV-2 from first introduction into the body to the onset of the infection.
No, you did not get COVID-19 in the fall of 2019
Allison Black, a genomic epidemiologist in the Bedford Lab, debunked sentiments that SARS-CoV-2 was circulating in the U.S. in fall 2019.
Modified sleep apnea machines may ease the ventilator crunch
A study from Fred Hutch researchers on the use of ventilators in COVID-19 patients is cited.
Can smart phone apps help beat pandemics?
Trevor Bedford’s work on NextTrace, a digital COVID-19 tracing method, is highlighted.
COVID-19 and cancer: How to protect ‘the most vulnerable’ during pandemic
Dr. Steve Pergam commented on the increased susceptibility for COVID-19 within cancer patients, and how oncologists should prepare.
Before the flood
Dr. Steve Pergam, along with other first responders in the Seattle area, published a piece on the COVID-19 pandemic and outbreaks in Washington.
Social distancing is controlling COVID-19; now scientists need to figure out which measures are most effective
Trevor Bedford’s latest tweets suggesting physical distancing measures have been effective in Washington state are cited.
Blood tests promise to show who had COVID-19 and didn’t know it
Drs. Keith Jerome and Larry Corey explained work on blood tests for CoV-2 antibodies and the need for a vaccine.
Most New York coronavirus cases came from Europe, genomes show
Trevor Bedford reinforced that his genomic analysis suggested a January introduction of COVID-19 to the U.S.
'Did I already have coronavirus?': People wonder if they previously had COVID-19, but the answer isn't easy
Trevor Bedford’s analysis suggesting a mid-January start date for the COVID-19 outbreak in Washington state is referenced.
100+ doctors on coronavirus
Dr. Anne McTiernan is featured in a video of scientists and doctors discussing COVID-19.
COVID-19 models: What makes them tick?
Dr. Ruth Etzioni explained the different types of modeling, what they mean and how they are used to predict COVID-19 parameters.
Tech leaders help kick off $50M fundraising campaign for UW Medicine’s COVID-19 work
Fred Hutch is listed among institutions fundraising for COVID-19 work.
Seattle’s COVID-19 lessons are yielding hope
Trevor Bedford’s initial research suggesting community COVID-19 transmission in Washington is recalled.
Immunomedics halts late-stage clinical trial, confirming drug benefit for aggressive type of breast cancer
Dr. Julie Gralow commented on the success of a new breast cancer treatment trial, with the drug illustrating benefits across the study.
How the coronavirus overwhelmed Washington state’s early efforts to contain it
Trevor Bedford’s early analysis that COVID-19 was circulating undetected in Washington State is referenced.
Alexa, do I have coronavirus?
Trevor Bedford is referenced for his work and comments on fighting COVID-19.
Blood test may detect multiple cancer types: Study
Dr. William Grady commented on an outside study on blood tests and cancer detection.
How do COVID-19 deaths compare to flu deaths in Washington state?
Dr. Steve Pergam’s comments on how COVID-19 compares to the flu are included.
Infectious disease expert Steve Pergam shares his prescription for a safe weekend get-together
GeekWire covered Dr. Steve Pergam’s live COVID-19 Q&A, highlighting ways to stay safe but social.
Questions but few answers on COVID-19
Dr. Elizabeth Halloran answered questions about the outlook for COVID-19, and next steps to stop the pandemic.
ASH research collaborative's data hub creates international data registry for patients with blood cancers and COVID-19
Dr. Stephanie Lee spoke about the new ASH COVID-19 registry for patients run who had or currently have blood cancers.
COVID-19 spreads too fast for traditional contact tracing. New digital tools could help
STAT featured Trevor Bedford and NextTrace, a new platform that uses digital contact tracing to stop COVID-19.
Data registry to guide care for patients with COVID-19, blood cancers
Dr. Stephanie Lee commented on the new ASH COVID-19 Registry for cancer patients with COVID-19.
Coronavirus sleuths kick off campaign for digital tracing of COVID-19 contacts
GeekWire profiled Trevor Bedford’s new program NextTrace, that uses contact-tracing to stop COVID-19.
COVID-19: What's happening now (April 1, 2020)
Dr. Gary Lyman and Dr. Michael Boeckh discussed patient care and safety during COVID-19, and the Cancer Care COVID-19 registry.
In the race to crack COVID-19, scientists bypass peer review
Undark mentioned Trevor Bedford’s use of twitter to comment on a preprint paper about COVID-19.
Genetic analysis of the coronavirus gives scientists clues about how it’s spreading
Trevor Bedford’s use of genetic data to link the COVID-19 patients in Washington is cited.
With record-setting speed, vaccine makers take their first shots at the new coronavirus
Dr. Larry Corey commented on the quick development of potential vaccines and vaccine trials for COVID-19.
Virologists are divided over need for draconian shutdowns
Trevor Bedford’s proposed strategies for slowing and tracking COVID-19 spread are considered, along with others.
The mathematics of predicting the course of the coronavirus
Wired reflected on Trevor Bedford’s analysis that by early March COVID-19 had already been circulating in Washington State for weeks.
As coronavirus spreads, Seattle scientists fast-track potential treatments for COVID-19
Dr. Larry Corey explained how the Seattle scientific community is stepping up to tackle COVID-19.
One Seattle party, 8 coronavirus cases: An anatomy of an outbreak
Trevor Bedford’s analysis indicating COVID-19 community transmission had occurred in January is discussed.
The human DNA is littered with fossils of viruses past that attacked us. And lost
Drs. Michael Emerman and Harmit Malik’s work on how they use paleovirology to study viruses, specifically HIV, is discussed.
Experts converge on plans for easing coronavirus restrictions safely
The Washington Post discussed a report co-written by Trevor Bedford, outlining steps to guide states through the COVID-19 outbreak.
Handicapping the future of financial markets
Trevor Bedford is included in a list of scientific resources on COVID-19.
The other coronavirus test we need
Dr. Jesse Bloom discussed the logistics of developing and using a serological test for the virus causing COVID-19, to determine who has been exposed to the virus.
Cancer moonshot workshop highlights recent research advances
Dr. Pete Nelson’s recent presentation on new prostate cancer treatment methods is included in a summary of the Cancer Moonshot meeting.
Not all or nothing: Anti-virus lockdowns could lift slowly
Elizabeth Halloran called for widespread COVID-19 testing as the first step to bring down the pandemic.
The Seattle scientific community, mobilized
Dr. Kristin Anderson wrote about the researchers in Seattle who are working together to study and combat COVID-19, including Drs. Keith Jerome, Alex Greninger and Trevor Bedford.
March 27: The week in cancer news
Tips for cancer patients in light of COVID-19 from a Fred Hutch news story are included in a weekly round-up.
‘It isn’t our normal way of working’: Coronavirus outbreak tests limits of remote work in Seattle area
Kelly Crimmins discussed how working remotely has impacted her and her team’s work life and productivity.
Dr. Julie McElrath on lifting physical distancing measures
Dr. Julie McElrath estimated when the COVID-19 outbreak will reach its peak and when we might see a lift on physical distancing measures.
How coronavirus mutations can track its spread—and disprove conspiracies
Trevor Bedford explained how Nextstrain has evolved with open and rapid data sharing, allowing for real time tracking of COVID-19 mutations and spread.
Dr. Julie McElrath on COVID-19 vaccines
Dr. Julie McElrath discussed potential COVID-19 vaccine options and programs.
The U.S. now has more confirmed coronavirus cases than anywhere else in the world
Vox mentioned Trevor Bedford’s U.S. COVID-19 infection estimates and research on the spread of the virus.
Cancer consortium launches COVID-19 registry in urgent appeal for data to save lives at risk from infection
Dr. Gary Lyman commented on the new COVID-19 and Cancer Consortium (CCC19) registry and how they will use COVID-19 data to inform treatment.
How does the coronavirus behave inside a patient?
Dr. Joshua Schiffer and Bryan Mayer discussed viral load variability in patients and what that could mean for COVID-19.
Dr. Tom Lynch on COVID-19 challenges
Dr. Tom Lynch described the challenges of testing and accurately reporting COVID-19 in a Fred Hutch town hall.
Eerily on the mark, a gene detective's coronavirus findings raise hope and fear in equal measure
The Nextstrain project and Trevor Bedford’s analyses on COVID-19 are explained.
How ASH supports the hematology community during COVID-19, with Drs. Stephanie Lee & Laura Michaelis
Dr. Stephanie Lee spoke about COVID-19 and hematology, and how ASH is supporting the community.
The coronavirus is mutating. But that may not be a problem for humans
Trevor Bedford commented on the implications of COVID-19’s slow mutation rates, suggesting it will lead to immunity after exposure.
The coronavirus mutates more slowly than the flu — which means a vaccine will likely be effective long-term
Trevor Bedford’s comments on the mutation patterns of COVID-19 and how that impacts vaccine production are cited.
COVID-19 poses special challenges to cancer care
Drs. Steve Pergam and Masumi Ueda gave expert advice on treating cancer patients during the COVID-19 pandemic.
The blind leading the blind: COVID-19, cancer, and the need for more data
Dr. Gary Lyman discussed best practices for treating cancer patients during the COVID-19 outbreak.
Fred Hutch researcher: ‘We need facts from experts’ in coronavirus briefings
Dr. Steve Pergam called for more scientific involvement in decisions around COVID-19 containment.
Some cancer patients face delayed surgeries and scaled-back treatments as the coronavirus advances
Dr. Nancy E. Davidson discussed how cancer patient treatment has evolved in light of COVID-19.
Seattle coronavirus assessment network launches with boost from Bill Gates, Amazon and volunteers
The new SCAN initiative is profiled, mentioning Fred Hutch as one of the founding partners.
A virologist answers your questions about coronavirus
Jesse Bloom answered questions from community members on COVID-19 and the current status of COVID-19 research.
Cancer care and COVID-19 in Seattle, the first U.S. epicenter
Dr. Masumi Ueda explained how Fred Hutch’s clinical care partner Seattle Cancer Care Alliance approached COVID-19 prevention and identification in clinics and workspaces.
How long will the outbreak last? It depends on what we do now
Trevor Bedford is quoted on ideas to tackle the COVID-19 pandemic through social distancing and extensive testing.
The coronavirus testing paradox
Trevor Bedford’s tweets on suggested strategies to curb the COVID-19 pandemic are quoted, specifically on the need for increased testing and social distancing.
Amazon will deliver and pick up test kits being issued by a new coronavirus program in Seattle
Fred Hutch is listed among other partners involved in the new SCAN program to test for COVID-19 across Seattle, through mailed test kits.
When will the coronavirus pandemic end? What scientists can say about life returning to normal
Dr. Elizabeth Halloran reinforced the need for COVID-19 testing to control the pandemic.
How the virus got out
Trevor Bedford and Dr. Elizabeth Halloran provided expertise for this interactive COVID-19 map, which overlays travel and migration data with epidemiological data.
How the coronavirus became an American catastrophe
The Atlantic described Trevor Bedford’s work in discovering COVID-19 had spread in Washington to his recommendations for slowing the pandemic.
The 9 most important unanswered questions about COVID-19
Trevor Bedford commented on U.S. COVID-19 infection rates, providing estimates between 10,000 – 40,000.
How to navigate cancer in the wake of the COVID-19 pandemic
Dr. Steve Pergam gave insight on the risk of cancer patients for COVID-19 infection.
Study suggests COVID-19 might follow seasonal pattern
Dr. Elizabeth Halloran provides context to COVID-19 transmission rates and spread.
How genetic mapping is allowing scientists to track the spread of coronavirus
Trevor Bedford and Jesse Bloom gave context to how they used genomic analysis of COVID-19 to track its spread.
How long will Americans be fighting the coronavirus?
Dr. Elizabeth Halloran explained community transmission and how it can lead to an epidemic in reference to COVID-19.
The danger of a second wave
Trevor Bedford’s methods for stopping the COVID-19 outbreak are outlined, including isolating the infected, and having those who are recovered return to work.
Covid-19 roundup: Fred Hutch cuts down further on lab work, Roche joins Regeneron and Sanofi in IL-6 trials, China orders a vaccine effort
Fred Hutch is included in a round up of COVID-19 updates across cancer and biotechnology companies.
In hard-hit Seattle, coronavirus pushes biotechs to a new normal
Hilary Hehman discussed how Fred Hutch is continuing research and supporting partnerships during the COVID-19 pandemic.
Coronavirus sleuth outlines his ‘Apollo program’ for bringing down the pandemic
Trevor Bedford commented on a new modeling report, suggesting how social distancing measures and testing can stop the COVID-19 pandemic.
Mild cases may be driving coronavirus spread
WebMD discussed Dr. Elizabeth Halloran’s Science paper on COVID-19 modeling and preventative measures to limit transmission.
How South Korea scaled coronavirus testing while the U.S. fell dangerously behind
Trevor Bedford commented on the Ohio COVID-19 infection numbers, suggesting they are overestimated.
Why social distancing is so hard – and so important
Dr. Steve Pergam provided crucial advice on social distancing and the role it plays in preventing COVID-19 spread.
11 things everyone should know about getting the novel coronavirus
Vox mentioned Trevor Bedford’s estimates that there are around 20,000 COVID-19 cases across the U.S. to date.
Coronavirus is hiding in plain sight
Dr. Elizabeth Halloran, an infectious disease expert, provided commentary on the need for widespread COVID-19 testing.
Over 85% of COVID-19 infections in China went undetected early on
Dr. Elizabeth Halloran reinforced the importance of testing and social distancing to lower COVID-19 transmission.
COVID-19 and cancer
Dr. Steve Pergam gave Healio in depth advice to cancer patients to protect themselves from COVID-19.
Why Washington state is at the center of the US coronavirus outbreak
Dr. Keith Jerome’s COVID-19 test kit and the development of UW’s testing facilities are discussed.
'Invisible enemy'
Politico referenced Trevor Bedford’s estimate that there are between 10,000 – 40,000 U.S. COVID-19 cases.
Coronavirus: Infected people without symptoms are driving epidemic’s fast spread
Dr. Elizabeth Halloran stressed the importance of wide-spread testing to slow the spread of COVID-19.
Scott Gottlieb discusses coronavirus on 'Face the Nation' March 15, 2020
Trevor Bedford’s commented on COVID-19 infection rate estimates across the U.S. are considered.
How it spreads, infects: Coronavirus impact comes into focus
The Associated Press explored if reinfection is possible, referencing research on COVID-19 mutation rates from Fred Hutch.
Can people who recover from COVID-19 become reinfected?
Snopes referenced Fred Hutch research on mutation rates of COVID-19 in relation to the possibility of reinfection.
Seattle expert estimates 20,000 novel coronavirus infections in the U.S. now
Trevor Bedford’s estimates of U.S. COVID-19 infection rates are mentioned in light of new outbreaks.
Coronavirus hot zone: Research and responses in the U.S. epicenter
Dr. Steve Pergam is interviewed on COVID-19 and the risk to immunocompromised people.
The etiquette of social distancing in the time of coronavirus, from the ‘Miss Manners’ of germs
Dr. Steve Pergam, an infectious disease expert, provided commentary on social distancing in light of COVID-19.
Trump is banning travelers from the UK to combat coronavirus. Domestic travel restrictions could come next
Trevor Bedford’s research suggesting most new COVID-19 cases are due to community transmission rather than travel is highlighted.
Flu watchdog spots more with fever and cough, but it’s not flu
Trevor Bedford’s tweets on transmission chains leading to COVID-19 outbreaks across the U.S. are mentioned.
Mapping the social network of coronavirus
Betz Halloran commented on the power of data science and modeling to track COVID-19 and other viruses.
COVID-19 can’t spread if you stay home
A modeling study from Fred Hutch is cited on results suggesting Seattle two weeks ago was approximately in the position of Wuhan, China, on Jan. 1.
Is your cancer center ready for COVID-19?
Dr. Steve Pergam provided expert commentary for cancer patients in light of COVID-19 and increased risk.
Efforts to control coronavirus could get even more extreme
Results from a preliminary paper indicating that social distancing is effective at lowering disease spread by Trevor Bedford and colleagues is mentioned.
Microbiome predicts blood-cell transplant success
David Fredricks commented on outcomes of a large, international study showing that the microbiome predicts transplant success.
Data sharing and open source software help combat COVID-19
Open data sharing and the use of Nextstrain by Trevor Bedford and colleagues to track COVID-19 is discussed.
How much is coronavirus spreading under the radar?
Trevor Bedford’s discovery of community transmission of COVID-19 in Washington is referenced.
Cancelations and rising confusion: This week’s coronavirus news
Trevor Bedford is included in a list of COVID-19 experts.
Coronavirus is already here. Blocking travelers won’t prevent its spread.
Vox referenced Trevor Bedford’s analysis on the impact of travel bans to prevent COVID-19 spread.
Without ‘social distancing,’ 400 could die from coronavirus in Western Washington by April 7, study suggests
Results from a preliminary paper indicating that social distancing is effective at lowering disease spread by Trevor Bedford and colleagues is mentioned.
Local efforts are much more important than travel bans to stop the spread of infection
Dr. Elizabeth Halloran discussed her Science study showing how travel bans slowed but did not stop the spread of COVID-19.
FOX News Rundown
Dr. Jesse Bloom explained COVID-19 and its spread from his point of view as a virologist.
Sports provide a refuge, but they blurred our vision on coronavirus
A study by Trevor Bedford and colleagues predicting infection rates is referenced in light of new social distancing measures.
Researcher says more coronavirus testing will help manage outbreak, but travel bans? Not so much
Trevor Bedford’s analysis on infection rates and the efficacy of travel bans to lower COVID-19 transmission is discussed.
Scientist links 2 state outbreaks with genetic fingerprints
Trevor Bedford explained his analysis of the transmission pathway of COVID-19 throughout Washington, likely beginning with one person.
Merkel gives Germans a hard truth about the coronavirus
Infectious disease expert Betz Halloran provided global infection rate estimates based on her research.
Please, listen to experts about the coronavirus. Then step up.
Trevor Bedford is referenced for his research suggesting a larger outbreak in Washington than testing has reflected.
AP source: Inslee to ban large gatherings in Seattle area
Trevor Bedford’s research with Seattle Flu Study is referenced as support for new social distancing measures.
“The nature of viruses is to mutate”: Mapping the spread of a deadly disease
Vanity Fair profiled Trevor Bedford and Nextstrain collaborators, referencing tracking COVID-19, genomic analysis and transmission rates.
Why older and chronically ill Americans are at greatest risk from coronavirus
Dr. Steve Pergam comments on COVID-19 risk for cancer patients.
How does one Seattle coronavirus patient turn into two six weeks later?
Massive Science delves into how COVID-19 spread without detection, referencing Trevor Bedford’s detailed genetic analysis of community transmission.
Cancer patients and coronavirus: Here's everything to know
Dr. Steve Pergam is quoted on his advice for cancer patients in light of increased risk for COVID-19.
How to cope with Seattle’s coronavirus outbreak? Pretend that you’re snowed in
GeekWire discussed social distancing in light of Trevor Bedford’s COVID-19 transmission predictions.
Italy’s coronavirus crisis could be America’s
Trevor Bedford is quoted among other Nextstrain collaborators on their COVID-19 analysis, in light of Italy's outbreak.
Mutations can reveal how the coronavirus moves—but they’re easy to overinterpret
Trevor Bedford’s genetic analysis on the spread of COVID-19 into Italy and the spread across Washington State is considered.
Seattle’s patient zero spread coronavirus despite ebola-style lockdown
Bloomberg followed the Washington COVID-19 outbreak, including Trevor Bedford’s discovery of community transmission and subsequent genetic analysis of the spread.
Coronavirus mismanagement is risking American lives
Fred Hutch and Trevor Bedford’s modeling results suggesting undetected COVID-19 are cited in a commentary about COVID-19 spread.
Gates Foundation to deliver at-home coronavirus test kits, additional funding to Seattle
Fred Hutch is mentioned as one of the institutions supporting Seattle Flu Study.
Coronavirus: A disease that thrives on human error
Trevor Bedford is quoted on his research on missed transmission pathways of COVID-19.
The official coronavirus numbers are wrong, and everyone knows it
Trevor Bedford’s data indicating untracked COVID-19 spread in Washington State is referenced.
Study says travel restrictions can delay, but can’t defeat a global coronavirus outbreak
Biostatistician Elizabeth Halloran’s research on the role of travel restrictions in delaying COVID-19 spread is discussed.
I live in Kirkland, epicenter of the US outbreak. We need Trump to take this seriously
Fred Hutch research on COVID-19 community transmission rates in Kirkland, Washington is mentioned.
Coronavirus vs. oncology: Meeting cancellations, travel restrictions, fears about drug supply chain
The Cancer Letter includes Fred Hutch’s remote work policy in a list of updates related to COVID-19.
Fred Hutch mandates remote working to curb COVID-19
FierceBiotech profiled Fred Hutch for COVID-19 remote work policies and for Trevor Bedford’s COVID-19 research.
Some good coronavirus news: genetic detectives are on the case
Computational biologist Trevor Bedford explained how researchers are using Nextstrain and genetic analysis techniques to track COVID-19 in real time.
Seattle's critical coronavirus test
Gates Foundation funding of COVID-19 research, including Fred Hutch and Seattle Flu Study, is mentioned.
Scientists say coronavirus mutations aren’t more deadly or contagious
Computational biologist Trevor Bedford discussed how he has been using Nextstrain to understand COVID-19 genetics and spread.
The race to unravel the United States’ biggest coronavirus outbreak
Seattle Flu Study is profiled, delving into Drs. Keith Jerome, Helen Chu and Trevor Bedford’s research on COVID19 genetic analysis and vaccine development.
Software and genetic sequencing track the coronavirus's path
Trevor Bedford’s research using the Nextstrain platform is explored, specifically its role in real time tracking of COVID-19.
Coronavirus in the US: Tracking cases and deaths
Trevor Bedford's research suggesting under detection of COVID-19 cases in Washington State is mentioned.
Exclusive: The strongest evidence yet that America is botching coronavirus testing
Virologist Dr. Keith Jerome’s COVID-19 testing kit is discussed, along with Trevor Bedford’s computational analysis of COVID-19 spread.
Fred Hutchinson Center initiates mandatory work-from-home policy as outbreak roils businesses, conferences
Fred Hutch’s work from home policy is mentioned, among other local organizations, as a response to the COVID-19 outbreak in Washington State.
In the age of coronavirus, our nation needs a responsible leader who trusts scientists
Trevor Bedford explains how a lack of testing allowed COVID-19 to spread undetected in Washington State.
Why Washington State? How did it start? Questions answered on the U.S. coronavirus outbreak
Trevor Bedford’s work on the spread and genetic variation of COVID-19 from China to the US is discussed.
Washington coronavirus update: Pence heads to state amid outbreak as school close, companies’ employees told to work remotely and more
Fred Hutch is included in a summary of coronavirus updates about Washington State, for the implementation of the work from home policy.
Microsoft, Amazon and other tech firms urge employees to work from home to slow spread of coronavirus
Fred Hutch’s work from home policy is mentioned, among other local organizations, as a response to the COVID-19 outbreak in Washington State.
Coronavirus Live Updates: The latest COVID-19 developments in Seattle and the world of tech
Fred Hutch is included in a round up of Seattle tech companies implementing work policy changes in response to COVID-19.
The coronavirus is exposing another disease we need to cure, stat
A columnist referenced computational biologist Trevor Bedford and his blog content on COVID-19 projected spread and recommendations.
Response in China slowed outbreak of coronavirus — but experts caution against extreme measures in Seattle
Fred Hutch and computational biologist Trevor Bedford are referenced on the COVID-19 outbreak and preventative measures cities are taking to slow the spread of the virus.
Feds investigate nursing home as U.S. death toll hits 11
Fred Hutch is cited as one the organizations implementing social distancing policies as a result of the COVID-19 outbreak in Washington State.
UW Medicine ramps up new coronavirus lab test; Gates Foundation pledges $5M for detection
The Seattle Flu study is discussed, including Fred Hutch’s role in the project, as part of the release of a new testing kit for COVID-19.
UW Medicine gets green light to test for coronavirus
Dr. Keith Jerome, a virologist, provided commentary on his new COVID-19 testing kit at UW Medicine.
Column: COVID-19 could kill the for-profit science publishing model. That would be a good thing
The rapid data sharing involved in Trevor Bedford’s work is discussed as an example of open science.
Inside the work being done to conquer blood diseases
Dr. Stephanie Lee explained the work of hematologists and the role of ASH in moving hematology forward.
Washington State risks seeing explosion in coronavirus cases without dramatic action, new analysis says
Computational biologist Trevor Bedford explained his analysis on COVID-19 spread and provided recommendations for the greater Seattle area.
What people with HIV need to know about the new coronavirus
Infectious disease expert Dr. Steve Pergam comments on what people with HIV need to know about COVID-19
Authorities announce 2nd coronavirus death in US
Trevor Bedford, a computational biologist, is quoted on his COVID-19 genetic analysis.
Coronavirus may have spread in Washington state for weeks, according to study
Computational biologist Trevor Bedford and his research on the Washington COVID-19 outbreak is discussed.
New coronavirus cases in Western Washington are likely doubling every 6 days, Fred Hutch scientist says
Trevor Bedford, a computational biologist, provided expert commentary on the infection rates and genetic analysis of COVID-19.
What people with cancer need to know about the new coronavirus
Dr. Steve Pergam, an infectious disease expert, provided insight on COVID-19 risk for cancer patients.
Genetic analysis suggests coronavirus infections double every six days, spreading to hundreds
Computational biologist Trevor Bedford discussed his analysis providing COVID-19 infection estimates for Washington state
A dire phase of the coronavirus outbreak? ‘Boom’ of US cases ‘should be expected’ as global death toll tops 3,000
Trevor Bedford, a computational biologist, is quoted on the COVID-19 spread and genetic analysis.
A second person in the U.S. – and King County – dies of novel coronavirus; more cases likely
Computational biologist Trevor Bedford is quoted on COVID-19 transmission in Seattle.
Coronavirus may have spread in U.S. for weeks, gene sequencing suggests
Computational biologist Trevor Bedford is quoted on the COVID-19 outbreak in Seattle.
As testing quickly ramps up, expect more U.S. coronavirus cases
Trevor Bedford, a computational biologist, is mentioned in reference to COVID-19 genetic analysis and spread in Washington.
Scott Gottlieb “Face the Nation”
Computational biologist Trevor Bedford and Fred Hutch are mentioned in reference to the COVID-19 outbreak and genetic analysis.
No, the coronavirus was not genetically engineered in a Wuhan lab, expert says
Trevor Bedford, a computational biologist, provided expert commentary on the origins of COVID-19.
Here’s how computer models simulate the future spread of new coronavirus
Elizabeth Halloran, an infectious disease expert, discussed modeling and projections for COVID-19’s spread.
'We're opening everything': Scientists share coronavirus data in unprecedented way to contain, treat disease
Trevor Bedford, a computational biologist, shared his thoughts on how open data sharing has aided real-time tracking of COVID-19.
Mining coronavirus genomes for clues to the outbreak’s origins
Trevor Bedford, a computational biologist, discussed COVID-19 and his research on the virus’ genome.
Robot is helping to treat man with coronavirus in special isolation room at hospital north of Seattle
Computational biologist Trevor Bedford’s research on COVID-19 is mentioned in reference to a patient in Everett, Washington.
Containing new coronavirus may not be feasible, experts say, as they warn of possible sustained global spread
Computational biologist Trevor Bedford discussed projections for the spread of COVID-19.
Scientists race to find out how Wuhan victims became ill
Trevor Bedford, a computational biologist, provided expert commentary on COVID-19.
New virus paralyzes Chinese cities
Computational biologist Trevor Bedford discussed COVID-19.
Could China's new coronavirus become a global epidemic?
Trevor Bedford, a computational biologist, discussed his analysis of COVID-19 genomes.
China coronavirus: Six questions scientists are asking
Computational biologist Trevor Bedford provided expert commentary on COVID-19.
Ex-Bristol R&D Chief to helm Seattle cancer center
Dr. Thomas J. Lynch shared some of his top goals for Fred Hutch as its incoming president and director.
Scientists link mysterious snippets of DNA to cell growth and tumor suppresion
Dr. Rob Bradley discussed the importance of poison exons and tumor suppression.
Taking supplements during breast cancer treatment increase risk of death and relapse, what does this mean for patients?
Dr. Kevin Cheung provided expert commentary on the relationship between breast cancer and nutritional supplements.
Leaving the reservation for higher education: The story of two brothers
Great Falls Tribune profiled Josh Marceau and his path to Fred Hutch.
CAR T-cell therapy in pediatric ALL
OncLive featured Dr. David Maloney in a panel on CAR T-cell therapies for pediatric ALL.
Barbie puts on a lab coat and finds formula to win holiday diorama contest at Seattle’s Fred Hutch
Graeme Black of Fred Hutch’s immunology program commented on the idea behind his “Winterfest” diorama contest entry.
Now & then: Grown-up Joey Hutchinson’s fire is ‘all part of the legacy’
Joey Hutchinson, grandson of Fred Hutchinson, discussed his family’s legacy.
How one common immune cell prevents checkpoint inhibitors from attacking cancer
FierceBiotech covered Dr. McGarry Houghton’s study on neutrophils and checkpoint inhibitors.
Fred Hutchinson is researching new cancer treatments in the cloud with AWS
Dr. Raphael Gottardo discussed how machine learning can help his work in immunotherapy research.
Don’t call me Karen, Cheryl, Nancy, Reshma, Cornelia, Caryn, Sharon, …call me “Doctor”.
Dr. Nancy Davidson shared her experiences with gender bias in oncology.
Thin metal films loaded with immune cells show promise as cancer therapy
Dr. Matthias Stephan commented on his research on CAR T-cell delivery systems.
Why didn’t we hatch from eggs? Thank viruses, says biologist
Dr. Harmit Malik discussed his research on retroviruses.
Gary Gilliland: Seattle has ‘extraordinary potential’ to be a leader in cancer research
Dr. Gary Gilliland shared his views on the future of Fred Hutch.
A new study says hair dyes and chemical straighteners may cause cancer
Dr. Anne McTiernan provided expert commentary on the relationship between hair dyes and cancer.
An HIV vaccine by 2021? Here is what needs to happen
Forbes detailed the current status of HIV trials, including those conducted by the HIV Vaccine Trials Network, which is headquartered at Fred Hutch.
Cancer sends many patients into bankruptcy. Advisors are stepping up to stop that
Dr. Veena Shankaran shared her insights about the financial burden of cancer care.
Lung-MAP trial reveals genetic testing knowledge gaps among patients
Dr. Joshua Roth discussed his study on genetic testing knowledge.
Melanoma rates falling sharply among teens and young adults, UW study finds
KOMO News covered a recent study between Fred Hutch and UW researchers that found that melanoma rates are decreasing in young adults.
Lung cancer rates among women are falling much slower than those in men. Here’s why
Dr. Alice Berger commented on the possible roles of genetics in lung cancer prevalence among women who do not smoke.
Denise Galloway helped pave the way for the HPV vaccine
Dr. Denise Galloway shared some career highlights as part of winning a 2019 Women of Influence Award.
From cancer patient to medical crusader: Fred Hutch researcher shares her journey
Dr. Kristin Anderson shared her personal story about what led her to study immunology in ovarian cancer.
How clinical trials are leading to breakthroughs in cancer treatments
Dr. Damian Green discussed the importance of clinical trials.
Hormone therapy for breast cancer
Dr. Hannah M. Linden provided expert commentary on hormone therapy.
How Washington keeps America sick and fat
Dr. Mario Kratz commented on clinical nutrition research funding.
The Health 202: cancer patients have steep expenses beyond treatment. This rock band is trying to help.
Washington Post Dr. Anne McTiernan provided expert commentary on cancer risk factors.
The Health 202: cancer patients have steep expenses beyond treatment. This rock band is trying to help.
Washington Post Dr. Anne McTiernan provided expert commentary on cancer risk factors.
Vaginal fluid transplants hold promise but raise safety concerns
Dr. David Fredricks, a microbiome researcher, provided expert commentary on vaginal microbiota transplantation.
Vaginal fluid transplants hold promise but raise safety concerns
Dr. David Fredricks, a microbiome researcher, provided expert commentary on vaginal microbiota transplantation.
Fred Hutch scientists on how gold nanoparticles could bring CRISPR to the developing world
GeekWire featured Dr. Jennifer Adair’s research on CRISPR and gold nanoparticles.
Fred Hutch scientists on how gold nanoparticles could bring CRISPR to the developing world
GeekWire featured Dr. Jennifer Adair’s research on CRISPR and gold nanoparticles.
Why the women most likely to die of breast cancer have gotten the least attention
TIME included expert commentary from Dr. Cyrus Ghajar on metastatic breast cancer.
ElevateBio founds HighPassBio to develop Fred Hutch cell therapy
FierceBiotech highlighted new spinout HighPassBio, founded by Hutch researcher Marie Bleakley.
Seattle researchers seeking volunteers for breast cancer study
KING 5 highlighed a current study led by Dr. Anne McTiernan looking at the effects of exercise on breast cancer.
ElevateBio founds HighPassBio to develop Fred Hutch cell therapy
FierceBiotech highlighted new spinout HighPassBio, founded by Hutch researcher Marie Bleakley.
Seattle researchers seeking volunteers for breast cancer study
KING 5 highlighted a current study led by Dr. Anne McTiernan looking at the effects of exercise on breast cancer.
Why the women most likely to die of breast cancer have gotten the least attention
Time included expert commentary from Dr. Cyrus Ghajar on metastatic breast cancer.
GeekWire Summit: Health tech innovators to discuss gene editing; AI; telemedicine; and more
GeekWire highlighted Dr. Jennifer Adair’s talk on gene editing at the GeekWire Summit.
Milestones in Medicine: How Immunotherapy Began in Cancer Care
Cure featured Dr. Phil Greenberg’s research on T-cell receptor therapies.
Gift to Fred Hutchinson Cancer Research Center fueling push to cure pediatric cancer
KIRO 7 featured Fred Hutch’s efforts in pediatric cancer research.
Gift to Fred Hutchinson Cancer Research Center fueling push to cure pediatric cancer
KIRO 7 featured Fred Hutch’s efforts in pediatric cancer research.
GeekWire Summit: Health tech innovators to discuss gene editing; AI; telemedicine; and more
GeekWire highlighted Dr. Jennifer Adair’s talk on gene editing at the GeekWire Summit.
Milestones in Medicine: How Immunotherapy Began in Cancer Care
Cure featured Dr. Phil Greenberg’s research on T-cell receptor therapies.
Dr. Lyman on challenges with biosimilar policies
Dr. Gary Lyman, senior lead of health care quality and policy at Fred Hutch, provided expert commentary on biosimilar policies.
Dr. Lyman on challenges with biosimilar policies
Dr. Gary Lyman, senior lead of health care quality and policy at Fred Hutch, provided expert commentary on biosimilar policies.
HIV vaccine shows signs of cross-subtype protection
FierceBiotech featured a Fred Hutch study suggesting cross-subtype immune response against HIV in South Africa.
HIV vaccine shows signs of cross-subtype protection
FierceBiotech featured a Fred Hutch study suggesting cross-subtype immune response against HIV in South Africa.
Life after surviving cancer: the relief, challenges, and new fears
KUOW hosted Laura Landro, WSJ contributor, who discusses her treatment at Fred Hutch.
Life after surviving cancer: the relief, challenges, and new fears
KUOW hosted Laura Landro, WSJ contributor, who discusses her treatment at Fred Hutch.
Dr. Grivas on biomarker for Pembrolizumab response in urothelial cancer
OncLive highlighted Dr. Petros Grivas and his work on urothelial cancer.
Fred Hutch President Gary Gilliland to step down as leader of cancer research powerhouse
GeekWire featured President Gary Gilliland’s statement on stepping down from his role at Fred Hutch.
Fred Hutch President Gary Gilliland to step down as leader of cancer research powerhouse
GeekWire featured President Gary Gilliland’s statement on stepping down from his role at Fred Hutch.
Dr. Grivas on biomarker for Pembrolizumab response in urothelial cancer
OncLive highlighted Dr. Petros Grivas and his work on urothelial cancer.
A Patient’s Guide to Acute Lymphoblastic Leukemia
Dr. Ryan Cassaday shared his expertise on Acute Lymphoblastic Leukemia.
Reducing the risk of blood clots in patients with Multiple Myeloma
Cure Today featured Dr. Ang Li’s paper on risk factors for patients with Multiple Myeloma.
A Patient’s Guide to Acute Lymphoblastic Leukemia
Dr. Ryan Cassaday shared his expertise on Acute Lymphoblastic Leukemia.
Reducing the risk of blood clots in patients with Multiple Myeloma
Cure Today featured Dr. Ang Li’s paper on risk factors for patients with Multiple Myeloma.
Weight loss possible with psychiatric drugs
Dr. Anne McTiernan provided expert commentary on a weight loss and psychiatric drug interaction study.
Weight loss possible with psychiatric drugs
Anne McTiernan provided expert commentary on a weight loss and psychiatric drug interaction study.
Low-Fat Dietary Pattern Offers Long-Term Health Benefits
HealthDay features Dr. Ross Prentice and the Women’s Health Initiative research on the benefits of long-term benefits of low-fat diets for
Highlights from ASCO’s quality care symposium: A clinical trial may offer the best survival odds for people battling Non-Small-Cell Lung Cancer, but not enough patients enroll in them
Everyday Health highlights Dr. Cristina Merkhofer’s research on how clinical trial participation increases non-small-cell lung cancer survival times.
Low-Fat Dietary Pattern Offers Long-Term Health Benefits
HealthDay features Dr. Ross Prentice and the Women’s Health Initiative research on the benefits of long-term benefits of low-fat diets for
Highlights from ASCO’s quality care symposium: A clinical trial may offer the best survival odds for people battling Non-Small-Cell Lung Cancer, but not enough patients enroll in them
Everyday Health highlights Dr. Cristina Merkhofer’s research on how clinical trial participation increases non-small-cell lung cancer survival times.
Paperwork, high costs could mean worse survival for lung cancer patients
HealthDay highlights Dr. Bernardo Goulart’s work on the impact of high out-pocket costs on the survival of lung cancer patients with certain mutations.
Seeking Immunity: Exploring Kaposi’s Sarcoma
Dr. Thomas Uldrick provides expert commentary on Kaposi’s sarcoma- associated herpesvirus.
Seeking Immunity: Exploring Kaposi’s Sarcoma
Dr. Thomas Uldrick provides expert commentary on Kaposi’s sarcoma- associated herpesvirus.
CRISPR slows the growth of triple-negative breast cancer in mice
FierceBiotech references Fred Hutch research on the use of gold nanoparticles to deliver CRISPR edited cells to targeted areas.
CRISPR slows the growth of triple-negative breast cancer in mice
FierceBiotech references Fred Hutch research on the use of gold nanoparticles to deliver CRISPR edited cells to targeted areas.
Fred Hutch program inspires teens interested in science
KING 5 News profiled Fred Hutch’s Jeanne Ting Chowning and her work with the Pathway Explorers Program to educate and train the next-generation of scientists.
What does your waist say about your health? According to a new study, a lot more than you’d think.
The Seattle Times features Dr. Marian Neuhouser’s research on body mass index, waist size and health correlates.
Fred Hutch program inspires teens interested in science
KING 5 News profiled Fred Hutch’s Jeanne Ting Chowning and her work with the Pathway Explorers Program to educate and train the next-generation of scientists.
What does your waist say about your health? According to a new study, a lot more than you’d think.
The Seattle Times features Dr. Marian Neuhouser’s research on body mass index, waist size and health correlates.
Fred Hutch program inspires teens interested in science
KING 5 News profiled Fred Hutch’s Jeanne Ting Chowning and her work with the Pathway Explorers Program to educate and train the next-generation of scientists.
What does your waist say about your health? According to a new study, a lot more than you’d think.
The Seattle Times features Dr. Marian Neuhouser’s research on body mass index, waist size and health correlates.
NMSU and University of Washington students learn community health first-hand in rural NM
This article highlights the Health Disparities Field Experience, a 2-week immersive experience for University of Washington graduate students to travel to New Mexico and learn about health disparities in communities in the U.S Southwest. This was the first annual Health Disparities Field Experience sponsored by the Partnership for the Advancement of Cancer Research, a federally funded partnership between NMSU and Fred Hutch. .
NMSU and University of Washington students learn community health first-hand in rural NM
This article highlights the Health Disparities Field Experience, a 2-week immersive experience for University of Washington graduate students to travel to New Mexico and learn about health disparities in communities in the U.S Southwest. This was the first annual Health Disparities Field Experience sponsored by the Partnership for the Advancement of Cancer Research, a federally funded partnership between NMSU and Fred Hutch. .
NMSU and University of Washington students learn community health first-hand in rural NM
This article highlights the Health Disparities Field Experience, a 2-week immersive experience for University of Washington graduate students to travel to New Mexico and learn about health disparities in communities in the U.S Southwest. This was the first annual Health Disparities Field Experience sponsored by the Partnership for the Advancement of Cancer Research, a federally funded partnership between NMSU and Fred Hutch. .
Dr. John Hansen, who made marrow transplants safer, dies at 76
The New York Times highlights honored the late-Dr. John Hansen and his contributions to bone marrow transplant research. Note: Subscription required.
Dr. John Hansen, who made marrow transplants safer, dies at 76
The New York Times highlights honored the late-Dr. John Hansen and his contributions to bone marrow transplant research. Note: Subscription required.
Dr. John Hansen, who made marrow transplants safer, dies at 76
The New York Times highlights honored the late-Dr. John Hansen and his contributions to bone marrow transplant research. Note: Subscription required.
Dr. John Hansen, who made marrow transplants safer, dies at 76
The New York Times highlights honored the late-Dr. John Hansen and his contributions to bone marrow transplant research. Note: Subscription required.
Dense breast notification laws not leading to more screening ultrasounds
Reuters highlighted Dr. Christoph Lee’s study, which showed that despite state laws requiring women be notified of dense breast tissue, indicating higher cancer risk, this does not lead to increased screening ultrasound rates.
Dense breast notification laws not leading to more screening ultrasounds
Reuters highlighted Dr. Christoph Lee’s study, which showed that despite state laws requiring women be notified of dense breast tissue, indicating higher cancer risk, this does not lead to increased screening ultrasound rates.
Dense breast notification laws not leading to more screening ultrasounds
Reuters highlighted Dr. Christoph Lee’s study, which showed that despite state laws requiring women be notified of dense breast tissue, indicating higher cancer risk, this does not lead to increased screening ultrasound rates.
Dense breast notification laws not leading to more screening ultrasounds
Reuters highlighted Dr. Christoph Lee’s study, which showed that despite state laws requiring women be notified of dense breast tissue, indicating higher cancer risk, this does not lead to increased screening ultrasound rates.
Can an immune strategy used to treat cancer also wipe out HIV infections?
Hans-Peter Kiem provides expert commentary on the application of CAR T cell immunotherapy for HIV.
Can an immune strategy used to treat cancer also wipe out HIV infections?
Hans-Peter Kiem provides expert commentary on the application of CART cell immunotherapy for HIV.
Can an immune strategy used to treat cancer also wipe out HIV infections?
Hans-Peter Kiem provides expert commentary on the application of CART cell immunotherapy for HIV.
Can an immune strategy used to treat cancer also wipe out HIV infections?
Hans-Peter Kiem provides expert commentary on the application of CART cell immunotherapy for HIV.
Meet the 30 young leaders who are transforming the future of healthcare and disrupting a $3.5 trillion industry
Emily Silgard was chosen as one of Business Insider’s 30 under 40 awardees. This article highlights her efforts in leading a data science team at Fred Hutch. Note: Subscription required.
What we need to do to get more people with cancer into clinical trials
Dr. Joseph Unger provided expert commentary focused on clinical trial participation barriers.
Meet the 30 young leaders who are transforming the future of healthcare and disrupting a $3.5 trillion industry
Emily Silgard was chosen as one of Business Insider’s 30 under 40 awardees. This article highlights her efforts in leading a data science team at Fred Hutch. Note: Subscription required.
What we need to do to get more people with cancer into clinical trials
Dr. Joseph Unger provided expert commentary focused on clinical trial participation barriers.
Meet the 30 young leaders who are transforming the future of healthcare and disrupting a $3.5 trillion industry
Emily Silgard was chosen as one of Business Insider’s 30 under 40 awardees. This article highlights her efforts in leading a data science team at Fred Hutch. Note: Subscription required.
What we need to do to get more people with cancer into clinical trials
Dr. Joseph Unger provided expert commentary focused on clinical trial participation barriers.
Meet the 30 young leaders who are transforming the future of healthcare and disrupting a $3.5 trillion industry
Emily Silgard was chosen as one of Business Insider’s 30 under 40 awardees. This article highlights her efforts in leading a data science team at Fred Hutch. Note: Subscription required.
Reversing sickle cell disease with CRISPR-edited stem cells
FierceBiotech highlights Hans-Peter Kiem’s research on the use of CRISPR to alter genes related to fetal hemoglobin production.
Reversing sickle cell disease with CRISPR-edited stem cells
FierceBiotech highlights Hans-Peter Kiem’s research on the use of CRISPR to alter genes related to fetal hemoglobin production.
Reversing sickle cell disease with CRISPR-edited stem cells
FierceBiotech highlights Hans-Peter Kiem’s research on the use of CRISPR to alter genes related to fetal hemoglobin production.
Seattle mom turns the flight of her life into funds for cancer research
KING 5 News profiled Dr. Damian Green’s work on multiple myeloma with patient and fundraising advocate Sarah Kaufmann- Fink.
Seattle mom turns the flight of her life into funds for cancer research
KING 5 News profiled Dr. Damian Green’s work on multiple myeloma with patient and fundraising advocate Sarah Kaufmann- Fink.
Seattle mom turns the flight of her life into funds for cancer research
KING 5 News profiled Dr. Damian Green’s work on multiple myeloma with patient and fundraising advocate Sarah Kaufmann- Fink.
Ongoing study will examine cardiac toxicity of breast cancer treatment
Cure Today featured Kerryn Reding, a member of the UPBEAT study team, and their research on the cardiovascular effects of breast cancer.
Ongoing study will examine cardiac toxicity of breast cancer treatment
Cure Today featured Kerryn Reding, a member of the UPBEAT study team, and their research on the cardiovascular effects of breast cancer.
Gene found in embryos can cloak cancer from common immunotherapy methods, researchers find
GeekWire highlighted research led by Drs. Robert Bradley and Stephen Tapscott on how a gene normally found in early development, helps cancer cells avoid detection from the immune system.
Gene found in embryos can cloak cancer from common immunotherapy methods, researchers find
GeekWire highlighted research led by Drs. Robert Bradley and Stephen Tapscott on how a gene normally found in early development, helps cancer cells avoid detection from the immune system.
A’s Stephen Piscotty, the 2019 Hutch Award winner, on a mission to find cure for ALS after losing mother
The Seattle Times ran a feature on 2019 Hutch Award winner Stephen Piscotty.
A’s Stephen Piscotty, the 2019 Hutch Award winner, on a mission to find cure for ALS after losing mother
The Seattle Times ran a feature on 2019 Hutch Award winner Stephen Piscotty.
The Promise and price of cellular therapies
The July 22 issue of The New Yorker spotlights Fred Hutch’s pioneering research in bone marrow transplantation and how it led to cell therapies using a patient’s own cells.
The Promise and price of cellular therapies
The July 22 issue of The New Yorker spotlights Fred Hutch’s pioneering research in bone marrow transplantation and how it led to cell therapies using a patient’s own cells.
Microsoft joins with Pacific NW medical research institutions on data discovery platform
GeekWire covered the Cascadia Data Discovery Initiative, a new collaboration between Fred Hutch and Microsoft to create a shared network of research data.
Microsoft joins with Pacific NW medical research institutions on data discovery platform
GeekWire covered the Cascadia Data Discovery Initiative, a new collaboration between Fred Hutch and Microsoft to create a shared network of research data.
Fred Hutch appoints execs from Amazon and Celgene to board
The Puget Sound Business Journal covered the recent additions to the Fred Hutch board of directors. Sean Boyle from Amazon Web Services, and Dr. Corsee Sanders from Celgene will be added to the board.
Biopsies May Help Guide Treatment for Bladder Cancer
The Cancer Network analyzed Dr. Andrew Hsieh’s study on bladder cancer and rapid autopsies.
Geeking out with a goal: Regina Wu brings Hutch research to classrooms
The Seattle Times profiled Regina Wu, a curriculum designer and educator at Fred Hutch, in its “Cool Jobs” feature.
Avoid these cancer-causing foods
Dr. Jeannette Schenk commented on what foods people should limit or avoid in order to reduce their cancer risk.
Fred Hutch appoints execs from Amazon and Celgene to board
The Puget Sound Business Journal covered the recent additions to the Fred Hutch board of directors. Sean Boyle from Amazon Web Services, and Dr. Corsee Sanders from Celgene will be added to the board.
Biopsies May Help Guide Treatment for Bladder Cancer
The Cancer Network analyzed Dr. Andrew Hsieh’s study on bladder cancer and rapid autopsies.
Geeking out with a goal: Regina Wu brings Hutch research to classrooms
The Seattle Times profiled Regina Wu, a curriculum designer and educator at Fred Hutch, in its “Cool Jobs” feature.
Avoid these cancer-causing foods
Dr. Jeannette Schenk commented on what foods people should limit or avoid in order to reduce their cancer risk.
The Summer of Fred Hutch
Fred Hutch vice president Kelly O’Brien appeared on KING 5 News to discuss the community events Fred Hutch is organizing over the summer to fund cancer research.
The Summer of Fred Hutch
Fred Hutch vice president Kelly O’Brien appeared on KING 5 News to discuss the community events Fred Hutch is organizing over the summer to fund cancer research.
Why this cancer researcher (and survivor) is climbing Kilimanjaro to raise money to study cancer
GeekWire featured Dr. Kristin Anderson, a post-doctoral researcher at Fred Hutch who is climbing Mount Kilimanjaro this summer to raise money for Fred Hutch as part of the Climb to Fight Cancer fundraising effort.
How Fred Hutchinson saved baseball in Seattle
Lookout Landing posted a profile of Fred Hutchinson and his legacy on the field and in the community
Stored in synapses: How scientists completed a map of the roundworm’s brain
Fred Hutch Dr. Aakanksha Singhvi provided expert commentary on recent research that shows a map the roundworm’s brain and what it means for understanding how brain controls behavior.
Influx of Targeted Therapies Prompts Several Questions in AML Paradigms
OncLive profiled Dr. Mary-Beth Percival about her work using targeted agents to treat patients with acute myeloid leukemia.
Who was Fred Hutchinson?
KING 5 Evening aired a feature on Fred Hutchinson’s career and the legacy of his namesake cancer center.
Dr. Shadman on challenges with CAR T-cell therapy
Dr. Mazyar Shadman explains that one of the main challenges with CAR T-cell therapy is that there are an increasing number of CAR T-cell therapies, making it difficult for an effective product to stand out.
Hutch, the baseball hero and namesake for the cancer research center founded by his brother, was born in Seattle 100 years ago
The Seattle Times’ Pacific NW Magazine dedicated its “Now & Then” feature to Fred Hutchinson honoring what would have been his 100th birthday.
Lung cancer screening guidelines may miss more African Americans at risk
Dr. Jaimee Heffner provided expert commentary on a new study about lung cancer screening guidelines. This story was re-printed in several other outlets, including Business Insider.
Prostate cancer diagnosis may become easier with new urine test
Dr. Ruth Etzioni provided expert commentary about a new urine test to detect prostate cancer.
Cost effectiveness of CAR T-Cell therapy depends on long-term outcomes
Dr. Josh Roth provided expert commentary about a study on cost of CAR-T therapy.
Concurrent ibrutinib with CAR T-Cell therapy improves ORR, reduces severe CRS in high-risk CLL
OncLive featured Dr. Jordan Gauthier’s study of a combination immunotherapy for patients with high risk- chronic lymphocytic leukemia (CLL).
Phase 1 study demonstrates safety of pembrolizumab in patients with HIV and advanced cancer
American Journal of Managed Care featured Dr. Tom Uldrick’s recent study showing that pembrolizumab is safe in cancer patients with HIV.
HBV tied to non-liver digestive-tract cancers
MedPage Today highlighted a study led by Fred Hutch’s Dr. Scott Ramsey, which showed that newly diagnosed cancer patients were unaware that they were infected with Hepatitis B and other viruses.
Disrupted gut microbiome promotes breast cancer spread in mice
Dr. Susan Bullman commented on a study about the gut microbiome and breast cancer.
Recruiting an Old Drug for a New Purpose in Battle Against Pediatric AML
Dr. Allison Kaeding is featured in a profile piece for her work on pediatric acute myeloid leukemia (AML).
CRISPR gene-edited babies may be at increased risk of early death, study finds
Fred Hutch Dr. Hans-Peter Kiem, director of the Stem Cell and Gene Therapy Program at Fred Hutch, provided expert commentary on a study about editing genes passed down to offspring.
Listen: A special episode from the halls of the ASCO meeting
STAT interviewed Dr. Parth Shah on The Readout Loud podcast about his research on increasing HPV vaccination rates in the U.S.
Genetic mutation that prevents HIV infection tied to earlier death
Dr. Hans-Peter Kiem provided expert commentary on a recent study showing that a genetic mutation of a gene that protects HIV infection is associated with earlier death.
Dr. Gary Gilliland on Fred Hutch and Washington commerce
United Airlines’ in-flight magazine interviewed Dr. Gary Gilliland to learn more about Fred Hutch’s work with Microsoft and Amazon to help advance cancer research.
Local study asks, does a day's exercise fight breast cancer?
Dr. Anne McTiernan shared her expertise on exercise and cancer prevention in a segment that highlighted her new exercise study.
Protecting against RSV
Reader’s Digest covered Dr. Justin Taylor’s recent study in Science Immunology on B cell engineering.
OncLive honors 15 trailblazers with giants of cancer care program
OncLive included Dr. Fred Appelbaum as one of this year’s “Giants of Cancer Care” for his leukemia work.
Fred Hutchinson team uses gold nanoparticles to improve CRISPR gene editing
Fred Hutch Dr. Jennifer Adair’s recent research published in Nature Materials shows how to use a gold nanoparticle to deliver gene editing machinery to blood stem cells.
Health claims in nutrition books can be a ‘volcano of nonsense.’ A new website is fighting back.
Dr. Mario Kratz provided comments on why he reviews the latest nutrition and health books for the Red Pen Reviews website.
Historic steam plant in Seattle gets a fresh new look courtesy of Fred Hutch
GeekWire highlighted Fred Hutch’s recent developments to move into the historic Lake Union Steam Plant building.
Piscotty honored as Hutch Award winner
MLB.com covered the news of Oakland A’s outfielder Stephen Piscotty winning the Hutch Award. The news was also published in the San Francisco Chronicle, NBC Sports Bay Area, and the San Jose Mercury News.
Genetically engineered immune cells fight off deadly virus in mice
Science covered a B cell engineering study led by Dr. Justin Taylor.
Researchers use gene editing to make cells immune to HIV and other infections in Fred Hutch study
GeekWire covered Fred Hutch Dr. Justin Taylor’s recent work using gene editing to protect against HIV and other viruses.
Seattle skyline to glow orange for National Cancer Research Month
King 5 highlighted Fred Hutch’s ‘Glow Orange to Cure Cancer’ campaign, a week-long campaign where Seattle landmarks and businesses glowed orange for a week in May in honor of National Cancer Research month.
Does sleep apnea cause cancer? New evidence suggests women could be at more risk
Dr Amanda Phipps, was interviewed by Survivornet about the association of sleep apnea and cancer risk.
Study highlights challenges in using artificial intelligence to personalize cancer treatment
STAT covered Dr. Bernardo Goulart’s study on using artificial intelligence to identify certain lung cancer patients.
Algorithms help spot cancer ‘lottery winners’ in new Fred Hutch study
GeekWire profiled Fred Hutch Dr. Bernardo Goulart’s recent study on using artificial intelligence to identify lung cancer patients that have certain mutations.
Recruiting an Old Drug for a New Purpose in Battle Against Pediatric AML
Dr. Allison Kaeding is featured in a profile piece for her work on pediatric acute myeloid leukemia (AML).
A new study links sugary drinks with disease. The reality is more complicated
The Seattle Times cited Dr. Mario Kratz about the health impact of sugary beverages.
Fred Hutch researchers map how bird flu jumps to humans
GeekWire covered Fred Hutch Dr. Jesse Bloom’s recent study looking at how the bird flu travels to humans.
How you can climb the spire on top of the Space Needle
KING 5 aired a story on the Base 2 Space fundraising event that benefits Fred Hutch.
Tech Moves: Madrona Venture Labs staffs up; Washington State Opportunity Scholarship executive director departs; and more
GeekWire highlighted Drs. Nancy Davidson and Denise Galloway recent induction into the Academy of Arts and Sciences, a scholarly society that began in 1780.
High-deductible health policies linked to delayed diagnosis and treatment
Dr. Veena Shankaran, co-director of Fred Hutch’s health care and economics policy research group, the Hutchinson Institute for Cancer Outcomes Research, commented on the impact of high-deductible health plans on people with cancer.
5' UTR mutations in prostate cancer
At the American Association for Cancer Research annual meeting, Fred Hutch Dr. Yiting Lim explained the 5’ UTR mutations that are present among the DNA of prostate cancer patients.
5' UTR mutations in prostate cancer
Ecancer, April 15, 2019
At the American Association for Cancer Research annual meeting, Fred Hutch Dr. Yiting Lim explained the 5’ UTR mutations that are present among the DNA of prostate cancer patients.
The disturbing links between too much weight and several types of cancer
Fred Hutch Dr. Jonathan Wright provided expert commentary on the relationship between excess weight and cancer risk.
The disturbing links between too much weight and several types of cancer
Fred Hutch Dr. Jonathan Wright provided expert commentary on the relationship between excess weight and cancer risk. Dr. Wright is currently conducting a trial on overweight patients with low-grade, slow growing prostate cancer to see if monitoring their glucose levels through a weight loss period will improve their cancer outcomes.
A's Stephen Piscotty, Giants' Buster Posey nominated for Hutch Award
NBC Sports Bay Area profiled the nominees for the 54th annual Hutch Awards and how the honor represents the legacy of Fred Hutchinson.
A's Stephen Piscotty, Giants' Buster Posey nominated for Hutch Award
NBC Sports Bay Area profiled the nominees for the 54th annual Hutch Awards and how the honor represents the legacy of Fred Hutchinson.
Q&A: Epigenetic therapies for breast cancer
In this Q&A, Dr. Nancy E. Davidson, director of Fred Hutch’s Clinical Research Division and executive director and president of Seattle Cancer Care Alliance, discussed the latest breast cancer research and what has been learned so far in clinical trials for epigenetic therapies.
Q&A: Epigenetic therapies for breast cancer
In this Q&A, Dr. Nancy E. Davidson, director of Fred Hutch’s Clinical Research Division and executive director and president of Seattle Cancer Care Alliance, discussed the latest breast cancer research and what has been learned so far in clinical trials for epigenetic therapies.
Working Geek: Fred Hutch CIO Kathy Alexion shifts from ‘corporate soldier’ to mission driven
Fred Hutch CIO Kathy Alexion is profiled in this feature piece as GeekWire’s ‘Working Geek’.
Working Geek: Fred Hutch CIO Kathy Alexion shifts from ‘corporate soldier’ to mission driven
Fred Hutch CIO Kathy Alexion is profiled in this feature piece as GeekWire’s ‘Working Geek’.
Seattle Mayor Jenny Durkan promotes cancer research amid personal battle
KING 5 documented Seattle Mayor Jenny Durkan’s visit to Fred Hutch to discuss the future of cancer research in Seattle.
Seattle’s only community lab puts a DIY spin on biotech
Regina Wu, who works in Fred Hutch’s Science Education Partnership program, is featured for her efforts in co-founding Seattle’s only community science lab.
Seattle Mayor Jenny Durkan promotes cancer research amid personal battle
KING 5 documented Seattle Mayor Jenny Durkan’s visit to Fred Hutch to discuss the future of cancer research in Seattle.
Seattle’s only community lab puts a DIY spin on biotech
Regina Wu, who works in Fred Hutch’s Science Education Partnership program, is featured for her efforts in co-founding Seattle’s only community science lab.
Oral blood thinner may reduce blood clots in high-risk patients with cancer
CURE profiled Dr. Gary Lyman and a New England Journal of Medicine study he co-authored that evaluated a drug’s safety and efficacy in preventing blood clots in cancer patients. The results from this study, known as the CASSINI trial, showed that the drug may reduce the risk of blood clots in cancer patients.
Oral blood thinner may reduce blood clots in high-risk patients with cancer
CURE profiled Dr. Gary Lyman and a New England Journal of Medicine study he co-authored that evaluated a drug’s safety and efficacy in preventing blood clots in cancer patients. The results from this study, known as the CASSINI trial, showed that the drug may reduce the risk of blood clots in cancer patients.
An antibody-inspired small molecule could make for a better flu treatment
Fred Hutch’s Dr. Jesse Bloom commented on a study evaluating the early development of a new antiviral drug for influenza. He said, “We need more drugs in the fight against flu, and this approach could provide them."
An antibody-inspired small molecule could make for a better flu treatment
Fred Hutch’s Dr. Jesse Bloom commented on a study evaluating the early development of a new antiviral drug for influenza. He said, “We need more drugs in the fight against flu, and this approach could provide them."
Diversity in Science
Vishavjit Singh, a political cartoonist, performance artist and activist visited Fred Hutch to discuss how to confront biases and celebrate diversity and inclusion. This piece highlights his visit and the efforts at Fred Hutch to foster a supportive and inclusive scientific community.
Second HIV patient may be cured after treatment
Dr. Hans-Peter Kiem, co-director of Fred Hutch’s HIV cure research program, provided insight around the second person who reportedly has been cured of HIV.
London man seems to be free of HIV in second such case
Fred Hutch virologist Dr. Keith Jerome provided expert commentary about the second person who reportedly has been cured of HIV.
Diversity in Science
Vishavjit Singh, a political cartoonist, performance artist and activist visited Fred Hutch to discuss how to confront biases and celebrate diversity and inclusion. This piece highlights his visit and the efforts at Fred Hutch to foster a supportive and inclusive scientific community.
Second HIV patient may be cured after treatment
Dr. Hans-Peter Kiem, co-director of Fred Hutch’s HIV cure research program, provided insight around the second person who reportedly has been cured of HIV.
London man seems to be free of HIV in second such case
Fred Hutch virologist Dr. Keith Jerome provided expert commentary about the second person who reportedly has been cured of HIV.
Tobacco 21 and cancer consequences
KING 5 aired multiple stories on Dr. Jonathan Bricker’s efforts to help cancer patients quit smoking and to support the Washington state tobacco 21 bill which will raise the age of smoking from 18 to 21. The bill was signed into law at Fred Hutch on April 5th.
Ten years after the ‘Berlin patient,’ doctors announce a second person has been effectively ‘cured’ of HIV
Fred Hutch virologist Dr. Keith Jerome provided context around news of the second person who reportedly has been cured of HIV. He commented, “Now there’s not one, but two people that others living with HIV can look toward for encouragement.”
Tobacco 21 and cancer consequences
KING 5 aired multiple stories on Dr. Jonathan Bricker’s efforts to help cancer patients quit smoking and to support the Washington state tobacco 21 bill which will raise the age of smoking from 18 to 21. The bill was signed into law at Fred Hutch on April 5th.
Ten years after the ‘Berlin patient,’ doctors announce a second person has been effectively ‘cured’ of HIV
Fred Hutch virologist Dr. Keith Jerome provided context around news of the second person who reportedly has been cured of HIV. He commented, “Now there’s not one, but two people that others living with HIV can look toward for encouragement.”
From LA's 'Jungle' to the forefront of cancer research in Seattle
In this profile piece, Eric Nealy, a graduate research assistant in Dr. Jim Olson’s lab, discusses how with the help of his mom, his high school biology teacher, and the only African American science professor he could find at college helped him pursue a career in cancer research.
Hutchinson Institute for Cancer Outcomes Research names co-director
Dr. Veena Shankaran is profiled about her new role as the co-director of Hutchinson Institute for Cancer Outcomes Research.
From LA's 'Jungle' to the forefront of cancer research in Seattle
In this profile piece, Eric Nealy, a graduate research assistant in Dr. Jim Olson’s lab, discusses how with the help of his mom, his high school biology teacher, and the only African American science professor he could find at college helped him pursue a career in cancer research.
Hutchinson Institute for Cancer Outcomes Research names co-director
Dr. Veena Shankaran is profiled about her new role as the co-director of Hutchinson Institute for Cancer Outcomes Research.
Many newly diagnosed Patients with Cancer Are Unaware of Hepatitis Infection
This article features a recent study by Fred Hutch researcher Dr. Scott Ramsey published in JAMA Oncology which found that many cancer patients were had undiagnosed Hepatitis B and C and HIV infection.
Many newly diagnosed Patients with Cancer Are Unaware of Hepatitis Infection
This article features a recent study by Fred Hutch researcher Dr. Scott Ramsey published in JAMA Oncology which found that many cancer patients were had undiagnosed Hepatitis B and C and HIV infection.
Adding ibrutinib to CAR T-Cell therapy increases response rates in CLL
Dr. Jordan Gauthier explains his findings on a combination immunotherapy treatment. Gauthier and his team found that adding the targeted therapy drug ibrutinib to CAR T-cell therapy led to improved responses in patients with relapsed/refractory chronic lymphocytic leukemia.
Adding ibrutinib to CAR T-Cell therapy increases response rates in CLL
Dr. Jordan Gauthier explains his findings on a combination immunotherapy treatment. Gauthier and his team found that adding the targeted therapy drug ibrutinib to CAR T-cell therapy led to improved responses in patients with relapsed/refractory chronic lymphocytic leukemia.
Rivaroxaban decreases VTE incidence during intervention period among patients with cancer
This article features Dr. Gary Lyman’s recent research published in the New England Journal of Medicine. This was the first clinical study investigating the use of the direct oral anticoagulant, rivaroxaban, to prevent blood clots in patients with cancer at high-risk.
Rivaroxaban decreases VTE incidence during intervention period among patients with cancer
This article features Dr. Gary Lyman’s recent research published in the New England Journal of Medicine. This was the first clinical study investigating the use of the direct oral anticoagulant, rivaroxaban, to prevent blood clots in patients with cancer at high-risk.
Dormant tumor cells can be sensitized to chemotherapy
This blog post features Dr. Cyrus Ghajar’s latest work on metastatic breast cancer showing that dormant tumor cells can be sensitized to chemotherapy.
Dormant tumor cells can be sensitized to chemotherapy
This blog post features Dr. Cyrus Ghajar’s latest work on metastatic breast cancer showing that dormant tumor cells can be sensitized to chemotherapy.
Vaccines don’t work against some viruses. CRISPR might one day fix that
This article notes research led by Dr. Justin Taylor using CRISPR, a gene-editing tool, to fight viruses when vaccines can’t. Taylor explained how his team has been investigating CRISPR as a tool to edit B cells in mice that could synthesize antibodies against respiratory syncytial virus (RSV).
Why do only eight percent of cancer patients in the U.S. participate in clinical trials?
This article features Dr. Joe Unger’s recent study on barriers to clinical trials. Unger’s study showed that structural and clinical barriers prevent more than 3 out of 4 cancer patients from participating in clinical trials.
Next steps for CAR T cells in B-cell lymphomas
Dr. Victor Chow explains different treatment settings that CAR T-cell therapy is used in patients with B-cell lymphomas. He states that, “While CAR T cells have been approved for treatment of individuals after two or more lines of therapy, studies are now looking at moving this to the upfront setting.”
Vaccines don’t work against some viruses. CRISPR might one day fix that
This article notes research led by Dr. Justin Taylor using CRISPR, a gene-editing tool, to fight viruses when vaccines can’t. Taylor explained how his team has been investigating CRISPR as a tool to edit B cells in mice that could synthesize antibodies against respiratory syncytial virus (RSV).
Why do only eight percent of cancer patients in the U.S. participate in clinical trials?
This article features Dr. Joe Unger’s recent study on barriers to clinical trials. Unger’s study showed that structural and clinical barriers prevent more than 3 out of 4 cancer patients from participating in clinical trials.
Next steps for CAR T cells in B-cell lymphomas
Dr. Victor Chow explains different treatment settings that CAR T-cell therapy is used in patients with B-cell lymphomas. He states that, “While CAR T cells have been approved for treatment of individuals after two or more lines of therapy, studies are now looking at moving this to the upfront setting.”
Uncovering the enemy within
This article on new techniques to detect minimal residual disease includes expert commentary by Dr. Mary-Percival and highlights trials that are going on at Fred Hutch to examine personalized cell therapies for treating MRD in different blood cancers.
Uncovering the enemy within
This article on new techniques to detect minimal residual disease includes expert commentary by Dr. Mary-Percival and highlights trials that are going on at Fred Hutch to examine personalized cell therapies for treating MRD in different blood cancers.
Why gene editing may hold the promise of a herpes cure
Dr. Keith Jerome is featured in a story of research progress in treating herpes. He explains how his work with the gene editing tool – a class of enzymes called meganucleases – is showing more success in getting rid of the virus.
Why gene editing may hold the promise of a herpes cure
Dr. Keith Jerome is featured in a story of research progress in treating herpes. He explains how his work with the gene editing tool – a class of enzymes called meganucleases – is showing more success in getting rid of the virus.
Expert shares treatment options for localized muscle-invasive bladder cancer
Dr. Jonathan Wright discusses the available therapies for patients with localized muscle-invasive bladder cancer which include neoadjuvant chemotherapy, upfront cystectomy and immunotherapy.
Expert shares treatment options for localized muscle-invasive bladder cancer
Dr. Jonathan Wright discusses the available therapies for patients with localized muscle-invasive bladder cancer which include neoadjuvant chemotherapy, upfront cystectomy and immunotherapy.
Microsoft Healthcare reveals more of its strategy with new cloud and AI products for hospitals
GeekWire mentioned Fred Hutch’s work with Microsoft on helping cancer patients better track their treatment side effects.
Microsoft Healthcare reveals more of its strategy with new cloud and AI products for hospitals
GeekWire mentioned Fred Hutch’s work with Microsoft on helping cancer patients better track their treatment side effects.
An atlas of HIV’s ‘escape routes’ could improve vaccine design
This article features recent HIV research from Fred Hutch Drs. Jesse Bloom and Julie Overbaugh. Researchers have created an atlas of immune-evading mutations HIV mutations, providing insight on the functional interactions between antibodies and HIV.
Tech moves: Dave Parker leaves Seven Peaks Ventures; Fred Hutch names a new CIO; and more
Kathy Alexion’s new role as Fred Hutch’s CIO was announced in GeekWire’s weekly tech moves column. Alexion previously supported former CIO Matthew Trunnell since 2016.
Obesity triggering rising cancer rates in millennials
Fred Hutch researcher Dr. Stephen Schwartz provides expert commentary on a study published in The Lancet Public Health on obesity and cancer.
An atlas of HIV’s ‘escape routes’ could improve vaccine design
This article features recent HIV research from Fred Hutch Drs. Jesse Bloom and Julie Overbaugh. Researchers have created an atlas of immune-evading mutations HIV mutations, providing insight on the functional interactions between antibodies and HIV.
Tech moves: Dave Parker leaves Seven Peaks Ventures; Fred Hutch names a new CIO; and more
Kathy Alexion’s new role as Fred Hutch’s CIO was announced in GeekWire’s weekly tech moves column. Alexion previously supported former CIO Matthew Trunnell since 2016.
Obesity triggering rising cancer rates in millennials
Fred Hutch researcher Stephen Schwartz provides expert commentary on a study published in The Lancet Public Health on obesity and cancer.
Five benefits of being an early riser
This article features research led by Fred Hutch researcher Dr. Anne McTiernan showing that women who exercised for 45 minutes in the morning 5 days a week reported 70 percent better sleep than before the study.
Five benefits of being an early riser
This article features research led by Fred Hutch researcher Dr. Anne McTiernan showing that women who exercised for 45 minutes in the morning 5 days a week reported 70 percent better sleep than before the study.
Tech moves: Rhapsody adds CCO as ‘Powered by Napster’ formally launches; DreamBox hires CFO following cash infusion; and more
Dr. Veena Shankaran’s new role as the co-director of Fred Hutch’s healthcare economics and policy group was announced in GeekWire’s weekly tech moves column.
1st of its kind Seattle flu study aims to stop flu before it becomes pandemic
Fred Hutch Dr. Trevor Bedford comments on the value of the Seattle Flu Study.
Tech moves: Rhapsody adds CCO as ‘Powered by Napster’ formally launches; DreamBox hires CFO following cash infusion; and more
Dr. Veena Shankaran’s new role as the co-director of Fred Hutch’s healthcare economics and policy group was announced in GeekWire’s weekly tech moves column.
1st of its kind Seattle flu study aims to stop flu before it becomes pandemic
Fred Hutch Dr. Trevor Bedford comments on the value of the Seattle Flu Study.
Seattle’s HIV Hope
Fred Hutch researcher Drs. Keith Jerome, Hans-Peter Kiem and Michael Louella, who coordinates the research group’s Community Advisory Board, provide expert comments on the importance of community engagement in HIV research.
Seattle’s HIV Hope
Fred Hutch researcher Drs. Keith Jerome, Hans-Peter Kiem and Michael Louella, who coordinates the research group’s Community Advisory Board, provide expert comments on the importance of community engagement in HIV research.
Healthy Living: Daily dose of exercise key woman living with stage 4 cancer
Fred Hutch researcher Dr. Anne McTiernan provided expert commentary on the value of exercise for those who have breast cancer.
Healthy Living: Moderate exercise can reduce breast cancer risk 20%, research finds
Fred Hutch researcher Dr. Anne McTiernan is featured in this segment for her research on exercise in relation to breast cancer prevention. Dr. McTiernan found that moderate exercise, 45 minutes a day, 5 days a week, can reduce breast cancer risk by as much as 20%.
Healthy Living: Daily dose of exercise key woman living with stage 4 cancer
Fred Hutch researcher Dr. Anne McTiernan provided expert commentary on the value of exercise for those who have breast cancer.
Healthy Living: Moderate exercise can reduce breast cancer risk 20%, research finds
Fred Hutch researcher Dr. Anne McTiernan is featured in this segment for her research on exercise in relation to breast cancer prevention. Dr. McTiernan found that moderate exercise, 45 minutes a day, 5 days a week, can reduce breast cancer risk by as much as 20%.
Information, not urgency, boosts parents’ confidence in HPV vaccine
This article features Fred Hutch researcher Dr. Parth Shah’s latest research on HPV vaccination. Dr. Shah found that parents were more confident in HPV vaccination and more motivated to have their child vaccinated by being exposed to physician messages that provided information rather than a sense of urgency.
Information, not urgency, boosts parents’ confidence in HPV vaccine
This article features Fred Hutch researcher Dr. Parth Shah’s latest research on HPV vaccination. Dr. Shah found that parents were more confident in HPV vaccination and more motivated to have their child vaccinated by being exposed to physician messages that provided information rather than a sense of urgency.
A Conversation with Gary Lyman, MD: Biosimilars and the Search for the Cure To Cancer Treatment’s Financial Toxicity
Fred Hutch researcher Dr. Gary Lyman is featured in this Q&A piece on biosimilars. Dr. Lyman provides comments about how the high prices of cancer treatment contribute to financial toxicity
Undiagnosed hepatitis common among people with cancer
This article highlights a recent study which found a high rate of undiagnosed acute and chronic hepatitis among cancer patients. Fred Hutch researcher Dr. Scott Ramsey provides expert commentary on the implications the study has in terms of screening. U.S. News & World Report also covered this study.
A Conversation with Gary Lyman, MD: Biosimilars and the Search for the Cure To Cancer Treatment’s Financial Toxicity
Fred Hutch researcher Dr. Gary Lyman is featured in this Q&A piece on biosimilars. Dr. Lyman provides comments about how the high prices of cancer treatment contribute to financial toxicity
Undiagnosed hepatitis common among people with cancer
This article highlights a recent study which found a high rate of undiagnosed acute and chronic hepatitis among cancer patients. Fred Hutch researcher Dr. Scott Ramsey provides expert commentary on the implications the study has in terms of screening. U.S. News & World Report also covered this study.
Got the flu? Seattle wants to swab your nose for a massive health data project
This story features the Seattle Flu Study, a new project from the Brotman Baty Institute which was co-founded by Seattle Children’s, UW Med and Fred Hutch. The study will look at 10,000 swabs to better understand how the flu spreads and how to prevent it. Fred Hutch’s Dr. Trevor Bedford is the lead data scientist for the study.
What to eat – and how to feel better – during menopause
This article includes a mention of a Fred Hutch study led by Dr. Marian Neuhouser which found that women diagnosed with breast cancer who ate a low-fat diet were more likely to survive.
Got the flu? Seattle wants to swab your nose for a massive health data project
This story features the Seattle Flu Study, a new project from the Brotman Baty Institute which was co-founded by Seattle Children’s, UW Med and Fred Hutch. The study will look at 10,000 swabs to better understand how the flu spreads and how to prevent it. Fred Hutch’s Dr. Trevor Bedford is the lead data scientist for the study.
What to eat – and how to feel better – during menopause
This article includes a mention of a Fred Hutch study led by Dr. Marian Neuhouser which found that women diagnosed with breast cancer who ate a low-fat diet were more likely to survive.
Scientists discover new potential way to stop breast cancer from spreading
Dr. Cyrus Ghajar’s latest research on metastatic breast cancer is the focus of this piece. Dr. Ghajar’s work details how to kill dormant breast cancer cells in their sleep. Several other outlets including GeekWire, KOMO-TV and FireceBiotech also covered this news.
Scientists discover new potential way to stop breast cancer from spreading
Dr. Cyrus Ghajar’s latest research on metastatic breast cancer is the focus of this piece. Dr. Ghajar’s work details how to kill dormant breast cancer cells in their sleep. Several other outlets including GeekWire, KOMO-TV and FireceBiotech also covered this news.
Lung transplant patients face elevated lung cancer risk
Fred Hutch Dr. Matthew Triplette’s recent research on lung cancer is featured in this piece. Dr. Triplette and his team showed that lung cancer risk was increased after lung transplantation, especially in the non-transplanted lung of single lung transplant recipients.
Lung transplant patients face elevated lung cancer risk
Fred Hutch Dr. Matthew Triplette’s recent research on lung cancer is featured in this piece. Dr. Triplette and his team showed that lung cancer risk was increased after lung transplantation, especially in the non-transplanted lung of single lung transplant recipients.
Medical ‘breakthrough’ may spell end of potentially toxic drugs in transplant recipients ABC News (Australia), Jan. 17, 2019
Dr. Geoffrey Hill and collaborators in Australia discovered how a common virus called cytomegalovirus reactivates in transplantation patients. In a study published in Science, the researchers found that strain-specific antibodies made from B cells are responsible for keeping CMV suppressed in mice, without the need for any other immune cells.
Medical ‘breakthrough’ may spell end of potentially toxic drugs in transplant recipients ABC News (Australia), Jan. 17, 2019
Dr. Geoffrey Hill and collaborators in Australia discovered how a common virus called cytomegalovirus reactivates in transplantation patients. In a study published in Science, the researchers found that strain-specific antibodies made from B cells are responsible for keeping CMV suppressed in mice, without the need for any other immune cells.
Comorbidities associated with lower clinical trial participation
This article features Dr. Joseph Unger’s recent study in JAMA Oncology on clinical trial participation. Dr. Unger shows that patients with comorbidities are less likely to participate in clinical trials.
Comorbidities associated with lower clinical trial participation
This article features Dr. Joseph Unger’s recent study in JAMA Oncology on clinical trial participation. Dr. Unger shows that patients with comorbidities are less likely to participate in clinical trials.
5 ways to protect your prostate
This piece highlights a study published in JNCI by Fred Hutch Dr. Joseph Unger, which shows that men who’ve taken 5-alpha reductase inhibitors had a 21 percent reduced risk of PCa 16 years later.
5 ways to protect your prostate
This piece highlights a study published in JNCI by Fred Hutch Dr. Joseph Unger, which shows that men who’ve taken 5-alpha reductase inhibitors had a 21 percent reduced risk of PCa 16 years later.
Geek of the Week: Fred Hutch’s Steve Pergam caught a ’bug’ for infectious diseases and research
Fred Hutch researcher Dr. Steve Pergam is featured as GeekWire’s ‘Geek of the Week’. Dr. Pergam is an associate member of the Vaccine and Infectious Disease Division at Fred Hutch.
Cancer comorbidities reduce clinical trial participation, new SWOG study shows
Fred Hutch researcher Dr. Joseph Unger’s latest research on clinical trial participation is featured in this piece. Dr. Unger and his team showed that cancer patients with other illnesses or conditions, are less likely to be offered to join a clinical trial, and therefore less likely to enroll. This research was published in several other outlets including Healio, Medical Health News and MedPage Today.
Cancer comorbidities reduce clinical trial enrollment, study finds
This piece features Fred Hutch Dr. Joseph Unger’s latest research showing that expanding clinical trial eligibility criteria to allow patients with comorbidities would give opportunities for up to 6,317 cancer patients to be allowed to join a trial every year.
Geek of the Week: Fred Hutch’s Steve Pergam caught a ’bug’ for infectious diseases and research
Fred Hutch researcher Dr. Steve Pergam is featured as GeekWire’s ‘Geek of the Week’. Dr. Pergam is an associate member of the Vaccine and Infectious Disease Division at Fred Hutch.
Cancer comorbidities reduce clinical trial participation, new SWOG study shows
Fred Hutch researcher Dr. Joseph Unger’s latest research on clinical trial participation is featured in this piece. Dr. Unger and his team showed that cancer patients with other illnesses or conditions, are less likely to be offered to join a clinical trial, and therefore less likely to enroll. This research was published in several other outlets including Healio, Medical Health News and MedPage Today.
Cancer comorbidities reduce clinical trial enrollment, study finds
This piece features Fred Hutch Dr. Joseph Unger’s latest research showing that expanding clinical trial eligibility criteria to allow patients with comorbidities would give opportunities for up to 6,317 cancer patients to be allowed to join a trial every year.
Cord blood transplantation provides ‘donor for every patient’
Fred Hutch Dr. Filippo Milano in featured in this Q&A piece about how cord blood is used for transplants.
Cord blood transplantation provides ‘donor for every patient’
Fred Hutch Dr. Filippo Milano in featured in this Q&A piece about how cord blood is used for transplants.
Fred Hutchinson bone marrow transplant program receives national recognition
Fred Hutch’s bone marrow transplant program at Seattle Cancer Care Alliance, the Hutch’s clinical care partner, received national recognition for its survival rates by the Center for International Blood and Marrow Transplant Research’s annual report.
Fred Hutchinson bone barrow transplant program receives national recognition
Fred Hutch’s bone marrow transplant program at Seattle Cancer Care Alliance, the Hutch’s clinical care partner, received national recognition for its survival rates by the Center for International Blood and Marrow Transplant Research’s annual report.
Knowledge of benefits, harms of medical marijuana for cancer ‘far from complete’
Fred Hutch researcher Dr. Steve Pergam comments on cannabis use among cancer patients.
Knowledge of benefits, harms of medical marijuana for cancer ‘far from complete’
Fred Hutch researcher Dr. Steve Pergam comments on cannabis use among cancer patients.
6 vitamin myths you have to stop believing – and 2 vitamins you actually do need
Fred Hutch Dr. Marian Neuhouser provides expert comments on the benefits of multivitamins.
The Allen Institute for Immunology
Dr. Gary Gilliland, Fred Hutch president and director, comments on the newly-announced Allen Institute for Immunology, which includes a research collaboration with Fred Hutch.
The Allen Institute for Immunology
Dr. Gary Gilliland, Fred Hutch president and director, comments on the newly-announced Allen Institute for Immunology, which includes a research collaboration with Fred Hutch.
Excess body weight responsible for 4% of cancers worldwide, study says
Fred Hutch Dr. Anne McTiernan provides expert commentary on a new study that found that excess body weight is responsible for 4% of cancer globally.
Biotech journalist Luke Timmerman sets his sights on Mount Kilimanjaro and $1M for cancer research
This article features Luke Timmerman, a local biotech journalist who is climbing Mount Kilimanjaro in July as a part of the Climb to Fight Cancer to raise money for Fred Hutch. After climbing Mount Everest in 2018, Timmerman raised $340,000 for cancer research. Timmerman now hopes to raise $850,00 with this climb.
Excess body weight responsible for 4% of cancers worldwide, study says
Fred Hutch Dr. Anne McTiernan provides expert commentary on a new study that found that excess body weight is responsible for 4% of cancer globally.
Biotech journalist Luke Timmerman sets his sights on Mount Kilimanjaro and $1M for cancer research
This article features Luke Timmerman, a local biotech journalist who is climbing Mount Kilimanjaro in July as a part of the Climb to Fight Cancer to raise money for Fred Hutch. After climbing Mount Everest in 2018, Timmerman raised $340,000 for cancer research. Timmerman now hopes to raise $850,00 with this climb.
Robust future ahead for stem cell transplants
Fred Hutch’s Dr. Geoffrey Hill provides expert commentary on stem cell transplantation in relation to CAR Ts.
Robust future ahead for stem cell transplants
Fred Hutch’s Dr. Geoffrey Hill provides expert commentary on stem cell transplantation in relation to CAR Ts.
Seattle-area health care chiefs debate cancer treatment costs and innovations
Fred Hutch Dr. Jim Olson provides expert commentary on the field of cancer care and research as a Seattle-area health care leader at a PSBJ health care event held earlier this month. Olson’s “tumor paint” technology is highlighted as a leading technology in the field of cancer care.
Amazon push into health data analytics inspires awe – and skepticism
This article highlights Fred Hutch’s work with Amazon on AWS’ Comprehend Medical Service. Matthew Trunnell provides expert commentary on the benefits of the service.
Seattle-area health care chiefs debate cancer treatment costs and innovations
Fred Hutch Dr. Jim Olson provides expert commentary on the field of cancer care and research as a Seattle-area health care leader at a PSBJ health care event held earlier this month. Olson’s “tumor paint” technology is highlighted as a leading technology in the field of cancer care.
Amazon push into health data analytics inspires awe – and skepticism
This article highlights Fred Hutch’s work with Amazon on AWS’ Comprehend Medical Service. Matthew Trunnell provides expert commentary on the benefits of the service.
CAR-T Cell Therapy combination shows promise in relapsed/refractor leukemia
This article features Fred Hutch Dr. Jordan Gauthier’s study findings presented at the 2018 ASH conference. His study shows that using chimeric antigen receptor (CAR)-T cell therapy plus Imbruvica, a targeted treatment, could improve outcomes in patients with relapsed or refractory chronic lymphocytic leukemia. Gauthier participated in an ASH press briefing and his work was covered by numerous other outlets including OncLive, Medpage Today, HemOnc Today, Targeted Oncology, and the Video Journal of Hematological Oncology.
CAR-T Cell Therapy combination shows promise in relapsed/refractor leukemia
This article features Fred Hutch Dr. Jordan Gauthier’s study findings presented at the 2018 ASH conference. His study shows that using chimeric antigen receptor (CAR)-T cell therapy plus Imbruvica, a targeted treatment, could improve outcomes in patients with relapsed or refractory chronic lymphocytic leukemia. Gauthier participated in an ASH press briefing and his work was covered by numerous other outlets including OncLive, Medpage Today, HemOnc Today, Targeted Oncology, and the Video Journal of Hematological Oncology.
Fred Hutch gala raises $10.4 million for cancer research, including $4 million from Microsoft
Fred Hutch’s 2018 annual holiday gala is featured for raising $10.4 million for cancer research.
Study identifies 40 new genetic variants associated with colorectal cancer risk
This article features the most comprehensive genome-wide association study of colorectal cancer risk to date, led by Dr. Ulrike “Riki” Peters. Peters and her team have discovered 40 new genetic variants associated with colorectal cancer risk.
Fred Hutch gala raises $10.4 million for cancer research, including $4 million from Microsoft
Fred Hutch’s 2018 annual holiday gala is featured for raising $10.4 million for cancer research.
Study identifies 40 new genetic variants associated with colorectal cancer risk
This article features the most comprehensive genome-wide association study of colorectal cancer risk to date, led by Dr. Ulrike “Riki” Peters. Peters and her team have discovered 40 new genetic variants associated with colorectal cancer risk.
Why should you care about Amazon’s new medical language processing service
Fred Hutch CIO Matthew Trunnell is quoted about how Fred Hutch is using Amazon’s new Comprehend Medical service.
World AIDS Day
This segment, which aired on the eve of World AIDS Day, covers local and global HIV vaccine trials led by Fred Hutch. It includes interviews with Drs. Janine Maenza, Larry Corey and an HIV study vaccine participant.
Amazon launches patient data-mining service to assist docs
This story details how Fred Hutch plans to utilize Amazon Comprehend Medical’s natural language processing capabilities and the benefits of doing so.
Why should you care about Amazon’s new medical language processing service
Fred Hutch CIO Matthew Trunnell is quoted about how Fred Hutch is using Amazon’s new Comprehend Medical service.
World AIDS Day
This segment, which aired on the eve of World AIDS Day, covers local and global HIV vaccine trials led by Fred Hutch. It includes interviews with Drs. Janine Maenza, Larry Corey and an HIV study vaccine participant.
Amazon launches patient data-mining service to assist docs
This story details how Fred Hutch plans to utilize Amazon Comprehend Medical’s natural language processing capabilities and the benefits of doing so.
Big tech expands footprint in health
This article mentions Fred Hutch's collaboration with Amazon Web Services on the new Comprehend Medical natural language processing service. Subscription required
Amazon unveils new service to mine and decode media records using artificial intelligence
Fred Hutch CIO Matthew Trunnell is quoted about how Fred Hutch is using Amazon’s new Comprehend Medical service.
Big tech expands footprint in health
This article mentions Fred Hutch's collaboration with Amazon Web Services on the new Comprehend Medical natural language processing service. Subscription required
Amazon unveils new service to mine and decode media records using artificial intelligence
Fred Hutch CIO Matthew Trunnell is quoted about how Fred Hutch is using Amazon’s new Comprehend Medical service.
Coping with head and neck cancer
Salene Jones, an assistant member in the Public Health Sciences Division at Fred Hutch, provides comments on depression screening for cancer patients in relation to a recent study that adds new information about suicide risk in head and neck cancer patients and survivors.
Coping with head and neck cancer
Salene Jones, an assistant member in the Public Health Sciences Division at Fred Hutch, provides comments on depression screening for cancer patients in relation to a recent study that adds new information about suicide risk in head and neck cancer patients and survivors.
Majority of HIV persistence during ART due to infected cell proliferation
This article features a recent study by Fred Hutch Drs. Dan Reeves and Josh Schiffer that shows that a majority of the HIV-infected cells that persist in HIV-infected individuals even during suppressive antiretroviral therapy (ART) originate from cellular proliferation, not viral replication.
Majority of HIV persistence during ART due to infected cell proliferation
This article features a recent study by Fred Hutch Drs. Dan Reeves and Josh Schiffer that shows that a majority of the HIV-infected cells that persist in HIV-infected individuals even during suppressive antiretroviral therapy (ART) originate from cellular proliferation, not viral replication.
Solving lymphoma’s stem-cell problem
Drs. Mary Flowers and Stephanie Lee provide expert comments on GvHD.
Solving lymphoma’s stem-cell problem
Drs. Mary Flowers and Stephanie Lee provide expert comments on GvHD.
Forbes 30 under 30: Healthcare
Alex Salter, a graduate student working in Stan Riddell's lab, made the Forbes 30 under 30 healthcare list for his work in immunotherapy.
Forbes 30 under 30: Healthcare
Alex Salter, a graduate student working in Stan Riddell's lab, made the Forbes 30 under 30 healthcare list for his work in immunotherapy.
It’s too early to take baby aspirin to cut ovarian cancer risk, but not too early to improve your diet
This article features research and comments by Dr. Marian Neuhouser on diet in relation to cancer prevention.
It’s too early to take baby aspirin to cut ovarian cancer risk, but not too early to improve your diet
This article features research and comments by Dr. Marian Neuhouser on diet in relation to cancer prevention.
How tech is unlocking a new way of thinking about health
Fred Hutch Dr. Elizabeth Krakow is featured in a recap of the personalized medicine panel at GeekWire's recent 2018 summit.
How tech is unlocking a new way of thinking about health
Fred Hutch Dr. Elizabeth Krakow is featured in a recap of the personalized medicine panel at GeekWire's recent 2018 summit.
Pricey precision medicine often financially toxic for cancer patients
Dr. Scott Ramsey and Dr. Gary Lyman provide expert comments on the cost of precision medicine and the impact it has on patients.
Pricey precision medicine often financially toxic for cancer patients
Dr. Scott Ramsey and Dr. Gary Lyman provide expert comments on the cost of precision medicine and the impact it has on patients.
Research finds 71 percent of tumors misidentified in children with rare cancer
This story summarizes a recent study by Dr. Jim Olson that shows 71 percent of tumors are misidentified in children with rare brain cancer due to limits in standard diagnostic methods.
Research finds 71 percent of tumors misidentified in children with rare cancer
This story summarizes a recent study by Dr. Jim Olson that shows 71 percent of tumors are misidentified in children with rare brain cancer due to limits in standard diagnostic methods.
Women Who Lead: Kelly O'Brien, mountaineer and philanthropy chief at Fred Hutch, aims high
This profile features Kelly O'Brien, vice president of philanthropy, in its Women Who Lead column that highlights “influential women leaders who are driving innovation and growth in the Puget Sound region."
Women Who Lead: Kelly O'Brien, mountaineer and philanthropy chief at Fred Hutch, aims high
This profile features Kelly O'Brien, vice president of philanthropy, in its Women Who Lead column that highlights “influential women leaders who are driving innovation and growth in the Puget Sound region."
The smaller the city, the bigger the flu epidemic
Dr. Trevor Bedford comments on a study that suggests that people living in smaller cities are more likely to face an intense outbreaks of seasonal flu during flu season.
The smaller the city, the bigger the flu epidemic
Dr. Trevor Bedford comments on a study that suggests that people living in smaller cities are more likely to face an intense outbreaks of seasonal flu during flu season.
Healthy Living: Doctors say exercise and diet can reduce risk of breast cancer
Dr. Anne McTiernan shares her top prevention tips during this breast cancer awareness month-focused interview.
Healthy Living: Doctors say exercise and diet can reduce risk of breast cancer
Dr. Anne McTiernan shares her top prevention tips during this breast cancer awareness month-focused interview.
The cancer that changed the course of Paul Allen’s life, and shaped his legacy
This story summarizes Paul Allen's experience with cancer, featuring research by Dr. David Maloney.
The cancer that changed the course of Paul Allen’s life, and shaped his legacy
This story summarizes a recent study by Dr. Jim Olson that shows 71 percent of tumors are misidentified in children with rare brain cancer due to limits in standard diagnostic methods.
Fred Hutch president on Non-Hodgkin’s Lymphoma
Our president and director Gary Gilliland, explains non-Hodgkin Lymphoma.
Fred Hutch president on Non-Hodgkin’s Lymphoma
Our president and director Gary Gilliland, explains non-Hodgkin Lymphoma.
Childhood abuse may increase the risk of endometriosis, study finds
This story featured a study led by Fred Hutch epidemiologist Holly Harris which shows that women who reported severe or chronic childhood abuse were 79% more likely to have endometriosis.
Childhood abuse may increase the risk of endometriosis, study finds
This story featured a study led by Fred Hutch epidemiologist Holly Harris which shows that women who reported severe or chronic childhood abuse were 79% more likely to have endometriosis.
Seattle scientists lead the way on HIV vaccine research
KOMO featured Kristen Cohen and Ro Yoon in a story about a new HIV vaccine trial for which Fred Hutch is one of two sites.
Seattle scientists lead the way on HIV vaccine research
KOMO featured Kristen Cohen and Ro Yoon in a story about a new HIV vaccine trial for which Fred Hutch is one of two sites.
New HIV vaccine study will test first-of-its-kind tech, with backing from the Gates Foundation
GeekWire covered the launch of a new HIV vaccine trial for which Fred Hutch will serve as one of two sites.
New HIV vaccine study will test first-of-its-kind tech, with backing from the Gates Foundation
GeekWire covered the launch of a new HIV vaccine trial for which Fred Hutch will serve as one of two sites.
Ongoing Efforts Seek to Refine, Expand CAR T-Cell Therapy
Fred Hutch’s Dr. Brian Till shared his expertise on new developments in CAR T cell therapy.
Ongoing Efforts Seek to Refine, Expand CAR T-Cell Therapy
Fred Hutch’s Dr. Brian Till shared his expertise on new developments in CAR T cell therapy.
Breast Cancer: Everything you should know to keep it out of your future
Dr. Jennifer Specht shared her insights in diagnosing, treating and preventing breast cancer.
Breast Cancer: Everything you should know to keep it out of your future
Dr. Jennifer Specht shared her insights in diagnosing, treating and preventing breast cancer.
How one Fort Collins girl gave hope to 86,000 people with blood cancers
Dr. Fred Applebaum, the Hutch’s executive vice president and deputy director, commented about the recipient of the first unrelated donor transplant, that eventually led to the national match registry.
Hyundai grant to Fred Hutch to help childhood leukemia research
This story focused on a $300k grant Dr. Roland Walter received from Hyundai. It included interviews with Dr. Walter & a pediatric cancer patient.
Hyundai grant to Fred Hutch to help childhood leukemia research
This story focused on a $300k grant Dr. Roland Walter received from Hyundai. It included interviews with Dr. Walter & a pediatric cancer patient.
How one Fort Collins girl gave hope to 86,000 people with blood cancers
Dr. Fred Applebaum, the Hutch’s executive vice president and deputy director, commented about the recipient of the first unrelated donor transplant, that eventually led to the national match registry.
Hyundai grant to Fred Hutch to help childhood leukemia research
This story focused on a $300k grant Dr. Roland Walter received from Hyundai. It included interviews with Dr. Walter & a pediatric cancer patient.
Hyundai grant to Fred Hutch to help childhood leukemia research
This story focused on a $300k grant Dr. Roland Walter received from Hyundai. It included interviews with Dr. Walter & a pediatric cancer patient.
Should we rely on artificial intelligence to provide advice about cancer?
Dr. Scott Ramsey, director of Fred Hutch’s health economics group, talked about a partnership between the Hutch and Microsoft, using artificial intelligence technology to help cancer patients detect early, subtle signs of complications in an effort to improve patient health while lowering costs.
Should we rely on artificial intelligence to provide advice about cancer?
Dr. Scott Ramsey, director of Fred Hutch’s health economics group, talked about a partnership between the Hutch and Microsoft, using artificial intelligence technology to help cancer patients detect early, subtle signs of complications in an effort to improve patient health while lowering costs.
Fred Hutch study discovers how cancer evades immunotherapies, sometimes returning years later
Fred Hutch researchers Drs. Aude Chapuis and Kelly Paulson were quoted about their study identifying a potential cause for relapse in patients treated with immunotherapy for Merkel cell carcinoma, a skin cancer.
Fred Hutch study discovers how cancer evades immunotherapies, sometimes returning years later
Fred Hutch researchers Drs. Aude Chapuis and Kelly Paulson were quoted about their study identifying a potential cause for relapse in patients treated with immunotherapy for Merkel cell carcinoma, a skin cancer.
The Roots of Rural Health Disparities
This story summarized a study led by Dr. Joe Unger focused on outcomes for rural vs. urban cancer patients.
Do bacteria cause stomach cancer?
This article mentions research by Fred Hutch’s Dr. Nina Salama and her team that identified a strain of Helicobacter pylori associated with stomach cancer.
The Roots of Rural Health Disparities
This story summarized a study led by Dr. Joe Unger focused on outcomes for rural vs. urban cancer patients.
Do bacteria cause stomach cancer?
This article mentions research by Fred Hutch’s Dr. Nina Salama and her team that identified a strain of Helicobacter pylori associated with stomach cancer.
Fred Hutchinson and Seattle’s baseball renaissance of 1938
This historical feature about Fred Hutchinson's baseball career includes comments from Dr. Fred Appelbaum on how naming the Center in Hutchinson's honor keeps it tied to the Seattle community and culture.
What’s the likelihood that CRISPR will cure cancer?
Dr. Hans-Peter Kiem, director of Fred Hutch’s stem cell and gene therapy program, is featured in this article about CRISPR, a new gene-editing tool.
Fred Hutchinson and Seattle’s baseball renaissance of 1938
This historical feature about Fred Hutchinson's baseball career includes comments from Dr. Fred Appelbaum on how naming the Center in Hutchinson's honor keeps it tied to the Seattle community and culture.
What’s the likelihood that CRISPR will cure cancer?
Dr. Hans-Peter Kiem, director of Fred Hutch’s stem cell and gene therapy program, is featured in this article about CRISPR, a new gene-editing tool.
How glioblastoma is treated
In this CNN story, Fred Hutch’s Dr. Eric Holland said studies using targeted cancer therapies against glioblastoma have been unexpectedly disappointing.
How glioblastoma is treated
In this CNN story, Fred Hutch’s Dr. Eric Holland said studies using targeted cancer therapies against glioblastoma have been unexpectedly disappointing.
Overlooked molecule might be key to how well cancer-fighting CAR-T cells work
Lead author Alex Salter and senior author Dr. Stanley Riddell were quoted in this STAT article about a Fred Hutch study on co-stimulatory domain, a component of chimeric antigen receptor (CAR) T cells. Different co-stimulatory domains might affect safety and efficacy of these immunotherapies.
Overlooked molecule might be key to how well cancer-fighting CAR-T cells work
Lead author Alex Salter and senior author Dr. Stanley Riddell were quoted in this STAT article about a Fred Hutch study on co-stimulatory domain, a component of chimeric antigen receptor (CAR) T cells. Different co-stimulatory domains might affect safety and efficacy of these immunotherapies.
Teens in Fred Hutch program aspire to be scientists, doctors
Fred Hutch's Science Education Partnership program was featured in this story, focusing on a new training program for high school sophomores and juniors
Teens in Fred Hutch program aspire to be scientists, doctors
Fred Hutch's Science Education Partnership program was featured in this story, focusing on a new training program for high school sophomores and juniors
Colon cancer screening guidelines may need revising
This story cites new research led by Fred Hutch focused on the ideal age for men and women to receive their first colonoscopy screening.
Colon cancer screening guidelines may need revising
This story cites new research led by Fred Hutch focused on the ideal age for men and women to receive their first colonoscopy screening.
Maple Valley mom among growing number of millennials with colon cancer
Lauren Nudo, a stage 4 colon cancer patient, is featured in this story about the importance of awareness and raising money for cancer research.
Woman learns to bike to honor late father at Fred Hutch’s Obliteride
KING-TV newscasts provided extensive coverage of Fred Hutch’s Obliteride biking/walking fundraising event, including numerous stories about participants and their inspiration and motivation. This story profiled Smeeta Hirani and how she learned to ride a bike to honor her father, who died from lung cancer.
Maple Valley mom among growing number of millennials with colon cancer
Lauren Nudo, a stage 4 colon cancer patient, is featured in this story about the importance of awareness and raising money for cancer research.
Woman learns to bike to honor late father at Fred Hutch’s Obliteride
KING-TV newscasts provided extensive coverage of Fred Hutch’s Obliteride biking/walking fundraising event, including numerous stories about participants and their inspiration and motivation. This story profiled Smeeta Hirani and how she learned to ride a bike to honor her father, who died from lung cancer.
How this cancer therapy went from scientific underdog to potential cure
This GeekWire article and podcast weaves together Fred Hutch expertise in bone marrow transplantation and newer cell therapies, such as CAR T. The Hutch’s Dr. Stan Riddell and Dr. David Maloney talk about how CAR T-cell immunotherapy and how it was considered a crazy idea in the 1980s.
How this cancer therapy went from scientific underdog to potential cure
This GeekWire article and podcast weaves together Fred Hutch expertise in bone marrow transplantation and newer cell therapies, such as CAR T. The Hutch’s Dr. Stan Riddell and Dr. David Maloney talk about how CAR T-cell immunotherapy and how it was considered a crazy idea in the 1980s.
Opportunities, issues and challenges for biosimilars in oncology
In an article on the future of biosimilars, biologic agents that are highly similar but not identical to approved reference biologic agents, The ASCO Post quoted extensively from a recent article by the Hutch’s Dr. Gary Lyman and colleagues in The New England Journal of Medicine.
ASCO endorses guidelines for integrative therapies during and after breast cancer treatment
Fred Hutch’s Dr. Gary Lyman is quoted in this article announcing that the American Society of Clinical Oncology now accepts certain integrative therapies for patients and survivors of breast cancer. Lyman was co-chair of the ASCO panel reviewing the clinical practice guidelines.
Childhood abuse linked to endometriosis risk
Fred Hutch’s Dr. Holly Harris is quoted in this story about a study she authored on the association between childhood physical and sexual abuse and adulthood endometriosis.
Opportunities, issues and challenges for biosimilars in oncology
In an article on the future of biosimilars, biologic agents that are highly similar but not identical to approved reference biologic agents, The ASCO Post quoted extensively from a recent article by the Hutch’s Dr. Gary Lyman and colleagues in The New England Journal of Medicine.
ASCO endorses guidelines for integrative therapies during and after breast cancer treatment
Fred Hutch’s Dr. Gary Lyman is quoted in this article announcing that the American Society of Clinical Oncology now accepts certain integrative therapies for patients and survivors of breast cancer. Lyman was co-chair of the ASCO panel reviewing the clinical practice guidelines.
Childhood abuse linked to endometriosis risk
Fred Hutch’s Dr. Holly Harris is quoted in this story about a study she authored on the association between childhood physical and sexual abuse and adulthood endometriosis.
Top fundraisers from Base 2 Space climb given chance to climb to top of Space Needle mast
Jean Nelson, a top-10 “Base 2 Space” stair-climber in last year’s event, is among those who got to climb to the top of the Space Needle mast. “Base 2 Space” participants ascend the 832 stairs of Seattle’s landmark, and the latest event raised more than $860,000 for Fred Hutch research.
Fred Hutch program gives Washington science teachers a chance to hone their lab skills
This story profiles the experience of two high school science teachers, participating in Fred Hutch’s Science Education Partnership. The program pairs science teachers with Fred Hutch researchers to gain skills and expertise to bring into the classroom.
Is Station 31 making Seattle firefighters sick? Study hopes to find answers about ‘Cancer House’
Fred Hutch researchers are working with the city of Seattle to investigate whether firefighters at Station 31 have higher cancer rates than those at other stations. Designed to answer longstanding questions, the study is expected to conclude by summer 2019.
How does sleep influence cancer risk?
Dr. Amanda Phipps provided comment in this story, examining the links of sleep and cancer. Phipps notes “from a biological perspective, there are a lot of good reasons for us to suspect that insufficient sleep, chronic sleep debt or short sleep duration could have an impact on the development of cancer."
Fred Hutch study: Nanoparticles could help cutting-edge therapies get inside solid tumors
Fred Hutch researchers led by Dr. Matthias Stephan used nanoparticles to deliver two drugs directly into solid tumors to shut down the tumors’ defense mechanisms and rally the immune system. Although this was a preclinical study, not done in human patients, it opens the possibility that chimeric antigen receptor (CAR) T-cell therapies could be used not just in blood cancers but also in solid tumors. The drugs would precondition the patient and the tumor so the T cells would work better, Stephan said.
Fred Hutch report plots the nexus of cost and quality
This article published by Managed Care, focuses on the “Community Cancer Care in Washington State: Quality and Cost Report” recently released by the Hutch’s health care economics group, HICOR. “Committing to transparency as a catalyst for improvement, 27 hospital systems and cancer centers across Washington State bare all in the first public report to integrate clinic-level quality and cost data in oncology,” the article said.
Clinical trial inclusion, specialist collaboration can improve cancer outcomes for those with HIV
Drs. Jeffrey Schouten and Thomas Uldrick were interviewed for a cover story on HIV and cancer for Healio’s HemOnc Today. “How to prevent cancer in people with HIV and oncogenic viral infections, and how to diagnose the resultant cancers early so that treatment outcomes are improved, are important issues that need to be addressed for patients,” Schouten said.
Fred Hutch study finds genetic cause of aggressive brain cancer
Fred Hutch physician-scientist Dr. Eric Holland, senior vice president and director of the Human Biology Division, led a study that found that a subset of brain cancers called ependymomas can be traced back to a single, catastrophic mutation in a patient’s DNA. “It looks like a region of the DNA blew up,” he said. The GeekWire story also was reported on KIRO-TV.
Columnist shares dad’s story of long-term cancer survival
Jane Ann Morrison, a columnist with the Las Vegas Review-Journal, told readers that her 88-year-old father, Jim Morrison, a retired Boeing engineer who was diagnosed with non-Hodgkin lymphoma in 1991, was honored as a Hutch Hero at a June 14 Seattle Mariners game. “His bone marrow transplant at the center in 1993 has given my dad 25 additional years (and I predict even more),” she said.
Two or more servings of red meat a week raises women’s risk of endometriosis by more than 50%
The U.K. newspaper Daily Mail, Yahoo! UK, ABC News Australia and other sites carried an article about Fred Hutch research published in the American Journal of Obstetrics and Gynecology suggesting that red meat intake increases estrogen levels, which can lead to endometriosis.
The Hutch’s 30-year journey to the Lake Union steam plant
Four days after the Hutch’s lease of the historic Lake Union steam plant was announced, real estate developer William Justen recounted the deal’s three-decade history.
A leading oncology association says some complementary therapies helpful to women with breast cancer with HIV
Dr. Heather Greenlee, a Fred Hutch specialist in naturopathic medicine and integrative therapies, explained new guidelines adopted by the American Society of Clinical Oncology on the use of certain integrative approaches for managing symptoms and side effects of breast cancer treatment. She is a co-author of an article announcing the guidelines in the Journal of Clinical Oncology.
‘Intersections of innovation:’ Madrona director Matt McIlwain named Fred Hutch chair as more tech execs join board
New Fred Hutch Board of Trustees chair Matt McIlwain and Fred Hutch COO Steve Stadum talk about the intersection of cancer research and technology. The story also notes the new additions of board members Allan Jones, president and CEO of the Allen Institute, and Lyft CFO Brian Roberts, a former high-ranking Microsoft executive.
External relations director for the HIV Vaccine Trial Network profiled
“The HIV epidemic is global and our research works to make sure our solutions reach those most vulnerable,” said Steven Wakefield, president of the Pride Foundation in a feature profile. Wakefield is external relations director for the HIV Vaccine Trial Network that is headquartered at the Hutch, where he established The Legacy Project to increase racial and ethnic involvement in clinical trials.
Will there ever be a vaccine against cancer?
Dr. Seth M. Pollack, a sarcoma expert at Fred Hutch, talks about the potential for – and the challenges in – creating vaccines to treat and prevent cancer. “There almost certainly is not a universal target. The vaccine has to tell the immune system to go find something specific, but there’s nothing specific that the immune system can look for that is common to all cancers,” he said, adding that “there are some targets that are expressed by lots of cancers.”
Fred Hutch breast cancer researcher says study will help many women avoid chemotherapy
Dr. Jennifer Specht, a Fred Hutch breast cancer researcher, appeared live on KING 5's "Take Five" news show to provide expert commentary on a new breast cancer treatment study.
Fred Hutch doctor comments on reducing need for breast cancer patients to undergo chemotherapy
Research presented at the American Society of Clinical Oncology (ASCO) and published in the New England Journal of Medicine suggests that new genetic testing may make it possible for 70 percent of early-stage breast cancer patients to avoid chemotherapy. Fred Hutch’s Dr. Kevin Cheung explained the study and its implications for patients.
The high cost of cancer treatment
Dr. Gary Lyman, co-director of the Hutch’s health economics group, HICOR, was quoted extensively in an AARP article on financial toxicity associated with cancer treatment. “Recent studies we’ve done have shown high rates of bankruptcy among patients with cancer. And this has escalated over the past decade, as some of the exciting new agents that have come along have just skyrocketed,” he said.
The high cost of cancer treatment
Dr. Gary Lyman, co-director of the Hutch’s health economics group, HICOR, was quoted extensively in an AARP article on financial toxicity associated with cancer treatment. “Recent studies we’ve done have shown high rates of bankruptcy among patients with cancer. And this has escalated over the past decade, as some of the exciting new agents that have come along have just skyrocketed,” he said.
Study presented at American Society of Clinical Oncology compares US and Canadian cancer care costs
Dr. Heather Greenlee, a Fred Hutch specialist in naturopathic medicine and integrative therapies, explained new guidelines adopted by the American Society of Clinical Oncology on the use of certain integrative approaches for managing symptoms and side effects of breast cancer treatment. She is a co-author of an article announcing the guidelines in the Journal of Clinical Oncology.
Study presented at American Society of Clinical Oncology compares US and Canadian cancer care costs
Dr. Heather Greenlee, a Fred Hutch specialist in naturopathic medicine and integrative therapies, explained new guidelines adopted by the American Society of Clinical Oncology on the use of certain integrative approaches for managing symptoms and side effects of breast cancer treatment. She is a co-author of an article announcing the guidelines in the Journal of Clinical Oncology.
New promise for bone-marrow transplants
Fred Hutch’s Dr. Stephanie Lee and Dr. Colleen Delaney are quoted in a feature story on companies striving to make bone-marrow transplants safer. Delaney explained an experimental therapy called NLA101 that was developed at Fred Hutch and then spun out as the company Nohla Therapeutics. Delaney is director of Fred Hutch’s cord-blood transplant program and founder and chief medical officer at Nohla.
New promise for bone-marrow transplants
Fred Hutch’s Dr. Stephanie Lee and Dr. Colleen Delaney are quoted in a feature story on companies striving to make bone-marrow transplants safer. Delaney explained an experimental therapy called NLA101 that was developed at Fred Hutch and then spun out as the company Nohla Therapeutics. Delaney is director of Fred Hutch’s cord-blood transplant program and founder and chief medical officer at Nohla.
Does eating soy products increase or lower risk of breast cancer?
Dr. Marian L. Neuhouser, head of the Cancer Prevention Program at Fred Hutch, discussed possible links between soy products and breast cancer. She noted compounds found in soybeans and other plants can mimic the effects of estrogen, a prime driver of most breast cancers, but most studies have found no negative association between soy consumption and breast cancer risk.
Seattle writer summits Mount Everest to raise money for Fred Hutch
KOMO News, GeekWire, KING-TV, KIRO-TV and other outlets covered the achievement of Seattle biotech writer Luke Timmerman, who reached the peak of Mount Everest on May 22 in his quest to raise funds for cancer research at Fred Hutch. Coverage continued through early June with interviews with Timmerman and recaps of his expedition on KING-TV, KOMO News, and KATU-TV. He has raised about $340,000 so far.
Seattle writer summits Mount Everest to raise money for Fred Hutch
KOMO News, GeekWire, KING-TV, KIRO-TV and other outlets covered the achievement of Seattle biotech writer Luke Timmerman, who reached the peak of Mount Everest on May 22 in his quest to raise funds for cancer research at Fred Hutch. Coverage continued through early June with interviews with Timmerman and recaps of his expedition on KING-TV, KOMO News, and KATU-TV. He has raised about $340,000 so far.
Cancer patients are twice as likely to declare bankruptcy
In an Associated Press story on the financial toll that cancer treatment can take, Fred Hutch’s Dr. Veena Shankaran, of the Hutch’s health economics group, HICOR, spoke about the financial struggles faced by cancer patients. She said, “A lot of times people don’t realize there are resources available until they’ve already gone broke.” The story appeared in the Chicago Tribune, The Seattle Times, at CBS News online and in numerous other outlets.
Cancer patients are twice as likely to declare bankruptcy
In an Associated Press story on the financial toll that cancer treatment can take, Fred Hutch’s Dr. Veena Shankaran, of the Hutch’s health economics group, HICOR, spoke about the financial struggles faced by cancer patients. She said, “A lot of times people don’t realize there are resources available until they’ve already gone broke.” The story appeared in the Chicago Tribune, The Seattle Times, at CBS News online and in numerous other outlets.
The Hutch closes in on a cancer cure
Dr. Gary Gilliland, president and director, and others at Fred Hutch are quoted in an in-depth feature on the institution’s history and day-to-day work, especially in cancer immunotherapy. “We’re curing people. The question is: Why aren’t we curing everybody, and how do we extend those curative methods to other types of cancers that have been more recalcitrant?” Gilliland said. The magazine also published a story behind the story. Coverage was picked up by Tacoma’s News Tribune and other outlets.
The Hutch closes in on a cancer cure
Dr. Gary Gilliland, president and director, and others at Fred Hutch are quoted in an in-depth feature on the institution’s history and day-to-day work, especially in cancer immunotherapy. “We’re curing people. The question is: Why aren’t we curing everybody, and how do we extend those curative methods to other types of cancers that have been more recalcitrant?” Gilliland said. The magazine also published a story behind the story. Coverage was picked up by Tacoma’s News Tribune and other outlets.
Fred Hutch president named “Geek of the Year”
Gary Gilliland, president and director of Fred Hutch was named “Geek of the Year” at the 2018 GeekWire Awards presentation. In selecting Gilliland for the prestigious award, GeekWire noted, “The nationally recognized cancer center is working on some of the hottest frontiers in cancer research, namely cellular immunotherapy treatments that specifically target a patient’s unique cancer mutations. Under Gilliland’s leadership, the Hutch has recruited big names from the technology field to its board of trustees, including Microsoft CEO Satya Nadella and Mike Clayville, a vice president at Amazon Web Services.” Mentioned as one of the most touching moments of the evening was when Gilliland asked his fellow nominees to share the stage with him.
Fred Hutch president named “Geek of the Year”
Gary Gilliland, president and director of Fred Hutch was named “Geek of the Year” at the 2018 GeekWire Awards presentation. In selecting Gilliland for the prestigious award, GeekWire noted, “The nationally recognized cancer center is working on some of the hottest frontiers in cancer research, namely cellular immunotherapy treatments that specifically target a patient’s unique cancer mutations. Under Gilliland’s leadership, the Hutch has recruited big names from the technology field to its board of trustees, including Microsoft CEO Satya Nadella and Mike Clayville, a vice president at Amazon Web Services.” Mentioned as one of the most touching moments of the evening was when Gilliland asked his fellow nominees to share the stage with him.
Artificial intelligence takes scientists inside living human cells
A 3D model of a living human cell – the newly unveiled Allen Integrated Cell – could help scientists solve many medical mysteries. Fred Hutch molecular biologist Roger Brent, who has been using the tool for several months, said, “This lets you see things with a simple microscope that are going to be helpful to researchers all over the world – including in less affluent places.”
Artificial intelligence takes scientists inside living human cells
A 3D model of a living human cell – the newly unveiled Allen Integrated Cell – could help scientists solve many medical mysteries. Fred Hutch molecular biologist Roger Brent, who has been using the tool for several months, said, “This lets you see things with a simple microscope that are going to be helpful to researchers all over the world – including in less affluent places.”
Experts have new advice on prostate cancer screening. Here’s why they put it back on the table
Ruth Etzioni, a biostatistician in the Public Health Sciences Division, commented on prostate cancer screening recommendations issued by the U.S. Preventive Services Task Force on how men can judge whether testing is right for them. “It means the benefits and harms of the decision are going to be different for different people. Screening might be a good decision for you, but your friend may come up with a different decision, she said. The LA Times article also appeared in The Seattle Times and other outlets.
Experts have new advice on prostate cancer screening. Here’s why they put it back on the table
Ruth Etzioni, a biostatistician in the Public Health Sciences Division, commented on prostate cancer screening recommendations issued by the U.S. Preventive Services Task Force on how men can judge whether testing is right for them. “It means the benefits and harms of the decision are going to be different for different people. Screening might be a good decision for you, but your friend may come up with a different decision, she said. The LA Times article also appeared in The Seattle Times and other outlets.
Microsoft partners with Fred Hutch to tackle chemotherapy side effects using new AI tech
Fred Hutch and Microsoft are working together to reduce the side effects of chemotherapy and the emergency room visits that result. “They’ve unveiled a new pilot program that will leverage Microsoft’s artificial intelligence technology and Fred Hutch’s clinical and data science expertise,” said a story in GeekWire. The story also appeared on KIRO-TV.
Microsoft partners with Fred Hutch to tackle chemotherapy side effects using new AI tech
Fred Hutch and Microsoft are working together to reduce the side effects of chemotherapy and the emergency room visits that result. “They’ve unveiled a new pilot program that will leverage Microsoft’s artificial intelligence technology and Fred Hutch’s clinical and data science expertise,” said a story in GeekWire. The story also appeared on KIRO-TV.
Seattle skyline to glows orange for Fred Hutch’s efforts to battle cancer
The Seattle Times noted that landmarks across Seattle would glow orange for several nights during the week of May 7 to bring attention to Fred Hutch’s annual Obliteride bike ride that raises money to fight cancer. The event, which will be on Aug. 11, has brought in $12 million since it started. The story also was covered by KZJO-TV, KING-TV, KOMO-TV and KCPQ-TV.
Seattle skyline to glows orange for Fred Hutch’s efforts to battle cancer
The Seattle Times noted that landmarks across Seattle would glow orange for several nights during the week of May 7 to bring attention to Fred Hutch’s annual Obliteride bike ride that raises money to fight cancer. The event, which will be on Aug. 11, has brought in $12 million since it started. The story also was covered by KZJO-TV, KING-TV, KOMO-TV and KCPQ-TV.
Fred Hutch report aims to improve quality and costs of cancer care
Dr. Gary Gilliland, Fred Hutch president and director, was quoted in an article about the release of the Community Cancer Care in Washington State: Quality and Cost Report. “Participants in this endeavor can use it to learn where their efforts to improve quality and control costs are working most efficiently, and where they are not,” he said in a blog post, according to the article. The Hutchinson Institute for Cancer Outcomes Research worked on the report for five years, collecting data in partnership with providers and insurers.
Fred Hutch report aims to improve quality and costs of cancer care
Dr. Gary Gilliland, Fred Hutch president and director, was quoted in an article about the release of the Community Cancer Care in Washington State: Quality and Cost Report. “Participants in this endeavor can use it to learn where their efforts to improve quality and control costs are working most efficiently, and where they are not,” he said in a blog post, according to the article. The Hutchinson Institute for Cancer Outcomes Research worked on the report for five years, collecting data in partnership with providers and insurers.
Gene editing shows promise in combating HIV reservoirs
FierceBiotech and other outlets reported on a study published by Drs. Christopher Peterson and Hans-Peter Kiem of the Fred Hutch Clinical Research Division about a gene editing technique studied in non-human primates that may one day help fight HIV in people.
Gene editing shows promise in combating HIV reservoirs
FierceBiotech and other outlets reported on a study published by Drs. Christopher Peterson and Hans-Peter Kiem of the Fred Hutch Clinical Research Division about a gene editing technique studied in non-human primates that may one day help fight HIV in people.
Fred Hutch researcher among scientists receiving new funding to map every cell in the body
The Chan Zuckerberg Initiative announced a new infusion of funding in support of scientists working on the Human Cell Atlas, including Fred Hutch researcher Raphael Gottardo, a member of the Vaccine and Infectious Disease Division and the Public Health Sciences Division. The project to map every cell in the human body is part of the $3 billion Chan Zuckerberg Initiative, the philanthropic organization of Facebook founder Mark Zuckerberg and his wife Priscilla Chan, according to GeekWire.
Fred Hutch researcher among scientists receiving new funding to map every cell in the body
The Chan Zuckerberg Initiative announced a new infusion of funding in support of scientists working on the Human Cell Atlas, including Fred Hutch researcher Raphael Gottardo, a member of the Vaccine and Infectious Disease Division and the Public Health Sciences Division. The project to map every cell in the human body is part of the $3 billion Chan Zuckerberg Initiative, the philanthropic organization of Facebook founder Mark Zuckerberg and his wife Priscilla Chan, according to GeekWire.
CRISPR trials are about to begin in people — but we still don’t know how well it works in monkeys
Dr. Hans-Peter Kiem, a Fred Hutch oncologist, stem cell and gene therapy researcher, is quoted in this story about the gene-editing tool CRISPR, which may allow doctors to cure some diseases by altering a patient’s DNA. “Since monkeys are so similar to humans, I don’t think there’s going to be a huge challenge in translating this work to humans,” he said.
CRISPR trials are about to begin in people — but we still don’t know how well it works in monkeys
Dr. Hans-Peter Kiem, a Fred Hutch oncologist, stem cell and gene therapy researcher, is quoted in this story about the gene-editing tool CRISPR, which may allow doctors to cure some diseases by altering a patient’s DNA. “Since monkeys are so similar to humans, I don’t think there’s going to be a huge challenge in translating this work to humans,” he said.
Preventive benefit of finasteride for prostate cancer maintained for 16 years
A new study found that men who took finasteride for seven years had reduced risk for prostate cancer throughout 16 years of follow-up. “One concern with these kinds of interventions is that while people are taking the intervention that prostate cancer may be prevented, but then rates snap back once the intervention is discontinued. That did not happen here. The preventive benefit of finasteride was maintained over the 16 years,” said Dr. Joseph Unger, assistant member of the Cancer Prevention Program.
Preventive benefit of finasteride for prostate cancer maintained for 16 years
A new study found that men who took finasteride for seven years had reduced risk for prostate cancer throughout 16 years of follow-up. “One concern with these kinds of interventions is that while people are taking the intervention that prostate cancer may be prevented, but then rates snap back once the intervention is discontinued. That did not happen here. The preventive benefit of finasteride was maintained over the 16 years,” said Dr. Joseph Unger, assistant member of the Cancer Prevention Program.
News of Note—I-O in ovarian cancer; a single target for pain, obesity and depression
FierceBiotech highlighted work conducted by Dr. Kristin Anderson in Dr. Phil Greenberg’s lab on immunotherapy in ovarian cancer. The results, which were presented at the 2019 American Association for Cancer Research annual meeting showed that when combining engineered T cells with two other immune boosting treatments, the growth of ovarian tumors in mice was decreased.
News of Note—I-O in ovarian cancer; a single target for pain, obesity and depression
FierceBiotech highlighted work conducted by Dr. Kristin Anderson in Dr. Phil Greenberg’s lab on immunotherapy in ovarian cancer. The results, which were presented at the 2019 American Association for Cancer Research annual meeting showed that when combining engineered T cells with two other immune boosting treatments, the growth of ovarian tumors in mice was decreased.
It’s possible for women to have male DNA in their bodies, but there’s no need for alarm
A story that went viral in 2017 launched a wave of inaccurate stories about women acquiring male DNA from sexual partners. Not true, said Dr. J. Lee Nelson, a Fred Hutch autoimmunity researcher and rheumatologist. She explained that the most common source of male DNA in adult women is from prior pregnancy with a male child and how the mixing of DNA could benefit health.
It’s possible for women to have male DNA in their bodies, but there’s no need for alarm
A story that went viral in 2017 launched a wave of inaccurate stories about women acquiring male DNA from sexual partners. Not true, said Dr. J. Lee Nelson, a Fred Hutch autoimmunity researcher and rheumatologist. She explained that the most common source of male DNA in adult women is from prior pregnancy with a male child and how the mixing of DNA could benefit health.
Dr. Gary Lyman sees knowledge of biosimilars in cancer has improved
Fred Hutch Dr. Gary Lyman discussed the role of biosimilars and their growing use in cancer treatment.
Dr. Gary Lyman sees knowledge of biosimilars in cancer has improved
Fred Hutch Dr. Gary Lyman discussed the role of biosimilars and their growing use in cancer treatment.
Can we gene-edit herpes away?
Dr. Keith Jerome, a virologist at Fred Hutch, co-authored a 2016 study about gene editing in herpes-infected mice. “His is the first study to show that gene-editing technology can reach the latent virus in a nerve cell, and the first to use that technology to damage some of the virus’ DNA,” according to a Smithsonian.com article on this and other efforts to combat the virus in humans.
Can we gene-edit herpes away?
Dr. Keith Jerome, a virologist at Fred Hutch, co-authored a 2016 study about gene editing in herpes-infected mice. “His is the first study to show that gene-editing technology can reach the latent virus in a nerve cell, and the first to use that technology to damage some of the virus’ DNA,” according to a Smithsonian.com article on this and other efforts to combat the virus in humans.
Fred Hutch president applauds Amazon’s health care partnership
Dr. Gary Gilliland, Fred Hutch president and director, said the Amazon-JPMorgan Chase-Berkshire Hathaway partnership aimed at driving down health care costs could help change the industry for the better, but it won’t be easy because this is new territory for the companies and there are many complexities to confront.
Fred Hutch president applauds Amazon’s health care partnership
Dr. Gary Gilliland, Fred Hutch president and director, said the Amazon-JPMorgan Chase-Berkshire Hathaway partnership aimed at driving down health care costs could help change the industry for the better, but it won’t be easy because this is new territory for the companies and there are many complexities to confront.
Racial minorities with hematologic cancers receive more aggressive end-of-life care
Dr. Kedar Kirtane, a fellow in the Hematology/Oncology Fellowship Program at Fred Hutch discussed a retrospective study he and colleagues conducted that found that racial minorities with blood cancers had lower rates of advance directives and received significantly more aggressive care than white patients. Kirtane said providers need to do a better job of discussing palliative care and advanced care planning, especially for historically disadvantaged groups.
Racial minorities with hematologic cancers receive more aggressive end-of-life care
Dr. Kedar Kirtane, a fellow in the Hematology/Oncology Fellowship Program at Fred Hutch discussed a retrospective study he and colleagues conducted that found that racial minorities with blood cancers had lower rates of advance directives and received significantly more aggressive care than white patients. Kirtane said providers need to do a better job of discussing palliative care and advanced care planning, especially for historically disadvantaged groups.
Robert W. Day, former president of Fred Hutchinson, dies at 87
In a tribute, Dr. Gary Gilliland talked about working with Dr. Robert W. Day and the last accomplishments the former president made, including moving the Fred Hutch campus to its current location in South Lake Union.
Robert W. Day, former president of Fred Hutchinson, dies at 87
In a tribute, Dr. Gary Gilliland talked about working with Dr. Robert W. Day and the last accomplishments the former president made, including moving the Fred Hutch campus to its current location in South Lake Union.
Microsoft invests in Fred Hutch spinoff to detect diseases at earliest stages
Microsoft will partner with Adaptive Biotechnologies, which was formed in 2009 with Fred Hutch technology, to develop blood tests that will “alert doctors when people are fighting specific diseases".
Microsoft invests in Fred Hutch spinoff to detect diseases at earliest stages
Microsoft will partner with Adaptive Biotechnologies, which was formed in 2009 with Fred Hutch technology, to develop blood tests that will “alert doctors when people are fighting specific diseases.
Working to reduce cancer deaths in black women
In a story featuring Bridgette Hempstead, founder of the Cierra Sisters, a support group for black women with breast cancer, Dr. Nancy Davidson, senior vice president and director of the Clinical Research Division, said there is a common and false misconception that nothing can be done about a breast cancer diagnosis.
Experiences and influences that shaped a career in cancer research
In an American Society of Hematology Q&A, Hutch president and director Dr. Gary Gilliland talks about the people and events that inspired him to become a doctor and specialize in hematology.
Experiences and influences that shaped a career in cancer research
In an American Society of Hematology Q&A, Hutch president and director Dr. Gary Gilliland talks about the people and events that inspired him to become a doctor and specialize in hematology.
Working to reduce cancer deaths in black women
In a story featuring Bridgette Hempstead, founder of the Cierra Sisters, a support group for black women with breast cancer, Dr. Nancy Davidson, senior vice president and director of the Clinical Research Division, said there is a common and false misconception that nothing can be done about a breast cancer diagnosis.
New targets, diseases for CAR T-cell therapy – but expansion to solid tumors remains problematic
In an article on chimeric antigen receptor T-cell therapy, Dr. Brian Till, in the Hutch’s Clinical Research Division, discussed the practicality of using two different CAR T cells to attack two antigens – CD19 and CD20 – in lymphoma, and said the solid tumor microenvironment is more hostile to T cells.
New targets, diseases for CAR T-cell therapy – but expansion to solid tumors remains problematic
In an article on chimeric antigen receptor T-cell therapy, Dr. Brian Till, in the Hutch’s Clinical Research Division, discussed the practicality of using two different CAR T cells to attack two antigens – CD19 and CD20 – in lymphoma, and said the solid tumor microenvironment is more hostile to T cells.
Cognitive behavioral therapy may improve sleep during menopause
For women experiencing sleep disturbances associated with menopause, talking with a sleep coach and adopting personalized advice and tools was more effective than other measures aimed at improving sleep, according to Dr. Katherine Guthrie of the Public Health Sciences Division, who led a study that appeared in the journal Sleep.
Cognitive behavioral therapy may improve sleep during menopause
For women experiencing sleep disturbances associated with menopause, talking with a sleep coach and adopting personalized advice and tools was more effective than other measures aimed at improving sleep, according to Dr. Katherine Guthrie of the Public Health Sciences Division, who led a study that appeared in the journal Sleep.
Hutch doctor helps dispel breast cancer myths
Getting regular exercise is one way to improve the odds against breast cancer. For women who need to get started, Dr. Anne McTiernan, cancer prevention researcher, suggests starting slowly and working up, choosing an enjoyable form of exercise.
Hutch doctor helps dispel breast cancer myths
Getting regular exercise is one way to improve the odds against breast cancer. For women who need to get started, Dr. Anne McTiernan, cancer prevention researcher, suggests starting slowly and working up, choosing an enjoyable form of exercise.
Questions about vitamin D and calcium supplements for bone health in the elderly
A new study says vitamin D and calcium supplements may not help in preventing bone fractures in the elderly, but Dr. Anne McTiernan, a Fred Hutch expert on diet and cancer, questions the doses given in the studies and notes that other research suggests that vitamin D may lower some cancer risk factors.
Questions about vitamin D and calcium supplements for bone health in the elderly
A new study says vitamin D and calcium supplements may not help in preventing bone fractures in the elderly, but Dr. Anne McTiernan
, a Fred Hutch expert on diet and cancer, questions the doses given in the studies and notes that other research suggests that vitamin D may lower some cancer risk factors.
Vaccine for sarcoma reprograms the immune system
Dr. Seth Pollack of the Clinical Research Division said an experimental drug that reprograms the immune system to fight sarcoma cells appears to be helping patients live longer with few side effects. A Phase 3 clinical trial will launch soon.
Cancer survivors must remain vigilant throughout their lifetimes
In a commentary in JAMA Oncology, Dr. Nancy E. Davidson, senior vice president and director of the Clinical Research Division, said cancer survivors and their doctors should follow surveillance guidelines because there is no guarantee that a patient successfully treated for one cancer is not at risk for another.
Cancer survivors must remain vigilant throughout their lifetimes
In a commentary in JAMA Oncology, Dr. Nancy E. Davidson, senior vice president and director of the Clinical Research Division, said cancer survivors and their doctors should follow surveillance guidelines because there is no guarantee that a patient successfully treated for one cancer is not at risk for another.
The next generation of T-cell therapies takes on solid tumors
Dr. Matthias Stephan explained that experimental technology developed at Fred Hutch aims to make T-cell therapies more easily produced and more affordable.
The next generation of T-cell therapies takes on solid tumors
Dr. Matthias Stephan explained that experimental technology developed at Fred Hutch aims to make T-cell therapies more easily produced and more affordable.
Specialized CAR T-cell product targets aggressive B-cell lymphoma
In an article on chimeric antigen receptor T-cell therapy, Dr. Brian Till, in the Hutch’s Clinical Research Division, discussed the practicality of using two different CAR T cells to attack two antigens – CD19 and CD20 – in lymphoma, and said the solid tumor microenvironment is more hostile to T cells.
Specialized CAR T-cell product targets aggressive B-cell lymphoma
In an article on chimeric antigen receptor T-cell therapy, Dr. Brian Till, in the Hutch’s Clinical Research Division, discussed the practicality of using two different CAR T cells to attack two antigens – CD19 and CD20 – in lymphoma, and said the solid tumor microenvironment is more hostile to T cells.
Fred Hutch doctor turned a radical idea into a cancer cure
Local NPR affiliate KUOW profiles Dr. E. Donnall Thomas' pioneering work on bone marrow transplant and how it set the stage for the Seattle biotech industry.
Fred Hutch doctor turned a radical idea into a cancer cure
Local NPR affiliate KUOW profiles Dr. E. Donnall Thomas' pioneering work on bone marrow transplant and how it set the stage for the Seattle biotech industry.
Researchers on racial disparity: ‘We are failing black women with breast cancer’
In a Seattle Times opinion article on racial disparities in treatment and outcomes, Dr. Nancy Davidson, senior vice president and director of the Clinical Research Division, and Dr. Beti Thompson, director of the Health Disparities Research Center, said clinical trials often fail to include people of color, and black women have too little access to information and services.
Researchers on racial disparity: ‘We are failing black women with breast cancer’
In a Seattle Times opinion article on racial disparities in treatment and outcomes, Dr. Nancy Davidson, senior vice president and director of the Clinical Research Division, and Dr. Beti Thompson, director of the Health Disparities Research Center, said clinical trials often fail to include people of color, and black women have too little access to information and services.
Many women with breast cancer get too much testing and treatment
Dr. Scott Ramsey and Dr. Gary Lyman, leaders of the Hutchinson Institute for Cancer Outcomes Research, were quoted in an NPR story on expensive, painful and unnecessary tests and treatments that many women with breast cancer endure. This story originally appeared in Kaiser Health News.
Many women with breast cancer get too much testing and treatment
Dr. Scott Ramsey and Dr. Gary Lyman, leaders of the Hutchinson Institute for Cancer Outcomes Research, were quoted in an NPR story on expensive, painful and unnecessary tests and treatments that many women with breast cancer endure. This story originally appeared in Kaiser Health News.
FDA approves another amazing and costly cancer-killing gene therapy
Dr. David Maloney of Fred Hutch commented on the FDA approval of a CAR T-cell treatment for lymphoma and the promise the immunotherapy has for saving lives.
FDA approves another amazing and costly cancer-killing gene therapy
Dr. David Maloney of Fred Hutch commented on the FDA approval of a CAR T-cell treatment for lymphoma and the promise the immunotherapy has for saving lives.
Cancer researchers learn more about toxic side effects of new treatments
Fred Hutch researchers led by Dr. Cameron Turtle published detailed descriptions on the two most common side effects of CAR T-cell therapy, to better understand which patients are most vulnerable and how to prevent the effects.
Cancer researchers learn more about toxic side effects of new treatments
Fred Hutch researchers led by Dr. Cameron Turtle published detailed descriptions on the two most common side effects of CAR T-cell therapy, to better understand which patients are most vulnerable and how to prevent the effects.
Future battles against cancer will expand tech frontiers, Fred Hutch’s chief says
Dr. Gary Gilliland discussed his prediction for cancer cures by 2025 and the importance of the technology and data science communities in making that goal a reality. He spoke at the 2017 GeekWire Summit.
Fred Hutch director: We can cure cancer by 2025
NBC affiliate shared footage of Dr. Gary Gilliland's appearance at the 2017 GeekWire Summit during which he spoke about how technology has a role in cancer cures.
Future battles against cancer will expand tech frontiers, Fred Hutch’s chief says
Dr. Gary Gilliland discussed his prediction for cancer cures by 2025 and the importance of the technology and data science communities in making that goal a reality. He spoke at the 2017 GeekWire Summit.
Lymphoma physician-scientist Oliver Press, MD, PhD, dies at 65
Blood cancer physician-scientist Dr. Oliver Press of Fred Hutch made foundational contributions to the development of targeted cancer therapies. He died Sept. 29 of complications from glioma.
Immunotherapy combinations offer hope in glioblastoma
Dr. Eric Holland discussed the challenges in treating glioblastoma and the importance of understanding the biology of the disease and developing targeted treatments that involve immunotherapy.
Innovator of the Month: Blaze Bioscience uses scorpion venom to light up cancer tumors
Fred Hutch spinout, Blaze Bioscience, is featured as innovator of the month for its "tumor paint" technology which was developed in the lab of Dr. Jim Olson.
Lymphoma physician-scientist Oliver Press, MD, PhD, dies at 65
Blood cancer physician-scientist Dr. Oliver Press of Fred Hutch made foundational contributions to the development of targeted cancer therapies. He died Sept. 29 of complications from glioma.
Immunotherapy combinations offer hope in glioblastoma
Dr. Eric Holland discussed the challenges in treating glioblastoma and the importance of understanding the biology of the disease and developing targeted treatments that involve immunotherapy.
Innovator of the Month: Blaze Bioscience uses scorpion venom to light up cancer tumors
Fred Hutch spinout, Blaze Bioscience, is featured as innovator of the month for its "tumor paint" technology which was developed in the lab of Dr. Jim Olson.
Why Fred Hutch President Gary Gilliland is enlisting techies to defeat cancer by 2025
Article featuring Dr. Gary Gilliland discussing how Fred Hutch is bringing big-data experts on board to make good on his prediction that there could be cures and therapies for, "most, if not all, human cancers" by 2025.
Why Fred Hutch President Gary Gilliland is enlisting techies to defeat cancer by 2025
Article featuring Dr. Gary Gilliland discussing how Fred Hutch is bringing big-data experts on board to make good on his prediction that there could be cures and therapies for, "most, if not all, human cancers" by 2025.
Why Fred Hutch President Gary Gilliland is enlisting techies to defeat cancer by 2025
Article featuring Dr. Gary Gilliland discussing how Fred Hutch is bringing big-data experts on board to make good on his prediction that there could be cures and therapies for, "most, if not all, human cancers" by 2025.
Why Fred Hutch President Gary Gilliland is enlisting techies to defeat cancer by 2025
Article featuring Dr. Gary Gilliland discussing how Fred Hutch is bringing big-data experts on board to make good on his prediction that there could be cures and therapies for, "most, if not all, human cancers" by 2025.
Tinkering with T cells
Dr. Brian Till gave context to CAR-T therapies for blood cancers in an article summarizing recent FDA approvals of the therapy which appeared in a magazine published by the world's oldest and largest professional organization of its kind, the American Association for Cancer Research.
Tinkering with T cells
Dr. Brian Till gave context to CAR-T therapies for blood cancers in an article summarizing recent FDA approvals of the therapy which appeared in a magazine published by the world's oldest and largest professional organization of its kind, the American Association for Cancer Research.
Juno Therapeutics ready for another round in war on cancer
Dr. Stanley Riddell commented on advances in CAR-T therapy for treating blood cancers and how he believes that the side effects of the therapy will be manageable. Juno is a spinout of Fred Hutch.
Juno Therapeutics ready for another round in war on cancer
Dr. Stanley Riddell commented on advances in CAR-T therapy for treating blood cancers and how he believes that the side effects of the therapy will be manageable. Juno is a spinout of Fred Hutch.
Re-analysis finds benefit in cancer screening. Should you believe it?
Article on study from senior author Dr. Ruth Etzioni which found that prostate cancer screening is linked to reduced mortality. The study looked at two major clinical trials, previously reported as contradictory, and found that after re-analyzing the data, the studies were complimentary.
Re-analysis finds benefit in cancer screening. Should you believe it?
Article on study from senior author Dr. Ruth Etzioni which found that prostate cancer screening is linked to reduced mortality. The study looked at two major clinical trials, previously reported as contradictory, and found that after re-analyzing the data, the studies were complimentary.
Do prostate cancer screenings significantly reduce deaths?
Article on study from senior author Dr. Ruth Etzioni which found that prostate cancer screening is linked to reduced mortality. The study looked at two major clinical trials, previously reported as contradictory, and found that after re-analyzing the data, the studies were complimentary. The article was republished from STAT.
New studies lend support for PSA screening for prostate cancer
Article on study from senior author Dr. Ruth Etzioni which found that prostate cancer screening is linked to reduced mortality. The study looked at two major clinical trials, previously reported as contradictory, and found that after re-analyzing the data, the studies were complimentary.
Do prostate cancer screenings significantly reduce deaths?
Article on study from senior author Dr. Ruth Etzioni which found that prostate cancer screening is linked to reduced mortality. The study looked at two major clinical trials, previously reported as contradictory, and found that after re-analyzing the data, the studies were complimentary. The article was republished from STAT.
New studies lend support for PSA screening for prostate cancer
Article on study from senior author Dr. Ruth Etzioni which found that prostate cancer screening is linked to reduced mortality. The study looked at two major clinical trials, previously reported as contradictory, and found that after re-analyzing the data, the studies were complimentary.
Prostate cancer test saves lives, risks remain
Article on study from senior author Dr. Ruth Etzioni which found that prostate cancer screening is linked to reduced mortality. The study looked at two major clinical trials, previously reported as contradictory, and found that after re-analyzing the data, the studies were complimentary.
PSA screening for prostate cancer saves lives after all, study says
Article on study from senior author Dr. Ruth Etzioni which found that prostate cancer screening is linked to reduced mortality. The study looked at two major clinical trials, previously reported as contradictory, and found that after re-analyzing the data, the studies were complimentary.
New apps help people with addictions
Dr. Jaimee Heffner was quoted in an article about using apps to help battle addiction. Heffner and colleagues developed Smart Quit, an app to assist people stop smoking, and in the article she was quoted about the benefits and complexities of the approach.
New study offers support for prostate testing
Article on study from senior author Dr. Ruth Etzioni which found that prostate cancer screening is linked to reduced mortality. The study looked at two major clinical trials, previously reported as contradictory, and found that after re-analyzing the data, the studies were complimentary
Prostate cancer test saves lives, risks remain
Article on study from senior author Dr. Ruth Etzioni which found that prostate cancer screening is linked to reduced mortality. The study looked at two major clinical trials, previously reported as contradictory, and found that after re-analyzing the data, the studies were complimentary.
PSA screening for prostate cancer saves lives after all, study says
Article on study from senior author Dr. Ruth Etzioni which found that prostate cancer screening is linked to reduced mortality. The study looked at two major clinical trials, previously reported as contradictory, and found that after re-analyzing the data, the studies were complimentary.
New apps help people with addictions
Dr. Jaimee Heffner was quoted in an article about using apps to help battle addiction. Heffner and colleagues developed Smart Quit, an app to assist people stop smoking, and in the article she was quoted about the benefits and complexities of the approach.
New study offers support for prostate testing
Article on study from senior author Dr. Ruth Etzioni which found that prostate cancer screening is linked to reduced mortality. The study looked at two major clinical trials, previously reported as contradictory, and found that after re-analyzing the data, the studies were complimentary
US clears breakthrough gene therapy for childhood leukemia
Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CAR T cells to fight childhood leukemia
US clears breakthrough gene therapy for childhood leukemia
Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CAR T cells to fight childhood leukemia
Hailing a breakthrough in fighting cancer, FDA approves gene therapy that functions as a ‘living drug’
Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CART cells to fight childhood leukemia
Landmark FDA approval clears the way for gene therapy treatments that fight cancer
Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CART cells to fight childhood leukemia
‘Hit-and-run’ gene therapy nanoparticles could enhance CAR-T treatments
Dr. Matthias Stephan was quoted on his study developing nanoparticle technology to streamline the manufacturing of cell therapies and make these treatments more off-the-shelf.
New ‘hit-and-run’ gene editing tool temporarily rewrites genetics to treat cancer and HIV
Dr. Matthias Stephan was quoted on his study developing nanoparticle technology to streamline the manufacturing of cell therapies and make these treatments off-the-shelf
Pioneering cancer gene therapy gets green light — and $475,000 price tag
Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CAR T cells to fight childhood leukemia
First cancer 'living drug' gets go-ahead
Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CAR T cells to fight childhood leukemia
Hailing a breakthrough in fighting cancer, FDA approves gene therapy that functions as a ‘living drug’
Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CART cells to fight childhood leukemia
Landmark FDA approval clears the way for gene therapy treatments that fight cancer
Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CART cells to fight childhood leukemia
‘Hit-and-run’ gene therapy nanoparticles could enhance CAR-T treatments
Dr. Matthias Stephan was quoted on his study developing nanoparticle technology to streamline the manufacturing of cell therapies and make these treatments more off-the-shelf.
New ‘hit-and-run’ gene editing tool temporarily rewrites genetics to treat cancer and HIV
Dr. Matthias Stephan was quoted on his study developing nanoparticle technology to streamline the manufacturing of cell therapies and make these treatments off-the-shelf
Pioneering cancer gene therapy gets green light — and $475,000 price tag
Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CAR T cells to fight childhood leukemia
First cancer 'living drug' gets go-ahead
Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CAR T cells to fight childhood leukemia
Steady may win the weight-loss race
Dr. Anne McTiernan was quoted in an article on the benefits of steady weight loss opposed to dramatic results. “Slow and steady wins the race,” she said.
Steady may win the weight-loss race
Dr. Anne McTiernan was quoted in an article on the benefits of steady weight loss opposed to dramatic results. “Slow and steady wins the race,” she said.
Vitamin B6 and B12 supplements appear to cause cancer in men
Article covers research from Drs. Theodore Brasky and Emily White on a link between lung cancer and long-term use of B6 and B12 dietary supplements, particularly in men.
Vitamin B6 and B12 supplements appear to cause cancer in men
Article covers research from Drs. Theodore Brasky and Emily White on a link between lung cancer and long-term use of B6 and B12 dietary supplements, particularly in men.
Can baby powder really cause ovarian cancer?
Dr. Robyn Anderson was quoted on links between talcum powder and ovarian cancer. Anderson commented on the potential risks of talcum powder use.
Can baby powder really cause ovarian cancer?
Dr. Robyn Anderson was quoted on links between talcum powder and ovarian cancer. Anderson commented on the potential risks of talcum powder use.
Are the health benefits of red wine actually legit?
Dr. Anne McTiernan shed light on the science behind the potential health benefits and risks of drinking red wine
Are the health benefits of red wine actually legit?
Dr. Anne McTiernan shed light on the science behind the potential health benefits and risks of drinking red wine
A cancer conundrum: too many drug trials, too few patients
Dr. Scott Ramsey, co-director of the Hutchinson Center for Cancer Outcomes Research, or HICOR, was quoted in an article about the lack of patients available to participate in immunotherapy clinical trials
A cancer conundrum: too many drug trials, too few patients
Dr. Scott Ramsey, co-director of the Hutchinson Center for Cancer Outcomes Research, or HICOR, was quoted in an article about the lack of patients available to participate in immunotherapy clinical trials
New Hutch center to focus on cancers caused by microbes
Article covers the launch of the new Pathogen-Associated Malignancy Integrated Research Center (PAM-IRC) and quotes its director, Dr. Denise Galloway
Fred Hutch takes step toward 'moonshot' goal with new pathogen-caused-cancer center
Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CAR T cells to fight childhood leukemia
Conquer cancer foundation researcher spotlight
Dr. Aude Chapuis was featured in a spotlight article on her career and research using T-cell therapy and checkpoint inhibitors to treat cancer
Fred Hutch unveils new research center aimed at eliminating cancers caused by infections
Article covers the launch of the new Pathogen-Associated Malignancy Integrated Research Center (PAM-IRC) and quotes its director, Dr. Denise Galloway
Advances in the treatment of triple-negative breast cancer
Dr. Nancy Davidson, senior vice president and director of the Clinical Research Division, was featured in an article about recent advances in the research and treatment of triple-negative breast cancer
New Hutch center to focus on cancers caused by microbes
Article covers the launch of the new Pathogen-Associated Malignancy Integrated Research Center (PAM-IRC) and quotes its director, Dr. Denise Galloway
Fred Hutch takes step toward 'moonshot' goal with new pathogen-caused-cancer center
Dr. David Maloney was quoted on the FDA’s announcement to approve the breakthrough treatment, Kymriah. The immunotherapy treatment uses CAR T cells to fight childhood leukemia
Conquer cancer foundation researcher spotlight
Dr. Aude Chapuis was featured in a spotlight article on her career and research using T-cell therapy and checkpoint inhibitors to treat cancer
Fred Hutch unveils new research center aimed at eliminating cancers caused by infections
Article covers the launch of the new Pathogen-Associated Malignancy Integrated Research Center (PAM-IRC) and quotes its director, Dr. Denise Galloway
Advances in the treatment of triple-negative breast cancer
Dr. Nancy Davidson, senior vice president and director of the Clinical Research Division, was featured in an article about recent advances in the research and treatment of triple-negative breast cancer
More than 3 million life-years added over 60 years as a result of SWOG clinical trials
An interview with Dr. Joseph Unger on the effectiveness of SWOG, a federal clinical trial consortium of which Fred Hutch is a leading member
More than 3 million life-years added over 60 years as a result of SWOG clinical trials
An interview with Dr. Joseph Unger on the effectiveness of SWOG, a federal clinical trial consortium of which Fred Hutch is a leading member
Antipsychotic added to ASCO antiemetic guide
Dr. Gary Lyman was quoted on updated ASCO guidelines recommending adding olanzapine to a standard three-drug regimen for patients treated with highly emetogenic cancer chemotherapy
Antipsychotic added to ASCO antiemetic guide
Dr. Gary Lyman was quoted on updated ASCO guidelines recommending adding olanzapine to a standard three-drug regimen for patients treated with highly emetogenic cancer chemotherapy
Antipsychotic added to ASCO antiemetic guide
Dr. Gary Lyman was quoted on updated ASCO guidelines recommending adding olanzapine to a standard three-drug regimen for patients treated with highly emetogenic cancer chemotherapy
Antipsychotic added to ASCO antiemetic guide
Dr. Gary Lyman was quoted on updated ASCO guidelines recommending adding olanzapine to a standard three-drug regimen for patients treated with highly emetogenic cancer chemotherapy
Taking another look at whole milk yogurt
Dr. Mario Kratz was quoted in an article on the health factors associated with nonfat and full-fat yogurt saying there were associations between all types of yogurt and health benefits
Taking another look at whole milk yogurt
Dr. Mario Kratz was quoted in an article on the health factors associated with nonfat and full-fat yogurt saying there were associations between all types of yogurt and health benefits
These experimental treatments target brain cancer like John McCain’s
Dr. Eric Holland was quoted in an article about why treatment for glioblastoma, the type of brain cancer Sen. John McCain was diagnosed with, is particularly complicated
Lab etiquette: The perils of pet peeves
Nature quoted Dr. Karen Peterson in an article about laboratory etiquette and how to foster good relationships in research groups
Medicine's movable feast: What jumping genes can teach us about treating disease
Dr. Michael Emerman was quoted in an article on transposable elements in genomes that can jump around chromosomes, contribute to life-threatening diseases and come from dormant viruses
These experimental treatments target brain cancer like John McCain’s
Dr. Eric Holland was quoted in an article about why treatment for glioblastoma, the type of brain cancer Sen. John McCain was diagnosed with, is particularly complicated
Lab etiquette: The perils of pet peeves
Nature quoted Dr. Karen Peterson in an article about laboratory etiquette and how to foster good relationships in research groups
Medicine's movable feast: What jumping genes can teach us about treating disease
Dr. Michael Emerman was quoted in an article on transposable elements in genomes that can jump around chromosomes, contribute to life-threatening diseases and come from dormant viruses
Brain cancer like McCain's has hundreds of experimental therapies (with little success)
Dr. Eric Holland was quoted in an article about why treatment for glioblastoma, the type of brain cancer Senator John McCain was diagnosed with, is particularly complicated
Brain cancer like McCain's has hundreds of experimental therapies (with little success)
Dr. Eric Holland was quoted in an article about why treatment for glioblastoma, the type of brain cancer Senator John McCain was diagnosed with, is particularly complicated
Why John McCain's type of brain tumor is so hard to treat
Dr. Eric Holland was quoted in an article on glioblastoma, the type of brain cancer Sen. John McCain was diagnosed with
Why John McCain's type of brain tumor is so hard to treat
Dr. Eric Holland was quoted in an article on glioblastoma, the type of brain cancer Sen. John McCain was diagnosed with
The future of treatment for glioblastoma
Dr. Eric Holland was quoted in an article about why treatment for glioblastoma, the type of brain cancer Senator John McCain was diagnosed with, is particularly complicated
The future of treatment for glioblastoma
Dr. Eric Holland was quoted in an article about why treatment for glioblastoma, the type of brain cancer Senator John McCain was diagnosed with, is particularly complicated
The future of treatment for glioblastoma
Dr. Eric Holland was quoted in an article about why treatment for glioblastoma, the type of brain cancer Senator John McCain was diagnosed with, is particularly complicated
The future of treatment for glioblastoma
Dr. Eric Holland was quoted in an article about why treatment for glioblastoma, the type of brain cancer Senator John McCain was diagnosed with, is particularly complicated
First Person: Rainer Storb, MD
Dr. Rainer Storb was featured in an article on his life and research. The article also quoted Dr. Brenda Sandmaier, a mentee of Storb
First Person: Rainer Storb, MD
Dr. Rainer Storb was featured in an article on his life and research. The article also quoted Dr. Brenda Sandmaier, a mentee of Storb
Novel cancer treatment wins endorsement of FDA advisers
Dr. David Maloney quoted in an article on the Food and Drug Administration recommendation to approve a CAR-T therapy
Novel cancer treatment wins endorsement of FDA advisers
Dr. David Maloney quoted in an article on the Food and Drug Administration recommendation to approve a CAR-T therapy
A stem cell transplant helped beat back a young doctor’s cancer. Now, it’s assaulting his body
An in-depth look at stem cell transplantation for leukemia and the complications that arise, highlighting Drs. Paul Martin, Marie Bleakley and Leslie Kean and the late Dr. E. Donnall Thomas and his Nobel Prize
A stem cell transplant helped beat back a young doctor’s cancer. Now, it’s assaulting his body
An in-depth look at stem cell transplantation for leukemia and the complications that arise, highlighting Drs. Paul Martin, Marie Bleakley and Leslie Kean and the late Dr. E. Donnall Thomas and his Nobel Prize
First gene therapy — ‘a true living drug’ — on the cusp of FDA approval
Dr. David Maloney quoted in an article on the Food and Drug Administration recommendation to approve a CAR-T therapy
First gene therapy — ‘a true living drug’ — on the cusp of FDA approval
Dr. David Maloney quoted in an article on the Food and Drug Administration recommendation to approve a CAR-T therapy
How children change their mothers — and their mothers’ DNA
An article on microchimerism, a process in which the placenta allows a small transfer of cells between mother and fetus during pregnancy, quoting Dr. J. Lee Nelson
How children change their mothers — and their mothers’ DNA
An article on microchimerism, a process in which the placenta allows a small transfer of cells between mother and fetus during pregnancy, quoting Dr. J. Lee Nelson
Is Alcohol Good for You? An Industry-Backed Study Seeks Answers
Dr. Anne McTiernan in an article on a new $100 million clinical trial, funded by the National Institutes of Health, to test whether small amounts of alcohol can benefit health
Robots are milking scorpions for venom that can be used in cancer research
An article on a robot being used to milk scorpion venom for medical research that referenced work at Fred Hutch in adapting the venom to be used as tumor paint to light up cancer cells
Is Alcohol Good for You? An Industry-Backed Study Seeks Answers
Dr. Anne McTiernan in an article on a new $100 million clinical trial, funded by the National Institutes of Health, to test whether small amounts of alcohol can benefit health
Robots are milking scorpions for venom that can be used in cancer research
An article on a robot being used to milk scorpion venom for medical research that referenced work at Fred Hutch in adapting the venom to be used as tumor paint to light up cancer cells
Health Tech Podcast: Psychologists become app developers to help people kick addictions
Article on work by Drs. Jonathan Bricker and Jaimee Heffner on fighting smoking addiction with their app, SmartQuit
Health Tech Podcast: Psychologists become app developers to help people kick addictions
Article on work by Drs. Jonathan Bricker and Jaimee Heffner on fighting smoking addiction with their app, SmartQuit
Amazon CEO Jeff Bezos is searching for philanthropic ideas
Article about Jeff Bezos' approach to philanthropy notes the Bezos family's generous philanthropic support of Fred Hutch
Scientists are using decade-old snot to combat the flu
An article on research from Dr. Jesse Bloom and Katherine Xue about how the evolution of the influenza virus in an individual could shed light on the evolution of future virus strains
National project led by Fred Hutch researcher fights ovarian cancer deaths with predictive medicine
Article on a new initiative by the National Cancer Institute co-led by Dr. Amanda Paulovich to identify the best treatment for patients with ovarian cancer
A clever new way to predict next year's flu
An article on research from Dr. Jesse Bloom and Katherine Xue about how the evolution of the influenza virus in an individual could shed light on the evolution of future virus strains
National project led by Fred Hutch researcher fights ovarian cancer deaths with predictive medicine
Article on a new initiative by the National Cancer Institute co-led by Dr. Amanda Paulovich to identify the best treatment for patients with ovarian cancer
Is working at night healthy? Late shifts may increase risk of cancer and lead to poor health
An article covers work from Dr. Parveen Bhatti on the potentially harmful effects of working night shifts
Could shift work damage your DNA?
An article covers work from Dr. Parveen Bhatti on the potentially harmful effects of working night shifts
Amazon CEO Jeff Bezos is searching for philanthropic ideas
Article about Jeff Bezos' approach to philanthropy notes the Bezos family's generous philanthropic support of Fred Hutch
Scientists are using decade-old snot to combat the flu
An article on research from Dr. Jesse Bloom and Katherine Xue about how the evolution of the influenza virus in an individual could shed light on the evolution of future virus strains
National project led by Fred Hutch researcher fights ovarian cancer deaths with predictive medicine
Article on a new initiative by the National Cancer Institute co-led by Dr. Amanda Paulovich to identify the best treatment for patients with ovarian cancer
A clever new way to predict next year's flu
An article on research from Dr. Jesse Bloom and Katherine Xue about how the evolution of the influenza virus in an individual could shed light on the evolution of future virus strains
National project led by Fred Hutch researcher fights ovarian cancer deaths with predictive medicine
Article on a new initiative by the National Cancer Institute co-led by Dr. Amanda Paulovich to identify the best treatment for patients with ovarian cancer
Is working at night healthy? Late shifts may increase risk of cancer and lead to poor health
An article covers work from Dr. Parveen Bhatti on the potentially harmful effects of working night shifts
Could shift work damage your DNA?
An article covers work from Dr. Parveen Bhatti on the potentially harmful effects of working night shifts
The clue to next year's flu strain could be inside you
An article on research from Dr. Jesse Bloom and Katherine Xue about how the evolution of the influenza virus in an individual could shed light on the evolution of future virus strains
The clue to next year's flu strain could be inside you
An article on research from Dr. Jesse Bloom and Katherine Xue about how the evolution of the influenza virus in an individual could shed light on the evolution of future virus strains
Fred Hutch receives $24M contract to expand National Cancer Institute Contact Center operations
Nancy Gore is quoted on the importance of operating the NCI's only call center for patients, which is housed at Fred Hutch
Fred Hutch receives $24M contract to expand National Cancer Institute Contact Center operations
Nancy Gore is quoted on the importance of operating the NCI's only call center for patients, which is housed at Fred Hutch
Young kids may have mature biases against overweight people
Dr. Anne McTiernen quoted in a story on research on whether children have a bias against overweight people early on in life
Young kids may have mature biases against overweight people
Dr. Anne McTiernen quoted in a story on research on whether children have a bias against overweight people early on in life
Why pancreatic cancer is such a killer, and what's being done about it
An article about the difficulties in treating pancreatic cancer and promising research advances that have been made. The story featured Fred Hutch physician-scientist Dr. Sunil Hingorani
Coconut oil has more ‘bad’ fat than beef and butter: heart doctors
Dr. John Potter quoted in an article on an advisory from the American Heart Association on the health implications of coconut oil
Why pancreatic cancer is such a killer, and what's being done about it
An article about the difficulties in treating pancreatic cancer and promising research advances that have been made. The story featured Fred Hutch physician-scientist Dr. Sunil Hingorani
Coconut oil has more ‘bad’ fat than beef and butter: heart doctors
Dr. John Potter quoted in an article on an advisory from the American Heart Association on the health implications of coconut oil
Triple therapy potent approach in aggressive skin cancer
Article covering Dr. Kelly Paulson's presentation of findings for a new treatment for Merkel cell carcinoma at the annual American Society for Clinical Oncology meeting
Triple therapy potent approach in aggressive skin cancer
Article covering Dr. Kelly Paulson's presentation of findings for a new treatment for Merkel cell carcinoma at the annual American Society for Clinical Oncology meeting
Study informs use of NSAID benefit in colon cancer
Article covers study led by Dr. Polly Newcomb indicating that use of nonsteroidal anti-inflammatory drugs can increase survival rate in colorectal cancer patients without KRAS wild-type tumors
Biologists debate how to license preprints
Dr. Jesse Bloom is quoted on open access to scientific research and how he approaches sharing results prior to journal publication
PEGPH20 could improve metastatic pancreatic cancer outcomes
Article covers presentation by Dr. Sunil Hingorani at the annual American Society of Clinical Oncology meeting of the results in a pancreatic cancer trial
Study informs use of NSAID benefit in colon cancer
Article covers study led by Dr. Polly Newcomb indicating that use of nonsteroidal anti-inflammatory drugs can increase survival rate in colorectal cancer patients without KRAS wild-type tumors
Biologists debate how to license preprints
Dr. Jesse Bloom is quoted on open access to scientific research and how he approaches sharing results prior to journal publication
PEGPH20 could improve metastatic pancreatic cancer outcomes
Article covers presentation by Dr. Sunil Hingorani at the annual American Society of Clinical Oncology meeting of the results in a pancreatic cancer trial
At last, Jeff Bezos offers a hint of his philanthropic plans
Article about Jeff Bezos' approach to philanthropy notes the Bezos family's generous philanthropic support of Fred Hutch
Jeff Bezos wants ideas for philanthropy, so he asked Twitte
Article about Jeff Bezos' approach to philanthropy notes the Bezos family's generous philanthropic support of Fred Hutch
At last, Jeff Bezos offers a hint of his philanthropic plans
Article about Jeff Bezos' approach to philanthropy notes the Bezos family's generous philanthropic support of Fred Hutch
Jeff Bezos wants ideas for philanthropy, so he asked Twitte
Article about Jeff Bezos' approach to philanthropy notes the Bezos family's generous philanthropic support of Fred Hutch
For experimental cancer therapy, a struggle to ensure supply keeps up with demand
Article quotes Dr. David Maloney on potential challenges of treating patients with cellular immunotherapies once they're approved for wider use
For experimental cancer therapy, a struggle to ensure supply keeps up with demand
Article quotes Dr. David Maloney on potential challenges of treating patients with cellular immunotherapies once they're approved for wider use
New frontier in cancer care: Turning blood into living drugs
Story explores the field of cellular immunotherapy to treat cancer, featuring leading Fred Hutch researchers Drs. Phil Greenberg, Stan Riddell and David Maloney
5 man-killing cancers you might not spot until it's too late
Article on several cancers that men should be aware of, including comments from Dr. William Grady on symptoms and treatment for colorectal cancer
New frontier in cancer care: Turning blood into living drugs
Story explores the field of cellular immunotherapy to treat cancer, featuring leading Fred Hutch researchers Drs. Phil Greenberg, Stan Riddell and David Maloney
5 man-killing cancers you might not spot until it's too late
Article on several cancers that men should be aware of, including comments from Dr. William Grady on symptoms and treatment for colorectal cancer
Got cancer questions? This little-known hotline is here to help
Highlights the Fred Hutch-run, National Cancer Institute-supported Contact Center that patients can call, chat or email to get answers
Got cancer questions? This little-known hotline is here to help
Highlights the Fred Hutch-run, National Cancer Institute-supported Contact Center that patients can call, chat or email to get answers
NCI-funded trials have extended lives of US patients with cancer
Coverage of the Fred Hutch-led study that found trials run by the SWOG collaborative group saved an estimated 3.34 million years of life for cancer patients. Quotes study author Dr. Joseph Unger
NCI-funded trials have extended lives of US patients with cancer
Coverage of the Fred Hutch-led study that found trials run by the SWOG collaborative group saved an estimated 3.34 million years of life for cancer patients. Quotes study author Dr. Joseph Unger
PEGPH20 extends PFS in metastatic pancreatic ductal adenocarcinoma
Quotes Dr. Sunil Hingorani on new results for a pancreatic cancer treatment that were presented at the American Society of Clinical Oncology annual meeting
Big returns on small cancer research investment, study suggests
Fred Hutch-led study found that trials run by the National Cancer Institute-supported SWOG collaborative group have saved an estimated 3.34 million years of life. Article quotes study author Dr. Joseph Unger on how the team measured the program's benefit
PEGPH20 extends PFS in metastatic pancreatic ductal adenocarcinoma
Quotes Dr. Sunil Hingorani on new results for a pancreatic cancer treatment that were presented at the American Society of Clinical Oncology annual meeting
Big returns on small cancer research investment, study suggests
Fred Hutch-led study found that trials run by the National Cancer Institute-supported SWOG collaborative group have saved an estimated 3.34 million years of life. Article quotes study author Dr. Joseph Unger on how the team measured the program's benefit
Hope and hype around cancer immunotherapy
Article explores the current state of cancer immunotherapy research, quoting Dr. Phil Greenberg, as the American Society for Clinical Oncology annual meeting begins
Hope and hype around cancer immunotherapy
Article explores the current state of cancer immunotherapy research, quoting Dr. Phil Greenberg, as the American Society for Clinical Oncology annual meeting begins
Amazon exec Mike Clayville sees the cure for cancer in the cloud
Q&A with Fred Hutch Board of Trustees member Mike Clayville about the intersection of cancer research and technology
Amazon exec Mike Clayville sees the cure for cancer in the cloud
Q&A with Fred Hutch Board of Trustees member Mike Clayville about the intersection of cancer research and technology
Just one drink a day raises breast cancer risk
Quotes Dr. Anne McTiernan on a report she co-authored that systematically analyzed 119 breast cancer prevention studies
Just one drink a day raises breast cancer risk
Quotes Dr. Anne McTiernan on a report she co-authored that systematically analyzed 119 breast cancer prevention studies
Fred Hutch lands $24M contact to keep NCI's only cancer information center open
Coverage of the continuation of NCI funding for a call center for patients, located at Fred Hutch
Fred Hutch lands $24M contact to keep NCI's only cancer information center open
Coverage of the continuation of NCI funding for a call center for patients, located at Fred Hutch
Just one alcoholic drink a day increases risk of breast cancer, study says
Quotes Dr. Anne McTiernan on a report she co-authored that systematically analyzed 119 breast cancer prevention studies
'Half a glass of wine every day' increases breast cancer risk
Quotes Dr. Anne McTiernan on a report she co-authored that systematically analyzed 119 breast cancer prevention studies
Health buzz: 1 daily drink boosts breast cancer risk
Quotes Dr. Anne McTiernan on a report she co-authored that systematically analyzed 119 breast cancer prevention studies
Drinking and breast cancer: Risk increases with just one drink, study finds
Quotes Dr. Anne McTiernan on a report she co-authored that systematically analyzed 119 breast cancer prevention studies
Consuming just 1 alcoholic drink a day increases breast cancer risk, study finds
Quotes Dr. Anne McTiernan on a report she co-authored that systematically analyzed 119 breast cancer prevention studies
A drink a day tied to higher breast cancer risk, report says
Quotes Dr. Anne McTiernan on a report she co-authored that systematically analyzed 119 breast cancer prevention studies
A glass of wine a day each day increases your breast cancer risk, according to a new study
Quotes Dr. Anne McTiernan on a report she co-authored that systematically analyzed 119 breast cancer prevention studies
Breast cancer study finds strong links between lifestyle choices and risk
Quotes Dr. Anne McTiernan on a report she co-authored that systematically analyzed 119 breast cancer prevention studies
One small drink a day increases breast cancer risk, study shows
Quotes Dr. Anne McTiernan on a report she co-authored that systematically analyzed 119 breast cancer prevention studies
Just one alcoholic drink a day increases risk of breast cancer, study says
Quotes Dr. Anne McTiernan on a report she co-authored that systematically analyzed 119 breast cancer prevention studies
'Half a glass of wine every day' increases breast cancer risk
Quotes Dr. Anne McTiernan on a report she co-authored that systematically analyzed 119 breast cancer prevention studies
Health buzz: 1 daily drink boosts breast cancer risk
Quotes Dr. Anne McTiernan on a report she co-authored that systematically analyzed 119 breast cancer prevention studies
Drinking and breast cancer: Risk increases with just one drink, study finds
Quotes Dr. Anne McTiernan on a report she co-authored that systematically analyzed 119 breast cancer prevention studies
Consuming just 1 alcoholic drink a day increases breast cancer risk, study finds
Quotes Dr. Anne McTiernan on a report she co-authored that systematically analyzed 119 breast cancer prevention studies
A drink a day tied to higher breast cancer risk, report says
Quotes Dr. Anne McTiernan on a report she co-authored that systematically analyzed 119 breast cancer prevention studies
A glass of wine a day each day increases your breast cancer risk, according to a new study
Quotes Dr. Anne McTiernan on a report she co-authored that systematically analyzed 119 breast cancer prevention studies
Breast cancer study finds strong links between lifestyle choices and risk
Quotes Dr. Anne McTiernan on a report she co-authored that systematically analyzed 119 breast cancer prevention studies
One small drink a day increases breast cancer risk, study shows
Quotes Dr. Anne McTiernan on a report she co-authored that systematically analyzed 119 breast cancer prevention studies
More women are living longer with metastatic breast cancer, but questions remain
A study led by the National Cancer Institute and including Fred Hutch found that women with metastatic breast cancer are seeing an improved survival rate across all age groups
Women with advanced breast cancer are surviving longer, study says
A study led by the National Cancer Institute and including Fred Hutch found that women with metastatic breast cancer are seeing an improved survival rate across all age groups
Women living longer with metastatic breast cancer
Coverage of the continuation of NCI funding for a call center for patients, located at Fred Hutch
More women are living longer with metastatic breast cancer, but questions remain
A study led by the National Cancer Institute and including Fred Hutch found that women with metastatic breast cancer are seeing an improved survival rate across all age groups
Women with advanced breast cancer are surviving longer, study says
A study led by the National Cancer Institute and including Fred Hutch found that women with metastatic breast cancer are seeing an improved survival rate across all age groups
Women living longer with metastatic breast cancer
Coverage of the continuation of NCI funding for a call center for patients, located at Fred Hutch
As the budget ax looms, who's stepping up for cancer research?
Coverage of the continuation of NCI funding for a call center for patients, located at Fred Hutch
As the budget ax looms, who's stepping up for cancer research?
Coverage of the continuation of NCI funding for a call center for patients, located at Fred Hutch
Q&A: Cancer research leader Nancy Davidson on the innovations of the past decade, and where things are heading next
Profile of Dr. Nancy Davidson, in which she discusses some of the most impactful innovations in cancer research to date and how the field can build on those advances
Fred Hutch study: Cancer drug inspired by bacteria could boost immunotherapy treatments
Article covers Dr. Seth Pollack's presentation at the American Association for Cancer Research's annual conference. Pollack's study in patients with sarcoma found a bacteria-inspired drug could help heighten immune response
Q&A: Cancer research leader Nancy Davidson on the innovations of the past decade, and where things are heading next
Profile of Dr. Nancy Davidson, in which she discusses some of the most impactful innovations in cancer research to date and how the field can build on those advances
Fred Hutch study: Cancer drug inspired by bacteria could boost immunotherapy treatments
Article covers Dr. Seth Pollack's presentation at the American Association for Cancer Research's annual conference. Pollack's study in patients with sarcoma found a bacteria-inspired drug could help heighten immune response
Is Obliteride changing this year?
Column includes information about early registration for Obliteride, Fred Hutch's weekend-long bike ride to raise funds for cancer research
Discussing the latest advances in prostate cancer treatment
Dr. Celesita Higano on early use of chemotherapy, PARP inhibitors and radium-223 as treatment options for prostate cancer
Is Obliteride changing this year?
Column includes information about early registration for Obliteride, Fred Hutch's weekend-long bike ride to raise funds for cancer research
Discussing the latest advances in prostate cancer treatment
Dr. Celesita Higano on early use of chemotherapy, PARP inhibitors and radium-223 as treatment options for prostate cancer
Trump's proposed NIH cuts would hit Seattle innovation hard
Coverage of the continuation of NCI funding for a call center for patients, located at Fred Hutch
Q&A: Some preclinical promise in using cellular therapy for ovarian cancer
Dr. Kristin Anderson discusses promising findings from an immunotherapy study she presented at the annual American Association for Cancer Research meeting
Trump's proposed NIH cuts would hit Seattle innovation hard
Coverage of the continuation of NCI funding for a call center for patients, located at Fred Hutch
Q&A: Some preclinical promise in using cellular therapy for ovarian cancer
Dr. Kristin Anderson discusses promising findings from an immunotherapy study she presented at the annual American Association for Cancer Research meeting
Fred Hutchinson Cancer Research Center receives largest donation
Article about the Bezos family donation of $35 million to Fred Hutch. The donation, the largest ever to Fred Hutch, will be used to draw top researchers and explore new ways to fight cancer
Fred Hutchinson Cancer Research Center receives largest donation
Article about the Bezos family donation of $35 million to Fred Hutch. The donation, the largest ever to Fred Hutch, will be used to draw top researchers and explore new ways to fight cancer
Fred Hutch receives $35 million donation, largest ever, from Bezos family
Article about the Bezos family donation of $35 million to Fred Hutch. The donation, the largest ever to Fred Hutch, will be used to draw top researchers and explore new ways to fight cancer.
Bezos family gives Fred Hutch $35 million
Story about the largest ever to Fred Hutch, which will be used to draw top researchers and explore new ways to fight cancer
Bezos family makes record-breaking $35M donation to Fred Hutch to fund cancer research
Article about the Bezos family's $35 million donation to Fred Hutch
Jeff Bezos and family give $35 million to Fred Hutch, its biggest gift ever
Article about the Bezos family donation of $35 million to Fred Hutch. The donation, the largest ever to Fred Hutch, will be used to draw top researchers and explore new ways to fight cancer
Bezos family donates $35 million to Fred Hutchinson Cancer Research Center
Story about the largest ever to Fred Hutch, which will be used to draw top researchers and explore new ways to fight cancer
Fred Hutch receives $35 million donation, largest ever, from Bezos family
Article about the Bezos family donation of $35 million to Fred Hutch. The donation, the largest ever to Fred Hutch, will be used to draw top researchers and explore new ways to fight cancer.
Bezos family gives Fred Hutch $35 million
Story about the largest ever to Fred Hutch, which will be used to draw top researchers and explore new ways to fight cancer
Bezos family makes record-breaking $35M donation to Fred Hutch to fund cancer research
Article about the Bezos family's $35 million donation to Fred Hutch
Jeff Bezos and family give $35 million to Fred Hutch, its biggest gift ever
Article about the Bezos family donation of $35 million to Fred Hutch. The donation, the largest ever to Fred Hutch, will be used to draw top researchers and explore new ways to fight cancer
Bezos family donates $35 million to Fred Hutchinson Cancer Research Center
Story about the largest ever to Fred Hutch, which will be used to draw top researchers and explore new ways to fight cancer
The lifesaving treatment that's being thrown in the trash
Features research co-led by Drs. Filippo Milano and Colleen Delaney into how umbilical cord transplants can treat leukemia
The lifesaving treatment that's being thrown in the trash
Features research co-led by Drs. Filippo Milano and Colleen Delaney into how umbilical cord transplants can treat leukemia
Fred Hutch researcher awarded $3.2M to test novel cancer-zapping radiation treatment
Coverage of a $3.2 million National Cancer Institute grant awarded to Dr. Damian Green to investigate a potential treatment for multiple myeloma
Fred Hutch researcher awarded $3.2M to test novel cancer-zapping radiation treatment
Coverage of a $3.2 million National Cancer Institute grant awarded to Dr. Damian Green to investigate a potential treatment for multiple myeloma
Big Climb for leukemia and lymphoma Sunday
Story covers a fundraiser by the Leukemia and Lymphoma Society benefiting research at Fred Hutch by Dr. Jerry Radich
Big Climb for leukemia and lymphoma Sunday
Story covers a fundraiser by the Leukemia and Lymphoma Society benefiting research at Fred Hutch by Dr. Jerry Radich
Obliteride: New 100-miler & early-bird rate
Article encourages readers to take advantage of the early-bird registration rate and sign-up for Obliteride, Fred Hutch’s weekend-long bicycling event to raise funds for cancer research
Debate reignites over the contributions of ‘bad luck’ mutations to cancer
Dr. Anne McTiernan weighs in on a risk controversial study on cancer
Most cancer mutations arise from ‘bad luck,’ but many cases still preventable, researchers say
Fred Hutch biostatistician Dr. Ross Prentice comments on a controversial study on the role DNA mutations play in cancer risk. Scientific American also ran this story
More than two-thirds of cancer mutations are due to random DNA copying errors, study says
Dr. Anne McTiernan comments on limitations of a study on the role DNA mutation plays in cancer risk
Obliteride: New 100-miler & early-bird rate
Article encourages readers to take advantage of the early-bird registration rate and sign-up for Obliteride, Fred Hutch’s weekend-long bicycling event to raise funds for cancer research
Debate reignites over the contributions of ‘bad luck’ mutations to cancer
Dr. Anne McTiernan weighs in on a risk controversial study on cancer
Most cancer mutations arise from ‘bad luck,’ but many cases still preventable, researchers say
Fred Hutch biostatistician Dr. Ross Prentice comments on a controversial study on the role DNA mutations play in cancer risk. Scientific American also ran this story
More than two-thirds of cancer mutations are due to random DNA copying errors, study says
Dr. Anne McTiernan comments on limitations of a study on the role DNA mutation plays in cancer risk
Common cold can be dangerous after a bone marrow transplant
Coverage of a study by Dr. Michael Boeckh that found the common cold can be dangerous for bone marrow transplant patients. Story also ran in the U.S. News & World Report, Arizona Daily Star, The Post-Star (Glen Falls, NY), Montana Standard, Military News, and several other outlets
Does President Trump realize he stands in the way of cancer cures?
Op-ed by Dr. Gary Gilliland on how President Trump's proposed budget cuts to the National Institutes of Health would impact patients and their families, and recent progress in cancer research
Common cold can be dangerous after a bone marrow transplant
Coverage of a study by Dr. Michael Boeckh that found the common cold can be dangerous for bone marrow transplant patients. Story also ran in the U.S. News & World Report, Arizona Daily Star, The Post-Star (Glen Falls, NY), Montana Standard, Military News, and several other outlets
Does President Trump realize he stands in the way of cancer cures?
Op-ed by Dr. Gary Gilliland on how President Trump's proposed budget cuts to the National Institutes of Health would impact patients and their families, and recent progress in cancer research
Fred Hutch director: ‘People will die’ under Trump’s proposed budget
Radio interview with Dr. Gary Gilliland, hosted by KIRO Radio's Ron and Don, on the negative impact of President Trump's proposed budget cuts to the National Institute of Health
Fred Hutch director: ‘People will die’ under Trump’s proposed budget
Radio interview with Dr. Gary Gilliland, hosted by KIRO Radio's Ron and Don, on the negative impact of President Trump's proposed budget cuts to the National Institute of Health
Fred Hutch director: ‘People will die’ under Trump’s proposed budget
Radio interview with Dr. Gary Gilliland, hosted by KIRO Radio's Ron and Don, on the negative impact of President Trump's proposed budget cuts to the National Institute of Health
Fred Hutch director: ‘People will die’ under Trump’s proposed budget
Radio interview with Dr. Gary Gilliland, hosted by KIRO Radio's Ron and Don, on the negative impact of President Trump's proposed budget cuts to the National Institute of Health
Researchers call Trump’s proposed NIH cuts ‘shocking’
Radio interview with Dr. Gary Gilliland, hosted by KIRO Radio's Ron and Don, on the negative impact of President Trump's proposed budget cuts to the National Institute of Health
Nancy Davidson: This is the time for investment, not for retreat
Q&A with Dr. Nancy Davidson, director of the Clinical Research Division at Fred Hutch and outgoing president of the American Association for Cancer Research, on the importance of federal funding to cancer research
Beth Caldwell: People like me will die because of these cuts
Story features metastatic breast cancer patient Beth Caldwell who spoke out against President Trump's proposed budget cuts to the National Institutes of Health at a Fred Hutch news conferenceh
Researchers call Trump’s proposed NIH cuts ‘shocking’
Radio interview with Dr. Gary Gilliland, hosted by KIRO Radio's Ron and Don, on the negative impact of President Trump's proposed budget cuts to the National Institute of Health
Nancy Davidson: This is the time for investment, not for retreat
Q&A with Dr. Nancy Davidson, director of the Clinical Research Division at Fred Hutch and outgoing president of the American Association for Cancer Research, on the importance of federal funding to cancer research
Beth Caldwell: People like me will die because of these cuts
Story features metastatic breast cancer patient Beth Caldwell who spoke out against President Trump's proposed budget cuts to the National Institutes of Health at a Fred Hutch news conferenceh
UW, Fred Hutch slam Trump’s proposed budget, calling it ‘major step backward’ and ‘indefensible’
Coverage of Dr. Gary Gilliland's statement on President Trump's proposed budget cuts to the National Institutes of Health
Local researchers progressing on malaria vaccine
Segment features interviews with malaria researcher Dr. Jim Kublin and study participants Molly Perry and Joelle Mumley who took part in a study coordinated by Kublin at the Fred Hutch-based Seattle Malaria Clinical Trials Center
Researchers sound the alarm over Trump’s budget, across the nation and in Seattle
Roundup of statements from leaders in scientific research against President Trump's proposed budget cuts to the National Institutes of Health
Seattle health leaders say proposed NIH budget cuts are ‘devastating’ and will cost patient lives
Report of local leaders, including Dr. Gary Gilliland, who have raised concerns about the impact of President Trump's proposed budget cuts to the National Institutes of Health on scientific research
UW, Fred Hutch slam Trump’s proposed budget, calling it ‘major step backward’ and ‘indefensible’
Coverage of Dr. Gary Gilliland's statement on President Trump's proposed budget cuts to the National Institutes of Health
Local researchers progressing on malaria vaccine
Segment features interviews with malaria researcher Dr. Jim Kublin and study participants Molly Perry and Joelle Mumley who took part in a study coordinated by Kublin at the Fred Hutch-based Seattle Malaria Clinical Trials Center
Researchers sound the alarm over Trump’s budget, across the nation and in Seattle
Roundup of statements from leaders in scientific research against President Trump's proposed budget cuts to the National Institutes of Health
Seattle health leaders say proposed NIH budget cuts are ‘devastating’ and will cost patient lives
Report of local leaders, including Dr. Gary Gilliland, who have raised concerns about the impact of President Trump's proposed budget cuts to the National Institutes of Health on scientific research
This week on "Sunday Morning" (March 12): "Beyond Cancer"sible’
CBS News "Sunday Morning" devoted this week's episode to promising developments in cancer diagnosis, treatment and research, including Dr. Jim Olson's work on Tumor Paint
Joe Biden asks innovators at SXSW for help with cancer initiative, shouts out Amazon and Fred Hutch
Coverage of a speech at South by Southwest by former Vice President Joe Biden that called out Fred Hutch as a leader in cancer research
This week on "Sunday Morning" (March 12): "Beyond Cancer"sible’
CBS News "Sunday Morning" devoted this week's episode to promising developments in cancer diagnosis, treatment and research, including Dr. Jim Olson's work on Tumor Paint
Joe Biden asks innovators at SXSW for help with cancer initiative, shouts out Amazon and Fred Hutch
Coverage of a speech at South by Southwest by former Vice President Joe Biden that called out Fred Hutch as a leader in cancer research
This lab-in-a-box could make gene therapy less elitist
Article explores Dr. Jennifer Adair's efforts to expand gene therapy beyond costly labs to lower-resource settings, using a machine that is more portable, affordable and user-friendly than existing options
This lab-in-a-box could make gene therapy less elitist
Article explores Dr. Jennifer Adair's efforts to expand gene therapy beyond costly labs to lower-resource settings, using a machine that is more portable, affordable and user-friendly than existing options
Intensive therapy increases survival in patients with AML
Coverage of a study presented by Dr. Mohamed Sorror indicating that patients with acute myeloid leukemia who received intensive therapy had higher 2-year survival rates than patients treated with non-intensive therapy
For breast cancer survivors, eating soy tied to a longevity boost
Quotes Dr. Marion Neuhouser on a study that found some positive benefits of soy consumption among breast cancer survivors
Intensive therapy increases survival in patients with AML
Coverage of a study presented by Dr. Mohamed Soror indicating that patients with acute myeloid leukemia who received intensive therapy had higher 2-year survival rates than patients treated with non-intensive therapy
For breast cancer survivors, eating soy tied to a longevity boost
Quotes Dr. Marion Neuhouser on a study that found some positive benefits of soy consumption among breast cancer survivors
Open-source project uses genetic data from viruses to help scientists track outbreaks in real time
Coverage of Open Science Prize, awarded to Drs. Trevor Bedford and Richard Neher
A new genetic tool maps how deadly viruses spread around the world in real time
Article explains a new genetic tool, Nexstrain, for which creators Drs. Trevor Bedford and Richard Neher were awarded the inaugural Open Science Prize by the National Institutes of Health, Wellcome Trust and Howard Hughes Medical Institute
Fred Hutch researcher aims to cure HIV with 'ninja warrior' cells
Profile of Dr. Larry Corey and his research on how immunotherapy could be used to attack HIV and other viruses
Open-source project uses genetic data from viruses to help scientists track outbreaks in real time
Coverage of Open Science Prize, awarded to Drs. Trevor Bedford and Richard Neher
A new genetic tool maps how deadly viruses spread around the world in real time
Article explains a new genetic tool, Nexstrain, for which creators Drs. Trevor Bedford and Richard Neher were awarded the inaugural Open Science Prize by the National Institutes of Health, Wellcome Trust and Howard Hughes Medical Institute
Fred Hutch researcher aims to cure HIV with 'ninja warrior' cells
Profile of Dr. Larry Corey and his research on how immunotherapy could be used to attack HIV and other viruses
Cancer: New way of tracking rare T cells should improve immunotherapy
Follows a study by Dr. Aude Chapuis and collaborators using a technique akin to barcoding to identify which T cells deliver the largest anti-cancer punch
Cancer: New way of tracking rare T cells should improve immunotherapy
Follows a study by Dr. Aude Chapuis and collaborators using a technique akin to barcoding to identify which T cells deliver the largest anti-cancer punch
Fred Hutch study discovers rare set of cells that are highly effective at fighting cancer
Follows a study by Dr. Aude Chapuis and collaborators using a technique akin to barcoding to identify which T cells deliver the largest anti-cancer punch
Fred Hutch study discovers rare set of cells that are highly effective at fighting cancer
Follows a study by Dr. Aude Chapuis and collaborators using a technique akin to barcoding to identify which T cells deliver the largest anti-cancer punch
Exercise reduces death from breast cancer relapse by 40 per cent
Article on breast cancer and exercise study quotes Dr. Anne McTiernan
Exercise reduces death from breast cancer relapse by 40 per cent
Article on breast cancer and exercise study quotes Dr. Anne McTiernan
Washington state’s life science industry sheds 3% of jobs, as new study calls for revival of state support
Article covers a report issued by the Washington Life Science & Global Health Advisory Council showing a downturn in the sector's job growth, and mentions Fred Hutch and other leaders in the industry
Washington state’s life science industry sheds 3% of jobs, as new study calls for revival of state support
Article covers a report issued by the Washington Life Science & Global Health Advisory Council showing a downturn in the sector's job growth, and mentions Fred Hutch and other leaders in the industry
Culture: Cultivate the muse
Article explores how creative writing can enrich scientists' lives. Dr. Anne McTiernan's recent memoir is discussed as an example of how some researchers "weave their work into their writing"
Culture: Cultivate the muse
Article explores how creative writing can enrich scientists' lives. Dr. Anne McTiernan's recent memoir is discussed as an example of how some researchers "weave their work into their writing"
How Fred Hutch is accelerating its mission to cure cancer
Puget Sound Business Journal awarded Fred Hutch 'Innovator of the Year.' The accompanying story features interviews with Drs. Gary Gilliland and Fred Appelbaum and Niki Robinson
A comprehensive guide to the many skybridges across Seattle
A list of Seattle's skybridges that includes structures connecting several buildings on Fred Hutch's campus
How Fred Hutch is accelerating its mission to cure cancer
Puget Sound Business Journal awarded Fred Hutch 'Innovator of the Year.' The accompanying story features interviews with Drs. Gary Gilliland and Fred Appelbaum and Niki Robinson
A comprehensive guide to the many skybridges across Seattle
A list of Seattle's skybridges that includes structures connecting several buildings on Fred Hutch's campus
A comprehensive guide to the many skybridges across Seattle
A list of Seattle's skybridges that includes structures connecting several buildings on Fred Hutch's campus
Inside Nohla Therapeutics' new Seattle biotech lab as Gov. Jay Inslee geeks out on science
Article covers opening of new facilities at Fred Hutch spinoff Nohla Therapeutics
Inside Nohla Therapeutics' new Seattle biotech lab as Gov. Jay Inslee geeks out on science
Article covers opening of new facilities at Fred Hutch spinoff Nohla Therapeutics
Fred Hutch lab will lead Biden Cancer Moonshot project, aimed at more effectively matching patients to treatments
Article about an effort led by Dr. Amanda Paulovich and her lab to develop protein tests that could match cancer patients to the most effective treatment
Fred Hutch lab will lead Biden Cancer Moonshot project, aimed at more effectively matching patients to treatments
Article about an effort led by Dr. Amanda Paulovich and her lab to develop protein tests that could match cancer patients to the most effective treatment
Losing weight can reduce cancer risk, researchers say
A list of Seattle's skybridges that includes structures connecting several buildings on Fred Hutch's campus
Fat shaming tied to increased risk of metabolic problems
Quotes Dr. Anne McTiernan of Fred Hutch about the importance of treating a patient's number on the scale as a measure of health risk, just like blood pressure
Who's ordering tests and imaging for breast cancer survivors?
Julia Walker, a member of the Hutchinson Institute for Cancer Outcomes Research, is quoted explaining a study looking into why breast cancer patients may be receiving biomarker testing or imaging that doesn't adhere to recommendations
Who's ordering tests and imaging for breast cancer survivors?
Julia Walker, a member of the Hutchinson Institute for Cancer Outcomes Research, is quoted explaining a study looking into why breast cancer patients may be receiving biomarker testing or imaging that doesn't adhere to recommendations
Could immunotherapy cure HIV? $2.6M grant will help Fred Hutch researcher find out
Article about a $2.6 million grant from Gilead Sciences to Dr. Larry Corey for HIV-cure research
Diabetic pitcher for Marlins wins national honor
Article about Miami Marlins' Hutch Award winner Dustin McGowan, a diabetes advocate
Could immunotherapy cure HIV? $2.6M grant will help Fred Hutch researcher find out
Article about a $2.6 million grant from Gilead Sciences to Dr. Larry Corey for HIV-cure research
Diabetic pitcher for Marlins wins national honor
Article about Miami Marlins' Hutch Award winner Dustin McGowan, a diabetes advocate
Health effects of fish oil: Where do we stand?
Article mentions a Fred Hutch study that found a link between fish oil supplement consumption and an increased risk of prostate cancer
Health effects of fish oil: Where do we stand?
Article mentions a Fred Hutch study that found a link between fish oil supplement consumption and an increased risk of prostate cancer
Food, body image, and self worth with a nutrition doctor
Interview with Dr. Anne McTiernan, a cancer prevention researcher at Fred Hutch who recently wrote a memoir, "Starved: A Nutrition Doctor's Journey from Empty to Full," about her early-childhood of neglect and near-starvation and how she overcame these obstacles to become a leading nutrition researcher
Fred Hutch study: Biotech company's new genetic data system could advance cancer research
Article about a new study co-led by Dr. Jason Bielas at Fred Hutch regarding new technology he developed in collaboration with 10x Genomics that allows scientists to examine gene-expression data from cells on an individual level and gather data from a huge collection of cells to examine trends and patterns across the entire blood sample
Food, body image, and self worth with a nutrition doctor
Interview with Dr. Anne McTiernan, a cancer prevention researcher at Fred Hutch who recently wrote a memoir, "Starved: A Nutrition Doctor's Journey from Empty to Full," about her early-childhood of neglect and near-starvation and how she overcame these obstacles to become a leading nutrition researcher
Fred Hutch study: Biotech company's new genetic data system could advance cancer research
Article about a new study co-led by Dr. Jason Bielas at Fred Hutch regarding new technology he developed in collaboration with 10x Genomics that allows scientists to examine gene-expression data from cells on an individual level and gather data from a huge collection of cells to examine trends and patterns across the entire blood sample
Many women tune out mammogram confusion
Quotes Dr. Ruth Etzioni about a recent study out of Denmark that suggests one in three breast cancers found through mammography are "overdiagnosed," meaning they are non-life-threatening and may not need treatment
Many women tune out mammogram confusion
Quotes Dr. Ruth Etzioni about a recent study out of Denmark that suggests one in three breast cancers found through mammography are "overdiagnosed," meaning they are non-life-threatening and may not need treatment
Ancient origins of retroviruses
Quotes Dr. Michael Emerman about the evolution of retroviruses over the past 450 million years
Ancient origins of retroviruses
Quotes Dr. Michael Emerman about the evolution of retroviruses over the past 450 million years
Ancient retroviruses emerged half a billion years ago
Dr. Michael Emerman comments on a study indicating that foamy viruses may have evolved half a billion years ago, much earlier than was previously thought
Ancient retroviruses emerged half a billion years ago
Dr. Michael Emerman comments on a study indicating that foamy viruses may have evolved half a billion years ago, much earlier than was previously thought
Ancient retroviruses emerged half a billion years ago
Dr. Michael Emerman comments on a study indicating that foamy viruses may have evolved half a billion years ago, much earlier than was previously thought
Ancient retroviruses emerged half a billion years ago
Dr. Michael Emerman comments on a study indicating that foamy viruses may have evolved half a billion years ago, much earlier than was previously thought
Change of scenery: Sound Effect, Episode 80
Radio program explores how virologist Dr. Maxine Linial experienced a change of perspective several years ago when she lost her sight
Microsoft pioneer Ric Weiland's huge bequest changed science, society
Article about late Seattle philanthropist Ric Weiland prominently mentions his support of HIV research at Fred Hutch, where researchers in the laboratory of Dr. Hans-Peter Kiem are working on a gene-editing approach to prevent HIV from entering cells
Change of scenery: Sound Effect, Episode 80
Radio program explores how virologist Dr. Maxine Linial experienced a change of perspective several years ago when she lost her sight
Microsoft pioneer Ric Weiland's huge bequest changed science, society
Article about late Seattle philanthropist Ric Weiland prominently mentions his support of HIV research at Fred Hutch, where researchers in the laboratory of Dr. Hans-Peter Kiem are working on a gene-editing approach to prevent HIV from entering cells
Halozyme's pancreatic cancer drug succeeds in mid-stage trial
Dr. Sunil Hingorani, principal investigator of a trial for pancreatic cancer drug PEGPH20, is quoted on recent clinical trial results
PEGPH20 extends PFS in advanced pancreatic cancer
Dr. Sunil Hingorani, principal investigator of a trial for pancreatic cancer drug PEGPH20, is quotes on recent clinical trial results
Halozyme's pancreatic cancer drug succeeds in mid-stage trial
Dr. Sunil Hingorani, principal investigator of a trial for pancreatic cancer drug PEGPH20, is quoted on recent clinical trial results
PEGPH20 extends PFS in advanced pancreatic cancer
Dr. Sunil Hingorani, principal investigator of a trial for pancreatic cancer drug PEGPH20, is quotes on recent clinical trial results
Fred Hutchinson Cancer Research Center opens immunotherapy clinic
Interview with newly-opened Bezos Family Immunotherapy Clinic medical director Dr. David Maloney
Study: Genetically engineered malaria vaccine could be a breakthrough in fighting deadly disease
A study co-authored by Dr. Jim Kublin and Center for Infectious Disease Research investigator Dr. Stefan Kappe found a promising approach to developing a malaria vaccine
New vaccine candidate could be the next step toward eliminating malaria
A study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research found a promising new approach to developing a malaria vaccine
Mosquitoes are the new syringe? Seattle lab nibbles at malaria vaccine
A study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research found a promising approach to developing a malaria vaccine
Volunteers get bit to test new strategy for malaria vaccine
Story covers a study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research that found genetically engineered malaria parasites could be a promising approach to developing a malaria vaccineh
A genetically modified malaria vaccine has passed an important hurdle
A study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research found a promising approach to developing a malaria vaccine
Fred Hutchinson Cancer Research Center opens immunotherapy clinic
Interview with newly-opened Bezos Family Immunotherapy Clinic medical director Dr. David Maloney
Study: Genetically engineered malaria vaccine could be a breakthrough in fighting deadly disease
A study co-authored by Dr. Jim Kublin and Center for Infectious Disease Research investigator Dr. Stefan Kappe found a promising approach to developing a malaria vaccine
New vaccine candidate could be the next step toward eliminating malaria
A study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research found a promising new approach to developing a malaria vaccine
Mosquitoes are the new syringe? Seattle lab nibbles at malaria vaccine
A study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research found a promising approach to developing a malaria vaccine
Volunteers get bit to test new strategy for malaria vaccine
Story covers a study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research that found genetically engineered malaria parasites could be a promising approach to developing a malaria vaccineh
A genetically modified malaria vaccine has passed an important hurdle
A study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research found a promising approach to developing a malaria vaccine
Fred Hutch announces $1M in grants to commercialize cutting-edge cancer and HIV research
Article covers Fred Hutch's Evergreen Fund, a $1 million fund to support the commercialization of lifesaving research
Fred Hutch announces $1M in grants to commercialize cutting-edge cancer and HIV research
Article covers Fred Hutch's Evergreen Fund, a $1 million fund to support the commercialization of lifesaving research
A new urgency to protect survivors of childhood cancer
Article explores efforts to track the long-term effects of treatment for childhood cancers, including a study led by Dr. Eric Chow that looks at effectiveness of a drug to prevent later heart damage in childhood cancer survivors
A new urgency to protect survivors of childhood cancer
Article explores efforts to track the long-term effects of treatment for childhood cancers, including a study led by Dr. Eric Chow that looks at effectiveness of a drug to prevent later heart damage in childhood cancer survivors
The good fight: Local trailblazers lead the way in HIV/AIDS research, medicine and education
Story profiles the work of Dr. Larry Corey, virologist and Fred Hutch president and director emeritus, and Michael Louella, community advisory board coordinator for defeatHIV
The good fight: Local trailblazers lead the way in HIV/AIDS research, medicine and education
Story profiles the work of Dr. Larry Corey, virologist and Fred Hutch president and director emeritus, and Michael Louella, community advisory board coordinator for defeatHIV
Cancer cells spread way earlier than thought, seeding metastases that cause most deaths
Article quotes Fred Hutch's Dr. Cyrus Ghajar, who co-authored a Nature commentary about a new study that found cancer cells are able to spread from a primary tumor to distant sites much earlier than previously thought
Cancer cells spread way earlier than thought, seeding metastases that cause most deaths
Article quotes Fred Hutch's Dr. Cyrus Ghajar, who co-authored a Nature commentary about a new study that found cancer cells are able to spread from a primary tumor to distant sites much earlier than previously thought
Fred Hutch's new Bezos Family Immunotherapy Clinic could change the game for cancer treatment
Coverage of official opening of the Bezos Family Immunotherapy Clinic at Seattle Cancer Care Alliance quotes Dr. David Maloney, medical director of the new clinic
Fred Hutch's new Bezos Family Immunotherapy Clinic could change the game for cancer treatment
Coverage of official opening of the Bezos Family Immunotherapy Clinic at Seattle Cancer Care Alliance quotes Dr. David Maloney, medical director of the new clinic
Q&A: What Washington state can teach DC about public health collaboration
Article explores Washington state's global health industry, which includes Fred Hutch, whose Vaccine and Infectious Disease Division researches HIV/AIDS, malaria and other diseases.
Q&A: What Washington state can teach DC about public health collaboration
Article explores Washington state's global health industry, which includes Fred Hutch, whose Vaccine and Infectious Disease Division researches HIV/AIDS, malaria and other diseases.
Study: Test for rare skin cancer could save lives with early detection
Coverage of a new skin cancer test pioneered by Dr. Paul Nghiem and developed by researchers at Fred Hutch and the University of Washington
Study: Test for rare skin cancer could save lives with early detection
Coverage of a new skin cancer test pioneered by Dr. Paul Nghiem and developed by researchers at Fred Hutch and the University of Washington
Can CAR-T cancer treatments be fine-tuned to avoid toxic side effects?
Coverage of findings presented by Hutch scientists at the annual American Society of Hematology meeting in San Diego
The Hutch Holiday Gala raises $13.4 million for pediatric cancer research
Coverage of 41st annual Hutch Holiday Gala quotes featured speaker Dr. Jim Olson, a pediatric oncologist
CAR T-cell immunotherapy proves a plus in treatment-resistant chronic lymphocytic leukemia
Coverage of promising immunotherapy research presented by Dr. Cameron Turtle at the annual meeting of the American Society of Hematology in San Diego, California
Fred Hutch research shows immunotherapy could prevent leukemia patients from relapsing
Coverage of the immunotherapy research of Drs. Aude Chapuis, Phil Greenberg and Dan Egan that is showing promising initial results in patients with acute myeloid leukemia
Can CAR-T cancer treatments be fine-tuned to avoid toxic side effects?
Coverage of findings presented by Hutch scientists at the annual American Society of Hematology meeting in San Diego
The Hutch Holiday Gala raises $13.4 million for pediatric cancer research
Coverage of 41st annual Hutch Holiday Gala quotes featured speaker Dr. Jim Olson, a pediatric oncologist
CAR T-cell immunotherapy proves a plus in treatment-resistant chronic lymphocytic leukemia
Coverage of promising immunotherapy research presented by Dr. Cameron Turtle at the annual meeting of the American Society of Hematology in San Diego, California
Fred Hutch research shows immunotherapy could prevent leukemia patients from relapsing
Coverage of the immunotherapy research of Drs. Aude Chapuis, Phil Greenberg and Dan Egan that is showing promising initial results in patients with acute myeloid leukemia
Fred Hutch researcher Dr. Julie Overbaugh receives prestigious Nature award for mentoring in science
Fred Hutch HIV researcher Dr. Julie Overbaugh receives lifetime Nature Award for Mentoring in Science
Fred Hutch researcher Dr. Julie Overbaugh receives prestigious Nature award for mentoring in science
Fred Hutch HIV researcher Dr. Julie Overbaugh receives lifetime Nature Award for Mentoring in Science
The future belongs to the curious
Coverage of Cornell University lecture by Fred Hutch structural biologist Dr. Barry Stoddard regarding the undeniable importance of curiosity in research
50 things Seattle gave the world
List of Seattle-based innovations includes Fred Hutch's Dr. E. Donnall Thomas pioneering the bone marrow transplant
The future belongs to the curious
Coverage of Cornell University lecture by Fred Hutch structural biologist Dr. Barry Stoddard regarding the undeniable importance of curiosity in research
50 things Seattle gave the world
List of Seattle-based innovations includes Fred Hutch's Dr. E. Donnall Thomas pioneering the bone marrow transplant
Summer project turns into leukemia testing breakthrough
Article covers an affordable, easy-to-use diagnostic test for chronic myeloid leukemia and quotes Dr. Jerald Radich on how the effort began through a summer project for high school and college students in his lab
Summer project turns into leukemia testing breakthrough
Article covers an affordable, easy-to-use diagnostic test for chronic myeloid leukemia and quotes Dr. Jerald Radich on how the effort began through a summer project for high school and college students in his lab
Will CAR T cells always be reserved for late lines of therapy?
Point/counterpoint co-authored by Dr. Ryan D. Cassaday regarding the potential of CAR T cell therapy for B-cell malignancies
Will CAR T cells always be reserved for late lines of therapy?
Point/counterpoint co-authored by Dr. Ryan D. Cassaday regarding the potential of CAR T cell therapy for B-cell malignancies
For a healthy diet, be choosy about your cheese
Quotes Fred Hutch nutritional epidemiologist Dr. Marian Neuhouser
Many Medicare cancer patients hit by high out-of-pocket costs
Quotes Fred Hutch health care economist Dr. Scott Ramsey about a Johns Hopkins study that found cancer patients with only Medicare coverage face steep out-of-pocket costs
For a healthy diet, be choosy about your cheese
Quotes Fred Hutch nutritional epidemiologist Dr. Marian Neuhouser
Many Medicare cancer patients hit by high out-of-pocket costs
Quotes Fred Hutch health care economist Dr. Scott Ramsey about a Johns Hopkins study that found cancer patients with only Medicare coverage face steep out-of-pocket costs
This app could triple a smoker's chance of quitting, new study finds
Article about a study of an app developed by Dr. Jonathan Bricker and 2Morrow that found it could up to triple a smoker's chances of quitting
This app could triple a smoker's chance of quitting, new study finds
Article about a study of an app developed by Dr. Jonathan Bricker and 2Morrow that found it could up to triple a smoker's chances of quitting
A new clinic focused on cancer immunotherapy (podcast)
Podcast interview with Dr. David Maloney about the new Bezos Family Immunotherapy Clinic at Seattle Cancer Care Alliance
A new clinic focused on cancer immunotherapy (podcast)
Podcast interview with Dr. David Maloney about the new Bezos Family Immunotherapy Clinic at Seattle Cancer Care Alliance
Fred Hutch doctor receives prestigious American Cancer Society grant
Coverage of an award to physician-scientist Dr. Stan Riddell for his immunotherapy research
Fred Hutch doctor receives prestigious American Cancer Society grant
Coverage of an award to physician-scientist Dr. Stan Riddell for his immunotherapy research
Fred Hutchinson Cancer Research Center names executive VP
Article about the appointment of Dr. Bruce Clurman as Fred Hutch's new executive vice president and deputy director
Fred Hutchinson Cancer Research Center names executive VP
Article about the appointment of Dr. Bruce Clurman as Fred Hutch's new executive vice president and deputy director
An inside look at the labs where doctors intentionally infect people with malaria
Article about the quest to develop a malaria vaccine mentions Dr. Jim Kublin, medical director of the Malaria Clinical Trials Center and an investigator at Fred Hutch
Differences in risk factor estimates for prostate cancer
Coverage of a prostate cancer study by Drs. Catherine Tangen and colleagues that was published recently in the Journal of Clinical Oncology
An inside look at the labs where doctors intentionally infect people with malaria
Article about the quest to develop a malaria vaccine mentions Dr. Jim Kublin, medical director of the Malaria Clinical Trials Center and an investigator at Fred Hutch
Differences in risk factor estimates for prostate cancer
Coverage of a prostate cancer study by Drs. Catherine Tangen and colleagues that was published recently in the Journal of Clinical Oncology
Patching desktops and wrangling genomes: Meet the pioneering CIO who’s bringing the fight to cancer at Fred Hutch
List of Seattle-based innovations includes Fred Hutch's Dr. E. Donnall Thomas pioneering the bone marrow transplant
Financial toxicity: 1 in 3 cancer patients have to turn to friends or family to pay for care
Opinion piece by Drs. Scott Ramsey and Veena Shankaran of the Hutchinson Institute for Cancer Outcomes Research
Patching desktops and wrangling genomes: Meet the pioneering CIO who’s bringing the fight to cancer at Fred Hutch
List of Seattle-based innovations includes Fred Hutch's Dr. E. Donnall Thomas pioneering the bone marrow transplant
Financial toxicity: 1 in 3 cancer patients have to turn to friends or family to pay for care
Opinion piece by Drs. Scott Ramsey and Veena Shankaran of the Hutchinson Institute for Cancer Outcomes Research
Fred Hutch unveils first-of-its-kind immunotherapy clinic, named after Bezos family
Quotes Fred Hutch President and Director Dr. Gary Gilliland
Bezos family lends name to new Fred Hutch immunotherapy clinic
Article about today's announcement of Fred Hutch's new, state-of-the-art immunotherapy clinic named after Seattle's Bezos family, which has donated $30 million for immunotherapy research at the Hutch
Seattle cancer center bets big on experimental T-cell immunotherapy
Quotes Dr. Gary Gilliland, president and director of Fred Hutch; and Dr. David Maloney, medical director of the Bezos Family Immunotherapy Clinic, which recently opened at Seattle Cancer Care Alliance
Fred Hutch unveils first-of-its-kind immunotherapy clinic, named after Bezos family
Quotes Fred Hutch President and Director Dr. Gary Gilliland
Bezos family lends name to new Fred Hutch immunotherapy clinic
Article about today's announcement of Fred Hutch's new, state-of-the-art immunotherapy clinic named after Seattle's Bezos family, which has donated $30 million for immunotherapy research at the Hutch
Seattle cancer center bets big on experimental T-cell immunotherapy
Quotes Dr. Gary Gilliland, president and director of Fred Hutch; and Dr. David Maloney, medical director of the Bezos Family Immunotherapy Clinic, which recently opened at Seattle Cancer Care Alliance
Blue Nile CEO is 9 years cancer-free and the top fundraiser for Fred Hutch's Obliteride
Profile of Blue Nile CEO Harvey Kanter, who rides in the Fred Hutch Obliteride bicycling fundraiser every year to support cancer research; this year he was the largest single fundraiser, bringing in more than $51,000
Blue Nile CEO is 9 years cancer-free and the top fundraiser for Fred Hutch's Obliteride
Profile of Blue Nile CEO Harvey Kanter, who rides in the Fred Hutch Obliteride bicycling fundraiser every year to support cancer research; this year he was the largest single fundraiser, bringing in more than $51,000
Searching the human immune system for clues to cancer
List of Seattle-based innovations includes Fred Hutch's Dr. E. Donnall Thomas pioneering the bone marrow transplant
Searching the human immune system for clues to cancer
List of Seattle-based innovations includes Fred Hutch's Dr. E. Donnall Thomas pioneering the bone marrow transplant
Private struggle: Why some with breast cancer patients keep it to themselves
Quotes Dr. Jesse Fann, director of psychiatry and psychology services at Seattle Cancer Care Alliance, the treatment arm of Fred Hutch; as well as Dr. Bart Scott, a clinical researcher at Fred Hutch, about women with breast cancer, particularly those with stage 4 disease, who choose to keep their cancer diagnosis private
Private struggle: Why some with breast cancer patients keep it to themselves
Quotes Dr. Jesse Fann, director of psychiatry and psychology services at Seattle Cancer Care Alliance, the treatment arm of Fred Hutch; as well as Dr. Bart Scott, a clinical researcher at Fred Hutch, about women with breast cancer, particularly those with stage 4 disease, who choose to keep their cancer diagnosis private
Cutting calories may dial back 'metabolic syndrome' in older adults
Quotes Dr. Anne McTiernan about a study that found adding calorie restriction to a resistance training schedule improves metabolism in overweight and obese older men and women
Fred Hutch team wants to move clean-room gene therapy to tabletop
Coverage of a new study by Dr. Jennifer Adair published today in Nature Communications regarding her development of "gene therapy in a box"
Cutting calories may dial back 'metabolic syndrome' in older adults
Quotes Dr. Anne McTiernan about a study that found adding calorie restriction to a resistance training schedule improves metabolism in overweight and obese older men and women
Fred Hutch team wants to move clean-room gene therapy to tabletop
Coverage of a new study by Dr. Jennifer Adair published today in Nature Communications regarding her development of "gene therapy in a box"
Fred Hutch's Obliteride announces $2.4M raised by bikers this year, more than $9M in four years
Recently released fundraising amount was announced at an event for Obliteride participants and supporters
How scorpion venom is helping doctors treat cancer
List of Seattle-based innovations includes Fred Hutch's Dr. E. Donnall Thomas pioneering the bone marrow transplant
Fred Hutch's Obliteride announces $2.4M raised by bikers this year, more than $9M in four years
Recently released fundraising amount was announced at an event for Obliteride participants and supporters
How scorpion venom is helping doctors treat cancer
List of Seattle-based innovations includes Fred Hutch's Dr. E. Donnall Thomas pioneering the bone marrow transplant
Genetic fossil-hunters dig through HIV's long history for clues to new treatments
Article about paleovirology quotes Dr. Harmit Malik, an evolutionary geneticist at Fred Hutch
Genetic fossil-hunters dig through HIV's long history for clues to new treatments
Article about paleovirology quotes Dr. Harmit Malik, an evolutionary geneticist at Fred Hutch
No link between breast cancer and night shift work?
Quotes Fred Hutch public health researcher Dr. Parveen Bhatti about the link between shift work and cancer risk
No link between breast cancer and night shift work?
Quotes Fred Hutch public health researcher Dr. Parveen Bhatti about the link between shift work and cancer risk
Davidson moves to Seattle Cancer Consortium
Q&A with Dr. Nancy Davidson, as incoming director of clinical oncology for the Fred Hutch/UW Cancer Consortium
Davidson moves to Seattle cancer consortium
Q&A with Dr. Nancy Davidson, in incoming director of clinical oncology for the Fred Hutch/UW Cancer Consortium
Safety concerns blight promising cancer therapy
Article quotes Dr. Stan Riddell, immunologist at Fred Hutch, on a method his lab uses to sort and blend T cells in defined proportions
Safety concerns blight promising cancer therapy
Article quotes Dr. Stan Riddell, immunologist at Fred Hutch, on a method his lab uses to sort and blend T cells in defined proportions
For the very ill, legally ending life is increasingly costly
Quotes Dr. Veena Shankaran about a JAMA Oncology paper she co-authored regarding the high cost of medications that people with terminal illnesses may legally use to end their lives under Washington state's Death With Dignity Act
For the very ill, legally ending life is increasingly costly
Quotes Dr. Veena Shankaran about a JAMA Oncology paper she co-authored regarding the high cost of medications that people with terminal illnesses may legally use to end their lives under Washington state's Death With Dignity Act
Breast-cancer expert to lead Fred Hutch/UW Consortium
Dr. Nancy Davidson, director of the University of Pittsburgh Cancer Institute, has been named executive director of the Fred Hutch/University of Washington Cancer Consortium
Breast-cancer expert to lead Fred Hutch/UW consortium
Accouncement that Dr. Nancy Davidson, director of the University of Pittsburgh Cancer Institute, has been named executive director of the Fred Hutch/University of Washington Cancer Consortium
Novel study of pancreatic cancer aims to give patients more treatment options
Quotes Fred Hutch's Dr. Sunil Hingorani, who is leading one of 12 "Precision Promise" clinical trial sites nationwide to test personalized treatments for pancreatic cancer
Novel study of pancreatic cancer aims to give patients more treatment options
Quotes Fred Hutch's Dr. Sunil Hingorani, who is leading one of 12 "Precision Promise" clinical trial sites nationwide to test personalized treatments for pancreatic cancer
Cancer patients and survivors can have trouble with intimacy
Quotes Fred Hutch cancer survivorship expert Dr. Karen Syrjala
Cancer patients and survivors can have trouble with intimacy
Quotes Fred Hutch cancer survivorship expert Dr. Karen Syrjala
Cancer immunotherapy is moving fast. Here's what you need to know.
Article exploring the latest immunotherapy research quotes Dr. Phil Greenberg, head of immunology at Fred Hutch
Cancer immunotherapy is moving fast. Here's what you need to know.
Article exploring the latest immunotherapy research quotes Dr. Phil Greenberg, head of immunology at Fred Hutch
Cancer immunotherapy is moving fast. Here's what you need to know.
Article exploring the latest immunotherapy research quotes Dr. Phil Greenberg, head of immunology at Fred Hutch
From CAR Ts to checkpoints, here's what's coming in immuno-oncology
Dr. Phil Greenberg, head of immunology at Fred Hutch, comments on the promise and challenges of CAR-T therapy
From CAR Ts to checkpoints, here's what's coming in immuno-oncology
Dr. Phil Greenberg, head of immunology at Fred Hutch, comments on the promise and challenges of CAR-T therapy
Your bra could kill you -- and other breast cancer myths busted
Mentions a Fred Hutch study that refuted a link between bra-wearing and increased breast cancer risk
Your bra could kill you -- and other breast cancer myths busted
Mentions a Fred Hutch study that refuted a link between bra-wearing and increased breast cancer risk
Beware the hype: Top scientists cautious about fighting cancer with immunotherapy
Quotes Dr. Phil Greenberg, head of the Immunology Program at Fred Hutch, who spoke at the Second International Cancer Immunotherapy Conference in New York City
Physicians and physicists join forces to fight pancreatic cancer
Quotes Dr. Harlan Robins, a computational biologist at the Hutch who is part of a Stand Up To Cancer Dream Team in pancreatic cancer research, in which experts from disparate fields converge to pool their skills and knowledge
Beware the hype: Top scientists cautious about fighting cancer with immunotherapy
Quotes Dr. Phil Greenberg, head of the Immunology Program at Fred Hutch, who spoke at the Second International Cancer Immunotherapy Conference in New York City
Physicians and physicists join forces to fight pancreatic cancer
Quotes Dr. Harlan Robins, a computational biologist at the Hutch who is part of a Stand Up To Cancer Dream Team in pancreatic cancer research, in which experts from disparate fields converge to pool their skills and knowledge
Cross-border conference yields cancer partnership, innovation plan
Interview with Dr. Gary Gilliland, Fred Hutch president and director, about a new agreement between the Hutch and the BC Cancer Agency to speed the development of new cancer treatments
Cross-border conference yields cancer partnership, innovation plan
Interview with Dr. Gary Gilliland, Fred Hutch president and director, about a new agreement between the Hutch and the BC Cancer Agency to speed the development of new cancer treatments
Marking 20 years of STEM education at TAF, and planning for 20 more
Article about the Technology Access Foundation's 20th anniversary quotes Dr. Beverly Torok-Storb about how for the past seven years the Hutch has hosted TAF students during the academic year and for summer internships
Marking 20 years of STEM education at TAF, and planning for 20 more
Article about the Technology Access Foundation's 20th anniversary quotes Dr. Beverly Torok-Storb about how for the past seven years the Hutch has hosted TAF students during the academic year and for summer internships
In praise of Henrietta Lacks
Article about Fred Hutch President and Director Dr. Gary Gilliland's visit to Henrietta Lacks Health and Bioscience High School during his visit to Vancouver, Washington, to speak at the Columbia River Economic Development Council's fall luncheon
Fred Hutch, UW researchers help expand data sharing nationally
Article about how Fred Hutch's Dr. Amanda Paulovich, together with colleague Jeff Whiteaker and University of Washington's Andy Hoofnagle, are creating a new portal to allow researchers to share data so they can better understand how diseases work and are detected
In praise of Henrietta Lacks
Article about Fred Hutch President and Director Dr. Gary Gilliland's visit to Henrietta Lacks Health and Bioscience High School during his visit to Vancouver, Washington, to speak at the Columbia River Economic Development Council's fall luncheon
Fred Hutch, UW researchers help expand data sharing nationally
Article about how Fred Hutch's Dr. Amanda Paulovich, together with colleague Jeff Whiteaker and University of Washington's Andy Hoofnagle, are creating a new portal to allow researchers to share data so they can better understand how diseases work and are detected
Fred Hutch scientist loses her sight but not her vision
Interview with Fred Hutch Basic Sciences Division researcher Dr. Maxine Linial, who lost her sight five years ago in a car-pedestrian accident but continues to pursue her virology research
Fred Hutch scientist loses her sight but not her vision
Interview with Fred Hutch Basic Sciences Division researcher Dr. Maxine Linial, who lost her sight five years ago in a car-pedestrian accident but continues to pursue her virology research
Reviewers rule: Strategies for faculty advancement
Quotes Dr. Karen Peterson, director of the Office of Career Development at Fred Hutch, about strategies for advancing in academia, such as developing skills in reviewing grant proposals
Reviewers rule: Strategies for faculty advancement
Quotes Dr. Karen Peterson, director of the Office of Career Development at Fred Hutch, about strategies for advancing in academia, such as developing skills in reviewing grant proposals
New study: cancer-fighting benefits of cord blood transplants
Interview with cord blood transplant patient Crystal Day and her Fred Hutch physician, Dr. Filippo Milano
New study: cancer-fighting benefits of cord blood transplants
Interview with cord blood transplant patient Crystal Day and her Fred Hutch physician, Dr. Filippo Milano
A new cancer immunotherapy leads to remissions
Coverage on a small immunotherapy study led by Dr. Cameron Turtle that reported encouraging results among people with advanced non-Hodgkin lymphoma also quoted colleague Dr. Stan Riddell
Better outcomes with bone marrow versus peripheral blood
Quotes Dr. Stephanie Lee about her research comparing the effectiveness of transplanting stem cells from bone marrow versus peripheral blood
A new cancer immunotherapy leads to remissions
Coverage on a small immunotherapy study led by Dr. Cameron Turtle that reported encouraging results among people with advanced non-Hodgkin lymphoma also quoted colleague Dr. Stan Riddell
Better outcomes with bone marrow versus peripheral blood
Quotes Dr. Stephanie Lee about her research comparing the effectiveness of transplanting stem cells from bone marrow versus peripheral blood
Cord-blood transplants a boon for patients with deadly cancers
Article about new Fred Hutch cord blood transplant research findings quotes study authors Drs. Filippo Milano and Colleen Delaney, as well as patient Crystal Day
Cord-blood transplants a boon for patients with deadly cancers
Article about new Fred Hutch cord blood transplant research findings quotes study authors Drs. Filippo Milano and Colleen Delaney, as well as patient Crystal Day
There's hope for blood cancers, and it comes from umbilical cords
Article about umbilical cord blood transplantation quotes Fred Hutch's Dr. Colleen Delaney about how the procedure provides a tissue match in 99 percent of patients who otherwise couldn't find a donor
There's hope for blood cancers, and it comes from umbilical cords
Article about umbilical cord blood transplantation quotes Fred Hutch's Dr. Colleen Delaney about how the procedure provides a tissue match in 99 percent of patients who otherwise couldn't find a donor
A father and a son, a cause and a mountain
Article by Climb to Fight Cancer participant Ken Wiseman, whose team raised $30,000 for research at the Hutch
Diversity, funding, and grassroots organizing
Article by Biswajit "Bish" Paul, a graduate research assistant at Fred Hutch, on the relationship between funding restrictions and the lack of diversity in science
Is cocoa good for you? New study may settle it
Fred Hutch and Boston's Brigham and Women's Hospital are recruiting older men and women for a nationwide study looking at the effects of cocoa on the heart and brain
Diversity, funding, and grassroots organizing
Article by Biswajit "Bish" Paul, a graduate research assistant at Fred Hutch, on the relationship between funding restrictions and the lack of diversity in science
Is cocoa good for you? New study may settle it
Fred Hutch and Boston's Brigham and Women's Hospital are recruiting older men and women for a nationwide study looking at the effects of cocoa on the heart and brain
Fred Hutchinson Cancer Research Center puts the artistry of science on display
Preview of art walk featuring scientific images by Fred Hutch researchers
Fred Hutchinson Cancer Research Center puts the artistry of science on display
Preview of art walk featuring scientific images by Fred Hutch researchers
Immunotherapy can treat HIV, new study claims
Article quotes Dr. Larry Corey on how advances in using T-cell therapy to treat cancer could be relevant for HIV cure research
Immunotherapy can treat HIV, new study claims
Article quotes Dr. Larry Corey on how advances in using T-cell therapy to treat cancer could be relevant for HIV cure research
Study finds surprising link between cancer and mental health
Segment on a Swedish study that found a correlation between cancer and depression included comments from Fred Hutch cancer survivorship expert Dr. Karen Syrjala, who was not involved in the study
Study finds surprising link between cancer and mental health
Segment on a Swedish study that found a correlation between cancer and depression included comments from Fred Hutch cancer survivorship expert Dr. Karen Syrjala, who was not involved in the study
Obliteride raises more than $1 million to fight cancer
Slideshow about this year's fourth annual Obliteride bicycle fundraiser for Fred Hutch, which raised more than $1 million for cancer research
Obliteride raises more than $1 million to fight cancer
Slideshow about this year's fourth annual Obliteride bicycle fundraiser for Fred Hutch, which raised more than $1 million for cancer research
8 questions with an expert: Urinary incontinence and erectile dysfunction after prostate cancer
Q&A with Dr. Celestia "Tia" Higano, a prostate cancer clinician and researcher at Fred Hutch and the University of Washington
8 questions with an expert: Urinary incontinence and erectile dysfunction after prostate cancer
Q&A with Dr. Celestia "Tia" Higano, a prostate cancer clinician and researcher at Fred Hutch and the University of Washington
How much exercise do you need to prevent heart disease, cancer?
Quotes Dr. Anne McTiernan about new research that suggests to reduce the risk of certain cancers, heart disease, diabetes and stroke, people should get five to six times more physical activity than is currently recommended by the World Health Organization
How much exercise do you need to prevent heart disease, cancer?
Quotes Dr. Anne McTiernan about new research that suggests to reduce the risk of certain cancers, heart disease, diabetes and stroke, people should get five to six times more physical activity than is currently recommended by the World Health Organization
In cancer, it's back to the future as old treatments make cutting-edge ones more effective
Article about the synergy between traditional cancer treatments and cutting-edge immunotherapy quotes Dr. Gary Gilliland, president and director of Fred Hutch
Man cured, then uncured, of HIV speaks on Fred Hutch panel
HIV patient Gary Steinkohl and the researcher behind his treatment, Dr. Timothy Henrich held a Q&A hosted at Fred Hutch regarding his experience in a clinical trial that seemingly cured HIV in his body. Seven months later, the virus returned.
In cancer, it's back to the future as old treatments make cutting-edge ones more effective
Article about the synergy between traditional cancer treatments and cutting-edge immunotherapy quotes Dr. Gary Gilliland, president and director of Fred Hutch
Man cured, then uncured, of HIV speaks on Fred Hutch panel
HIV patient Gary Steinkohl and the researcher behind his treatment, Dr. Timothy Henrich held a Q&A hosted at Fred Hutch regarding his experience in a clinical trial that seemingly cured HIV in his body. Seven months later, the virus returned.
Immunotherapy: Harnessing your body's own defenses
As part of the Path for Breakthrough series with Robin Roberts, this segment features Dr. Phil Greenberg, Head of Immunology in the clinical research division and how immunotherapy reduces suffering while fighting cancer cells in the body
Immunotherapy: Harnessing your body's own defenses
As part of the Path for Breakthrough series with Robin Roberts, this segment features Dr. Phil Greenberg, Head of Immunology in the clinical research division and how immunotherapy reduces suffering while fighting cancer cells in the body
Only one person has been cured of AIDS — can we do it again?
Quotes staff scientist Chris Peterson on promising research involving genetically engineered stem cells in the monkey version of HIV, known as SHIV
Only one person has been cured of AIDS — can we do it again?
Quotes staff scientist Chris Peterson on promising research involving genetically engineered stem cells in the monkey version of HIV, known as SHIV
This ring can help stop the spread of HIV in women
Quotes Elizabeth Brown from the vaccine and infectious disease division on her study on women using vaginal rings to prevent HIV infection. Brown's research follows the larger ASPIRE study that tested the monthly ring
The elusive HIV vaccine: how Seattle scientists' frustration is turning to hope
Second in a two-part series about Fred Hutch's HIV vaccine research in South Africa quotes Dr. Larry Corey and Julie McElrath, among others
How vaginal bacteria could be stoking HIV cases and blocking prevention
Quotes Dr. David Fredricks, a microbiologist at the Hutch, in an article about how the vaginal microbiome might contribute to HIV risk
Weight loss reduces cancer-associated protein levels
Quotes Dr. Catherine Duggan about her research
This ring can help stop the spread of HIV in women
Quotes Elizabeth Brown from the vaccine and infectious disease division on her study on women using vaginal rings to prevent HIV infection. Brown's research follows the larger ASPIRE study that tested the monthly ring
The elusive HIV vaccine: how Seattle scientists' frustration is turning to hope
Second in a two-part series about Fred Hutch's HIV vaccine research in South Africa quotes Dr. Larry Corey and Julie McElrath, among others
The elusive HIV vaccine: how Seattle scientists' frustration is turning to hope
Second in a two-part series about Fred Hutch's HIV vaccine research in South Africa quotes Dr. Larry Corey and Julie McElrath, among others
How vaginal bacteria could be stoking HIV cases and blocking prevention
Quotes Dr. David Fredricks, a microbiologist at the Hutch, in an article about how the vaginal microbiome might contribute to HIV risk
Weight loss reduces cancer-associated protein levels
Quotes Dr. Catherine Duggan about her research
'We have only one shot': Fred Hutch's quest to wipe out AIDS in South Africa
First in a two-part series about Fred Hutch's HIV vaccine research in South Africa
'We have only one shot': Fred Hutch's quest to wipe out AIDS in South Africa
First in a two-part series about Fred Hutch's HIV vaccine research in South Africa
Weight loss might reduce cancer risk: study
Coverage of a study by Drs. Catherine Duggan and Anne McTiernan published today in the journal Cancer Research
Weight loss might reduce cancer risk: study
Coverage of a study by Drs. Catherine Duggan and Anne McTiernan published today in the journal Cancer Research
Amazon, Microsoft execs named to board of Fred Hutchinson Cancer Research Center
Quotes Dr. Gary Gilliland, president and director of Fred Hutch, about today's appointment of five new board members
Microsoft CEO Satya Nadella raises his community profile
Article quotes new Fred Hutch board member, Microsoft CEO Satya Nadella, among others
Amazon, Microsoft execs named to board of Fred Hutchinson Cancer Research Center
Quotes Dr. Gary Gilliland, president and director of Fred Hutch, about today's appointment of five new board members
Microsoft CEO Satya Nadella raises his community profile
Article quotes new Fred Hutch board member, Microsoft CEO Satya Nadella, among others
A new genetic test can spot aggressive prostate cancer
Quotes Dr. Peter Nelson and colleagues about the clinical implications of a paper of theirs published in The New England Journal of Medicine
Leading researchers recommend major change in prostate cancer treatment
Coverage of paper by Dr. Peter Nelson and colleagues
A new genetic test can spot aggressive prostate cancer
Quotes Dr. Peter Nelson and colleagues about the clinical implications of a paper of theirs published in The New England Journal of Medicine
Leading researchers recommend major change in prostate cancer treatment
Coverage of paper by Dr. Peter Nelson and colleagues
Breast cancer survivors not always clear about follow up care
Quotes Dr. Gary Lyman, co-director of the Hutchinson Institute for Cancer Outcomes Research about confusion among breast cancer patients about follow-up care
Breast cancer survivors not always clear about follow up care
Quotes Dr. Gary Lyman, co-director of the Hutchinson Institute for Cancer Outcomes Research about confusion among breast cancer patients about follow-up care
Inspired innovation at Fred Hutch
Profile of Dr. Jim Olson, a pediatric neuro-oncologist at Fred Hutch whose lab focuses on developing drugs derived from natural compounds made by plants and animals to treat cancer and other diseases, from Alzheimer's to arthritis
Biotech's coming cancer cure
Article follows the latest immunotherapy approaches, including T-cell therapies pioneered by Fred Hutch, Juno Therapeutics and Seattle Children's Hospital
Inspired innovation at Fred Hutch
Profile of Dr. Jim Olson, a pediatric neuro-oncologist at Fred Hutch whose lab focuses on developing drugs derived from natural compounds made by plants and animals to treat cancer and other diseases, from Alzheimer's to arthritis
Biotech's coming cancer cure
Article follows the latest immunotherapy approaches, including T-cell therapies pioneered by Fred Hutch, Juno Therapeutics and Seattle Children's Hospital
Cancer moonshot: My kid died of cancer, others don't have to
Coverage of moonshot summit at Fred Hutch quotes speaker Matthew Trunnell, chief information officer
Cancer moonshot: My kid died of cancer, others don't have to
Coverage of moonshot summit at Fred Hutch quotes speaker Matthew Trunnell, chief information officer
Could the fast-acting immune systems of babies pave the way to a HIV vaccine?
Quotes Dr. Julie Overbaugh about her research
Could the fast-acting immune systems of babies pave the way to a HIV vaccine?
Quotes Dr. Julie Overbaugh about her research
Study linking college education with brain tumor risk raises many questions
Quotes Fred Hutch brain cancer expert Dr. Eric Holland
The re-animators: How scientists are bringing people back from the dead
Article prominently features the suspended animation research of Dr. Mark Roth
Study linking college education with brain tumor risk raises many questions
Quotes Fred Hutch brain cancer expert Dr. Eric Holland
The re-animators: How scientists are bringing people back from the dead
Article prominently features the suspended animation research of Dr. Mark Roth
The 2nd most-common killer of men -- and how you can avoid it
Quotes Fred Hutch lung cancer expert Dr. David Madtes about certain professions that are associated with an increased risk of the disease, such as construction, plumbing and roofing
The 2nd most-common killer of men -- and how you can avoid it
Quotes Fred Hutch lung cancer expert Dr. David Madtes about certain professions that are associated with an increased risk of the disease, such as construction, plumbing and roofing
Giant colon goes on tour to promote cancer awareness
Story examines whether inflatable colons are successful tools for increasing cancer awareness and improving the rate of colon cancer testing among adults, referencing a recent Fred Hutch study on the topic
Giant colon goes on tour to promote cancer awareness
Story examines whether inflatable colons are successful tools for increasing cancer awareness and improving the rate of colon cancer testing among adults, referencing a recent Fred Hutch study on the topic
Cancer therapy re-engineers cells to hunt and destroy
Quotes Fred Hutch immunotherapy researcher Dr. David Maloney
Immunotherapy Q&A session with Aude G. Chapuis, M.D.
Q&A with Fred Hutch immunotherapy researcher Dr. Aude Chapuis
Cancer therapy re-engineers cells to hunt and destroy
Quotes Fred Hutch immunotherapy researcher Dr. David Maloney
Immunotherapy Q&A session with Aude G. Chapuis, M.D.
Q&A with Fred Hutch immunotherapy researcher Dr. Aude Chapuis
Legacies that save lives: Washington Life Science Hall of Fame gets first members
Six medical pioneers inducted into newly created Washington Life Science Hall of Fame include Fred Hutch's Dr. Don Thomas and his wife, Dottie, the "father and mother of bone marrow transplantation"
Legacies that save lives: Washington Life Science Hall of Fame gets first members
Six medical pioneers inducted into newly created Washington Life Science Hall of Fame include Fred Hutch's Dr. Don Thomas and his wife, Dottie, the "father and mother of bone marrow transplantation"
It's an 'exciting time' for cancer research
Article about a Fred Hutch immunotherapy patient whose late-stage malignant melanoma has been in remission for five years
It's an 'exciting time' for cancer research
Article about a Fred Hutch immunotherapy patient whose late-stage malignant melanoma has been in remission for five years
How we got here: Marie Bleakley and Soheil Meshinchi of Fred Hutchinson Research
Q&A with Fred Hutch pediatric oncologists Drs. Marie Bleakley and Soheil Meshinchi
How we got here: Marie Bleakley and Soheil Meshinchi of Fred Hutchinson Research
Q&A with Fred Hutch pediatric oncologists Drs. Marie Bleakley and Soheil Meshinchi
$2.5 million grant awarded for childhood obesity study in Lower Valley
Coverage of a $2.5 million grant to Dr. Linda Ko and colleagues at Fred Hutch to study and prevent childhood obesity in the Lower Yakima Valley
$2.5 million grant awarded for childhood obesity study in Lower Valley
Coverage of a $2.5 million grant to Dr. Linda Ko and colleagues at Fred Hutch to study and prevent childhood obesity in the Lower Yakima Valley
As Skyline boy battles brain tumor, big sister rallies to raise money for research
Story about Sam Taylor, a pediatric brain cancer patient whose sister is raising money for cancer research at Fred Hutch
Cancer deaths rose during the recession. But why?
Quotes Fred Hutch health economist Dr. Scott Ramsey
As Skyline boy battles brain tumor, big sister rallies to raise money for research
Story about Sam Taylor, a pediatric brain cancer patient whose sister is raising money for cancer research at Fred Hutch
Cancer deaths rose during the recession. But why?
Quotes Fred Hutch health economist Dr. Scott Ramsey
Working Geek: Fred Hutch commercialization lead Nicole Robinson is 'a scientific matchmaker'
Q&A with Nicole "Nikki" Robinson, vice president of Industry Relations and Business Development at Fred Hutch
New twist on T-cell therapy puts leukemia patients in remission
Quotes Hutch immunotherapy researcher Dr. David Maloney about promising new clinical trial results published today reporting 27 out of 29 leukemia patients having no detectable signs of disease
Value in cancer care must 'start with patients, not dollars'
Quotes Dr. Gary Lyman, co-director of the Hutchinson Institute for Cancer Outcomes Research
Working Geek: Fred Hutch commercialization lead Nicole Robinson is 'a scientific matchmaker'
Q&A with Nicole "Nikki" Robinson, vice president of Industry Relations and Business Development at Fred Hutch
New twist on T-cell therapy puts leukemia patients in remission
Quotes Hutch immunotherapy researcher Dr. David Maloney about promising new clinical trial results published today reporting 27 out of 29 leukemia patients having no detectable signs of disease
Value in cancer care must 'start with patients, not dollars'
Quotes Dr. Gary Lyman, co-director of the Hutchinson Institute for Cancer Outcomes Research
In menopausal women, phone-based cognitive behavioral intervention reduces insomnia, helps with hot flashes
Coverage of a study by Dr. Katherine Guthrie of Fred Hutch and Dr. Susan McCurry of the University of Washington School of Nursing, published recently in JAMA Internal Medicine
In menopausal women, phone-based cognitive behavioral intervention reduces insomnia, helps with hot flashes
Coverage of a study by Dr. Katherine Guthrie of Fred Hutch and Dr. Susan McCurry of the University of Washington School of Nursing, published recently in JAMA Internal Medicine
Should you eat more full-fat dairy?
Quotes Dr. Mario Kratz of the Public Health Sciences Division
Cancer: The final frontier
Article about the cancer moonshot and immunotherapy mentions Drs. Paul Nghiem and Shailender Bhatia, who are part of the Cancer Immunotherapy Trials Network, which is based at Fred Hutch
Should you eat more full-fat dairy?
Quotes Dr. Mario Kratz of the Public Health Sciences Division
Fighting cancer with killer T-cells: 5 developments to watch
Article about advances in immunotherapy mentions the research of Fred Hutch's Dr. Phil Greenberg as well as spinoff biotech company Juno Therapeutics
Cancer: The final frontier
Article about the cancer moonshot and immunotherapy mentions Drs. Paul Nghiem and Shailender Bhatia, who are part of the Cancer Immunotherapy Trials Network, which is based at Fred Hutch
Fred Hutch President Gary Gilliland elected to the American Academy of Arts and Sciences
New HIV vaccine trial aims to build on earlier modest success
Article covers upcoming HIV Vaccine Trials Network large-scale trial, set to begin later this year, and quotes Dr. Larry Corey, president and director emeritus at Fred Hutch and principal investigator of the HVTN
Fred Hutch President Gary Gilliland elected to the American Academy of Arts and Sciences
New HIV vaccine trial aims to build on earlier modest success
Article covers upcoming HIV Vaccine Trials Network large-scale trial, set to begin later this year, and quotes Dr. Larry Corey, president and director emeritus at Fred Hutch and principal investigator of the HVTN
Get moving to lower cancer risk
Dr. Anne McTiernan was interviewed about a recent study regarding the link between exercise and cancer prevention
Get moving to lower cancer risk
Dr. Anne McTiernan was interviewed about a recent study regarding the link between exercise and cancer prevention
In pursuit of an HIV vaccine and the AIDS-free generation
Editorial by Fred Hutch HIV vaccine researcher and Director Emeritus Dr. Larry Corey and Nobel laureate Dr. David Baltimore of the California Institute of Technology
In pursuit of an HIV vaccine and the AIDS-free generation
Editorial by Fred Hutch HIV vaccine researcher and Director Emeritus Dr. Larry Corey and Nobel laureate Dr. David Baltimore of the California Institute of Technology
New reasons why you should keep a food journal
Quotes Dr. Anne McTiernan about the health benefits of keeping a food journal; the article mentioned that her own research has found that women most adherent in tracking their daily food intake lost an average of 13 percent of their starting body weight as compared to an 8 percent weight loss for women who didn't journal consistently
New reasons why you should keep a food journal
Quotes Dr. Anne McTiernan about the health benefits of keeping a food journal; the article mentioned that her own research has found that women most adherent in tracking their daily food intake lost an average of 13 percent of their starting body weight as compared to an 8 percent weight loss for women who didn't journal consistently
Federal grant will help battle childhood obesity
Coverage of a $2.5 million grant to Dr. Linda Ko of Fred Hutch to study and prevent childhood obesity in the Lower Yakima Valley
Federal grant will help battle childhood obesity
Coverage of a $2.5 million grant to Dr. Linda Ko of Fred Hutch to study and prevent childhood obesity in the Lower Yakima Valley
In praise of oncologists
Letter to the editor gives kudos to oncology researchers at Fred Hutch for their lifesaving work
In praise of oncologists
Letter to the editor gives kudos to oncology researchers at Fred Hutch for their lifesaving work
New FDA e-cigarette rules leave local fans, foes sharply divided
Quotes Dr. Jonathan Bricker, a smoking-cessation expert at Fred Hutch
Mental health disorders common even before cancer
Quotes Dr. Karen Syrjala, director of Biobehavioral Sciences, about the link between cancer diagnosis and mental health disorders
New FDA e-cigarette rules leave local fans, foes sharply divided
Quotes Dr. Jonathan Bricker, a smoking-cessation expert at Fred Hutch
Mental health disorders common even before cancer
Quotes Dr. Karen Syrjala, director of Biobehavioral Sciences, about the link between cancer diagnosis and mental health disorders
5 questions with Knight Cancer's Steve Stadum, who is heading to the Hutch
Q&A with Steve Stadum, who is leaving Oregon Health & Science University to become Fred Hutch's new chief operating officer starting July 5
5 questions with Knight Cancer's Steve Stadum, who is heading to the Hutch
Q&A with Steve Stadum, who is leaving Oregon Health & Science University to become Fred Hutch's new chief operating officer starting July 5
Knight Cancer Institute exec takes job at Fred Hutchinson
Announcement about Fred Hutch's new chief operating officer, Steve Stadum, quotes President and Director Dr. Gary Gilliland about the new hire
People in research: Dr. Jonathan Bricker wants to help people quit smoking
Profile of Hutch smoking-cessation researcher Dr. Jonathan Bricker
Knight Cancer Institute exec takes job at Fred Hutchinson
Announcement about Fred Hutch's new chief operating officer, Steve Stadum, quotes President and Director Dr. Gary Gilliland about the new hire
People in research: Dr. Jonathan Bricker wants to help people quit smoking
Profile of Hutch smoking-cessation researcher Dr. Jonathan Bricker
Drinking, weight gain and processed meats could raise stomach cancer risk
Quotes Dr. Anne McTiernan about newly reported risk factors for stomach cancer
Drinking, weight gain and processed meats could raise stomach cancer risk
Quotes Dr. Anne McTiernan about newly reported risk factors for stomach cancer
Fighting cancer with killer T-cells: 5 developments to watch
Article about advances in immunotherapy mentions the research of Fred Hutch's Dr. Phil Greenberg as well as spinoff biotech company Juno Therapeutics
Fred Hutch, nonprofit Gay City work to remove barriers to HIV testing in trans community
Article about Fred Hutch's Health Disparities Research Program's grant writing workshops for community organizations, including Gay City, which was among three local nonprofits to receive $7,500 in funding from the Hutch
Fred Hutch, nonprofit Gay City work to remove barriers to HIV testing in trans community
Article about Fred Hutch's Health Disparities Research Program's grant writing workshops for community organizations, including Gay City, which was among three local nonprofits to receive $7,500 in funding from the Hutch
Santa Clarita Valley father, son team join the Climb to Fight Cancer
Article about a Los Angeles-area father and son participating in Fred Hutch's Climb to Fight Cancer research fundraiser
Latest progress in precision prevention of colorectal cancer
Coverage of findings by Drs. Li Hsu and Ulrike "Riki" Peters at the annual meeting of the American Association for Cancer Research in New Orleans
The list of cancers being taken down by immunotherapy keeps growing
Coverage of Merkel cell carcinoma immunotherapy research presented today by Dr. Paul Nghiem at the annual meeting of the American Association for Cancer Research in New Orleans also includes an interview with one of his patients, Stan Collender
Latest progress in precision prevention of colorectal cancer
Coverage of findings by Drs. Li Hsu and Ulrike "Riki" Peters at the annual meeting of the American Association for Cancer Research in New Orleans
The list of cancers being taken down by immunotherapy keeps growing
Coverage of Merkel cell carcinoma immunotherapy research presented today by Dr. Paul Nghiem at the annual meeting of the American Association for Cancer Research in New Orleans also includes an interview with one of his patients, Stan Collender
N.D. man accepted into clinical trial for leukemia treatment
Profile of Fred Hutch leukemia patient Matt Jahner of Bismarck, North Dakota quotes his physician, Dr. Cameron Turtle, about his immunotherapy treatment
N.D. man accepted into clinical trial for leukemia treatment
Profile of Fred Hutch leukemia patient Matt Jahner of Bismarck, North Dakota quotes his physician, Dr. Cameron Turtle, about his immunotherapy treatment
How to choose the healthiest fish
Quotes Fred Hutch nutrition researcher Dr. Marian Neuhouser about the health benefits of omega 3s found in foods such as fish
She wouldn't be denied
Profile of Fred Hutch immunotherapy patient Stephanie Florence
How to choose the healthiest fish
Quotes Fred Hutch nutrition researcher Dr. Marian Neuhouser about the health benefits of omega 3s found in foods such as fish
She wouldn't be denied
Profile of Fred Hutch immunotherapy patient Stephanie Florence
Adapted therapy boosts survival in advanced Hodgkin
Coverage of new research by Dr. Oliver Press, published in the Journal of Clinical Oncology
Adapted therapy boosts survival in advanced Hodgkin
Coverage of new research by Dr. Oliver Press, published in the Journal of Clinical Oncology
Cocktails for cancer with a measure of immunotherapy
Article about the next frontier in cancer immunotherapy quotes Dr. Martin "Mac" Cheever, a cancer immunologist at Fred Hutch
Cocktails for cancer with a measure of immunotherapy
Article about the next frontier in cancer immunotherapy quotes Dr. Martin "Mac" Cheever, a cancer immunologist at Fred Hutch
Tackling the financial toll of cancer, one patient at a time
Quotes Fred Hutch health economist Dr. Scott Ramsey
Seattle visit sparks effort to snuff China's smoking habit -- with an app
Article about Fred Hutch smoking-cessation researcher Dr. Jonathan Bricker and his collaboration with researchers at the University of Beijing to bring quit-smoking apps to people in China, where 315 million light up regularly and more than 1 million die from the habit each year
Tackling the financial toll of cancer, one patient at a time
Quotes Fred Hutch health economist Dr. Scott Ramsey
Seattle visit sparks effort to snuff China's smoking habit -- with an app
Article about Fred Hutch smoking-cessation researcher Dr. Jonathan Bricker and his collaboration with researchers at the University of Beijing to bring quit-smoking apps to people in China, where 315 million light up regularly and more than 1 million die from the habit each year
For some top nonprofits, changing the world begins in Seattle
Article about Seattle global health nonprofits mentions Fred Hutch among other leading research institutes in the South Lake Union area
For some top nonprofits, changing the world begins in Seattle
Article about Seattle global health nonprofits mentions Fred Hutch among other leading research institutes in the South Lake Union area
The burden of cancer isn't just cancer
Article about the financial toxicity of cancer quotes Fred Hutch health economist Dr. Scott Ramsey, whose research has found that people with cancer are 2.65 times more likely to file for bankruptcy that those without cancer
The burden of cancer isn't just cancer
Article about the financial toxicity of cancer quotes Fred Hutch health economist Dr. Scott Ramsey, whose research has found that people with cancer are 2.65 times more likely to file for bankruptcy that those without cancer
NCCN takes new look at vulvar cancer
Coverage of a presentation by Dr. Wui-Jin Koh, a radiation oncologist at Fred Hutch and Seattle Cancer Care Alliance about the shift toward less radical surgery for patients with vulvar cancer, which is extremely rare
NCCN takes new look at vulvar cancer
Coverage of a presentation by Dr. Wui-Jin Koh, a radiation oncologist at Fred Hutch and Seattle Cancer Care Alliance about the shift toward less radical surgery for patients with vulvar cancer, which is extremely rare
Socioeconomics affect participation in cancer clinical trials
Coverage of a recent JAMA Oncology paper by Dr. Joseph Unger
Socioeconomics affect participation in cancer clinical trials
Coverage of a recent JAMA Oncology paper by Dr. Joseph Unger
What if your immune system could be taught to kill cancer?
Cover story features the lifesaving immunotherapy research of Fred Hutch's Drs. David Maloney, Cameron Turtle and Stan Riddell, among others, and profiles immunotherapy patient Stephanie Florence, whose lymphoma was put into long-term remission
What if your immune system could be taught to kill cancer?
Cover story features the lifesaving immunotherapy research of Fred Hutch's Drs. David Maloney, Cameron Turtle and Stan Riddell, among others, and profiles immunotherapy patient Stephanie Florence, whose lymphoma was put into long-term remission
Crossing over: How science is redefining life and death
Article quotes Fred Hutch's Dr. Mark Roth about his research into metabolic flexibility and suspended animation
Crossing over: How science is redefining life and death
Article quotes Fred Hutch's Dr. Mark Roth about his research into metabolic flexibility and suspended animation
Why vitamin E is dangerous for your prostate health
Quotes Dr. Alan Kristal of the Public Health Sciences Division
Young adult cancer survivors hard hit by cancer treatment costs
Article quotes Dr. K. Scott Baker, director of the Fred Hutch Survivorship Program, about the financial toxicity of cancer treatment in young adults
Why vitamin E is dangerous for your prostate health
Quotes Dr. Alan Kristal of the Public Health Sciences Division
Young adult cancer survivors hard hit by cancer treatment costs
Article quotes Dr. K. Scott Baker, director of the Fred Hutch Survivorship Program, about the financial toxicity of cancer treatment in young adults
Conservative strategy alone makes PSA cost-effective
Coverage of a recent study by Drs. Ruth Etzioni and Joshua Roth
Conservative strategy alone makes PSA cost-effective
Coverage of a recent study by Drs. Ruth Etzioni and Joshua Roth
Seattle scientists create blood test to predict tuberculosis
Article about a new blood test to predict whether latent tuberculosis will develop into active TB mentions that a related TB vaccine clinical trial in Cape Town, South Africa, was designed by biostatisticians at Fred Hutch
Seattle scientists create blood test to predict tuberculosis
Article about a new blood test to predict whether latent tuberculosis will develop into active TB mentions that a related TB vaccine clinical trial in Cape Town, South Africa, was designed by biostatisticians at Fred Hutch
Childhood cancer survivors and motherhood chances
Quotes Dr. Eric Chow about his new study
Childhood cancer survivors and motherhood chances
Quotes Dr. Eric Chow about his new study
Lori Matsukawa interview with Vice Pres. Biden
News anchor Lori Matsukawa interviews Vice President Joe Biden during his "moonshot" listening tour at Fred Hutch
VP Joe Biden: Sharing big data is vital to cancer research and Seattle can help
Joe Biden says Americans need more optimism for the future: ‘We’ve lost some of our mojo’
Fred Hutchinson Cancer Research Center is the launchpad of new cures
Op-ed by Dr. Gary Gilliland, president and director of Fred Hutch
Lori Matsukawa interview with Vice Pres. Biden
News anchor Lori Matsukawa interviews Vice President Joe Biden during his "moonshot" listening tour at Fred Hutch
VP Joe Biden: Sharing big data is vital to cancer research and Seattle can help
Joe Biden says Americans need more optimism for the future: ‘We’ve lost some of our mojo’
Fred Hutchinson Cancer Research Center is the launchpad of new cures
Op-ed by Dr. Gary Gilliland, president and director of Fred Hutch
Positive phase 3 trials more often cited, published in high-impact journals
Article about a recent study by Dr. Joe Unger, a SWOG biostatistician based in the Public Health Sciences Division at Fred Hutch
Positive phase 3 trials more often cited, published in high-impact journals
Article about a recent study by Dr. Joe Unger, a SWOG biostatistician based in the Public Health Sciences Division at Fred Hutch
Fred Hutch doctor revolutionizing cancer treatment with 'Tumor Paint'
Article about the Tumor Paint research of Dr. Jim Olson, a pediatric brain cancer researcher at Fred Hutch who will be profiled on KIRO-TV at 10:30 p.m. PT March 17
Fred Hutch doctor revolutionizing cancer treatment with 'Tumor Paint'
Article about the Tumor Paint research of Dr. Jim Olson, a pediatric brain cancer researcher at Fred Hutch who will be profiled on KIRO-TV at 10:30 p.m. PT March 17
Unlocking secrets to metastatic breast cancer: 'Cells travel like a gang of thugs'
Interview with Dr. Kevin Cheung about his metastatic breast cancer research and how such work in women's cancer research is supported, in part, by Fred Hutch's annual Shop & Dine to Make a Difference fundraiser at University Village
Negative clinical trial results are still quite important
Coverage of a study by Dr. Joe Unger, a biostatistician in the SWOG Statistical Center at Fred Hutch, on the positive scientific contributions of negative clinical trial results
Unlocking secrets to metastatic breast cancer: 'Cells travel like a gang of thugs'
Interview with Dr. Kevin Cheung about his metastatic breast cancer research and how such work in women's cancer research is supported, in part, by Fred Hutch's annual Shop & Dine to Make a Difference fundraiser at University Village
Negative clinical trial results are still quite important
Coverage of a study by Dr. Joe Unger, a biostatistician in the SWOG Statistical Center at Fred Hutch, on the positive scientific contributions of negative clinical trial results
Are carbs as bad as red meat and cigarettes when it comes to lung cancer?
Quotes cancer prevention and nutrition researcher Dr. Marian Neuhouser
Are carbs as bad as red meat and cigarettes when it comes to lung cancer?
Quotes cancer prevention and nutrition researcher Dr. Marian Neuhouser
Blood cancer therapy is last chance for some
Segment about the lifesaving promise of cancer immunotherapy quotes Dr. Stanley Riddell, an immunotherapy researcher at Fred Hutch
Blood cancer therapy is last chance for some
Segment about the lifesaving promise of cancer immunotherapy quotes Dr. Stanley Riddell, an immunotherapy researcher at Fred Hutch
Viral 'fossils' in our DNA may help us fight infection
Quotes Fred Hutch evolutionary biologist Dr. Harmit Malik
Viral 'fossils' in our DNA may help us fight infection
Quotes Fred Hutch evolutionary biologist Dr. Harmit Malik
The 2016 Leaders in Health Care Awards: Outstanding Medical Research
Profile of Dr. Colleen Delaney, director of the Cord Blood Program at Fred Hutch and recipient of Seattle Business magazine's Outstanding Medical Research award
Jamaica-born public health expert named dean at Harvard
Dr. Michelle Williams, the new dean of the Harvard T.H. Chan School of Public Health, was an affiliate investigator at Fred Hutch from 1992 to 2010
Commercialized cord blood
Program about cord blood transplantation featuring Dr. Colleen Delaney, head of the Cord Blood Program at Fred Hutch, and patient Crystal Day
The 2016 Leaders in Health Care Awards: Outstanding Medical Research
Profile of Dr. Colleen Delaney, director of the Cord Blood Program at Fred Hutch and recipient of Seattle Business magazine's Outstanding Medical Research award
Jamaica-born public health expert named dean at Harvard
Dr. Michelle Williams, the new dean of the Harvard T.H. Chan School of Public Health, was an affiliate investigator at Fred Hutch from 1992 to 2010
Trish Dziko is fighting inequality in tech, one student at a time
Article about Technology Access Foundation Academy mentions Fred Hutch TAF Academy interns Favour Orji and Ericka Pegues
UW, Hutch, Cancer Care Alliance and Juno join forces on major clinical trials initiative
Quotes Dr. Fred Appelbaum about new clinical trials unit dedicated to immuno-oncology research
UW, Hutch, Cancer Care Alliance and Juno join forces on major clinical trials initiative
Quotes Dr. Fred Appelbaum about new clinical trials unit dedicated to immuno-oncology research
Juno, Fred Hutch launch clinical trials unit
Quotes Fred Hutch President and Director Dr. Gary Gilliland about new clinical trials unit that will focus on immuno-oncology research
Juno, Fred Hutch launch clinical trials unit
Quotes Fred Hutch President and Director Dr. Gary Gilliland about new clinical trials unit that will focus on immuno-oncology research
You asked: Is yoga good exercise?
Mentions a Fred Hutch study that found an association between yoga and weight loss.
Video: Experts predict the future of Big Data at #JPM16
Video of expert panel discussing Big Data at the J.P. Morgan 33rd annual Health Care Conference in San Francisco includes Matthew Trunnell, vice president and chief information officer at Fred Hutch
Cancer's financial burden tied to poorer survival, study finds
Quotes Dr. Scott Ramsey about his research into the link between cancer, bankruptcy and increased mortality
Mr. T-cell
Article about the lifesaving immunotherapy research of Dr. Stanley Riddell and colleagues at Fred Hutch
Video: Experts predict the future of Big Data at #JPM16
Video of expert panel discussing Big Data at the J.P. Morgan 33rd annual Health Care Conference in San Francisco includes Matthew Trunnell, vice president and chief information officer at Fred Hutch
You asked: Is yoga good exercise?
Mentions a Fred Hutch study that found an association between yoga and weight loss.
Video: Experts predict the future of Big Data at #JPM16
Video of expert panel discussing Big Data at the J.P. Morgan 33rd annual Health Care Conference in San Francisco includes Matthew Trunnell, vice president and chief information officer at Fred Hutch
Cancer's financial burden tied to poorer survival, study finds
Quotes Dr. Scott Ramsey about his research into the link between cancer, bankruptcy and increased mortality
Mr. T-cell
Article about the lifesaving immunotherapy research of Dr. Stanley Riddell and colleagues at Fred Hutch
Video: Experts predict the future of Big Data at #JPM16
Video of expert panel discussing Big Data at the J.P. Morgan 33rd annual Health Care Conference in San Francisco includes Matthew Trunnell, vice president and chief information officer at Fred Hutch
Opinion: It's more than hair -- a cancer researcher with cancer writes about family, identity, and being outed by her own hair
First-person installment of an occasional series by Fred Hutch postdoc Dr. Kiranjit Dhillon, published initially by Fred Hutch News Service
Opinion: It's more than hair -- a cancer researcher with cancer writes about family, identity, and being outed by her own hair
First-person installment of an occasional series by Fred Hutch postdoc Dr. Kiranjit Dhillon, published initially by Fred Hutch News Service
New cancer therapy could give hope to ‘incurable’ patients
Article about the promise of cancer immunotherapy at Fred Hutch
Here’s why scientists are shocked by the results of this cancer treatment trial
Article about the lifesaving immunotherapy research of Dr. Stanley Riddell and colleagues at Fred Hutch
Why the ‘moon shot’ to cure cancer might work
Cites Seattle Cancer Care Alliance’s collaboration between Fred Hutch, UW Medicine and Seattle Children’s as an example of the potential to receive the best possible return on research funding
New cancer therapy could give hope to ‘incurable’ patients
Article about the promise of cancer immunotherapy at Fred Hutch
Here’s why scientists are shocked by the results of this cancer treatment trial
Article about the lifesaving immunotherapy research of Dr. Stanley Riddell and colleagues at Fred Hutch
Why the ‘moon shot’ to cure cancer might work
Cites Seattle Cancer Care Alliance’s collaboration between Fred Hutch, UW Medicine and Seattle Children’s as an example of the potential to receive the best possible return on research funding
Why it’s too early to get excited about this ‘unprecedented’ new cancer treatment
Coverage of research by Fred Hutch's Dr. Stanley Riddell and colleagues, presented at the annual meeting of the American Association for the Advancement of Science in Washington, D.C.
Is this a major breakthrough?
Audio interview with Dr. Stanley Riddell about Fred Hutch's lifesaving immunotherapy research
Scientists claim ‘extraordinary’ success with treatment using immune cells to target cancer
Quotes Dr. Stanley Riddell about the promise of cancer immunotherapy research
Why it’s too early to get excited about this ‘unprecedented’ new cancer treatment
Coverage of research by Fred Hutch's Dr. Stanley Riddell and colleagues, presented at the annual meeting of the American Association for the Advancement of Science in Washington, D.C.
Is this a major breakthrough?
Audio interview with Dr. Stanley Riddell about Fred Hutch's lifesaving immunotherapy research
Scientists claim ‘extraordinary’ success with treatment using immune cells to target cancer
Quotes Dr. Stanley Riddell about the promise of cancer immunotherapy research
Cancer researchers claim ‘extraordinary results’ using T-cell therapy
Quotes Dr. Stanley Riddell
‘Extraordinary results’ for researchers using T-cell therapy to battle blood cancer
Quotes Dr. Stanley Riddell about his research
Cancer researchers claim ‘extraordinary results’ using T-cell therapy
Quotes Dr. Stanley Riddell
‘Extraordinary results’ for researchers using T-cell therapy to battle blood cancer
Quotes Dr. Stanley Riddell about his research
Experts urge Biden to expand access to therapies, patient genetics in cancer 'moonshot'
Fred Hutch President and Director Dr. Gary Gilliland, among several other cancer experts, was asked what advice he'd give to advance Vice President Joe Biden's cancer "moonshot" initiative
Experts urge Biden to expand access to therapies, patient genetics in cancer 'moonshot'
Fred Hutch President and Director Dr. Gary Gilliland, among several other cancer experts, was asked what advice he'd give to advance Vice President Joe Biden's cancer "moonshot" initiative
World Cancer Day: How to prevent cancer
Interview, in Spanish, about cancer prevention tips with Fred Hutch's Kathy Briant on World Cancer Day (interview broadcast Feb. 4, posted Feb. 12)
World Cancer Day: How to prevent cancer
Interview, in Spanish, about cancer prevention tips with Fred Hutch's Kathy Briant on World Cancer Day (interview broadcast Feb. 4, posted Feb. 12)
Finding enhancers with CRISPR
Article about gene-editing technology quotes Dr. Cecilia Moens, a basic scientist at Fred Hutch
Finding enhancers with CRISPR
Article about gene-editing technology quotes Dr. Cecilia Moens, a basic scientist at Fred Hutch
A good weight loss program is hard to find online
Quotes Fred Hutch cancer prevention expert Dr. Anne McTiernan
A good weight loss program is hard to find online
Quotes Fred Hutch cancer prevention expert Dr. Anne McTiernan
Seattle families face question: How much would you pay to live?
Interview with Fred Hutch health economists Drs. Scott Ramsey and Gary Lyman about the high cost of pharmaceutical drugs and how patients can be forced into bankruptcy in order to live
5 foods that may help lower your cancer risk
Quotes Dr. Johanna Lampe about the cancer-fighting properties of Brussels sprouts and other crucifers
Seattle families face question: How much would you pay to live?
Interview with Fred Hutch health economists Drs. Scott Ramsey and Gary Lyman about the high cost of pharmaceutical drugs and how patients can be forced into bankruptcy in order to live
5 foods that may help lower your cancer risk
Quotes Dr. Johanna Lampe about the cancer-fighting properties of Brussels sprouts and other crucifers
JP Morgan Healthcare Conference: Biotech industry descends on San Francisco for major investor gathering
Quotes Niki Robinson, vice president of Industry Relations and Business Development
2 lymphoma studies using CAR T-cell therapy report 'tremendously exciting' results
Mentions an immunotherapy study for non-Hodgkin lymphoma and chronic lymphocytic leukemia led by Dr. Cameron Turtle that is yielding "tremendously exciting" results
JP Morgan Healthcare Conference: Biotech industry descends on San Francisco for major investor gathering
Quotes Niki Robinson, vice president of Industry Relations and Business Development
2 lymphoma studies using CAR T-cell therapy report 'tremendously exciting' results
Mentions an immunotherapy study for non-Hodgkin lymphoma and chronic lymphocytic leukemia led by Dr. Cameron Turtle that is yielding "tremendously exciting" results
People in research: Dr. Kevin Cheung wants to stop breast cancer from metastasizing
Profile of Dr. Kevin Cheung, a Fred Hutch researcher who studies advanced, or metastatic, breast cancer
People in research: Dr. Kevin Cheung wants to stop breast cancer from metastasizing
Profile of Dr. Kevin Cheung, a Fred Hutch researcher who studies advanced, or metastatic, breast cancer
Cancer 'moonshot' initiative raises questions about what it means to cure cancer
Quotes Dr. Gary Gilliland, president and director of Fred Hutch, about his vision for a cancer cure
Obituary: Doug Walker, co-founder of Social Venture Partners
Obit about Doug Walker, longtime Fred Hutch board member and former board president
Lighting the way ahead in medicine
Article mentions the Tumor Paint research of Dr. Jim Olson
Cancer 'moonshot' initiative raises questions about what it means to cure cancer
Quotes Dr. Gary Gilliland, president and director of Fred Hutch, about his vision for a cancer cure
Obituary: Doug Walker, co-founder of Social Venture Partners
Obit about Doug Walker, longtime Fred Hutch board member and former board president
Lighting the way ahead in medicine
Article mentions the Tumor Paint research of Dr. Jim Olson
High drug prices mean you can't afford your medications? There's help
Article about the high cost of pharmaceuticals mentions a Fred Hutch study that found cancer patients who file for bankruptcy protection appear to have a higher risk of dying
High drug prices mean you can't afford your medications? There's help
Article about the high cost of pharmaceuticals mentions a Fred Hutch study that found cancer patients who file for bankruptcy protection appear to have a higher risk of dying
Doug Walker, killed in an apparent avalanche, used tech wealth to spread love for the outdoors
Article about the passing of former Fred Hutch board chair Doug Walker, a software entrepreneur, philanthropist and outdoorsman
Cells gang up to form breast cancer metastases, study shows
Article about new findings by Dr. Kevin Cheung and colleagues
Hutch pays up to $800 for blood stem cells donations, but donors are hard to find
Article about peripheral blood stem cell donation quotes Dr. Shelly Heimfeld of Fred Hutch and Seattle Cancer Care Alliance about how donated peripheral blood stem cells contribute to research
Doug Walker, killed in an apparent avalanche, used tech wealth to spread love for the outdoors
Article about the passing of former Fred Hutch board chair Doug Walker, a software entrepreneur, philanthropist and outdoorsman
Cells gang up to form breast cancer metastases, study shows
Article about new findings by Dr. Kevin Cheung and colleagues
Hutch pays up to $800 for blood stem cells donations, but donors are hard to find
Article about peripheral blood stem cell donation quotes Dr. Shelly Heimfeld of Fred Hutch and Seattle Cancer Care Alliance about how donated peripheral blood stem cells contribute to research
Wainwright receives community service award
Coverage of 51st annual Hutch Award winner Adam Wainwright of the St. Louis Cardinals
For Hutch Award winner Adam Wainwright, giving back is better than accolades
Sports columnist Larry Stone covers Hutch Award winner Adam Wainwright and Hall of Famer Carlton Fisk's visit to the Hutch School prior to the Hutch Award Luncheon
Wainwright receives community service award
Coverage of 51st annual Hutch Award winner Adam Wainwright of the St. Louis Cardinals
For Hutch Award winner Adam Wainwright, giving back is better than accolades
Sports columnist Larry Stone covers Hutch Award winner Adam Wainwright and Hall of Famer Carlton Fisk's visit to the Hutch School prior to the Hutch Award Luncheon
Take 2: Remembering the life, death and legacy of the great Fred Hutchinson
Legendary Major League Baseball player and namesake of Fred Hutchinson Cancer Research Center is remembered fondly by a Seattle baseball fan
Take 2: Remembering the life, death and legacy of the great Fred Hutchinson
Legendary Major League Baseball player and namesake of Fred Hutchinson Cancer Research Center is remembered fondly by a Seattle baseball fan
From a scientist who wasn't immunized to Lee Hood's new venture, a look back at this year's health care personalities
Mentions Fred Hutch President and Director Dr. Gary Gilliland
A fifth of cancer therapy trials fail to enlist enough participants
Article about a study by researchers at Fred Hutch and the University of Washington that found one in five publicly funded cancer clinical trials fail to recruit enough participants to yield reliable results
What accounts for low enrollment in clinical trials for cancer drugs?
Article about a new study by researchers at Fred Hutch and the University of Washington
From a scientist who wasn't immunized to Lee Hood's new venture, a look back at this year's health care personalities
Mentions Fred Hutch President and Director Dr. Gary Gilliland
A fifth of cancer therapy trials fail to enlist enough participants
Article about a study by researchers at Fred Hutch and the University of Washington that found one in five publicly funded cancer clinical trials fail to recruit enough participants to yield reliable results
What accounts for low enrollment in clinical trials for cancer drugs?
Article about a new study by researchers at Fred Hutch and the University of Washington
Gone in 2015: Commemorating ten outstanding women in science
Tribute to the late Dottie Thomas, the "mother of bone marrow transplantation" and wife of the late Fred Hutch bone marrow transplant pioneer Dr. E. Donnall Thomas
Gone in 2015: Commemorating ten outstanding women in science
Tribute to the late Dottie Thomas, the "mother of bone marrow transplantation" and wife of the late Fred Hutch bone marrow transplant pioneer Dr. E. Donnall Thomas
Norman Breslow dies at 74; biostatistician's work led to advances in medical research
Article about the passing of Dr. Norman Breslow, a biostatistician in Fred Hutch's Public Health Sciences Division and at the University of Washington School of Public Health
Norman Breslow dies at 74; biostatistician's work led to advances in medical research
Article about the passing of Dr. Norman Breslow, a biostatistician in Fred Hutch's Public Health Sciences Division and at the University of Washington School of Public Health
With millennial philanthropy money flowing, arts groups miss out
Article about millennial philanthropy prominently features Fred Hutch's Innovators Network, a group aimed at young professionals to help raise money for funding early-stage research
With millennial philanthropy money flowing, arts groups miss out
Article about millennial philanthropy prominently features Fred Hutch's Innovators Network, a group aimed at young professionals to help raise money for funding early-stage research
Therapy focus -- How do you solve a problem like CAR-T relapse?
Article about CAR-T immunotherapy mentions a clinical trial taking place at Fred Hutch sponsored by Juno Therapeutics
Therapy focus -- How do you solve a problem like CAR-T relapse?
Article about CAR-T immunotherapy mentions a clinical trial taking place at Fred Hutch sponsored by Juno Therapeutics
Cancer not just 'bad luck'
Article quotes Fred Hutch cancer prevention expert Dr. John Potter
Cancer not just 'bad luck'
Article quotes Fred Hutch cancer prevention expert Dr. John Potter
Why and how the Hutch moved to SLU
Quotes Fred Hutch Chief Financial Officer Randy Main
Up to 90% of cancer cases caused by lifestyle or environment, study says
Quotes Dr. John Potter, a cancer prevention expert at Fred Hutch
Why and how the Hutch moved to SLU
Quotes Fred Hutch Chief Financial Officer Randy Main
Up to 90% of cancer cases caused by lifestyle or environment, study says
Quotes Dr. John Potter, a cancer prevention expert at Fred Hutch
Cancer studies clash over mechanisms of malignancy
Quotes Dr. John Potter, a cancer prevention researcher at Fred Hutch
Cancer studies clash over mechanisms of malignancy
Quotes Dr. John Potter, a cancer prevention researcher at Fred Hutch
Most of the world's cancer cases are now in developing countries
Quotes Dr. Corey Casper, head of the Global Oncology Program at Fred Hutch
From the ivory tower to the corner office, academics infuse new life into pharma
Quotes Dr. Gary Gilliland, president and director of Fred Hutch, about his time working as a senior vice president at Merck
Most of the world's cancer cases are now in developing countries
Quotes Dr. Corey Casper, head of the Global Oncology Program at Fred Hutch
From the ivory tower to the corner office, academics infuse new life into pharma
Quotes Dr. Gary Gilliland, president and director of Fred Hutch, about his time working as a senior vice president at Merck
Clinical trials are subjecting cancer patients to too many biopsies, study finds
Quotes Dr. Ruth Etzioni, a Fred Hutch biostatistician, about a new study that found U.S. cancer patients in clinical trials are undergoing expensive, invasive therapies with no clear benefits
Clinical trials are subjecting cancer patients to too many biopsies, study finds
Quotes Dr. Ruth Etzioni, a Fred Hutch biostatistician, about a new study that found U.S. cancer patients in clinical trials are undergoing expensive, invasive therapies with no clear benefits
At hematological meeting, more than just biotech data runs blood red
Mentions new immunotherapy findings presented this week by Dr. Cameron Turtle at the annual meeting of the American Hematological Society in Orlando, Florida
At hematological meeting, more than just biotech data runs blood red
Mentions new immunotherapy findings presented this week by Dr. Cameron Turtle at the annual meeting of the American Hematological Society in Orlando, Florida
40th Fred Hutch Holiday Gala raises $6.7 million for cancer researcher and raises the roof with Huey Lewis
Coverage of 40th annual Hutch Holiday Gala, which raised $6.7 million for cancer research at Fred Hutch, surpassing the event's $100 million mark over four decades
What next? Cancer groups offer a map for breast cancer survivors
Quotes Dr. Gary Lyman, co-director of the Hutchinson Institute for Cancer Outcomes Research about new guidelines for cancer survivors issued today
40th Fred Hutch Holiday Gala raises $6.7 million for cancer researcher and raises the roof with Huey Lewis
Coverage of 40th annual Hutch Holiday Gala, which raised $6.7 million for cancer research at Fred Hutch, surpassing the event's $100 million mark over four decades
What next? Cancer groups offer a map for breast cancer survivors
Quotes Dr. Gary Lyman, co-director of the Hutchinson Institute for Cancer Outcomes Research about new guidelines for cancer survivors issued today
Fred Hutchinson Cancer Research Center spins out disease-fighting biotech startup Nohla Therapeutics
Article about new Hutch spinoff Nohla Therapeutics
Startup Nohla Therapeutics to build on Hutch cord-blood work
Quotes Fred Hutch cord blood transplant researcher Dr. Colleen Delaney about a new biotech spinoff company based on her work
Epigenetics: The genome unwrapped
Quotes geneticist Dr. Stephen Henikoff of the Basic Sciences Division
Fred Hutchinson Cancer Research Center spins out disease-fighting biotech startup Nohla Therapeutics
Article about new Hutch spinoff Nohla Therapeutics
Startup Nohla Therapeutics to build on Hutch cord-blood work
Quotes Fred Hutch cord blood transplant researcher Dr. Colleen Delaney about a new biotech spinoff company based on her work
Epigenetics: The genome unwrapped
Quotes geneticist Dr. Stephen Henikoff of the Basic Sciences Division
Targeting cancer with genomic tests
Quotes Dr. Eric Holland about the promise of precision medicine for cancer
Disease: Closing the door on HIV
Article about gene editing quotes Dr. Hans-Peter Kiem
Targeting cancer with genomic tests
Quotes Dr. Eric Holland about the promise of precision medicine for cancer
Disease: Closing the door on HIV
Article about gene editing quotes Dr. Hans-Peter Kiem
Seattle doctor featured on HBO's Vice for groundbreaking AIDS prevention
Fred Hutch virologist Dr. Larry Corey was interviewed about being featured in a VICE documentary on HBO, "Countdown to Zero," about the search for an HIV vaccine and cure.
Brain research gets a new nerve center at Allen Institute headquarters
Quotes Dr. Jim Olson, a pediatric brain cancer researcher at Fred Hutch, about how his team uses the Allen Brain Atlas on a regular basis
World AIDS Day: See how much has changed in the fight against HIV/AIDS
Quotes Fred Hutch HIV vaccine researcher Dr. Larry Corey
Seattle doctor featured on HBO's Vice for groundbreaking AIDS prevention
Fred Hutch virologist Dr. Larry Corey was interviewed about being featured in a VICE documentary on HBO, "Countdown to Zero," about the search for an HIV vaccine and cure.
Brain research gets a new nerve center at Allen Institute headquarters
Quotes Dr. Jim Olson, a pediatric brain cancer researcher at Fred Hutch, about how his team uses the Allen Brain Atlas on a regular basis
World AIDS Day: See how much has changed in the fight against HIV/AIDS
Quotes Fred Hutch HIV vaccine researcher Dr. Larry Corey
Fred Hutch featured on HBO documentary on HIV vaccine
Article about the participation of several Fred Hutch HIV researchers in "Countdown to Zero," a VICE special report that aired on HBO Dec. 1, World AIDS Day
Fred Hutch featured on HBO documentary on HIV vaccine
Article about the participation of several Fred Hutch HIV researchers in "Countdown to Zero," a VICE special report that aired on HBO Dec. 1, World AIDS Day
Updated ACS breast cancer screening guideline recognizes greater role for individual's values and preferences
Quotes Dr. Ruth Etzioni, co-author of the recently updated American Cancer Society breast cancer screening guidelines
ASCO University offers resources for palliative and team-based care
Quotes Dr. Gary Lyman of the Hutchinson Institute for Cancer Outcomes Research about his participation on a panel that aimed to provide practical recommendations for identifying and evaluating patients with cancer-related fatigue
Chronic myelogenous leukemia: What drug for which patient?
Quotes Dr. Jerald Radich about the treatment of CML with tyrosine kinase inhibitors
Updated ACS breast cancer screening guideline recognizes greater role for individual's values and preferences
Quotes Dr. Ruth Etzioni, co-author of the recently updated American Cancer Society breast cancer screening guidelines
ASCO University offers resources for palliative and team-based care
Quotes Dr. Gary Lyman of the Hutchinson Institute for Cancer Outcomes Research about his participation on a panel that aimed to provide practical recommendations for identifying and evaluating patients with cancer-related fatigue
Chronic myelogenous leukemia: What drug for which patient?
Quotes Dr. Jerald Radich about the treatment of CML with tyrosine kinase inhibitors
7 myths about HIV and the facts you need to know
Quotes Drs. Jim Kublin and Larry Corey of the Fred Hutch-based HIV Vaccine Trials Network
Charlie Sheen's HIV not likely a death sentence
Quotes Dr. Julie McElrath, director of Fred Hutch's Vaccine and Infectious Disease Division
7 myths about HIV and the facts you need to know
Quotes Drs. Jim Kublin and Larry Corey of the Fred Hutch-based HIV Vaccine Trials Network
Charlie Sheen's HIV not likely a death sentence
Quotes Dr. Julie McElrath, director of Fred Hutch's Vaccine and Infectious Disease Division
Charlie Sheen reveals he's HIV positive
Quotes Dr. Jim Kubin, executive director of the Fred Hutch-based HIV Vaccine Trials Network
University of Texas study links meat to kidney cancer
Quotes Dr. Ulrike "Riki" Peters about more evidence that eating meat increases the risk of cancer
University of Texas study links meat to kidney cancer
Quotes Dr. Ulrike "Riki" Peters about more evidence that eating meat increases the risk of cancer
Altered T cells hit pancreatic cancer
Article about a recent study by Drs. Phil Greenberg and Sunil Hingorani
Altered T cells hit pancreatic cancer
Article about a recent study by Drs. Phil Greenberg and Sunil Hingorani
Costs deter low-income patients from participating in clinical trials
Coverage of a recent study by Dr. Joe Unger
Costs deter low-income patients from participating in clinical trials
Coverage of a recent study by Dr. Joe Unger
Is bacon actually bad for you? It may depend on your DNA.
Quotes Dr. Ulrike "Riki" Peters about her research into the genetics of meat consumption and cancer risk
Scorpion venom to be used in fight against cancer, clinical trials on human begins
Article about the Tumor Paint research of Dr. Jim Olson of Fred Hutch and Blaze Biosciences
Is bacon actually bad for you? It may depend on your DNA.
Quotes Dr. Ulrike "Riki" Peters about her research into the genetics of meat consumption and cancer risk
Scorpion venom to be used in fight against cancer, clinical trials on human begins
Article about the Tumor Paint research of Dr. Jim Olson of Fred Hutch and Blaze Biosciences
How scorpions became an unlikely ally in the fight against cancer
Interview with Dr. Jim Olson about his research, which uses scorpion venom to "paint" cancer cells
Want more patients in your clinical trials? Then pay them
Article about a study by Dr. Joe Unger quotes him about his research
How scorpions became an unlikely ally in the fight against cancer
Interview with Dr. Jim Olson about his research, which uses scorpion venom to "paint" cancer cells
Want more patients in your clinical trials? Then pay them
Article about a study by Dr. Joe Unger quotes him about his research
Immunotherapy for pancreatic cancer boosts survival by more than 75% in preclinical models
Article about a new study by Drs. Sunil Hingorani, Phil Greenberg and colleagues
Study success hints at pancreatic cancer immunotherapy promise
Article about a new study by Drs. Sunil Hingorani, Phil Greenberg and colleagues that found immunotherapy can improve survival by more than 75 percent in mice with pancreatic cancer
Immunotherapy for pancreatic cancer boosts survival by more than 75% in preclinical models
Article about a new study by Drs. Sunil Hingorani, Phil Greenberg and colleagues
Black women and breast cancer: Disparities continue
Quotes doctoral student Lu Chen about her research
Black women and breast cancer: Disparities continue
Quotes doctoral student Lu Chen about her research
Sciex to commercialize Fred Hutchinson's targeted proteomics technology
Quotes Dr. Amanda Paulovich about her proteomics research
Breast cancer in the developing world: Rising rates, shrouded in silence
Q&A with Dr. Ben Anderson, director of the Breast Global Health Initiative at Fred Hutch
Sciex to commercialize Fred Hutchinson's targeted proteomics technology
Quotes Dr. Amanda Paulovich about her proteomics research
Breast cancer in the developing world: Rising rates, shrouded in silence
Q&A with Dr. Ben Anderson, director of the Breast Global Health Initiative at Fred Hutch
'It's not your bra': Gwyneth Paltrow's under fire for pushing debunked breast cancer myth
Article quotes Fred Hutch writer and breast cancer survivor Diane Mapes as well as public health researcher Lu Chen about the bra / breast cancer myth
'It's not your bra': Gwyneth Paltrow's under fire for pushing debunked breast cancer myth
Article quotes Fred Hutch writer and breast cancer survivor Diane Mapes as well as public health researcher Lu Chen about the bra / breast cancer myth
China first lady Peng Liyuan's role in culture and compassion
Article about first lady of China Madame Peng Liyuan includes mention of her visit to Fred Hutch in September
Study finds Metamark's prostate cancer test offers benefits beyond current standards of care
Article about Fred Hutch health economic analysis of new prostate cancer test
New breast cancer screening guidelines: clarity or confusion?
Quotes Dr. Ruth Etzioni about her research
China first lady Peng Liyuan's role in culture and compassion
Article about first lady of China Madame Peng Liyuan includes mention of her visit to Fred Hutch in September
Study finds Metamark's prostate cancer test offers benefits beyond current standards of care
Article about Fred Hutch health economic analysis of new prostate cancer test
New breast cancer screening guidelines: clarity or confusion?
Quotes Dr. Ruth Etzioni about her research
Acting globally: Global Oncology at Fred Hutchinson Cancer Research Center
Article about the Fred Hutch Global Oncology Program, which has received a "2015 Light a Fire / Acting Globally" award from SeattleMet magazine
Acting globally: Global Oncology at Fred Hutchinson Cancer Research Center
Article about the Fred Hutch Global Oncology Program, which has received a "2015 Light a Fire / Acting Globally" award from SeattleMet magazine
Breast cancer is especially dangerous for black and Hispanic women
Quotes Lu Chen about her research
Breast cancer is especially dangerous for black and Hispanic women
Quotes Lu Chen about her research
Why are black breast cancer patients left out of clinical trials?
Article about a study by Dr. Joe Unger
Poorer cancer patients may be less likely to join a clinical trial
Quotes Dr. Joe Unger about his research
More evidence poor cancer patients don't join clinical trials
Quotes Dr. Joe Unger about his research
Talking to kids about smoking risks may help parents quit
Article quotes Dr. Jonathan Bricker
Why are black breast cancer patients left out of clinical trials?
Article about a study by Dr. Joe Unger
Poorer cancer patients may be less likely to join a clinical trial
Quotes Dr. Joe Unger about his research
More evidence poor cancer patients don't join clinical trials
Quotes Dr. Joe Unger about his research
Talking to kids about smoking risks may help parents quit
Article quotes Dr. Jonathan Bricker
What women need to know about mammograms
Quotes Dr. V.K. Gadi about breast cancer screening
What women need to know about mammograms
Quotes Dr. V.K. Gadi about breast cancer screening
App can help smokers kick the habit
Q-and-A with Dr. Jonathan Bricker about his smoking-cessation research
What race has to do with breast cancer
Quotes Lu Chen about her research
11 healthy habits to start now to reduce your breast cancer risk later
Quotes Dr. Anne McTiernan about the association between smoking and increased risk of breast cancer
Dr. Jim Olson: How to defeat cancer, with help from nature, scorpions and innovative thinking
Article about a recent GeekWire Summit talk by Dr. Jim Olson, who studies pediatric brain cancer -- according to the article, it was one of the most popular sessions at the two-day Seattle conference
Minority women get worse breast cancer care, regardless of tumor type: Study
Quotes Dr. Lu Chen about her research
Black women more likely to get wrong breast cancer care, study confirms
Quotes Dr. Lu Chen about her research
New study finds minority women with breast cancer get worse care
Quotes Lu Chen about her research
App can help smokers kick the habit
Q-and-A with Dr. Jonathan Bricker about his smoking-cessation research
What race has to do with breast cancer
Quotes Lu Chen about her research
11 healthy habits to start now to reduce your breast cancer risk later
Quotes Dr. Anne McTiernan about the association between smoking and increased risk of breast cancer
Dr. Jim Olson: How to defeat cancer, with help from nature, scorpions and innovative thinking
Article about a recent GeekWire Summit talk by Dr. Jim Olson, who studies pediatric brain cancer -- according to the article, it was one of the most popular sessions at the two-day Seattle conference
Minority women get worse breast cancer care, regardless of tumor type: Study
Quotes Dr. Lu Chen about her research
Black women more likely to get wrong breast cancer care, study confirms
Quotes Dr. Lu Chen about her research
New study finds minority women with breast cancer get worse care
Quotes Lu Chen about her research
Diagnosis of additional small cancers suggests screening mammography leads to overdiagnosis
Quotes Dr. Ruth Etzioni, who co-authored an JAMA Internal Medicine editorial about a study led by researchers at Harvard and Dartmouth
A pregnancy souvenir: Cells that are not your own
Article quotes Dr. J. Lee Nelson about her microchimerism research, which explores the phenomenon of fetal cells lingering in the mother's body long after pregnancy
Diagnosis of additional small cancers suggests screening mammography leads to overdiagnosis
Quotes Dr. Ruth Etzioni, who co-authored an JAMA Internal Medicine editorial about a study led by researchers at Harvard and Dartmouth
A pregnancy souvenir: Cells that are not your own
Article quotes Dr. J. Lee Nelson about her microchimerism research, which explores the phenomenon of fetal cells lingering in the mother's body long after pregnancy
Another study finds kids who vape smoke real tobacco, too
Quotes Dr. Jonathan Bricker about the dangers of e-cigs
Another study finds kids who vape smoke real tobacco, too
Quotes Dr. Jonathan Bricker about the dangers of e-cigs
5 major breast cancer advancements you need to know about
Quotes Dr. Julie Gralow of the Clinical Research Division and director of Breast Cancer Medical Oncology at Seattle Cancer Care Alliance regarding the FDA's accelerated approval of the breast cancer drug Palbociclib earlier this year, among other breast cancer advances
Reducing the risk of breast cancer
Quotes Dr. Anne McTiernan on ways to reduce one's risk of breast cancer
5 major breast cancer advancements you need to know about
Quotes Dr. Julie Gralow of the Clinical Research Division and director of Breast Cancer Medical Oncology at Seattle Cancer Care Alliance regarding the FDA's accelerated approval of the breast cancer drug Palbociclib earlier this year, among other breast cancer advances
Reducing the risk of breast cancer
Quotes Dr. Anne McTiernan on ways to reduce one's risk of breast cancer
Diabetes and exercise: 10 science-backed reasons to start working out
Article leads with mention of Fred Hutch study that found a combination of diet and exercise is more effective than exercise alone when it comes to losing weight
Diabetes and exercise: 10 science-backed reasons to start working out
Article leads with mention of Fred Hutch study that found a combination of diet and exercise is more effective than exercise alone when it comes to losing weight
A cure for cancer
Interview with Dr. Gary Gilliland, president and director of Fred Hutch, about his vision of the future of cancer care and the promise of immune-based therapies
Relive the 2015 GeekWire Summi with photos, videos, Twitter reaction
GeekWire Summit roundup includes a photo of Dr. James Olson, who spoke at the event
A cure for cancer
Interview with Dr. Gary Gilliland, president and director of Fred Hutch, about his vision of the future of cancer care and the promise of immune-based therapies
Relive the 2015 GeekWire Summi with photos, videos, Twitter reaction
GeekWire Summit roundup includes a photo of Dr. James Olson, who spoke at the event
Nobel Prize winning scientists reflect on nearly sleeping through the life-changing call
Quotes Dr. Linda Buck about how she heard the news of her Nobel Prize
Nobel Prize winning scientists reflect on nearly sleeping through the life-changing call
Quotes Dr. Linda Buck about how she heard the news of her Nobel Prize
The cure for HIV is not around the corner
Article mentions that Fred Hutch researchers are working on gene editing techniques in the quest for an HIV cure
The cure for HIV is not around the corner
Article mentions that Fred Hutch researchers are working on gene editing techniques in the quest for an HIV cure
Ready, willing and able
Article about researchers with disabilities includes mention of Dr. Maxine Linial, a virologist at Fred Hutch who lost her sight five years ago after being hit by a car who relies on voice-recognition technology to stay active in her field
Cancer vaccines make a comeback, as Third Rock pumps $55M into Neon Therapeutics
Quotes Dr. Martin "Mac" Cheever, an immunotherapy researcher at Fred Hutch
Lost colonies
Article about the challenges of growing bacteria in the lab mentions the research of Dr. David Fredricks, a bacteriologist at the Hutch
Ready, willing and able
Article about researchers with disabilities includes mention of Dr. Maxine Linial, a virologist at Fred Hutch who lost her sight five years ago after being hit by a car who relies on voice-recognition technology to stay active in her field
Cancer vaccines make a comeback, as Third Rock pumps $55M into Neon Therapeutics
Quotes Dr. Martin "Mac" Cheever, an immunotherapy researcher at Fred Hutch
Lost colonies
Article about the challenges of growing bacteria in the lab mentions the research of Dr. David Fredricks, a bacteriologist at the Hutch
China's first lady focuses on global health in Fred Hutch tour
Coverage of the first lady of China's Fred Hutch visit quotes Dr. Gary Gilliland, Fred Hutch president and director, and smoking-cessation researcher Dr. Jonathan Bricker
China's first lady focuses on global health in Fred Hutch tour
Coverage of the first lady of China's Fred Hutch visit quotes Dr. Gary Gilliland, Fred Hutch president and director, and smoking-cessation researcher Dr. Jonathan Bricker
Fred Hutch looks to tap expertise from Druker, other OHSU aces
Article about potential research collaboration between Fred Hutch and Oregon Health & Science University quotes President and Director Dr. Gary Gilliland, who spoke at the Oregon Bio 2015 conference
Fred Hutch looks to tap expertise from Druker, other OHSU aces
Article about potential research collaboration between Fred Hutch and Oregon Health & Science University quotes President and Director Dr. Gary Gilliland, who spoke at the Oregon Bio 2015 conference
Men get double mastectomies, too
Quotes Dr. Larissa Korde, a clinical researcher at Fred Hutch, in an article about how more and more men with breast cancer are opting to get the unaffected breast removed as a precautionary measure against cancer recurrence
Men get double mastectomies, too
Quotes Dr. Larissa Korde, a clinical researcher at Fred Hutch, in an article about how more and more men with breast cancer are opting to get the unaffected breast removed as a precautionary measure against cancer recurrence
Infection with multiple HIV-1 variants leads to poorer clinical outcomes
Article about HIV-vaccine studies involving researchers from Fred Hutch
Personalized devices predict cancer drug sensitivity in vivo
Article about new device developed by Fred Hutch's Dr. Jim Olson in collaboration with Presage Biosciences to test a variety of drugs on tumors within the body prior to surgery and treatment
Infection with multiple HIV-1 variants leads to poorer clinical outcomes
Article about HIV-vaccine studies involving researchers from Fred Hutch
Personalized devices predict cancer drug sensitivity in vivo
Article about new device developed by Fred Hutch's Dr. Jim Olson in collaboration with Presage Biosciences to test a variety of drugs on tumors within the body prior to surgery and treatment
Back to the future: Chemotherapy dosing in overweight and obese patients with cancer
Commentary by Dr. Gary Lyman, co-director of the Hutchinson Institute for Cancer Outcomes Research, on the impact of obesity in chemotherapy dosing
Back to the future: Chemotherapy dosing in overweight and obese patients with cancer
Commentary by Dr. Gary Lyman, co-director of the Hutchinson Institute for Cancer Outcomes Research, on the impact of obesity in chemotherapy dosing
Link between birth control and breast cancer, but no clear answers
Quotes Drs. Christopher Li and V.K. Gadi about the nuances of interpreting breast cancer risk related to hormone use
Link between birth control and breast cancer, but no clear answers
Quotes Drs. Christopher Li and V.K. Gadi about the nuances of interpreting breast cancer risk related to hormone use
Is Coca-Cola shifting blame for obesity away from bad diets?
Article quotes Dr. Anne McTiernan about the benefits of calorie restriction versus physical activity for losing weight
Is Coca-Cola shifting blame for obesity away from bad diets?
Article quotes Dr. Anne McTiernan about the benefits of calorie restriction versus physical activity for losing weight
Does how often you eat have an effect on your overall health?
Interview with Dr. Martine "Petey" Perrigue about a study she's conducting to determine what is better for optimal health: grazing on small meals throughout the day or eating three square meals without snacking
With new tools, Adaptive Bio ready to bolt together a drug business
Article about a new technology for sequencing cells of the immune system developed by Fred Hutch spinoff Adaptive Biotechnologies quotes its chief scientific officer, Dr. Harlan Robins, a researcher in the Public Health Sciences Division at Fred Hutch
Does how often you eat have an effect on your overall health?
Interview with Dr. Martine "Petey" Perrigue about a study she's conducting to determine what is better for optimal health: grazing on small meals throughout the day or eating three square meals without snacking
With new tools, Adaptive Bio ready to bolt together a drug business
Article about a new technology for sequencing cells of the immune system developed by Fred Hutch spinoff Adaptive Biotechnologies quotes its chief scientific officer, Dr. Harlan Robins, a researcher in the Public Health Sciences Division at Fred Hutch
Getting the better of chemo brain
Article quotes Dr. Karen Syrjala, co-director of the Fred Hutchinson Cancer Research Center Survivorship Program, with tips on how to overcome memory problems and other issues associated with “chemo brain”
Getting the better of chemo brain
Article quotes Dr. Karen Syrjala, co-director of the Fred Hutchinson Cancer Research Center Survivorship Program, with tips on how to overcome memory problems and other issues associated with “chemo brain”
Why two MDs chose to study business: Because healthcare needs it
Profile of Palo Alto-based physician and health care investor Dr. Bob Kocher, whose dream while growing up in Seattle "was to be a leukemia and lymphoma doctor at Fred Hutchinson Cancer Research Center."
Sounders' supporters shield to be carried atop Mt. Rainier
Article about a Seattle Sounders fan and Hodgkin disease survivor Kevin Zelko, who is celebrating the end of his cancer treatment by participating in the Climb to Fight Breast Cancer, a fundraiser for Fred Hutch
Sounders' supporters shield to be carried atop Mt. Rainier
Article about a Seattle Sounders fan and Hodgkin disease survivor Kevin Zelko, who is celebrating the end of his cancer treatment by participating in the Climb to Fight Breast Cancer, a fundraiser for Fred Hutch
Study aims to determine how frequently people should eat for optimal health
Article about a new technology for sequencing cells of the immune system developed by Fred Hutch spinoff Adaptive Biotechnologies quotes its chief scientific officer, Dr. Harlan Robins, a researcher in the Public Health Sciences Division at Fred Hutch
Study aims to determine how frequently people should eat for optimal health
Article about a new technology for sequencing cells of the immune system developed by Fred Hutch spinoff Adaptive Biotechnologies quotes its chief scientific officer, Dr. Harlan Robins, a researcher in the Public Health Sciences Division at Fred Hutch
Bicyclists ride against cancer
Photos from the Obliteride fundraising event for Fred Hutch
Coca-Cola funds scientists who shift blame for obesity away from bad diets
Quotes Dr. Anne McTiernan of Fred Hutch, whose work is not funded by Coca-Cola, about her research regarding the effect of exercise and calorie restriction on weight loss.
Bicyclists ride against cancer
Photos from the Obliteride fundraising event for Fred Hutch
Coca-Cola funds scientists who shift blame for obesity away from bad diets
Quotes Dr. Anne McTiernan of Fred Hutch, whose work is not funded by Coca-Cola, about her research regarding the effect of exercise and calorie restriction on weight loss.
No need to wait for the perfect match -- cord blood is saving time and lives
Article by Dr. Colleen Delaney, director of the Cord Blood Transplantation Program at Fred Hutch
No need to wait for the perfect match -- cord blood is saving time and lives
Article by Dr. Colleen Delaney, director of the Cord Blood Transplantation Program at Fred Hutch
'What I'm doing on my summer vacation' (#5 in a series) -- Beti Thompson, Ph.D.
Profile of Fred Hutch public health researcher Dr. Beti Thompson, who is training for and participating in this weekend's Obliteride, an annual cycling fundraiser for the Hutch
'What I'm doing on my summer vacation' (#5 in a series) -- Beti Thompson, Ph.D.
Profile of Fred Hutch public health researcher Dr. Beti Thompson, who is training for and participating in this weekend's Obliteride, an annual cycling fundraiser for the Hutch
Teachers bond, build curriculum at Fred Hutch
Article on Science Education Partnership, a Fred Hutch program that provides local teachers with the opportunity to expand their science knowledge and curriculum with hands-on training in Fred Hutch’s and partnering institution’s research labs.
Meet StemBox, the subscription service that delivers science experiments to your door
Article highlighting Fred Hutch researcher, Cristina McAllister and her monthly-subscription box of science kits marketed to girls, called StemBox
Fred Hutch hires new vice president, CIO | On the Move
Article featuring Matthew Tunnell, new vice president and chief information officer at Fred Hutch
Meet StemBox, the subscription service that delivers science experiments to your door
Article highlighting Fred Hutch researcher, Cristina McAllister and her monthly-subscription box of science kits marketed to girls, called StemBox
Teachers bond, build curriculum at Fred Hutch
Article on Science Education Partnership, a Fred Hutch program that provides local teachers with the opportunity to expand their science knowledge and curriculum with hands-on training in Fred Hutch’s and partnering institution’s research labs.
Meet StemBox, the subscription service that delivers science experiments to your door
Article highlighting Fred Hutch researcher, Cristina McAllister and her monthly-subscription box of science kits marketed to girls, called StemBox
Fred Hutch hires new vice president, CIO | On the Move
Article featuring Matthew Tunnell, new vice president and chief information officer at Fred Hutch
Meet StemBox, the subscription service that delivers science experiments to your door
Article highlighting Fred Hutch researcher, Cristina McAllister and her monthly-subscription box of science kits marketed to girls, called StemBox
Can journalists be too skeptical about progress against cancer?
Article about the potential of curing most cancers within the decade quotes Fred Hutch President and Director Dr. Gary Gilliland: "It' is actually plausible that in 10 years we will have cures and therapies for most, if not all cancers."
Can journalists be too skeptical about progress against cancer?
Article about the potential of curing most cancers within the decade quotes Fred Hutch President and Director Dr. Gary Gilliland: "It' is actually plausible that in 10 years we will have cures and therapies for most, if not all cancers."
Should I eat yogurt-covered snacks?
Dr. Mario Kratz, a nutrition scientist and dairy researcher at Fred Hutch is quoted in this article about yogurt-covered snacks
The high cost of cancer care: Your money or your life?
Article mentioning a study by Fred Hutch that found those diagnosed with cancer are 2.5 times more likely to declare bankruptcy than those without cancer
Mary Toews recognized for her work in sharing arts with youth
Article on Fred Hutch and Familias Unidas on developing a program on surviving cancer
Should I eat yogurt-covered snacks?
Dr. Mario Kratz, a nutrition scientist and dairy researcher at Fred Hutch is quoted in this article about yogurt-covered snacks
The high cost of cancer care: Your money or your life?
Article mentioning a study by Fred Hutch that found those diagnosed with cancer are 2.5 times more likely to declare bankruptcy than those without cancer
Mary Toews recognized for her work in sharing arts with youth
Article on Fred Hutch and Familias Unidas on developing a program on surviving cancer
Introducing StemBox, Birchbox’s super smart little sister
Article highlighting Fred Hutch researcher, Cristina McAllister and her monthly-subscription box of science kits marketed to girls, called StemBox
Introducing StemBox, Birchbox’s super smart little sister
Article highlighting Fred Hutch researcher, Cristina McAllister and her monthly-subscription box of science kits marketed to girls, called StemBox
Nicole Robinson takes VP position at Fred Hutch | On the Move
Article highlights Nicole Robinson being named VP of industry relations and business development at Fred Hutch
Nicole Robinson takes VP position at Fred Hutch | On the Move
Article highlights Nicole Robinson being named VP of industry relations and business development at Fred Hutch
Genes may be key to a better HIV vaccine, study says
Article mentions a study co-authored by Fred Hutch researcher, Daniel Geraghty on how someone’s genetic makeup could determine whether an HIV vaccine will work
Genes may be key to a better HIV vaccine, study says
Article mentions a study co-authored by Fred Hutch researcher, Daniel Geraghty on how someone’s genetic makeup could determine whether an HIV vaccine will work
Happy birthday, Fred Hutch
Article about the Hutch marking its 40th anniversary this year
Happy birthday, Fred Hutch
Article about the Hutch marking its 40th anniversary this year
Happy birthday, Fred Hutch
Article about the Hutch marking its 40th anniversary this year
Fact or fiction? Chocolate is good for your health
Article mentions a study being conducted by Fred Hutch in collaboration with Brigham and Women's Hospital to determine the health benefits of chocolate
Poor sleep, snoring before diagnosis tied to trouble for breast cancer patients
Quotes Dr. Amanda Phipps about her research into the link between poor sleep and increased breast cancer risk
Juno Therapeutics breaks ground on HQ, establishing a new hub for biotech in Seattle
Fred Hutch immunotherapy biotech spinoff breaks ground on new building
Happy birthday, Fred Hutch
Article about the Hutch marking its 40th anniversary this year
Happy birthday, Fred Hutch
Article about the Hutch marking its 40th anniversary this year
Happy birthday, Fred Hutch
Article about the Hutch marking its 40th anniversary this year
Fact or fiction? Chocolate is good for your health
Article mentions a study being conducted by Fred Hutch in collaboration with Brigham and Women's Hospital to determine the health benefits of chocolate
Poor sleep, snoring before diagnosis tied to trouble for breast cancer patients
Quotes Dr. Amanda Phipps about her research into the link between poor sleep and increased breast cancer risk
Juno Therapeutics breaks ground on HQ, establishing a new hub for biotech in Seattle
Fred Hutch immunotherapy biotech spinoff breaks ground on new building
Obese postmenopausal women may face higher risk for breast cancer
Quotes Dr. Marian Neuhouser
Fight obesity before it happens as diets don't cut breast cancer risk, experts say
Article about a recent study led by Fred Hutch's Dr. Marian Neuhouser
Weight tied to breast cancer risk in older women
Quotes Fred Hutch's Dr. Marian Neuhouser about a study she led, published today in JAMA Oncology
Obese postmenopausal women may face higher risk for breast cancer
Quotes Dr. Marian Neuhouser about her research, published today in JAMA Oncology
Obese postmenopausal women may face higher risk for breast cancer
Quotes Dr. Marian Neuhouser
Fight obesity before it happens as diets don't cut breast cancer risk, experts say
Article about a recent study led by Fred Hutch's Dr. Marian Neuhouser
Weight tied to breast cancer risk in older women
Quotes Fred Hutch's Dr. Marian Neuhouser about a study she led, published today in JAMA Oncology
Obese postmenopausal women may face higher risk for breast cancer
Quotes Dr. Marian Neuhouser about her research, published today in JAMA Oncology
Here’s what cancer looks like to African-Americans
Story on the African-American cancer experience focuses on breast cancer survivor and advocate Bridgette Hempstead of Cierra Sisters, who works as a consultant with Fred Hutch’s Dr. Rachel Ceballos to tailor cancer survivorship programs for minority communities. Ceballos commented that many survivors don’t deal with the emotional aspects of their diagnosis until long after treatment is over.
Here’s what cancer looks like to African-Americans
Story on the African-American cancer experience focuses on breast cancer survivor and advocate Bridgette Hempstead of Cierra Sisters, who works as a consultant with Fred Hutch’s Dr. Rachel Ceballos to tailor cancer survivorship programs for minority communities. Ceballos commented that many survivors don’t deal with the emotional aspects of their diagnosis until long after treatment is over.
Every year brings a new strain of flu. Here's how it all starts.
Video featuring a demonstration by Fred Hutch's Dr. Trevor Bedford on how the flu spreads
Every year brings a new strain of flu. Here's how it all starts.
Video featuring a demonstration by Fred Hutch's Dr. Trevor Bedford on how the flu spreads
Hutch scientist receives $12.9 million grant
Article about a new federal grant to Dr. Rainier Storb and colleauges to refine stem-cell transplantation for people with noncancerous conditions such as "bubble boy disease" and sickle-cell anemia
Hutch scientist receives $12.9 million grant
Article about a new federal grant to Dr. Rainier Storb and colleauges to refine stem-cell transplantation for people with noncancerous conditions such as "bubble boy disease" and sickle-cell anemia
Screening mammograms don’t prevent breast cancer deaths, study finds
Article about breast cancer overdiagnosis mentions a commentary by Fred Hutch and University of Washington researchers published recently in JAMA Internal Medicine
Seattle researcher seeks cancer survivors for pilot program
Interview with Dr. Rachel Ceballos about SANA, a cancer support group study she is conducting that is recruiting local Hispanic and Latino cancer survivors
7 healthy perks of coffee
Article mentions a Fred Hutch study that found a link between coffee consumption and a lower incidence of prostate cancer recurrence and progression
Screening mammograms don’t prevent breast cancer deaths, study finds
Article about breast cancer overdiagnosis mentions a commentary by Fred Hutch and University of Washington researchers published recently in JAMA Internal Medicine
Seattle researcher seeks cancer survivors for pilot program
Interview with Dr. Rachel Ceballos about SANA, a cancer support group study she is conducting that is recruiting local Hispanic and Latino cancer survivors
7 healthy perks of coffee
Article mentions a Fred Hutch study that found a link between coffee consumption and a lower incidence of prostate cancer recurrence and progression
Heavy drinking and cancer
Quotes Dr. Polly Newcomb about the alcohol-cancer connection
Helping patients to heal themselves
Article about the Hutch marking its 40th anniversary this year
Looking to spin off more startups, Fred Hutchinson Cancer Research Center names new commercialization chief
Article about Fred Hutch's new vice president of Industry Relations and Business Development, Nicole Robinson
Exclusive: Fred Hutch office responsible for spinning out Juno just got a new leader
Article about Nicole Robinson, Fred Hutch's new vice president of Industry Relations and Business Development
Dye derived from scorpion venom will target brain cancer in kids
Article about a new clinical trial of "Tumor Paint" drug BLZ-100 for pediatric brain cancer patients quotes its inventor, Dr. Jim Olson, a clinical researcher at Fred Hutch and neuro-oncologist at Seattle Children's
How crowdfunding helps patients deal with the high cost of cancer care
Mentions a Fred Hutch study that found an association between cancer and bankruptcy
Heavy drinking and cancer
Quotes Dr. Polly Newcomb about the alcohol-cancer connection
Helping patients to heal themselves
Article about the Hutch marking its 40th anniversary this year
Looking to spin off more startups, Fred Hutchinson Cancer Research Center names new commercialization chief
Article about Fred Hutch's new vice president of Industry Relations and Business Development, Nicole Robinson
Exclusive: Fred Hutch office responsible for spinning out Juno just got a new leader
Article about Nicole Robinson, Fred Hutch's new vice president of Industry Relations and Business Development
Dye derived from scorpion venom will target brain cancer in kids
Article about a new clinical trial of "Tumor Paint" drug BLZ-100 for pediatric brain cancer patients quotes its inventor, Dr. Jim Olson, a clinical researcher at Fred Hutch and neuro-oncologist at Seattle Children's
How crowdfunding helps patients deal with the high cost of cancer care
Mentions a Fred Hutch study that found an association between cancer and bankruptcy
‘Navigators’ for cancer patients: A nice perk or something more?
Article quotes Dr. Scott Ramsey, director of the Hutchinson Institute for Cancer Outcomes Research
‘Navigators’ for cancer patients: A nice perk or something more?
Article quotes Dr. Scott Ramsey, director of the Hutchinson Institute for Cancer Outcomes Research
A perception problem: Seattle's biotech industry should not be a hidden secret
Fred Hutch President and Director Dr. Gary Gilliland is quoted in an article about how Seattle's biotech industry is not widely known outside the region
The lies that scars tell
Article about the research of Fred Hutch's Dr. Maxine Linial, a virologist who studies the enigma of why macaque trainers in Bangladesh are often bitten by their monkeys but rarely become infected by a particular simian retrovirus
A perception problem: Seattle's biotech industry should not be a hidden secret
Fred Hutch President and Director Dr. Gary Gilliland is quoted in an article about how Seattle's biotech industry is not widely known outside the region
The lies that scars tell
Article about the research of Fred Hutch's Dr. Maxine Linial, a virologist who studies the enigma of why macaque trainers in Bangladesh are often bitten by their monkeys but rarely become infected by a particular simian retrovirus
Combined weight loss, vitamin D reduces inflammation in cancer
Quotes Dr. Catherine Duggan about her research
Fred Hutch president says they've got cancer 'running scared,' predicts cure in 10 years
Article quotes Fred Hutch President and Director Dr. Gary Gilliland on the future of cancer research
Combined weight loss, vitamin D reduces inflammation in cancer
Quotes Dr. Catherine Duggan about her research
Fred Hutch president says they've got cancer 'running scared,' predicts cure in 10 years
Article quotes Fred Hutch President and Director Dr. Gary Gilliland on the future of cancer research
Fred Hutch scientist gets $4.1 million for breast cancer research
Article quotes Dr. Cyrus Ghajar about his research
Fred Hutch scientist gets $4.1 million for breast cancer research
Article quotes Dr. Cyrus Ghajar about his research
Vitamin D, weight loss cut cancer risk: Study
Quotes Dr. Catherine Duggan about her research
Vitamin D, weight loss cut cancer risk: Study
Quotes Dr. Catherine Duggan about her research
Fred Hutch scientist gets $3.1M for stop-smoking app
Article about Dr. Jonathan Bricker's smoking-cessation research
Fred Hutch scientist gets $3.1M for stop-smoking app
Article about Dr. Jonathan Bricker's smoking-cessation research
Genome studies show how Ebola spread initially
Article quotes Dr. Trevor Bedford about his research
Genome studies show how Ebola spread initially
Article quotes Dr. Trevor Bedford about his research
Effect of aspirin, NSAIDs on colorectal cancer risk may reflect genetic variations
Article about a study by Dr. Li Hsu regarding aspiring and colorectal cancer prevention
Hutch opens cancer research center -- 9,000 miles away
Quotes Dr. Corey Casper, director of Global Oncology at Fred Hutch, and Dr. Jackson Orem, director of the Uganda Cancer Institute; both are co-directors of the new Fred Hutch-UCI Cancer Centre in Kampala, Uganda
How an anonymous stem cell donation saved one boy's life
Article about an Ottawa boy whose life was saved by an anonymous stem cell donation quotes Dr. Ann Woolfrey, a transplantation researcher at Fred Hutch
The new cancer facility is a beacon of hope
Coverage of the new Fred Hutch-UCI Cancer Centre in Kampala, Uganda
Effect of aspirin, NSAIDs on colorectal cancer risk may reflect genetic variations
Article about a study by Dr. Li Hsu regarding aspiring and colorectal cancer prevention
Hutch opens cancer research center -- 9,000 miles away
Quotes Dr. Corey Casper, director of Global Oncology at Fred Hutch, and Dr. Jackson Orem, director of the Uganda Cancer Institute; both are co-directors of the new Fred Hutch-UCI Cancer Centre in Kampala, Uganda
How an anonymous stem cell donation saved one boy's life
Article about an Ottawa boy whose life was saved by an anonymous stem cell donation quotes Dr. Ann Woolfrey, a transplantation researcher at Fred Hutch
The new cancer facility is a beacon of hope
Coverage of the new Fred Hutch-UCI Cancer Centre in Kampala, Uganda
No proof e-cigs can help you stop smoking
Fred Hutch smoking-cessation expert Dr. Jonathan Bricker is quoted
Fred Hutch, Uganda Cancer Institute open cancer centre
Quotes Fred Hutch President and Director Dr. Gary Gillland; Dr. Corey Casper, head of Global Oncology at Fred Hutch and co-director of the UCI/Hutchinson Center Cancer Alliance; and Dr. Jackson Orem, director of the UCI and co-director of the UCI/Hutchinson Center Cancer Alliance
No proof e-cigs can help you stop smoking
Fred Hutch smoking-cessation expert Dr. Jonathan Bricker is quoted
Fred Hutch, Uganda Cancer Institute open cancer centre
Quotes Fred Hutch President and Director Dr. Gary Gillland; Dr. Corey Casper, head of Global Oncology at Fred Hutch and co-director of the UCI/Hutchinson Center Cancer Alliance; and Dr. Jackson Orem, director of the UCI and co-director of the UCI/Hutchinson Center Cancer Alliance
How a husband's cancer diagnosis inspired this founder to build a successful business
Article about a company called DataStat, which helps researchers automate their workflow, mentions its clients include Fred Hutch, which uses the software to help workers in Zambia organize HIV and AIDS data collection across 21 communities
How a husband's cancer diagnosis inspired this founder to build a successful business
Article about a company called DataStat, which helps researchers automate their workflow, mentions its clients include Fred Hutch, which uses the software to help workers in Zambia organize HIV and AIDS data collection across 21 communities
What if Americans ate like South Africans and vice versa?
Quotes Dr. Corey Casper, head of Global Oncology at Fred Hutch
What if Americans ate like South Africans and vice versa?
Quotes Dr. Corey Casper, head of Global Oncology at Fred Hutch
Latest Ebola data rule out rapid mutation
Quotes Fred Hutch's Dr. Trevor Bedford, a viral geneticist
Latest Ebola data rule out rapid mutation
Quotes Fred Hutch's Dr. Trevor Bedford, a viral geneticist
Juno Therapeutics buys Stage Cell Therapeutics for up to $223M
Article about Fred Hutch spinoff Juno Therapeutics acquiring a German-based biotech
Wilms study: saving kids, saving adults
Segment about a study by Dr. Norm Breslow that found an increased risk of breast cancer among women treated with radiation for Wilms tumor during childhoo
Talking cure? For cancer immunotherapy, still many rivers to cross
Coverage of Xconomy's annual Seattle biotech forum held at Fred Hutch quotes Dr. Gary Gilliland, president and director of the Hutch, who spoke the event
Juno Therapeutics buys Stage Cell Therapeutics for up to $223M
Article about Fred Hutch spinoff Juno Therapeutics acquiring a German-based biotech
Wilms study: saving kids, saving adults
Segment about a study by Dr. Norm Breslow that found an increased risk of breast cancer among women treated with radiation for Wilms tumor during childhoo
Talking cure? For cancer immunotherapy, still many rivers to cross
Coverage of Xconomy's annual Seattle biotech forum held at Fred Hutch quotes Dr. Gary Gilliland, president and director of the Hutch, who spoke the event
Studies show coffee fights heart disease, cancer, Alzheimer's
Article mentions a Fred Hutch study that found a link between coffee consumption and reduced risk of recurrent prostate cancer
Studies show coffee fights heart disease, cancer, Alzheimer's
Article mentions a Fred Hutch study that found a link between coffee consumption and reduced risk of recurrent prostate cancer
Informing decision-making about mammography screening
Commentary by Fred Hutch's Dr. Ruth Etzioni, a cancer biostatistician, regarding breast cancer overdiagnosis
Informing decision-making about mammography screening
Commentary by Fred Hutch's Dr. Ruth Etzioni, a cancer biostatistician, regarding breast cancer overdiagnosis
Five myths about breast cancer
Article mentions a Fred Hutch study that examined the association between oral contraceptive use and breast cancer risk
Five myths about breast cancer
Article mentions a Fred Hutch study that examined the association between oral contraceptive use and breast cancer risk
Statins may slow prostate cancer progression
Quotes Dr. Jorge Ramos, a hematology/oncology fellow at Fred Hutch and University of Washington, about the study's significance
Statins may slow prostate cancer progression
Quotes Dr. Jorge Ramos, a hematology/oncology fellow at Fred Hutch and University of Washington, about the study's significance
Seattle's Adaptive Biotechnologies raises whopping $195 million venture fund
Article about Fred Hutch spinoff company Adaptive Biotechnologies
Adaptive Biotechnologies raises $195 million in venture funding
Article about funding milestone for Fred Hutch spinoff Adaptive Biotechnologies, which develops technology to map immune system response to cancer and other diseases
Seattle's Adaptive Biotechnologies raises whopping $195 million venture fund
Article about Fred Hutch spinoff company Adaptive Biotechnologies
Adaptive Biotechnologies raises $195 million in venture funding
Article about funding milestone for Fred Hutch spinoff Adaptive Biotechnologies, which develops technology to map immune system response to cancer and other diseases
Can super foods reduce your risk of cancer?
Quotes Dr. Marian Neuhouser, an expert on nutrition and cancer prevention
Major breakthroughs in health research need continued NIH funding
Editorial cites the lifesaving research of Fred Hutch's Dr. E. Donnall Thomas, who received the Nobel Prize for his pioneering work in bone marrow transplantation
Can super foods reduce your risk of cancer?
Quotes Dr. Marian Neuhouser, an expert on nutrition and cancer prevention
Major breakthroughs in health research need continued NIH funding
Editorial cites the lifesaving research of Fred Hutch's Dr. E. Donnall Thomas, who received the Nobel Prize for his pioneering work in bone marrow transplantation
The mindful geek
Article about Fred Hutch's Dr. Jonathan Bricker, a smoking-cessation expert who is a finalist for GeekWire's "Geek of the Year Award"; online voting goes through the end of today
The mindful geek
Article about Fred Hutch's Dr. Jonathan Bricker, a smoking-cessation expert who is a finalist for GeekWire's "Geek of the Year Award"; online voting goes through the end of today
Microinjection platform tests multiple cancer drugs in tumors, predicts systemic response
Article about new drug-testing technology developed by Dr. Jim Olson and Fred Hutch spinoff Presage Biosciences
Microinjection platform tests multiple cancer drugs in tumors, predicts systemic response
Article about new drug-testing technology developed by Dr. Jim Olson and Fred Hutch spinoff Presage Biosciences
Microinjection platform tests multiple cancer drugs in tumors, predicts systemic response
Article about new drug-testing technology developed by Dr. Jim Olson and Fred Hutch spinoff Presage Biosciences
Microinjection platform tests multiple cancer drugs in tumors, predicts systemic response
Article about new drug-testing technology developed by Dr. Jim Olson and Fred Hutch spinoff Presage Biosciences
Too much alcohol increases the risk of liver cancer
Quotes Dr. Anne McTiernan about an expert panel she participated on that found a strong association between high alcohol intake and increased risk of liver cancer as well as a protective effect with regard to coffee consumption
Too much alcohol increases the risk of liver cancer
Quotes Dr. Anne McTiernan about an expert panel she participated on that found a strong association between high alcohol intake and increased risk of liver cancer as well as a protective effect with regard to coffee consumption
New technology tests tumors inside the patient to find best treatment
Article about a microinjection devices that test drugs within tumors, including one called "CIVO" that was invented by researchers at Fred Hutch and spinoff Presage Biosciences
AACR special: Serial killer cells on the side of the angels
Article covers immunotherapy presentations at the annual meeting of the American Association for Cancer Research, including one by Fred Hutch's Dr. Phil Greenberg, who spoke about his work with genetically engineered T cells that kill cancer
State's top-dog biomedical status is at risk
Editorial mentions that Juno Therapeutics' groundbreaking work in immunotherapy was built on work at Fred Hutch
New technology tests tumors inside the patient to find best treatment
Article about a microinjection devices that test drugs within tumors, including one called "CIVO" that was invented by researchers at Fred Hutch and spinoff Presage Biosciences
AACR special: Serial killer cells on the side of the angels
Article covers immunotherapy presentations at the annual meeting of the American Association for Cancer Research, including one by Fred Hutch's Dr. Phil Greenberg, who spoke about his work with genetically engineered T cells that kill cancer
State's top-dog biomedical status is at risk
Editorial mentions that Juno Therapeutics' groundbreaking work in immunotherapy was built on work at Fred Hutch
Obesity significantly increases prostate cancer risk in African-American men, study finds
Quotes Drs. Wendy Barrington and Alan Kristal about their research
Obesity significantly increases prostate cancer risk in African-American men, study finds
Quotes Drs. Wendy Barrington and Alan Kristal about their research
Baseball manager's lifesaving legacy
Article about the legacy of baseball great Fred Hutchinson mentions the lifesaving work being done at Fred Hutchinson Cancer Research Center in the U.S. and Uganda and also mentions the Hutch is celebrating its 40th anniversary this year
Baseball manager's lifesaving legacy
Article about the legacy of baseball great Fred Hutchinson mentions the lifesaving work being done at Fred Hutchinson Cancer Research Center in the U.S. and Uganda and also mentions the Hutch is celebrating its 40th anniversary this year
Making sense of scents: Why odors spark memory
Article and podcast mentions the olfactory research of Fred Hutch's Dr. Linda Buck, who received a Nobel for her work in 2004
Making sense of scents: Why odors spark memory
Article and podcast mentions the olfactory research of Fred Hutch's Dr. Linda Buck, who received a Nobel for her work in 2004
Obesity link to prostate cancer may vary by race
Quotes Dr. Wendy Barrington of Fred Hutch and the University of Washington School of Nursing about her research, published today in JAMA Oncology
Should I drink fat-free half and half?
Dr. Mario Kratz of the Fred Hutch Public Health Sciences Division is quoted in this article about fat-free versus full-fat dairy
Obesity link to prostate cancer may vary by race
Quotes Dr. Wendy Barrington of Fred Hutch and the University of Washington School of Nursing about her research, published today in JAMA Oncology
Should I drink fat-free half and half?
Dr. Mario Kratz of the Fred Hutch Public Health Sciences Division is quoted in this article about fat-free versus full-fat dairy
Oncologists weigh in on Ken Burns' cancer documentary
Dr. Nancy Davidson, former president of the American Society of Clinical Oncology, comments that Ken Burns' PBS cancer documentary "Cancer: The Emperor of All Maladies" could have linked bone-marrow transplant to Fred Hutch, where the procedure was developed to treat leukemia
Oncologists weigh in on Ken Burns' cancer documentary
Dr. Nancy Davidson, former president of the American Society of Clinical Oncology, comments that Ken Burns' PBS cancer documentary "Cancer: The Emperor of All Maladies" could have linked bone-marrow transplant to Fred Hutch, where the procedure was developed to treat leukemia
Girl with high-risk leukemia saved with stem cells from umbilical cord donation
Article about cord blood transplantation features Dr. Colleen Delaney and patient Jenna Gibson and her mother, Julie
Why just having 'good' communication skills is not enough for talking with seriously ill patients
A conversation with Dr. Anthony Back, a clinical researcher at Fred Hutch who practices at Seattle Cancer Care Alliance and co-directs the Cambia Palliative Care Center of Excellence at the University of Washington
Girl with high-risk leukemia saved with stem cells from umbilical cord donation
Article about cord blood transplantation features Dr. Colleen Delaney and patient Jenna Gibson and her mother, Julie
Why just having 'good' communication skills is not enough for talking with seriously ill patients
A conversation with Dr. Anthony Back, a clinical researcher at Fred Hutch who practices at Seattle Cancer Care Alliance and co-directs the Cambia Palliative Care Center of Excellence at the University of Washington
Doctors test tumor paint in people
Story about Tumor Paint, a molecule derived from scorpion venom developed by Fred Hutch's Dr. Jim Olson that lights up cancer so surgeons can better see, and remove, it
Doctors test tumor paint in people
Story about Tumor Paint, a molecule derived from scorpion venom developed by Fred Hutch's Dr. Jim Olson that lights up cancer so surgeons can better see, and remove, it
Cancer breakthroughs
Show explores the breakthroughs Fred Hutch scientists are making, and how Hutch physician-scientists are pioneering new treatments in immunotherapy and cord blood transplantation to fight some of the deadliest forms of cancer
Fighting cancer with vaccines
Interview with Fred Hutch's Dr. Corey Casper about our work in Uganda to study and treat infection-related cancers
Flipping the switch: Immunotherapy explained
An interview with Fred Hutch President and Director Dr. Gary Gilliland about how our researchers are harnessing the power of the immune system to fight cancer
How to travel by scent
Article about the sense of smell mentions the olfactory research of Fred Hutch's Dr. Linda Buck
Cancer breakthroughs
Show explores the breakthroughs Fred Hutch scientists are making, and how Hutch physician-scientists are pioneering new treatments in immunotherapy and cord blood transplantation to fight some of the deadliest forms of cancer
Fighting cancer with vaccines
Interview with Fred Hutch's Dr. Corey Casper about our work in Uganda to study and treat infection-related cancers
Flipping the switch: Immunotherapy explained
An interview with Fred Hutch President and Director Dr. Gary Gilliland about how our researchers are harnessing the power of the immune system to fight cancer
How to travel by scent
Article about the sense of smell mentions the olfactory research of Fred Hutch's Dr. Linda Buck
From many, one
Article about genetic chimerism -- when an individual carries two or more genetically distinct cell lines in different parts of their body -- quotes Fred Hutch's Dr. William Chan, who conducted a study that found male DNA in the brains of autopsied females
From many, one
Article about genetic chimerism -- when an individual carries two or more genetically distinct cell lines in different parts of their body -- quotes Fred Hutch's Dr. William Chan, who conducted a study that found male DNA in the brains of autopsied females
Seattle summit on global cancer seeks to bring treatment to developing world
Article about a symposium on global cancer issues held this week at Fred Hutch
Seattle summit on global cancer seeks to bring treatment to developing world
Article about a symposium on global cancer issues held this week at Fred Hutch
Fred Hutch lands $7.7M to improve cancer treatment
Coverage of award to the Hutchinson Institute for Health Outcomes Research to conduct a clinical trial to evaluate techniques that could improve cancer treatment
Fred Hutch lands $7.7M to improve cancer treatment
Coverage of award to the Hutchinson Institute for Health Outcomes Research to conduct a clinical trial to evaluate techniques that could improve cancer treatment
Fred Hutch president on immunotherapy treatments for cancer: 'We are on the threshold of a tsunami'
Coverage of a Rotary Club of Seattle presentation by Dr. Gary Gilliland, president and director of Fred Hutch
Fred Hutch president on immunotherapy treatments for cancer: 'We are on the threshold of a tsunami'
Coverage of a Rotary Club of Seattle presentation by Dr. Gary Gilliland, president and director of Fred Hutch
Fred Hutch president on immunotherapy treatments for cancer: 'We are on the threshold of a tsunami'
Coverage of a Rotary Club of Seattle presentation by Dr. Gary Gilliland, president and director of Fred Hutch
Fred Hutch president on immunotherapy treatments for cancer: 'We are on the threshold of a tsunami'
Coverage of a Rotary Club of Seattle presentation by Dr. Gary Gilliland, president and director of Fred Hutch
3 drinks a day may raise risk of liver cancer; coffee may lower it
Quotes cancer prevention researcher Dr. Anne McTiernan about an international panel she was part of that looked at risk factors for liver cancer
3 drinks a day may raise risk of liver cancer; coffee may lower it
Quotes cancer prevention researcher Dr. Anne McTiernan about an international panel she was part of that looked at risk factors for liver cancer
‘Angelina effect,’ again? Star’s candor boosts awareness, cancer experts say
Dr. M. Robyn Andersen is quoted about how many women with a BRCA mutation are aware of their increased risk for breast cancer but not their increased risk for ovarian cancer
‘Angelina effect,’ again? Star’s candor boosts awareness, cancer experts say
Dr. M. Robyn Andersen is quoted about how many women with a BRCA mutation are aware of their increased risk for breast cancer but not their increased risk for ovarian cancer
The strange science behind our sense of smell
Article about the sense of smell mentions the olfactory research of Nobel laureate Dr. Linda Buck of the Fred Hutch Basic Sciences Division
Cancer stories: Finding a match with cord blood
Segment about the cord blood research of Fred Hutch's Dr. Colleen Delaney featuring pediatric patient Ava Lee, 6
The strange science behind our sense of smell
Article about the sense of smell mentions the olfactory research of Nobel laureate Dr. Linda Buck of the Fred Hutch Basic Sciences Division
Cancer stories: Finding a match with cord blood
Segment about the cord blood research of Fred Hutch's Dr. Colleen Delaney featuring pediatric patient Ava Lee, 6
Certain painkillers may lower colon cancer risk for some
Article about new study by researchers at Fred Hutch and Massachusetts General Hospital published in JAMA
Certain painkillers may lower colon cancer risk for some
Article about new study by researchers at Fred Hutch and Massachusetts General Hospital published in JAMA
Cancer: The Emperor of All Maladies panel discussion
Coverage of Seattle Town Hall panel discussion with Fred Hutch's Drs. Fred Appelbaum and Philip Greenberg and "Emperor of All Maladies" cancer documentary director Barak Goodman in advance of its nationwide debut
Fred Hutchinson Cancer Research Center offers easy access to data with new 'Argos' tool
Fred Hutch unveils new database to help search for patterns that will help with cancer treatment
Fred Hutchinson Cancer Research Center offers easy access to data with new 'Argos' tool
Fred Hutch unveils new database to help search for patterns that will help with cancer treatment
Biosimilar drugs: FAQ
Coverage of a Rotary Club of Seattle presentation by Dr. Gary Gilliland, president and director of Fred Hutch
Biosimilar drugs: FAQ
Coverage of a Rotary Club of Seattle presentation by Dr. Gary Gilliland, president and director of Fred Hutch
U.S. clears first copycat biotech drug, jolting sector
Article quotes Dr. Gary Lyman, co-director of the Hutchinson Institute for Cancer Outcomes Research
Oral bisphosphonate use reduces risk of postmenopausal endometrial cancer
Article about a study led by Dr. Polly Newcomb
U.S. clears first copycat biotech drug, jolting sector
Article quotes Dr. Gary Lyman, co-director of the Hutchinson Institute for Cancer Outcomes Research
Oral bisphosphonate use reduces risk of postmenopausal endometrial cancer
Article about a study led by Dr. Polly Newcomb
Why full-fat dairy may be healthier than low-fat
Quotes Dr. Mario Kratz about a recent literature review he co-authored about the impact of full-fat versus low-fat dairy on heart health and diabetes
Artist Jennifer Zeyl thinks Seattle is the place to be of a tsunami'
Profile of Seattle set designer Jennifer Zeyl, who referenced how Intiman theater's collaboration with Fred Hutch on Tony Kushner's "Angels in America" production about HIV/AIDS was an example of good contemporary art that speaks to issues outside the art community
Why full-fat dairy may be healthier than low-fat
Quotes Dr. Mario Kratz about a recent literature review he co-authored about the impact of full-fat versus low-fat dairy on heart health and diabetes
Artist Jennifer Zeyl thinks Seattle is the place to be of a tsunami'
Profile of Seattle set designer Jennifer Zeyl, who referenced how Intiman theater's collaboration with Fred Hutch on Tony Kushner's "Angels in America" production about HIV/AIDS was an example of good contemporary art that speaks to issues outside the art community
2Morrow recruiting for second clinical trial of smoking cessation app program with employers
Article about quit-smoking smartphone app designed by Fred Hutch that is being tested in the workplace environment
2Morrow recruiting for second clinical trial of smoking cessation app program with employers
Article about quit-smoking smartphone app designed by Fred Hutch that is being tested in the workplace environment
Diet research built on a 'house of cards'?
Quotes Dr. Marian Neuhouser about using biomarkers to help correct for bias in self-reported nutrition data
Diet research built on a 'house of cards'?
Quotes Dr. Marian Neuhouser about using biomarkers to help correct for bias in self-reported nutrition data
Nutrition panel urges Americans to eat green
Quotes Dr. Marian Neuhouser, a Fred Hutch nutritional epidemiologist who participated in an expert panel that has updated recommendations for U.S. dietary guidelines
Nation's top nutrition panel: the American diet is killing us
Quotes Dr. Marian Neuhouser about the latest U.S. dietary recommendations that she helped draft
Nutrition panel urges Americans to eat green
Quotes Dr. Marian Neuhouser, a Fred Hutch nutritional epidemiologist who participated in an expert panel that has updated recommendations for U.S. dietary guidelines
Nation's top nutrition panel: the American diet is killing us
Quotes Dr. Marian Neuhouser about the latest U.S. dietary recommendations that she helped draft
Doctors strive to do less harm by inattentive care
Article about an effort to reduce patient suffering and inattentive care quotes Dr. Scott Ramsey, director of the Hutchinson Center for Cancer Outcomes Research
Doctors strive to do less harm by inattentive care
Article about an effort to reduce patient suffering and inattentive care quotes Dr. Scott Ramsey, director of the Hutchinson Center for Cancer Outcomes Research
Doctors strive to do less harm by inattentive care
Article about an effort to reduce patient suffering and inattentive care quotes Dr. Scott Ramsey, director of the Hutchinson Center for Cancer Outcomes Research
Doctors strive to do less harm by inattentive care
Article about an effort to reduce patient suffering and inattentive care quotes Dr. Scott Ramsey, director of the Hutchinson Center for Cancer Outcomes Research
Eat your fruits and veggies. That's a good way to help prevent cancer.
Quotes Dr. Marian Neuhouser
Seattle celebrates Blue Friday: Raising the 12th Man flag, downtown rally
Coverage of "Blue Friday" before the Seahawks versus Packers showdown includes a photo of a pep rally at Fred Hutch shot by Fred Hutch News Service photographer Bo Jungmayer
Looking for that fruit or vegetable that might prevent cancer?
Quotes nutritional epidemiologist Dr. Marian Neuhouser
Eat your fruits and veggies. That's a good way to help prevent cancer.
Quotes Dr. Marian Neuhouser
Seattle celebrates Blue Friday: Raising the 12th Man flag, downtown rally
Coverage of "Blue Friday" before the Seahawks versus Packers showdown includes a photo of a pep rally at Fred Hutch shot by Fred Hutch News Service photographer Bo Jungmayer
Looking for that fruit or vegetable that might prevent cancer?
Quotes nutritional epidemiologist Dr. Marian Neuhouser
A pediatric oncologist turns to creative ways to fund his research
Article about how Dr. Jim Olson is using social media to help fund his research
A pediatric oncologist turns to creative ways to fund his research
Article about how Dr. Jim Olson is using social media to help fund his research
Bad luck and cancer: A science reporter's reflections on a controversial story
Quotes Dr. Anne McTiernan
Bad luck and cancer: A science reporter's reflections on a controversial story
Quotes Dr. Anne McTiernan
The strange inevitability of evolution
Article about the complexity of evolution quotes Dr. Jesse Bloom of the Basic Sciences Division
The strange inevitability of evolution
Article about the complexity of evolution quotes Dr. Jesse Bloom of the Basic Sciences Division
Hutch honors Kansas City Royals Alex Gordon with its annual award
Columnist Nicole Brodeur covers this year's Hutch Award Luncheon
Hutch honors Kansas City Royals Alex Gordon with its annual award
Columnist Nicole Brodeur covers this year's Hutch Award Luncheon
Immunotherapy research is rebooting Seattle's biotech sector
Article about Seattle's growing immunotherapy sector features the research of Drs. David Maloney, Nora Disis and others
Immunotherapy research is rebooting Seattle's biotech sector
Article about Seattle's growing immunotherapy sector features the research of Drs. David Maloney, Nora Disis and others
Dana-Farber, Seattle hospital CEO take bets on Super Bowl
Article about friendly Super Bowl wager between Fred Hutch's president and director, Dr. Gary Gilliland, and Dana-Farber CEO Edward Benz Jr.
Dana-Farber, Seattle hospital CEO take bets on Super Bowl
Article about friendly Super Bowl wager between Fred Hutch's president and director, Dr. Gary Gilliland, and Dana-Farber CEO Edward Benz Jr.
Does rotten egg gas flow through the fountain of youth?
Article about the link between calorie restriction, endogenous hydrogen sulfide and longevity mentions the research of Dr. Mark Roth, who found that slightly elevated levels of hydrogen sulfide in the air can increase the lifespans of roundworms by 70 percent and can even put mice into a state of suspended animation
Does rotten egg gas flow through the fountain of youth?
Article about the link between calorie restriction, endogenous hydrogen sulfide and longevity mentions the research of Dr. Mark Roth, who found that slightly elevated levels of hydrogen sulfide in the air can increase the lifespans of roundworms by 70 percent and can even put mice into a state of suspended animation
ACT-SO winner has aspirations to be a Nobel Prize winner
Profile of Ericka Peagues, a senior at the TAF (Technology Access Foundation), who is interning at Fred Hutch, quotes her mentor, Dr. Beverly Torok-Storb
ACT-SO winner has aspirations to be a Nobel Prize winner
Profile of Ericka Peagues, a senior at the TAF (Technology Access Foundation), who is interning at Fred Hutch, quotes her mentor, Dr. Beverly Torok-Storb
The new year is the perfect time to quit smoking
Interview with Dr. Jonathan Bricker about ways to kick the smoking habit in the new year, including participating in his WebQuit.org online study (his segment starts about 16 minutes into the show and runs about 16 minutes)
The new year is the perfect time to quit smoking
Interview with Dr. Jonathan Bricker about ways to kick the smoking habit in the new year, including participating in his WebQuit.org online study (his segment starts about 16 minutes into the show and runs about 16 minutes)
Dorothy Thomas, the 'mother' of bone marrow transplants, dies at 92
Article about the passing of Dottie Thomas quotes Dr. Fred Appelbaum, executive vice president and deputy director of the Hutch
Dorothy Thomas, the 'mother' of bone marrow transplants, dies at 92
Article about the passing of Dottie Thomas quotes Dr. Fred Appelbaum, executive vice president and deputy director of the Hutch
Contact Our Media Relations Team
We are always available to help. Please include your deadline if your request is urgent.